{"messages": [{"role": "user", "content": "List of genes : <<< ADH1C,UGT2B15,UGT1A4,CYP2D6,UGT1A9,GSTK1,ADH6,GSTP1,UGT2B4,CYP2B6,MGST1,UGT1A1,GSTT2,GSTM4 >>>\nList of compounds : <<< alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde,Aflatoxin B1exo-8,9-epoxide-GSH,Chloral hydrate,9-Hydroxybenzo[a]pyrene,Aflatoxin B1-endo-8,9-epoxide,7,12-Dimethylbenz[a]anthracene,1,4-Naphthoquinone,Bromobenzene,Trichloroethanol glucuronide,(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene,Aflatoxin B1 diol,1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene,1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol,N-Hydroxy-1-aminonaphthalene >>>"}, {"role": "assistant", "content": "The analysis of the provided gene and compound lists suggests that the Metabolism of xenobiotics by cytochrome P450 pathway is significantly involved in the condition under investigation. This conclusion is supported by the presence of several key genes associated with this pathway, including CYP2D6, CYP2B6, UGT1A1, UGT1A4, UGT1A9, UGT2B15, and UGT2B4. These genes encode enzymes responsible for metabolizing various xenobiotics, which are foreign substances introduced into the body. The detected compounds, such as Aflatoxin B1exo-8,9-epoxide-GSH, Aflatoxin B1-endo-8,9-epoxide, and 1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene, are also known metabolites or products of cytochrome P450 enzymes, further corroborating the involvement of this pathway."}], "target": "Metabolism of xenobiotics by cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH3B1,GOT1,AOC3,GOT2,PAH,ALDH3B2,MAOA,MAOB,HPD,IL4I1,GOT1L1 >>>\nList of compounds : <<< 2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoA,N-Acetyl-L-phenylalanine,2-Hydroxyphenylacetate,Phenylacetylglutamine,Acetyl-CoA,(3S)-3-Hydroxyadipyl-CoA,Succinate,3-(2,3-Dihydroxyphenyl)propanoate,Phenylpyruvate,D-Phenylalanine,2-Hydroxy-3-phenylpropenoate,3-Oxoadipyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the provided data is Phenylalanine metabolism. This conclusion is supported by the alteration of several key genes and compounds associated with this pathway.\n\nGenes such as PAH (Phenylalanine Hydroxylase), GOT1 and GOT2 (Glutamic-Oxaloacetic Transaminase 1 and 2), and IL4I1 (Interleukin 4 Induced 1) are directly involved in the phenylalanine metabolism pathway. The presence of MAOA and MAOB (Monoamine Oxidase A and B) also suggests a role in phenylalanine metabolism as these enzymes are involved in the catabolism of phenylalanine derivatives.\n\nThe list of compounds further supports this conclusion. Compounds like D-Phenylalanine, N-Acetyl-L-phenylalanine, Phenylpyruvate, and Phenylacetylglutamine are direct intermediates in the phenylalanine metabolism pathway. The presence of 2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoA, 2-Hydroxyphenylacetate, 3-(2,3-Dihydroxyphenyl)propanoate, and 2-Hydroxy-3-phenylpropenoate, which are derivatives of phenylalanine, also point towards the involvement of the phenylalanine metabolism pathway."}], "target": "Phenylalanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GLUL,CAT,HYI,AGXT,ACAT2,HAO1,GRHPR,MCEE,ACSS2,ACAT1,SHMT2,PCCA,GLYCTK,SHMT1,MMUT,DLD,CS,GLDC,MDH2,MDH1,ACSS1,AFMID,HOGA1,HAO2 >>>\nList of compounds : <<< Glyoxylate,L-Glutamate,Isocitrate,(R)-Methylmalonyl-CoA,Pyruvate,2-Hydroxy-3-oxosuccinate,cis-Aconitate,(2S)-Methylsuccinyl-CoA,3-Phospho-D-glycerate,Mesaconate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Glyoxylate and dicarboxylate metabolism. This conclusion is based on the alterations in the genes and compounds associated with this pathway. The genes GLUL, CAT, AGXT, ACAT2, HAO1, GRHPR, MCEE, ACSS2, ACSS1, and DLD, along with the compounds Glyoxylate, L-Glutamate, Isocitrate, (R)-Methylmalonyl-CoA, 2-Hydroxy-3-oxosuccinate, cis-Aconitate, (2S)-Methylsuccinyl-CoA, and 3-Phospho-D-glycerate, are all directly or indirectly involved in this pathway. For instance, GLUL is involved in glutamate metabolism, ACAT2 and DLD in the citrate cycle, and HAO1 and GRHPR in glyoxylate metabolism. The presence of compounds like Glyoxylate and Isocitrate further supports this conclusion."}], "target": "Glyoxylate and dicarboxylate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP2C8,PLA2G6,PLA2G4D,PLA2G12B,PLA2G10,PLA2G2A,PLA2G5,PLB1,PLA2G3,PLA2G12A,CYP2J2,CYP3A4,PLA2G4C,PLA2G4F,ALOX15,PLA2G4A,PLA2G1B,PLA2G2C >>>\nList of compounds : <<< Linoleate,Phosphatidylcholine,Arachidonate,12,13-Epoxy-9-hydroxy-10-octadecenoate,9(10)-EpOME,(6Z,9Z,12Z)-Octadecatrienoic acid,9,12,13-TriHOME,9-OxoODE,12,13-DHOME,9(S)-HPODE,8(R)-HPODE,9,10-Dihydroxy-12,13-epoxyoctadecanoate,9,10,13-TriHOME,(9Z,11E)-12-[(1E)-Hex-1-en-1-yloxy]dodeca-9,11-dienoic acid,5S,8R-DiHODE,(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate,9,12,13-TriHOME,12(13)-EpOME,Crepenynate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Linoleic Acid Metabolism. This is supported by the alteration of numerous genes and compounds directly involved in this pathway. The genes CYP2C8, CYP2J2, and CYP3A4 code for enzymes that metabolize linoleic acid and related compounds. The PLA2G family of genes encode phospholipases, which release linoleic acid from phospholipids. The ALOX15 gene encodes an enzyme that oxygenates linoleic acid, leading to the production of various hydroxy and epoxy fatty acids, several of which were altered in this experiment, such as Linoleate, Arachidonate, 12,13-Epoxy-9-hydroxy-10-octadecenoate, and 9(10)-EpOME. Furthermore, the presence of compounds like 9,12,13-TriHOME, 9-OxoODE, and 12(13)-EpOME, which are downstream metabolites in the linoleic acid metabolism pathway, further supports this identification."}], "target": "Linoleic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AK9,DGUOK,ENTPD8,NT5C3B,ADSS2,NT5DC4,ADK,ADA2,DCTD,PNP,TYMS,AK3,AK2,ENPP3,TYMP,ASMTL,NUDT16,NT5C1B,DUT,NT5C,AK4,CMPK1,CTPS1,RRM1 >>>\nList of compounds : <<< Uridine,L-Glutamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is nucleotide metabolism. This conclusion is supported by the alteration of multiple genes involved in nucleotide biosynthesis, degradation, and salvage pathways. Genes such as AK9, DGUOK, ENTPD8, NT5C3B, ADSS2, NT5DC4, ADK, ADA2, DCTD, PNP, TYMS, AK3, AK2, ENPP3, TYMP, ASMTL, NUDT16, NT5C1B, DUT, NT5C, AK4, CMPK1, CTPS1, and RRM1 are all involved in nucleotide metabolism. Additionally, the altered compounds, Uridine and L-Glutamine, are also integral to nucleotide metabolism. Uridine is a pyrimidine nucleotide, and L-Glutamine is a crucial amino acid for nucleotide synthesis. Therefore, the alteration of these genes and compounds strongly suggests that nucleotide metabolism is a key pathway involved in the specific condition under investigation."}], "target": "Nucleotide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLCH1,CDIPT,PLCD1,PI4KB,ALDH6A1,ITPKA,PIP5K1A,IMPA1,INPP5K,INPP4A,IMPA2,PIP5K1C,INPP5F,ITPK1,PLCB1,PI4K2B,INPP5J,PLCE1 >>>\nList of compounds : <<< 1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate,D-Bornesitol,D-myo-Inositol 3,4-bisphosphate,Phytic acid,L-Bornesitol,2,4,6/3,5-Pentahydroxycyclohexanone,D-myo-Inositol 1,2,4,5,6-pentakisphosphate,Acetyl-CoA,1D-myo-Inositol 1,4,5,6-tetrakisphosphate,2-Deoxy-5-keto-D-gluconic acid 6-phosphate,Inositol 1,2,3,5,6-pentakisphosphate,1D-myo-Inositol 3-phosphate,2-Deoxy-5-keto-D-gluconic acid,5-Dehydro-L-gluconate,1-Keto-D-chiro-inositol,5-Deoxy-D-glucuronate,D-Glucuronate,D-Tagaturonate,1D-chiro-Inositol,D-Glyceraldehyde 3-phosphate,1-Phosphatidyl-1D-myo-inositol 3-phosphate,D-Glucose 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Inositol phosphate metabolism. This conclusion is supported by the alterations observed in multiple genes and compounds associated with this pathway. The genes PLCH1, CDIPT, PLCD1, PI4KB, ALDH6A1, ITPKA, PIP5K1A, IMPA1, INPP5K, INPP4A, IMPA2, PIP5K1C, INPP5F, ITPK1, PLCB1, PI4K2B, INPP5J, and PLCE1 are all involved in the synthesis, dephosphorylation, and signaling of inositol phosphates. Similarly, the compounds 1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate, D-Bornesitol, D-myo-Inositol 3,4-bisphosphate, Phytic acid, L-Bornesitol, 2,4,6/3,5-Pentahydroxycyclohexanone, D-myo-Inositol 1,2,4,5,6-pentakisphosphate, Acetyl-CoA, 1D-myo-Inositol 1,4,5,6-tetrakisphosphate, 2-Deoxy-5-keto-D-gluconic acid 6-phosphate, Inositol 1,2,3,5,6-pentakisphosphate, 1D-myo-Inositol 3-phosphate, 2-Deoxy-5-keto-D-gluconic acid, 5-Dehydro-L-gluconate, 1-Keto-D-chiro-inositol, 5-Deoxy-D-glucuronate, D-Glucuronate, D-Tagaturonate, 1D-chiro-Inositol, D-Glyceraldehyde 3-phosphate, 1-Phosphatidyl-1D-myo-inositol 3-phosphate, and D-Glucose 6-phosphate are all intermediates or products of the Inositol phosphate metabolism pathway. Therefore, it is reasonable to conclude that the Inositol phosphate metabolism pathway is involved in the specific condition being studied."}], "target": "Inositol phosphate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ASL,PFKL,TKTL1,PGAM1,ARG1,PKM,PGAM2,PFKM,ALDOA,RPIA,PSAT1,ARG2,MAT2A,PKLR,ENO2,PYCR1,ASNS,BCAT2,MTR,ABHD14A-ACY1,RPE,GPT,PGK2,ENO4,ASS1 >>>\nList of compounds : <<< 2-Oxoadipate,L-Glutamate 5-semialdehyde,D-Fructose 6-phosphate,L-Arginine,2-Oxoglutarate,L-Asparagine,5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide,D-Fructose 1,6-bisphosphate,2-Oxobutanoate,N-Acetyl-L-glutamate,5-O-(1-Carboxyvinyl)-3-phosphoshikimate,Citrate,O-Succinyl-L-homoserine,Chorismate,N-Succinyl-2-L-amino-6-oxoheptanedioate,alpha-Isopropylmalate,Phosphoribosyl-AMP,(R)-2-Methylmalate,(2R,3S)-3-Isopropylmalate,L-Isoleucine,3-Phospho-D-glyceroyl phosphate,L-Aspartate,L-Serine,L-Histidine,O-Acetyl-L-serine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes and compounds is the biosynthesis of amino acids. This is supported by the presence of several genes involved in amino acid metabolism, such as ARG1, ARG2, ASS1, and ASNS, which are associated with arginine and asparagine biosynthesis. The compound L-Arginine, a key intermediate in this pathway, was also found to be altered. Additionally, other genes like MAT2A, involved in the biosynthesis of S-adenosylmethionine, a universal methyl donor, and BCAT2, involved in branched-chain amino acid metabolism, further support this identification. The altered compounds such as L-Glutamate 5-semialdehyde, 5-O-(1-Carboxyvinyl)-3-phosphoshikimate, O-Succinyl-L-homoserine, Chorismate, and N-Succinyl-2-L-amino-6-oxoheptanedioate are also intermediates in amino acid biosynthesis, providing further evidence for this pathway's involvement."}], "target": "Biosynthesis of amino acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< RFK,ACP5,BLVRB >>>\nList of compounds : <<< Ribitol,Prenol,2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,Riboflavin,2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,2,5-Diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one,5-Amino-6-(5'-phosphoribosylamino)uracil,L-3,4-Dihydroxybutan-2-one 4-phosphate,D-Ribulose 5-phosphate,5-Amino-6-(1-D-ribitylamino)uracil,FMN,5-Amino-6-(5'-phospho-D-ribitylamino)uracil,Dimethylallyl phosphate,GTP,Reduced riboflavin,Lumichrome,Dimethylbenzimidazole,Reduced FMN >>>"}, {"role": "assistant", "content": "The analysis of the provided genes and compounds suggests that the Riboflavin metabolism pathway is significantly altered in the compared conditions. The presence of genes such as RFK (Riboflavin kinase), which is a key enzyme in the conversion of riboflavin to FMN (flavin mononucleotide), supports this conclusion. The altered compounds, including Riboflavin, FMN, and their reduced forms, as well as intermediates like 2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one, further substantiate the involvement of this pathway. Additionally, the presence of ACP5 (Acid Phosphatase 5), which can hydrolyze a variety of phosphate esters, and BLVRB (Biliverdin reductase B), which is involved in heme catabolism, could suggest potential crosstalk with other metabolic pathways. However, based on the provided information, the primary pathway affected appears to be Riboflavin metabolism."}], "target": "Riboflavin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< TAT,VKORC1L1,COQ3,COQ6,COQ2,GGCX,HPD,NQO1,COQ7,VKORC1,COQ5 >>>\nList of compounds : <<< 6-Amino-6-deoxyfutalosine,all-trans-Polyprenyl diphosphate,Dehypoxanthine futalosine,Geranyl diphosphate,Demethylmenaquinol,2-Methyl-6-phytylquinol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given experiment is the \"Ubiquinone and other terpenoid-quinone biosynthesis\" pathway. This identification is based on the alterations in several genes and compounds that are directly involved in this pathway.\n\nThe genes COQ2, COQ3, COQ5, COQ6, and COQ7 are all part of the ubiquinone biosynthesis pathway, which is responsible for the production of coenzyme Q10 (CoQ10), a vital component for electron transport in the mitochondria. The alterations in these genes could impact the production of CoQ10 and affect cellular energy production.\n\nThe presence of compounds such as all-trans-Polyprenyl diphosphate, Geranyl diphosphate, and Demethylmenaquinol also supports this identification. These are intermediates in the terpenoid-quinone biosynthesis pathway, further indicating that this pathway is affected in the given condition.\n\nThe alterations in other genes like TAT, VKORC1L1, GGCX, HPD, and NQO1, as well as the presence of compounds like 6-Amino-6-deoxyfutalosine, Dehypoxanthine futalosine, and 2-Methyl-6-phytylquinol, may be related to other metabolic pathways or could be secondary effects due to the disruption of the ubiquinone biosynthesis pathway."}], "target": "Ubiquinone and other terpenoid-quinone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDHA1,DHTKD1,GCSH,PDHA2,OGDH,ACSM1 >>>\nList of compounds : <<< Dihydrolipoylprotein,Dihydrolipoyl-AMP,CO2,5,10-Methylenetetrahydrofolate,Thiamin diphosphate,Octanoyl-[acp],[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine,Enzyme N6-(lipoyl)lysine,Ammonia >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Lipoic Acid Metabolism pathway. This is supported by the alteration of multiple genes directly involved in this pathway, including PDHA1, PDHA2, DHTKD1, and OGDH, which are components of the pyruvate dehydrogenase complex and the 2-oxoglutarate dehydrogenase complex, both of which require lipoic acid for their function. The alteration of GCSH, which is involved in the synthesis of glutathione, a compound that can interact with lipoic acid, also supports this finding. Furthermore, the presence of altered compounds such as Dihydrolipoylprotein, Dihydrolipoyl-AMP, and Enzyme N6-(lipoyl)lysine, which are direct products or intermediates of the lipoic acid metabolism pathway, further confirm this identification."}], "target": "Lipoic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DLAT,PGM1,LDHAL6A,PFKL,PGAM4,ALDH3B2,FBP2,ALDH3A1,ENO2,HK2 >>>\nList of compounds : <<< D-Glucose,Ethanol,2,3-Bisphospho-D-glycerate,Acetyl-CoA,Thiamin diphosphate,beta-D-Glucose 6-phosphate,D-Glyceraldehyde 3-phosphate,Enzyme N6-(dihydrolipoyl)lysine,(S)-Lactate,D-Fructose 6-phosphate,3-Phospho-D-glycerate,2-(alpha-Hydroxyethyl)thiamine diphosphate,alpha-D-Glucose,alpha-D-Glucose 6-phosphate,2-Phospho-D-glycerate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Arbutin,Acetate,D-Glucose 1-phosphate,D-Fructose 1,6-bisphosphate,beta-D-Glucose,Phosphoenolpyruvate,Salicin 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes and compounds is Glycolysis/Gluconeogenesis. This conclusion is supported by the presence of multiple genes directly involved in this pathway, such as PGM1, PFKL, PGAM4, ENO2, and HK2. The compounds D-Glucose, D-Fructose 6-phosphate, beta-D-Glucose 6-phosphate, D-Glyceraldehyde 3-phosphate, 3-Phospho-D-glycerate, 2-Phospho-D-glycerate, and Phosphoenolpyruvate are key intermediates in this pathway. Additionally, the presence of Acetyl-CoA and Acetate suggests involvement of pyruvate metabolism, which is closely linked to Glycolysis/Gluconeogenesis. The altered genes DLAT, LDHAL6A, ALDH3B2, ALDH3A1, and FBP2, while not directly in the pathway, are involved in related metabolic processes, further supporting the identification of Glycolysis/Gluconeogenesis as the affected pathway."}], "target": "Glycolysis / Gluconeogenesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ST3GAL5,ST8SIA5,ST3GAL1,ST6GALNAC6,HEXA,ST6GALNAC4 >>>\nList of compounds : <<< Lactosylceramide,GM2,GA1,GD1a,GQ1b,GM2alpha,GT1b,GD2,Fucosyl-GM1,9-O-Acetylated GD3,GT1aalpha,GD1b,GT1c,GM3,9-O-Acetylated GT3,N-Acetylgalactosaminyl GM1b,GD1a,GQ1balpha,GT2,GM1b >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosphingolipid biosynthesis - ganglio series. This pathway was suggested based on the alterations in multiple genes and compounds associated with it. The genes ST3GAL5, ST8SIA5, ST3GAL1, ST6GALNAC6, HEXA, and ST6GALNAC4 are all involved in the synthesis of gangliosides, complex glycosphingolipids found in the outer leaflet of the plasma membrane. The altered compounds, including Lactosylceramide, GM2, GA1, GD1a, GQ1b, GM2alpha, GT1b, GD2, Fucosyl-GM1, 9-O-Acetylated GD3, GT1aalpha, GD1b, GT1c, GM3, 9-O-Acetylated GT3, N-Acetylgalactosaminyl GM1b, GD1a, GQ1balpha, GT2, and GM1b, are all intermediates or end products of this pathway. Therefore, the alterations in these genes and compounds suggest that the Glycosphingolipid biosynthesis - ganglio series pathway is involved in the specific condition being studied."}], "target": "Glycosphingolipid biosynthesis - ganglio series"}
{"messages": [{"role": "user", "content": "List of genes : <<< MAOA,AGMAT,GATM,P4HA3,CKMT1A >>>\nList of compounds : <<< 1,3-Diaminopropane,4-(L-gamma-Glutamylamino)butanoate,Feruloyl-CoA,4-Aminobutyraldehyde,Feruloylputrescine,Glyoxylate,Agmatine,S-Adenosylmethioninamine,N2-Succinyl-L-ornithine,4-Guanidinobutanoate,L-Glutamate,N-Carbamoylputrescine,N-Succinyl-L-glutamate 5-semialdehyde,(4R)-4-Hydroxy-2-oxoglutarate,5-Guanidino-2-oxopentanoate,4-Guanidinobutanamide,N-Acetyl-L-glutamate 5-semialdehyde,Pyruvate,N-Methylhydantoin,L-Glutamyl 5-phosphate,S-Adenosyl-L-methionine,N1-[(S)-3-amino-3-carboxypropyl]agmatine,N2-Succinyl-L-arginine,trans-3-Hydroxy-L-proline >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Arginine and Proline Metabolism. This conclusion is supported by the alteration of several key genes and compounds involved in this pathway. The genes MAOA, AGMAT, and GATM are associated with the metabolism of amino acids, particularly arginine and proline. The presence of compounds such as Agmatine, N2-Succinyl-L-ornithine, L-Glutamate, and N2-Succinyl-L-arginine further corroborate this finding. These compounds are intermediates or products of the Arginine and Proline Metabolism pathway. Additionally, the presence of compounds like Feruloyl-CoA and Glyoxylate, which are involved in other metabolic pathways, suggest possible cross-talk or regulation between these pathways and Arginine and Proline Metabolism."}], "target": "Arginine and proline metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GCK,HK2,HKDC1 >>>\nList of compounds : <<< 2'-Deamino-2'-hydroxyneamine,2-Deoxy-scyllo-inosamine,Gentamicin C2b,6''-O-Carbamoylkanamycin A,UDP-kanosamine,6'-Oxokanamycin X,Kanamycin C,Lividamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Neomycin, kanamycin, and gentamicin biosynthesis\" pathway. This is supported by the alterations in several genes and compounds associated with this pathway. The genes GCK, HK2, and HKDC1 are involved in glycolysis, a pathway that provides precursors for amino sugar synthesis, which is a crucial step in the biosynthesis of these antibiotics. The presence of compounds such as 2-Deoxy-scyllo-inosamine, UDP-kanosamine, and Kanamycin C further supports this, as they are intermediates or end products of this pathway. The altered compounds 2'-Deamino-2'-hydroxyneamine, Gentamicin C2b, 6''-O-Carbamoylkanamycin A, 6'-Oxokanamycin X, and Lividamine are also derivatives or precursors in this biosynthetic pathway, suggesting a disruption or alteration in this metabolic process."}], "target": "Neomycin, kanamycin and gentamicin biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH6A1,ALDH3B1,ALDH3A2,AOC3,ALDH9A1,SMOX,ECHS1,CNDP1,ALDH3B2,ACOX3,ALDH1B1,ALDH3A1,DPYS,DPYD,HADHA,UPB1,CSAD,CARNS1,EHHADH >>>\nList of compounds : <<< beta-Alanyl-N(pi)-methyl-L-histidine,Uracil,beta-Alanine,3-Aminopropiononitrile,L-Aspartate,3-Hydroxypropanoate,5,6-Dihydrouracil,Pantothenate,Spermidine,Malonyl-CoA,Spermine,3-Oxopropanoate,beta-Nitropropanoate,N-Acetyl-beta-alanine,4-Aminobutanoate,Propenoyl-CoA,Acetyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the beta-Alanine metabolism pathway. This conclusion is supported by the significant alterations observed in multiple genes and compounds associated with this pathway. Genes such as ALDH3B1, ALDH3A2, ALDH3B2, and ALDH1B1, which are involved in the conversion of beta-Alanine to malonic semialdehyde, were found to be altered. Similarly, the compound beta-Alanine itself, along with its derivatives like N-Acetyl-beta-alanine and 3-Hydroxypropanoate, were also altered. The presence of compounds like 3-Aminopropiononitrile, a known inhibitor of beta-Alanine metabolism, further strengthens this conclusion. Therefore, the data strongly suggests that the beta-Alanine metabolism pathway is significantly involved in the observed conditions."}], "target": "beta-Alanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADH4,FH,GRHPR,ALDH9A1,ACYP1,ACOT12,PDHB,MDH2,ADH5,LDHAL6A,LDHA,GLO1,ADH1B,ACACB,DLAT,LDHC,ALDH2,ME1 >>>\nList of compounds : <<< Oxaloacetate,(R)-Lactate,2-(alpha-Hydroxyethyl)thiamine diphosphate,Phosphoenolpyruvate,2-Hydroxyethylenedicarboxylate,(S)-Lactaldehyde,(S)-Malate,Ethanol,Enzyme N6-(dihydrolipoyl)lysine,Malonyl-CoA,Fumarate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,2-Propylmalate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Pyruvate metabolism. This conclusion is supported by the alteration of several genes and compounds directly involved in this pathway. For instance, genes such as LDHA and LDHC, which encode lactate dehydrogenases responsible for converting pyruvate to lactate, are present. The presence of (R)-Lactate and (S)-Lactaldehyde, intermediates in this process, further supports this. Additionally, genes like PDHB and MDH2, involved in the conversion of pyruvate to acetyl-CoA and then to citrate in the TCA cycle, are altered. The presence of compounds such as Oxaloacetate, Malate, and Fumarate, intermediates in the TCA cycle, also aligns with this pathway. Furthermore, the alteration of genes like ADH4, ADH5, and ADH1B, which are involved in ethanol metabolism, a branch of pyruvate metabolism, and the presence of Ethanol, provide additional evidence. Therefore, the data strongly suggests that Pyruvate metabolism is the primary pathway affected in this condition."}], "target": "Pyruvate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CAD,DDO,GOT1,GLUD1,ALDH5A1,GLS2,ASPA,GPT,ADSL,IL4I1,GOT1L1,ASS1,RIMKLA,GFPT1,GAD2,GLUL,ASNS,PPAT >>>\nList of compounds : <<< 2-Oxoglutaramate,N-Acetyl-L-aspartate,L-Asparagine,Carbamoyl phosphate,Fumarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Alanine, Aspartate and Glutamate metabolism. This pathway was implicated due to the alterations in multiple genes and compounds involved in this metabolic process. For instance, the genes CAD, GOT1, GLUD1, GLS2, and GPT are directly involved in this pathway. The compound 2-Oxoglutaramate is a derivative of 2-Oxoglutarate, a key molecule in this pathway, while L-Asparagine and Carbamoyl phosphate are closely linked to aspartate and glutamate metabolism respectively. The alterations in these genes and compounds therefore suggest perturbations in this metabolic pathway."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT2,IL4I1,GOT1 >>>\nList of compounds : <<< 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate,N-(5-Phospho-D-ribosyl)anthranilate,1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,2-Benzylmalic acid,3-Hydroxybenzoate,5-O-(1-Carboxyvinyl)-3-phosphoshikimate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Phenylalanine, tyrosine and tryptophan biosynthesis pathway. This identification is supported by the altered genes and compounds observed. The GOT2 and GOT1 genes are involved in the conversion of aspartate to oxaloacetate, which is a precursor for the biosynthesis of these aromatic amino acids. The IL4I1 gene, on the other hand, is involved in the catabolism of tryptophan. The altered compounds, such as 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate, N-(5-Phospho-D-ribosyl)anthranilate, and 1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate, are intermediates in the phenylalanine, tyrosine, and tryptophan biosynthesis pathway. The presence of 2-Benzylmalic acid and 3-Hydroxybenzoate suggests that there may be disruptions in the metabolism of these amino acids. The 5-O-(1-Carboxyvinyl)-3-phosphoshikimate is a key intermediate in the shikimate pathway, which leads to the biosynthesis of aromatic amino acids. Therefore, the alterations in these genes and compounds strongly suggest that the phenylalanine, tyrosine, and tryptophan biosynthesis pathway is involved in the observed condition."}], "target": "Phenylalanine, tyrosine and tryptophan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< GALNT16,GALNT7,GCNT3,GALNT17,GALNTL6,ST3GAL1,GALNT12 >>>\nList of compounds : <<< T antigen,[Protein]-L-serine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Mucin type O-glycan biosynthesis, based on the altered genes and compounds observed. The genes GALNT16, GALNT7, GCNT3, GALNT17, GALNTL6, ST3GAL1, and GALNT12 are all involved in the synthesis of O-glycans, which are carbohydrate chains attached to proteins. The presence of the T antigen, a specific O-glycan structure, and [Protein]-L-serine, a substrate for O-glycan biosynthesis, further supports the involvement of this pathway. The alterations in these genes and compounds likely affect the production and structure of O-glycans, and may contribute to the specific condition being studied."}], "target": "Mucin type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ST6GALNAC3,HEXB,ST3GAL2,SLC33A1,HEXA,ST3GAL5 >>>\nList of compounds : <<< GP1c,GT3,GD1a,GD1b,9-O-Acetylated GD3,GQ1c,GM3,GM1,GD2 >>>"}, {"role": "assistant", "content": "In the experiment comparing the two conditions, the metabolic pathway identified was the Glycosphingolipid biosynthesis - ganglio series. This pathway was implicated due to the alterations observed in several key genes and compounds associated with this pathway.\n\nThe genes ST6GALNAC3, HEXB, ST3GAL2, SLC33A1, HEXA, and ST3GAL5 are all involved in the biosynthesis of gangliosides, complex glycosphingolipids found in the outer leaflet of the plasma membrane. These genes encode enzymes that catalyze specific steps in the biosynthesis of gangliosides, including the addition of sialic acid residues and the transport of substrates.\n\nThe compounds GP1c, GT3, GD1a, GD1b, 9-O-Acetylated GD3, GQ1c, GM3, GM1, and GD2 are all gangliosides that are produced in the ganglio series pathway. The alterations in these compounds suggest that the pathway is dysregulated in one or both of the conditions being compared.\n\nTherefore, the alterations in the genes and compounds associated with the ganglio series pathway suggest that this pathway is involved in the specific condition being studied."}], "target": "Glycosphingolipid biosynthesis - ganglio series"}
{"messages": [{"role": "user", "content": "List of genes : <<< PIGU,PIGF,GPAA1,PIGL,PIGN,MPPE1,PIGM >>>\nList of compounds : <<< 6-(alpha-D-glucosaminyl)-1D-myo-inositol,Ethanolamine phosphate,Phosphatidylethanolamine,UDP-N-acetyl-D-glucosamine,Dolichyl phosphate D-mannose,1-Phosphatidyl-D-myo-inositol,Phosphatidylethanolamine,Palmitoyl-CoA >>>"}, {"role": "assistant", "content": "The analysis of the given genes and compounds points towards the involvement of the Glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway in the specific condition under study. This pathway is crucial for the attachment of proteins to the cell membrane. The genes PIGU, PIGF, GPAA1, PIGL, PIGN, and PIGM are directly associated with the GPI-anchor biosynthesis. The altered compounds, including 6-(alpha-D-glucosaminyl)-1D-myo-inositol, Ethanolamine phosphate, Phosphatidylethanolamine, UDP-N-acetyl-D-glucosamine, Dolichyl phosphate D-mannose, 1-Phosphatidyl-D-myo-inositol, and Palmitoyl-CoA, are intermediates or products of this pathway. Therefore, the alteration in these genes and compounds strongly suggests the involvement of the GPI-anchor biosynthesis pathway in the observed condition."}], "target": "Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< GCK,HK3,HKDC1 >>>\nList of compounds : <<< 5-Ribosylparomamine,Gentamicin X2,3''-Oxogentamicin A2,2-Deoxy-scyllo-inosose,Antibiotic JI-20A,2-Deoxy-scyllo-inosamine,Antibiotic JI-20B,Gentamicin C1,Gentamicin A2,6'-Oxokanamycin X,Gentamicin C2,Gentamicin A,6''-O-Carbamoylkanamycin A,Paromamine,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyneomycin C,Ribostamycin,6'-Oxo-G418,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyparomomycin II,3''-Deamino-3''-hydroxykanamycin B,Butirosin A,Kanamycin X,2'-Deamino-2'-hydroxy-6'-dehydroparomamine >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the identified metabolic pathway is the Neomycin, kanamycin, and gentamicin biosynthesis pathway. This pathway is involved in the production of aminoglycoside antibiotics, including neomycin, kanamycin, and gentamicin.\n\nThe altered genes, GCK, HK3, and HKDC1, are involved in glucose metabolism and are not directly related to this pathway. However, the presence of multiple compounds involved in this pathway, such as Paromamine, Gentamicin A2, 6'-Oxokanamycin X, and 2'''-N-Acetyl-6'''-deamino-6'''-hydroxyneomycin C, suggests that this pathway is affected in the studied condition. The presence of these compounds, which are intermediates or derivatives of neomycin, kanamycin, and gentamicin, indicates that the biosynthesis of these antibiotics is altered in the condition being studied."}], "target": "Neomycin, kanamycin and gentamicin biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A4,UGT1A5,UGT1A7,UGT2B15,UGT2A3,UGT1A1,UGT2B11,ALDH7A1,AKR1A1,UGT1A9,UGT2B28,UGT1A6,UGT1A8,UGT2B17,MIOX,RGN,ALDH1B1,UGT2A1,ALDH2 >>>\nList of compounds : <<< L-Galactose,D-Galactarate,L-Galactonate,L-Ribulose 5-phosphate,1-Phospho-alpha-D-galacturonate,5-Dehydro-4-deoxy-D-glucarate,UDP-D-galacturonate,(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate,L-Lyxonate,beta-D-Glucuronoside,2-Dehydro-3-deoxy-L-arabinonate,L-Xylulose 5-phosphate,Ascorbate,D-Xylulose 5-phosphate,Threonate,3-Dehydro-L-gulonate 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is Ascorbate and aldarate metabolism. This pathway is characterized by the conversion of L-ascorbate, a form of vitamin C, into various aldaric acids. The altered genes, such as UGT1A4, UGT1A5, UGT1A7, UGT2B15, UGT2A3, UGT1A1, UGT2B11, ALDH7A1, AKR1A1, UGT1A9, UGT2B28, UGT1A6, UGT1A8, UGT2B17, MIOX, RGN, ALDH1B1, UGT2A1, and ALDH2, are all known to be involved in this pathway. They encode enzymes that catalyze various steps in the metabolism of ascorbate and related compounds. The altered compounds, such as L-Galactose, D-Galactarate, L-Galactonate, L-Ribulose 5-phosphate, 1-Phospho-alpha-D-galacturonate, 5-Dehydro-4-deoxy-D-glucarate, UDP-D-galacturonate, (4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate, L-Lyxonate, beta-D-Glucuronoside, 2-Dehydro-3-deoxy-L-arabinonate, L-Xylulose 5-phosphate, Ascorbate, D-Xylulose 5-phosphate, Threonate, and 3-Dehydro-L-gulonate 6-phosphate, are all intermediates or products of this pathway. Therefore, the identification of this pathway is consistent with the observed alterations in genes and compounds."}], "target": "Ascorbate and aldarate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B17,GSTA3,GSTM3,CYP3A5,GSTT4,ADH6,GSTT2,,ADH7,CYP1A2,GSTT1,ADH4,GSTP1,UGT1A7,ADH1C,GSTO2,CYP2C9,AOX1,CYP2B6,CYP2A6,UGT2B15,UGT1A8 >>>\nList of compounds : <<< Isophosphoramide mustard,Felbamate (USPINN),2,3-Dihydroxycarbamazepine,Citalopram N-oxide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is drug metabolism - cytochrome P450. This pathway involves the breakdown and elimination of drugs and other xenobiotics from the body. The involvement of this pathway is supported by the altered genes and compounds observed.\n\nMany of the genes listed, such as CYP3A5, CYP2C9, CYP2A6, and CYP2B6, are part of the cytochrome P450 superfamily, which are key enzymes in this pathway. The alterations in these genes could affect the efficiency of drug metabolism.\n\nThe compounds listed, including Isophosphoramide mustard, Felbamate (USPINN), 2,3-Dihydroxycarbamazepine, and Citalopram N-oxide, are known substrates for cytochrome P450 enzymes. The alterations in these compounds could indicate changes in their metabolism by these enzymes.\n\nTherefore, the changes in these genes and compounds suggest that the drug metabolism - cytochrome P450 pathway is involved in the observed condition."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< SRD5A2,CYP3A4,HSD17B8,HSD17B11,CYP1B1,HSD11B2,UGT2B4,HSD17B2,STS,CYP11A1,COMT,AKR1C3,LRTOMT >>>\nList of compounds : <<< 2-Methoxy-estradiol-17beta 3-glucuronide,Androstenedione,2-Methoxyestrone 3-sulfate,Estradiol-17beta 3-glucuronide,Estradiol-17alpha,21-Hydroxypregnenolone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Steroid Hormone Biosynthesis. This pathway was indicated due to the alterations in multiple genes and compounds directly involved in steroid hormone synthesis and metabolism.\n\nGenes such as SRD5A2, CYP3A4, HSD17B8, HSD17B11, CYP1B1, HSD11B2, UGT2B4, HSD17B2, STS, CYP11A1, COMT, and AKR1C3 are all implicated in steroid hormone biosynthesis, conversion, and degradation. For instance, SRD5A2 and HSD17B2 are involved in the conversion of testosterone to dihydrotestosterone and estradiol, respectively. CYP3A4 is responsible for the metabolism of various steroids, while CYP11A1 is the first and rate-limiting enzyme in steroidogenesis.\n\nThe identified compounds, including 2-Methoxy-estradiol-17beta 3-glucuronide, Androstenedione, 2-Methoxyestrone 3-sulfate, Estradiol-17beta 3-glucuronide, Estradiol-17alpha, and 21-Hydroxypregnenolone, are all intermediates or end products of the steroid hormone biosynthesis pathway. The presence and alterations of these compounds further support the involvement of the Steroid Hormone Biosynthesis pathway in the observed condition."}], "target": "Steroid hormone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PGP,PCCB,AGXT,ACSS1,MMUT,GLDC,HAO1,SHMT2,MDH2,HYI,AFMID,ACO2,CS,DLD,ACAT2,GLUL >>>\nList of compounds : <<< Butanoyl-CoA,Glycolate,(R)-3-Hydroxybutanoyl-CoA,Citrate,(2S)-Ethylmalonyl-CoA,Pyruvate,2-Hydroxy-3-oxosuccinate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Glyoxylate and dicarboxylate metabolism. This conclusion is supported by the alterations observed in several key genes and compounds associated with this pathway.\n\nThe genes PGP, PCCB, AGXT, GLDC, and SHMT2 are involved in various steps of glyoxylate metabolism. PGP and PCCB are involved in propionate metabolism, which is connected to the glyoxylate cycle. AGXT and GLDC participate in glycine, serine, and threonine metabolism, pathways that intersect with glyoxylate metabolism. SHMT2 is involved in one-carbon metabolism, which also interacts with glyoxylate metabolism.\n\nThe compounds Butanoyl-CoA, Glycolate, (R)-3-Hydroxybutanoyl-CoA, Citrate, (2S)-Ethylmalonyl-CoA, Pyruvate, and 2-Hydroxy-3-oxosuccinate are all intermediates or related compounds in the glyoxylate and dicarboxylate metabolism. For instance, Citrate and Pyruvate are key components of the citrate cycle, which is closely linked to the glyoxylate cycle.\n\nTherefore, the alterations in these genes and compounds suggest that the Glyoxylate and dicarboxylate metabolism pathway is significantly affected in the studied conditions."}], "target": "Glyoxylate and dicarboxylate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GALT,GFPT2,GMPPB,GFPT1,GALK1,NAGK >>>\nList of compounds : <<< UDP-4-dehydro-6-deoxy-D-glucose,UDP-2-acetamido-2,6-dideoxy-beta-L-mannose,2,4-Diacetamido-2,4,6-trideoxy-beta-L-gulose,UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate,N,N'-Diacetyllegionaminate,3,6-Dideoxy-3-oxo-dTDP-D-glucose,dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose,UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucose,N-Acetyl-D-glucosamine,UDP-kanosamine,UDP-4-keto-rhamnose,5-N-Acetyl-7-N-(D-alanyl)-legionaminic acid,L-Fucose 1-phosphate,UDP-L-arabinose,GDP-L-fucose,dTDP-3-amino-3,4,6-trideoxy-D-glucose,UDP-N-acetyl-D-galactosamine,UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose,Sedoheptulose 7-phosphate,GDP-6-deoxy-D-talose,dTDP-6-deoxy-D-allose,dTDP-4-oxo-5-C-methyl-L-rhamnose >>>"}, {"role": "assistant", "content": "The analysis of the provided gene and compound list indicates that the Biosynthesis of nucleotide sugars pathway is involved in the specific condition. This is supported by the alterations in genes such as GFPT1, GFPT2, and GALT, which are known to play crucial roles in the synthesis of nucleotide sugars. The presence of compounds like UDP-4-dehydro-6-deoxy-D-glucose, UDP-2-acetamido-2,6-dideoxy-beta-L-mannose, and UDP-N-acetyl-D-galactosamine, which are intermediates or final products in this pathway, further strengthens this conclusion. The alterations in these genes and compounds suggest a potential dysregulation in the Biosynthesis of nucleotide sugars pathway, which could be contributing to the observed condition."}], "target": "Biosynthesis of nucleotide sugars"}
{"messages": [{"role": "user", "content": "List of genes : <<< CHST15,CHST14,B3GALT6,CSGALNACT1,XYLT1,CHST7,CHST12,CHSY1,CHST11,CHST13,B3GAT3 >>>\nList of compounds : <<< Chondroitin,Adenosine 3',5'-bisphosphate,Adenosine 3',5'-bisphosphate,3'-Phosphoadenylyl sulfate,3'-Phosphoadenylyl sulfate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes and compounds is the Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate pathway. This identification is supported by the presence of several genes involved in this pathway, including CHST15, CHST14, B3GALT6, CSGALNACT1, XYLT1, CHST7, CHST12, CHSY1, CHST11, CHST13, and B3GAT3. These genes are known to encode enzymes that play crucial roles in the biosynthesis of chondroitin sulfate and dermatan sulfate. Furthermore, the altered compounds, including Chondroitin, Adenosine 3',5'-bisphosphate, and 3'-Phosphoadenylyl sulfate, are direct products or intermediates in this pathway, providing further evidence for its involvement in the observed condition."}], "target": "Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"}
{"messages": [{"role": "user", "content": "List of genes : <<< HK1,HK3,GCK >>>\nList of compounds : <<< Nebramine,3''-Oxogentamicin A2,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyneomycin C,Neamine,Antibiotic JI-20B,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyparomomycin II,Paromomycin II,Gentamicin C2,UDP-kanosamine,Neomycin C,L-Glutamate,2-Deoxy-scyllo-inosamine,Gentamicin C2b,Paromamine,Acyl-carrier protein,2'-Deamino-2'-hydroxyparomamine,6'''-Deamino-6'''-hydroxyneomycin C,Lividomycin B,Kanamycin B,6'''-Deamino-6'''-oxoparomomycin II >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Neomycin, Kanamycin, and Gentamicin biosynthesis pathway. This conclusion is supported by the alteration of several genes and compounds associated with this pathway. The genes HK1, HK3, and GCK are involved in the initial stages of this pathway, specifically in the production of glucose-6-phosphate, a key precursor for the biosynthesis of these antibiotics. The compounds Nebramine, Neamine, Antibiotic JI-20B, Paromomycin II, Neomycin C, and Gentamicin C2, among others, are intermediates or products of this pathway. The presence of these compounds, along with the alteration of the associated genes, strongly suggests that this pathway is indeed involved in the condition under study."}], "target": "Neomycin, kanamycin and gentamicin biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSS,RRM1,GPX7,SRM,NAT8,CHAC1,GSTA2,GGCT,GGT1,SMS,GPX4,LAP3,ODC1,MGST3,GSTT1,GSTT2 >>>\nList of compounds : <<< R-S-Cysteinylglycine,L-Amino acid,Trypanothione disulfide,Spermine,Glycine,Bis(glutathionyl)spermine disulfide,Putrescine,L-Ornithine,Aminopropylcadaverine,5-Oxoproline,L-Glutamate,Tryparedoxin,RX,Homotrypanothione disulfide,Spermidine,Glutathionylaminopropylcadaverine,L-Glutamate,Cys-Gly,Glutathionylspermidine,Bis-gamma-glutamylcystine,NADPH >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glutathione metabolism pathway. This conclusion is supported by the alterations in several key genes involved in this pathway, including GSS, GPX4, GPX7, GSTA2, GGCT, GGT1, GSTT1, and GSTT2. These genes are responsible for the synthesis, reduction, and recycling of glutathione, a critical antioxidant in the body.\n\nFurthermore, the altered compounds also align with this pathway. The presence of compounds such as R-S-Cysteinylglycine, Glycine, Bis(glutathionyl)spermine disulfide, and Glutathionylaminopropylcadaverine, which are intermediates or derivatives of glutathione, further supports the involvement of the Glutathione metabolism pathway. The presence of NADPH, a cofactor in the reduction of glutathione, also strengthens this conclusion. Overall, the data suggests that the Glutathione metabolism pathway plays a significant role in the condition being studied."}], "target": "Glutathione metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PFKFB4,PFKP,ALDOB,HK2,PFKM >>>\nList of compounds : <<< Mannan,GDP-mannose,D-Allose 6-phosphate,D-Fructose 6-phosphate,GDP-6-deoxy-D-mannose,Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,D-Allulose 6-phosphate,Sorbose 1-phosphate,D-Mannitol 1-phosphate,(S)-Lactate,(beta-D-Mannuronate)n,Glycerone phosphate,D-Fructose 1,6-bisphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Fructose and Mannose metabolism pathway. This conclusion is supported by the alterations observed in several key genes and compounds associated with this pathway. The genes PFKFB4, PFKP, ALDOB, HK2, and PFKM are all involved in various steps of glycolysis and fructose metabolism, with PFKFB4 and PFKP being involved in the conversion of fructose-6-phosphate to fructose-2,6-bisphosphate, ALDOB in the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate, HK2 in the phosphorylation of glucose to glucose-6-phosphate, and PFKM in the irreversible rate-limiting step of glycolysis, the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate. The altered compounds, such as D-Fructose 6-phosphate, D-Fructose 1,6-bisphosphate, Glycerone phosphate, and D-Mannitol 1-phosphate, are also intermediates in this pathway, further supporting the identification of the Fructose and Mannose metabolism pathway."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SDHA,SDHC,IDH3B,IDH1,MDH1,SUCLA2,SUCLG1,IDH3G,IDH2,ACLY,FH,ACO2,CS,IDH3A,MDH2,PDHB,PCK1,OGDH,DLST,PDHA2,DLD,SUCLG2,PDHA1 >>>\nList of compounds : <<< Enzyme N6-(dihydrolipoyl)lysine,Enzyme N6-(lipoyl)lysine,Succinate,Pyruvate,Succinyl-CoA,3-Carboxy-1-hydroxypropyl-ThPP,Thiamin diphosphate,2-Oxoglutarate,Enzyme N6-(dihydrolipoyl)lysine,Thiamin diphosphate,Fumarate,cis-Aconitate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Citrate cycle (TCA cycle). This conclusion is supported by the alteration of several key genes and compounds associated with this pathway. The genes SDHA, SDHC, SUCLA2, SUCLG1, SUCLG2, CS, OGDH, DLST, PDHA1, PDHA2, and PDHB are directly involved in the TCA cycle. The alteration of IDH1, IDH2, IDH3A, IDH3B, IDH3G, MDH1, and MDH2, which are involved in the conversion of isocitrate to alpha-ketoglutarate and further to succinyl-CoA, further supports this. The altered compounds, including Enzyme N6-(dihydrolipoyl)lysine, Enzyme N6-(lipoyl)lysine, Succinate, Pyruvate, Succinyl-CoA, 3-Carboxy-1-hydroxypropyl-ThPP, Thiamin diphosphate, 2-Oxoglutarate, Fumarate, and cis-Aconitate, are key intermediates or cofactors in the TCA cycle, providing further evidence for the involvement of this pathway in the condition under study."}], "target": "Citrate cycle (TCA cycle)"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACOX1,PLA2G12B,PLB1,ACAA1,PLA2G10,PLA2G4C,PLA2G5,PLA2G4B,FADS2,ACOX3,PLA2G2D,PLA2G1B,PLAAT2,PLA2G4D,PLAAT3,PLA2G2C,PLA2G2F,PLA2G2A,JMJD7-PLA2G4B >>>\nList of compounds : <<< (+)-7-Isomethyljasmonate,13(S)-HPOT,2(R)-HPOT,Stearidonic acid,(9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoic acid,OPC8-CoA,Volicitin,9(S)-HOT,17-Hydroxylinolenic acid,3-Oxo-OPC4-CoA,3-Oxo-OPC6-CoA,(+)-7-Isojasmonic acid CoA,Heptadecatrienal,Colnelenic acid,2(R)-HOT,9-Oxononanoic acid,9-Hydroxy-12-oxo-10(E),15(Z)-octadecadienoic acid,Norlinolenic acid,OPC6-CoA,3-Hexenol,3-Oxo-OPC8-CoA,trans-2-Enoyl-OPC4-CoA,(9Z,12Z,15Z)-Octadecatrienoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the provided list of genes and compounds is the alpha-Linolenic acid metabolism. This conclusion is supported by the presence of multiple genes involved in fatty acid metabolism, such as ACOX1, ACAA1, ACOX3, and FADS2. These genes are known to play significant roles in the oxidation and desaturation of fatty acids, which are crucial steps in the alpha-Linolenic acid metabolism.\n\nFurthermore, the compounds listed, including Stearidonic acid, 13(S)-HPOT, 2(R)-HPOT, and various oxidized and epoxidized derivatives of octadecenoic and octadecadienoic acids, are intermediates or products of the alpha-Linolenic acid metabolism. Additionally, the presence of compounds like Volicitin and (+)-7-Isomethyljasmonate, which are derived from alpha-Linolenic acid and play roles in plant defense and signaling, further supports the involvement of this pathway."}], "target": "alpha-Linolenic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< FMO1,GGT6,CSAD,BAAT,CDO1,GGT7,ADO,GAD1,GGT1,FMO5,GADL1,FMO4,GGT5,FMO2,GAD2 >>>\nList of compounds : <<< 5-L-Glutamyl-taurine,Cysteamine,Sulfoacetyl-CoA,Sulfoacetate,Hypotaurine,N-Phosphotaurocyamine,L-Cysteate,Taurine,2-Hydroxyethanesulfonate,Sulfoacetaldehyde,Pyruvate,Taurocholate,Sulfite,L-Glutamate,Aminoacetaldehyde,Acetaldehyde,L-Cysteine,Acetate,Acetyl phosphate,Acetyl-CoA,2-Oxoglutarate,3-Sulfino-L-alanine,Taurocyamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Taurine and Hypotaurine Metabolism. This conclusion is primarily based on the list of altered genes and compounds. For instance, the genes FMO1, FMO2, FMO4, and FMO5 are part of the Flavin-containing monooxygenase family, which is known to play a role in the metabolism of Taurine. Similarly, the genes GGT1, GGT5, GGT6, and GGT7 are Glutamate-Glyoxylate Aminotransferases that are involved in Taurine metabolism.\n\nThe list of compounds also supports this conclusion. For example, Taurine, Hypotaurine, 5-L-Glutamyl-taurine, N-Phosphotaurocyamine, Taurocholate, and Taurocyamine are all directly involved in the Taurine and Hypotaurine Metabolism pathway. Additionally, L-Glutamate, L-Cysteine, and Acetyl-CoA, which are precursors or intermediates in this pathway, are also present in the list. This suggests that the Taurine and Hypotaurine Metabolism pathway is significantly affected in the experimental conditions."}], "target": "Taurine and hypotaurine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NOS2,GLS2,GLS >>>\nList of compounds : <<< L-Arginine,N-Acetyl-L-glutamate,L-Ornithine,Carbamoyl phosphate,CO2,N-Acetyl-L-glutamate 5-phosphate,N-Acetylornithine,LysW-L-ornithine,L-Aspartate,Fumarate,LysW-L-glutamyl 5-phosphate,N-(L-Arginino)succinate,Urea,N-Acetyl-L-citrulline,2-Oxoglutarate,N-Acetyl-L-glutamate 5-semialdehyde >>>"}, {"role": "assistant", "content": "The analysis of the altered genes and compounds suggests the involvement of the Arginine biosynthesis pathway. The presence of NOS2, GLS2, and GLS genes, which are known to be involved in this pathway, supports this conclusion. The genes NOS2 and GLS2 encode Nitric Oxide Synthase 2 and Glutaminase 2, respectively, both of which play crucial roles in arginine metabolism. The GLS gene encodes Glutaminase, an enzyme that converts glutamine to glutamate, a precursor for arginine synthesis.\n\nThe altered compounds further strengthen this hypothesis. The presence of L-Arginine, N-Acetyl-L-glutamate, L-Ornithine, Carbamoyl phosphate, CO2, N-Acetyl-L-glutamate 5-phosphate, N-Acetylornithine, LysW-L-ornithine, L-Aspartate, Fumarate, LysW-L-glutamyl 5-phosphate, N-(L-Arginino)succinate, Urea, N-Acetyl-L-citrulline, 2-Oxoglutarate, and N-Acetyl-L-glutamate 5-semialdehyde are all intermediates or products of the Arginine biosynthesis pathway. Therefore, it is likely that the observed changes in these genes and compounds are due to alterations in the Arginine biosynthesis pathway."}], "target": "Arginine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PTGDS,CYP2C19,PTGR3,GGT5,PLA2G5,PLA2G4D,CYP2C9,ALOX15B,ALOX15,PTGES2,LTC4S,CYP2C8,PTGR2,PLA2G1B,PTGIS,PLA2G4B,PLA2G6,HPGD,PTGR1,CYP2U1,LTA4H,GGT1,PLB1 >>>\nList of compounds : <<< Thromboxane A2,Arachidonate,11H-14,15-EETA,8(R)-HPETE >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Arachidonic Acid Metabolism pathway. This is supported by the alteration of several genes involved in this pathway, including PTGDS, CYP2C19, PTGR3, PLA2G5, PLA2G4D, CYP2C9, ALOX15B, ALOX15, PTGES2, LTC4S, CYP2C8, PTGR2, PLA2G1B, PTGIS, PLA2G4B, PLA2G6, HPGD, PTGR1, CYP2U1, LTA4H. These genes play crucial roles in the metabolism of arachidonic acid, which is a polyunsaturated fatty acid. The alteration of compounds such as Thromboxane A2, Arachidonate, 11H-14,15-EETA, and 8(R)-HPETE, which are intermediate products or end products in the Arachidonic Acid Metabolism pathway, further supports this identification."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACAT1,MAOB,ASMT,TDO2,DDC,DHTKD1,HADH,ALDH7A1,TPH2,CYP1A1,INMT,ACMSD,AOC1,KYNU,ALDH1B1,ACAT2,ALDH3A2,IL4I1,AOX1,IDO1 >>>\nList of compounds : <<< Indolylmethylthiohydroximate,L-Tryptophan,5-Hydroxyindoleacetaldehyde,2-Oxoindole-3-acetate,Indole,4-(2-Aminophenyl)-2,4-dioxobutanoate,S-(Indolylmethylthiohydroximoyl)-L-cysteine,2-Aminomuconate,5-(3'-Carboxy-3'-oxopropenyl)-4,6-dihydroxypicolinate,6-Hydroxykynurenate >>>"}, {"role": "assistant", "content": "The experiment identified the Tryptophan metabolism pathway as the one primarily affected. This is consistent with the alterations in genes and compounds observed. The genes ACAT1, MAOB, ASMT, TDO2, DDC, TPH2, and IDO1, which are directly involved in Tryptophan metabolism, were affected. The presence of compounds such as L-Tryptophan, Indole, 5-Hydroxyindoleacetaldehyde, 2-Oxoindole-3-acetate, and 6-Hydroxykynurenate, which are intermediates in this pathway, further supports this conclusion. The alteration of other genes and compounds likely indicates secondary effects or crosstalk with other metabolic pathways."}], "target": "Tryptophan metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH7A1,EHMT1,CAMKMT,PRDM7,EZH1,PRDM9,PLOD3,COLGALT1,ALDH9A1,DHTKD1,SMYD3,MECOM,SETDB1,NSD2,PRDM16,PLOD2,PHYKPL,KMT2A,KMT2B,DOT1L >>>\nList of compounds : <<< 5-Aminopentanoate,4-Trimethylammoniobutanoate,Acetoacetyl-CoA,Protein N6,N6,N6-trimethyl-L-lysine,2-Oxoglutarate,5-Acetamidopentanoate,L-Lysine,Protein lysine,Carnitine,(S)-5-Amino-3-oxohexanoic acid,Acetoacetate,Glutarate,L-Pipecolate,4-Trimethylammoniobutanal >>>"}, {"role": "assistant", "content": "The metabolic pathway that was identified based on the altered genes and compounds is the Lysine degradation pathway. This pathway was inferred due to the presence of several genes that are directly involved in lysine metabolism, such as ALDH7A1, ALDH9A1, and DHTKD1. Additionally, the presence of compounds like L-Lysine, Protein lysine, and 2-Oxoglutarate, which are key intermediates in this pathway, further supports this conclusion. The alteration of genes like EHMT1, SMYD3, SETDB1, and NSD2, which are involved in lysine methylation, also suggests a potential role for the Lysine degradation pathway in the observed condition."}], "target": "Lysine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP2J2,ALOX5,PLA2G3,TBXAS1,PTGR2,CYP2C8,PLA2G1B,HPGD,LTA4H,PTGS1,PTGR3,CYP4F2,PTGIS,CYP2U1,PLA2G2A >>>\nList of compounds : <<< Trioxilin B3,Arachidonate,Prostaglandin D2,Lipoxin A4,15-OxoETE,5,6-Epoxytetraene,Lipoxin B4,9(S)-HETE,Hepoxilin B3,5(S)-HPETE,8(S)-HETE,15H-11,12-EETA,Leukotriene D4 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the provided list of genes and compounds is the Arachidonic Acid Metabolism pathway. This pathway is closely linked to the alterations observed in the genes and compounds. The genes listed, such as CYP2J2, ALOX5, PLA2G3, TBXAS1, and PTGS1, are known enzymes involved in the metabolism of arachidonic acid. The presence of arachidonic acid and its metabolites, including Prostaglandin D2, Lipoxin A4, and Leukotriene D4, among others, further supports this identification. The alterations in these genes and compounds suggest an active role of the Arachidonic Acid Metabolism pathway in the observed condition."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< XDH,NAT2 >>>\nList of compounds : <<< N,N'-Dimethylurea,Theophylline,3,7-Dimethyluric acid,Glyoxylate,1,7-Dimethyluric acid,N-Methylurea,1-Methylxanthine,5-Acetylamino-6-amino-3-methyluracil,Xanthine,Theobromine >>>"}, {"role": "assistant", "content": "The analysis of the provided data points towards the Caffeine metabolism pathway being significantly altered. This is primarily due to the presence of XDH (Xanthine Dehydrogenase), a key enzyme in this pathway, and NAT2 (N-Acetyltransferase 2), which is involved in the metabolism of caffeine and its metabolites. The altered compounds, such as Theophylline, Xanthine, Theobromine, and various dimethyluric acids, are known intermediates or byproducts in the caffeine metabolism pathway. The presence of N,N'-Dimethylurea, N-Methylurea, and 1-Methylxanthine further supports this conclusion, as they are related to the metabolism of urea and xanthine, respectively, which are components of this pathway."}], "target": "Caffeine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDHA1,LDHC,ACAT2,ME1,LDHA,LDHAL6B,ADH7,ALDH3A2,ACACB,ALDH9A1,ALDH7A1,ALDH1B1,PC,PDHB >>>\nList of compounds : <<< 2-(alpha-Hydroxyethyl)thiamine diphosphate,Acetaldehyde,Thiamin diphosphate,(R)-2-Hydroxybutane-1,2,4-tricarboxylate,Ethanol,(S)-Lactate,Acetoacetyl-CoA,(R)-Lactate,2-Propylmalate,(R)-2-Ethylmalate,(S)-Malate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is Pyruvate metabolism. This conclusion is supported by the alterations in multiple genes directly involved in this pathway, such as PDHA1 and PDHB, which are subunits of the pyruvate dehydrogenase complex, a key enzyme in pyruvate metabolism.\n\nFurthermore, LDHA and LDHL6B, which are involved in lactate production, and ME1, which catalyzes the conversion of malate to pyruvate, also point towards pyruvate metabolism.\n\nThe presence of compounds such as (R)-2-Hydroxybutane-1,2,4-tricarboxylate, a metabolite in pyruvate metabolism, (S)-Lactate, and (R)-Lactate, further supports this conclusion. The involvement of Acetaldehyde and Ethanol suggests a link to alcohol metabolism, which is closely related to pyruvate metabolism. Overall, the evidence strongly indicates that the Pyruvate metabolism pathway is significantly altered in the given conditions."}], "target": "Pyruvate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SDS,BCAT2,SDSL >>>\nList of compounds : <<< L-Threonine,3-Methyl-2-oxobutanoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Valine, Leucine, and Isoleucine Biosynthesis pathway. This conclusion is supported by the alterations in the genes SDS (Serine Dehydratase), BCAT2 (Branched-Chain Aminotransferase 2), and SDSL (Serine Dehydratase-Like). These genes play crucial roles in the biosynthesis of these branched-chain amino acids. The increased levels of L-Threonine, a precursor in this pathway, and 3-Methyl-2-oxobutanoic acid, an intermediate in this pathway, further support this identification. The alterations in these genes and compounds suggest an increased activity or dysregulation in this pathway."}], "target": "Valine, leucine and isoleucine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< NDST4,EXTL1,EXT1,B4GALT7 >>>\nList of compounds : <<< Adenosine 3',5'-bisphosphate,3'-Phosphoadenylyl sulfate,[Protein]-L-serine,Acetate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Glycosaminoglycan biosynthesis - heparan sulfate/heparin pathway. This conclusion is based on the altered genes and compounds observed. The genes NDST4, EXTL1, EXT1, and B4GALT7 are all directly involved in the biosynthesis of heparan sulfate or heparin. NDST4 is a N-deacetylase/N-sulfotransferase that modifies heparan sulfate, EXTL1 and EXT1 are involved in the synthesis of heparan sulfate chains, and B4GALT7 is a galactosyltransferase that adds a galactose to the growing heparan sulfate chain. The alteration of these genes suggests a disruption in the normal function of this pathway. The identified compounds also support this conclusion. Adenosine 3',5'-bisphosphate and 3'-Phosphoadenylyl sulfate are involved in the biosynthesis of glycosaminoglycans, including heparan sulfate and heparin. [Protein]-L-serine is a precursor for the synthesis of glycosaminoglycans, and Acetate is a metabolite involved in energy production, which could impact the energy-intensive process of glycosaminoglycan biosynthesis. Therefore, the data suggest that the Glycosaminoglycan biosynthesis - heparan sulfate/heparin pathway is significantly affected in the experiment."}], "target": "Glycosaminoglycan biosynthesis - heparan sulfate / heparin"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSTM1,GCLM,G6PD,GPX7,GSTO1,GPX8,OPLAH,HPGDS,RRM2,RRM2B,GSTA5,GPX1,GPX4,GSTO2,PGD,GSS,IDH2,GSTA3,GSTT4,GGT5,NAT8,LANCL1,MGST1,CHAC1,PRDX6 >>>\nList of compounds : <<< Dehydroascorbate,Glutathione disulfide,S-Substituted L-cysteine,R-S-Cysteinylglycine,L-Amino acid,Trypanothione,Glutathionylspermine,Glutathionylaminopropylcadaverine,NADP+,NADPH,L-Glutamate,Cadaverine,Glutathionylspermidine,Homotrypanothione disulfide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glutathione metabolism. This conclusion is supported by the alteration of multiple genes directly involved in this pathway, such as GSTM1, GCLM, G6PD, GPX7, GSTO1, GPX8, GSTA5, GPX1, GPX4, GSTO2, GSS, and GSTA3. These genes encode enzymes responsible for the synthesis, reduction, and recycling of glutathione, a key antioxidant in the cell.\n\nFurthermore, the list of altered compounds includes Glutathione disulfide, S-Substituted L-cysteine, R-S-Cysteinylglycine, NADP+, and NADPH, which are all intermediate metabolites in the Glutathione metabolism pathway. The presence of other compounds like Dehydroascorbate, L-Glutamate, and Cadaverine, which interact with glutathione or its synthesis, also supports this conclusion. Therefore, the evidence strongly suggests that the Glutathione metabolism pathway is significantly affected in this specific condition."}], "target": "Glutathione metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GADL1,GGT7,FMO1,ADO,GGT1,BAAT >>>\nList of compounds : <<< 3-Sulfino-L-alanine,L-Cysteate,Sulfoacetyl-CoA,2-Oxoglutarate,Taurocyamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Taurine and hypotaurine metabolism. This conclusion is supported by the alterations observed in the genes and compounds. Specifically, GGT7, GGT1, and BAAT are involved in the metabolism of taurine and its derivatives. The presence of compounds such as 3-Sulfino-L-alanine, L-Cysteate, and Sulfoacetyl-CoA, which are intermediates in this pathway, further confirms the involvement of this pathway. The presence of FMO1 and ADO, which are not directly involved in taurine metabolism, might suggest crosstalk with other pathways. However, their role in this specific condition remains to be elucidated."}], "target": "Taurine and hypotaurine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B4,HMOX1,ALAD,COX10,FECH,UGT2B7,UGT2B17,BLVRB,HCCS,UGT2A2,UGT2B15,PPOX,UGT2B28,CPOX,UGT2A3,UGT1A7,HMOX2 >>>\nList of compounds : <<< Bacteriochlorophyllide c,Nickel-sirohydrochlorin,Hemoglobin,Uroporphyrin I,12-Ethyl-8-propylbacteriochlorophyllide d,Chlorophyll b,Protochlorophyllide,8-Ethyl-12-methyl-3-vinylbacteriochlorophyllide d,Zn-Bacteriochlorophyll a,4,5-Dioxopentanoate,Cobalt-precorrin 6,Precorrin 6X,(3Z)-Phycocyanobilin,Transferrin[Fe(II)]2,Precorrin 3A >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Porphyrin metabolism. This conclusion is supported by the alterations in multiple genes and compounds directly involved in this pathway. The genes such as UGT2B4, HMOX1, ALAD, COX10, FECH, PPOX, and CPOX are key enzymes in the porphyrin metabolism pathway. The altered compounds, including Bacteriochlorophyllide c, Nickel-sirohydrochlorin, Hemoglobin, Uroporphyrin I, and Protochlorophyllide, are intermediates or products of this pathway. Furthermore, the presence of compounds like Precorrin 6X and Precorrin 3A, which are early intermediates in the porphyrin biosynthesis pathway, further supports the involvement of this pathway in the observed condition."}], "target": "Porphyrin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT2,GOT1 >>>\nList of compounds : <<< 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate,Phenylpyruvate,Indoleglycerol phosphate,3-Hydroxybenzoate,2-Oxo-4-phenylbutyric acid,L-Homophenylalanine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Phenylalanine, Tyrosine, and Tryptophan biosynthesis pathway. This conclusion is supported by the alterations in the genes GOT1 and GOT2, both of which are involved in the conversion of aspartate to oxaloacetate, a key step in the biosynthesis of these amino acids. Furthermore, the presence of compounds such as Phenylpyruvate, L-Homophenylalanine, and Indoleglycerol phosphate, which are intermediates in this pathway, strengthens this conclusion. The other altered compounds, while not directly part of this pathway, could be byproducts or intermediates in related pathways, further indicating a disruption in amino acid metabolism."}], "target": "Phenylalanine, tyrosine and tryptophan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< AMY1A,G6PC2,SI,GYG2,GBA3,MGAM,AGL,HKDC1, >>>\nList of compounds : <<< D-Glucose 1-phosphate,Levanbiose,Dextrin,3-Ketosucrose,alpha,alpha-Trehalose,alpha-D-Glucose 1,6-bisphosphate,Sucrose 6'-phosphate,Amylose,alpha-Maltose 1-phosphate,Starch,Dextran,D-Glucose 6-phosphate,D-Glucose 6-phosphate,D-Glucose,Dextran >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Starch and Sucrose Metabolism pathway. This conclusion is based on the alteration of key genes and compounds involved in this pathway. The genes AMY1A, MGAM, and AGL are associated with starch breakdown, while G6PC2 and HKDC1 are involved in glucose metabolism. The compounds identified, such as D-Glucose 1-phosphate, Dextrin, Amylose, Starch, and D-Glucose 6-phosphate, are intermediates or products of this pathway. The presence of Sucrose 6'-phosphate and alpha-Maltose 1-phosphate further supports this conclusion, as they are involved in the conversion between sucrose and starch. The alteration of these genes and compounds suggests a significant role for the Starch and Sucrose Metabolism pathway in the observed condition."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HSD17B12,HSD17B4,ACAA1,ELOVL1,ELOVL4,SCP2,ELOVL3,FADS2,ACOT2,HACD2 >>>\nList of compounds : <<< gamma-Linolenoyl-CoA,(13Z,16Z)-Docosadienoyl-CoA,cis-Vaccenoyl-CoA,(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA,alpha-Linolenoyl-ACP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Biosynthesis of Unsaturated Fatty Acids. This is supported by the altered genes and compounds. The genes HSD17B12, HSD17B4, and HACD2 are involved in fatty acid synthesis and elongation. ELOVL1, ELOVL3, ELOVL4, and FADS2 are specifically involved in the elongation and desaturation of unsaturated fatty acids. ACOT2 is involved in the degradation of fatty acids, which could be a compensatory mechanism for the increased synthesis. The compounds listed, such as gamma-Linolenoyl-CoA, (13Z,16Z)-Docosadienoyl-CoA, cis-Vaccenoyl-CoA, (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA, and alpha-Linolenoyl-ACP, are intermediates or products of this pathway, further supporting the identification of this pathway."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACACB,ACSBG1,MCAT,OXSM,OLAH >>>\nList of compounds : <<< Acyl-carrier protein,Octanoic acid,(9Z)-Octadecenoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is fatty acid biosynthesis. This conclusion is supported by the alterations in several key genes and compounds associated with this pathway. The ACACB gene encodes acetyl-CoA carboxylase beta, an enzyme that plays a crucial role in fatty acid synthesis. ACSBG1, or acyl-CoA synthetase bubblegum family member 1, is involved in activating long-chain fatty acids. MCAT, or malonyl-CoA-acyl carrier protein transacylase, is responsible for the transfer of malonyl groups during fatty acid biosynthesis. OXSM, or 3-oxoacyl-[acyl-carrier-protein] synthase III, is a critical enzyme in the elongation of fatty acids. OLAH, or oleate 12-hydroxylase, is involved in the synthesis of (9Z)-Octadecenoic acid, a monounsaturated fatty acid. The presence of Acyl-carrier protein and Octanoic acid, a product of fatty acid biosynthesis, further supports this conclusion."}], "target": "Fatty acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< HK1,HK2,HKDC1,HK3 >>>\nList of compounds : <<< 6'-Oxolividamine,UDP-kanosamine,D-Glucose 6-phosphate,4-(gamma-L-Glutamylamino)-(2S)-2-hydroxybutanoyl-[acp],Gentamicin C2a,6'-Oxokanamycin X,6'-Oxogentamicin X2,6'-Oxo-G418,Neamine,6'''-Deamino-6'''-oxoparomomycin II,6''-O-Carbamoylkanamycin A,4'-Oxonebramine,6'''-Deamino-6'''-hydroxyneomycin C,Gentamicin A2,Gentamicin C2b,Paromomycin II,4'-Oxolividamine,Kanamycin D,L-Glutamate,Kanamycin X,Nebramine,Paromomycin,gamma-L-Glutamyl-[acp],Gentamicin C1 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Neomycin, Kanamycin, and Gentamicin biosynthesis pathway. This is supported by the alteration of multiple genes involved in this pathway, including HK1, HK2, HKDC1, and HK3, which are known to be involved in the initial steps of hexose metabolism, a crucial part of this biosynthesis pathway. The presence of compounds such as D-Glucose 6-phosphate, a key intermediate in hexose metabolism, further supports this conclusion. Additionally, the presence of various aminoglycoside antibiotics (6'-Oxolividamine, Gentamicin C2a, 6'-Oxokanamycin X, 6'-Oxogentamicin X2, 6'-Oxo-G418, Neamine, Paromomycin II, etc.) and their intermediates (6'''-Deamino-6'''-oxoparomomycin II, 6''-O-Carbamoylkanamycin A, 4'-Oxonebramine, 6'''-Deamino-6'''-hydroxyneomycin C, etc.) directly implicates this pathway. The presence of L-Glutamate and gamma-L-Glutamyl-[acp] also supports this, as they are involved in the aminoacylation steps of this pathway."}], "target": "Neomycin, kanamycin and gentamicin biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ENPP3,BLVRB,RFK,ACP1 >>>\nList of compounds : <<< Ribitol,5-Amino-6-(1-D-ribitylamino)uracil,5-Amino-6-(5'-phosphoribosylamino)uracil,Reduced FMN,Lumichrome >>>"}, {"role": "assistant", "content": "The experiment revealed alterations in the Riboflavin metabolism pathway, supported by changes in both genes and compounds associated with this pathway. The genes ENPP3, BLVRB, RFK, and ACP1 are involved in various steps of riboflavin metabolism. ENPP3 and ACP1 are associated with the hydrolysis of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), respectively. BLVRB is involved in the biosynthesis of riboflavin, while RFK participates in the salvage pathway of riboflavin by phosphorylating riboflavin to FMN.\n\nThe altered compounds also support this finding. Ribitol is a precursor in the riboflavin biosynthesis pathway, while 5-Amino-6-(1-D-ribitylamino)uracil and 5-Amino-6-(5'-phosphoribosylamino)uracil are intermediates in this pathway. The presence of Reduced FMN indicates changes in the oxidation state of FMN, which is a key component of Riboflavin metabolism. Lumichrome, a degradation product of riboflavin, further supports the involvement of the Riboflavin metabolism pathway in the observed condition."}], "target": "Riboflavin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GCDH,CPT2,ACADSB,ADH7 >>>\nList of compounds : <<< Acyl-carrier protein,(S)-3-Hydroxytetradecanoyl-CoA,CoA,L-Palmitoylcarnitine,3-Oxodecanoyl-CoA,Long-chain fatty acid,3-Oxopalmitoyl-CoA,Glutaryl-CoA,(S)-3-Hydroxyhexadecanoyl-CoA,cis,cis-3,6-Dodecadienoyl-CoA,CoA,trans-Dec-2-enoyl-CoA,2-trans-Dodecenoyl-CoA,Alkane,3-Oxooctanoyl-CoA,(S)-Hydroxyhexanoyl-CoA,Crotonoyl-CoA,Acetoacetyl-CoA,Palmitoyl-CoA,trans-Tetradec-2-enoyl-CoA,Reduced rubredoxin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the fatty acid degradation pathway. This conclusion is based on the alterations observed in the genes and compounds associated with this pathway. The genes GCDH, CPT2, ACADSB, and ADH7 play crucial roles in fatty acid degradation. GCDH is involved in the breakdown of glutaryl-CoA, a compound found in the list. CPT2 transports long-chain fatty acids into the mitochondria for beta-oxidation, while ACADSB participates in the beta-oxidation process itself. ADH7 is involved in the breakdown of various fatty acids. The compounds listed, such as long-chain fatty acids, acyl-carrier protein, and various CoA-bound intermediates, are all key components of the fatty acid degradation pathway, further supporting this conclusion."}], "target": "Fatty acid degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< BCAT1,COASY,UPB1,PPCS,PPCDC,DPYD,CSAD,VNN2,ENPP1,DPYS,PANK2,GADL1,ENPP3,VNN1,ALDH3A2,ALDH2 >>>\nList of compounds : <<< 2-Dehydropantoate,Spermine,(R)-4'-Phosphopantothenoyl-L-cysteine,3-Ureidopropionate,3-Methyl-2-oxobutanoic acid,Pantetheine,(R)-2,3-Dihydroxy-3-methylbutanoate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the provided data is Pantothenate and CoA biosynthesis. This pathway was inferred based on the altered genes and compounds. Several genes involved in this pathway, such as COASY, PPCS, and PPCDC, were found to be affected. COASY encodes a bifunctional enzyme involved in the synthesis of CoA, while PPCS and PPCDC are involved in the synthesis of pantothenate, a precursor to CoA. The altered compounds, including 2-Dehydropantoate, (R)-4'-Phosphopantothenoyl-L-cysteine, and Pantetheine, are intermediates in this pathway. The changes in these genes and compounds suggest that the Pantothenate and CoA biosynthesis pathway is significantly affected under the given conditions."}], "target": "Pantothenate and CoA biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< IL4I1,MAOA,DBH,HGD,TYR,ADH5,TYRP1,GSTZ1,ADH1B,MIF,DCT,FAHD1,GOT1,ALDH3B2,ADH1C,ALDH3B1,ADH1A,FAH,PNMT,ADH6,LRTOMT,AOC2,AOC3 >>>\nList of compounds : <<< 2-Hydroxy-5-carboxymethylmuconate semialdehyde,N-Methyltyramine,Cysteinyldopa,4-Hydroxyphenylacetate,3-(3,4-Dihydroxyphenyl)pyruvate,4-Hydroxyphenylacetylglutamic acid,Stizolobinate,L-Tyrosine,5-Carboxymethyl-2-hydroxymuconate,3-Hydroxyphenylacetate,3,4-Dihydroxyphenylacetate,Maleylpyruvate,4-Maleylacetoacetate,Tyramine,Homovanillate,3,4-Dihydroxyphenylacetaldehyde,Gentisate aldehyde,3,5-Diiodo-L-tyrosine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Tyrosine metabolism. This conclusion is based on the alterations observed in multiple genes and compounds associated with this pathway. The genes such as TYR, DCT, TYRP1, and MIF are directly involved in Tyrosine metabolism, while others like IL4I1, MAOA, DBH, and ADH5 are indirectly linked. The compounds, including L-Tyrosine, 4-Hydroxyphenylacetate, 3-(3,4-Dihydroxyphenyl)pyruvate, and Homovanillate, are direct intermediates or products of this pathway. The presence of metabolites like 2-Hydroxy-5-carboxymethylmuconate semialdehyde, Gentisate aldehyde, and 3,5-Diiodo-L-tyrosine further supports the involvement of Tyrosine metabolism in the observed condition."}], "target": "Tyrosine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AOX1,PHOSPHO2,PSAT1 >>>\nList of compounds : <<< 2-Amino-3-oxo-4-phosphonooxybutyrate,O-Phospho-4-hydroxy-L-threonine,Pyridoxamine,4-Pyridoxate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Vitamin B6 metabolism. This is supported by the alterations in several genes and compounds associated with this pathway. The gene AOX1, also known as aldehyde oxidase 1, is involved in the metabolism of pyridoxal, a form of Vitamin B6. The gene PHOSPHO2 encodes an enzyme that catalyzes the conversion of 2-amino-3-oxo-4-phosphonooxybutyrate, a compound involved in the biosynthesis of Vitamin B6. The gene PSAT1, or phosphoserine aminotransferase 1, is involved in the serine biosynthesis pathway, which is linked to Vitamin B6 metabolism. The compounds 2-Amino-3-oxo-4-phosphonooxybutyrate, O-Phospho-4-hydroxy-L-threonine, Pyridoxamine, and 4-Pyridoxate are all directly related to Vitamin B6 metabolism, further supporting the identification of this pathway."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< L3HYPDH,ALDH2 >>>\nList of compounds : <<< Octopine,L-Ornithine,4-Aminobutanoate,L-Glutamate,gamma-Glutamyl-gamma-aminobutyraldehyde,Putrescine,5-Guanidino-2-oxopentanoate,N2-Succinyl-L-ornithine,Urea,1,3-Diaminopropane >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Arginine and Proline metabolism. This is supported by the alteration of several key genes and compounds associated with this pathway. The genes L3HYPDH and ALDH2 play crucial roles in this pathway. L3HYPDH is involved in the conversion of gamma-Glutamyl-gamma-aminobutyraldehyde to Gamma-glutamyl-beta-aminobutyrate, while ALDH2 converts acetaldehyde to acetic acid, a process that indirectly affects the Arginine and Proline metabolism. The presence of compounds such as Octopine, L-Ornithine, 4-Aminobutanoate, L-Glutamate, Putrescine, 5-Guanidino-2-oxopentanoate, N2-Succinyl-L-ornithine, Urea, and 1,3-Diaminopropane further supports this identification, as these are all intermediates or products of this metabolic pathway."}], "target": "Arginine and proline metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< RPN1,ALG10B,OSTC,ALG14,MAN2A1,DPAGT1,MGAT3,DDOST,MGAT5B,B4GALT3,MAN2A2,ALG5,ALG12 >>>\nList of compounds : <<< Polyprenol,Dolichyl phosphate D-mannose,Dolichyl diphosphate,GDP-mannose,Dolichyl phosphate,N-Acetyl-D-glucosaminyldiphosphodolichol,N,N'-Chitobiosyldiphosphodolichol,DS 3,Dolichol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is N-Glycan biosynthesis. This conclusion is supported by the alterations observed in several genes and compounds associated with this pathway.\n\nThe genes RPN1, ALG10B, OSTC, ALG14, MAN2A1, DPAGT1, MGAT3, DDOST, MGAT5B, B4GALT3, MAN2A2, ALG5, and ALG12 are all involved in N-Glycan biosynthesis. These genes encode enzymes that catalyze various steps in the assembly of N-glycans, a type of carbohydrate attached to asparagine residues on proteins.\n\nThe compounds Polyprenol, Dolichyl phosphate D-mannose, Dolichyl diphosphate, GDP-mannose, Dolichyl phosphate, N-Acetyl-D-glucosaminyldiphosphodolichol, N,N'-Chitobiosyldiphosphodolichol, and Dolichol are intermediates or cofactors in N-Glycan biosynthesis. Their alteration further supports the involvement of this pathway in the observed condition.\n\nTherefore, based on the alterations in these genes and compounds, it can be concluded that the N-Glycan biosynthesis pathway is involved in the specific condition under investigation."}], "target": "N-Glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PRXL2B,CYP4F2,PTGES,ALOX12B,LTA4H,GPX4,PTGIS,PTGR3,PLA2G2A,LTC4S,JMJD7-PLA2G4B,PLAAT3,PLAAT2,ALOX15B,PLA2G2E,PTGS1,TBXAS1,CYP2E1,PTGS2,HPGD >>>\nList of compounds : <<< Thromboxane B2,19(S)-HETE,6-Keto-prostaglandin E1,8,9-DHET,Prostaglandin D2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Arachidonic Acid Metabolism pathway. This conclusion is supported by the alterations in several genes and compounds specifically associated with this pathway. The genes PRXL2B, CYP4F2, PTGES, ALOX12B, LTA4H, GPX4, PTGIS, PTGR3, PLA2G2A, LTC4S, JMJD7-PLA2G4B, PLAAT3, PLAAT2, ALOX15B, PLA2G2E, PTGS1, TBXAS1, CYP2E1, PTGS2, and HPGD are all known to play crucial roles in the metabolism of arachidonic acid. Similarly, the compounds Thromboxane B2, 19(S)-HETE, 6-Keto-prostaglandin E1, 8,9-DHET, and Prostaglandin D2 are all products of arachidonic acid metabolism. Therefore, the observed changes in these genes and compounds suggest that this pathway is significantly involved in the condition under study."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< VKORC1L1,COQ6,GGCX,COQ3,COQ7 >>>\nList of compounds : <<< Homogentisate,Geranylgeranyl diphosphate,Chorismate,2-Phytyl-1,4-naphthoquinone,6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol,4-Hydroxybenzoyl-CoA,2-Polyprenylphenol,Futalosine,delta-Tocopherol,beta-Tocotrienol,Deoxyshikonin,4-Hydroxybenzoate,3-Methoxy-4-hydroxy-5-polyprenylbenzoate,4-Hydroxy-3-polyprenylbenzoate,Spirodilactone,2-Polyprenyl-6-methoxyphenol,3-Demethylubiquinol,beta-Tocopherol,Menaquinone,3-[(1-Carboxyvinyl)oxy]benzoate,1,4-Dihydroxy-2-naphthoyl-CoA,alpha-Tocotrienol,Menaquinol,Phytyl diphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Ubiquinone and other terpenoid-quinone biosynthesis pathway. This is supported by the alterations in several genes directly involved in this pathway, including COQ3, COQ6, and COQ7, which are essential for the biosynthesis of Coenzyme Q (ubiquinone). The alterations in VKORC1L1 and GGCX, which are involved in vitamin K metabolism, also suggest a connection to this pathway as vitamin K is structurally related to ubiquinone. The changes in various compounds, such as Geranylgeranyl diphosphate, 2-Phytyl-1,4-naphthoquinone, and 3-Demethylubiquinol, further support this conclusion as they are intermediates or derivatives in the ubiquinone biosynthesis pathway."}], "target": "Ubiquinone and other terpenoid-quinone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A6,FMO4,UGT1A9,GSTK1,CYP3A5,MGST1,CYP2B6,ADH7,GSTM4,UGT2B17,CYP2E1,UGT1A3,GSTM1,CYP3A4,CYP2A6,CYP2A7,UGT2B10,AOX1,MGST3,CYP2D7,UGT2A1,GSTA4 >>>\nList of compounds : <<< 4-Ketoifosfamide,Morphine (BAN),p-Hydroxyfelbamate,4-Ketocyclophosphamide,L-alpha-Acetyl-N,N-dinormethadol,2-Amino-3-methylbenzoate,Codeine,Valproic acid (USP),2-n-Propyl-4-oxopentanoic acid,2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine,Alcophosphamide,Didemethylcitalopram,N-Desmethyltamoxifen,2-Phenyl-1,3-propanediol monocarbamate,2-Dechloroethylifosfamide,2-Hydroxyiminostilbene,4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one,Dechloroethylcyclophosphamide,Felbamate (USPINN),Citalopram aldehyde >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Drug Metabolism - Cytochrome P450. This is supported by the alterations in multiple genes and compounds associated with this pathway. The genes listed, such as CYP3A4, CYP2B6, CYP2E1, and others, are all members of the Cytochrome P450 superfamily, which are responsible for metabolizing a wide range of drugs and other xenobiotics. The compounds listed, including Morphine, Codeine, Valproic acid, and various drug metabolites, are known substrates of these Cytochrome P450 enzymes. Therefore, the observed alterations in these genes and compounds suggest that the Drug Metabolism - Cytochrome P450 pathway is significantly involved in the condition under study."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP1A2,NAT2,XDH,CYP2A6,CYP2A7 >>>\nList of compounds : <<< 7-Methyluric acid,3,7-Dimethyluric acid,3,6,8-Trimethylallantoin,1,7-Dimethylxanthine,Theophylline,N-Methylurea,1,3,7-Trimethyl-5-hydroxyisourate,Xanthine,5-Acetylamino-6-amino-3-methyluracil,N,N'-Dimethylurea,7-Methylxanthosine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Caffeine metabolism pathway. This conclusion is supported by the alterations in several genes and compounds associated with this pathway. The genes CYP1A2, CYP2A6, and CYP2A7 are known to encode for cytochrome P450 enzymes, which are involved in the metabolism of caffeine. The compounds 7-Methyluric acid, 3,7-Dimethyluric acid, 1,7-Dimethylxanthine, Theophylline, Xanthine, and 7-Methylxanthosine are intermediates or products of caffeine metabolism. Additionally, NAT2, which encodes for N-acetyltransferase 2, is involved in the metabolism of caffeine to its intermediate products. The compound N-Methylurea is a metabolite of caffeine, and its presence further supports the involvement of the caffeine metabolism pathway. The alterations in these genes and compounds suggest that there are changes in the caffeine metabolism pathway in the specific condition being studied."}], "target": "Caffeine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MBOAT2,LPIN2,PNLIPRP2,DGKB,TKFC,LIPG,ALDH3A2,AKR1A1 >>>\nList of compounds : <<< UDP-6-sulfoquinovose,D-Glucose 1-phosphate,2-Phospho-D-glycerate,Fatty acid,Acyl-CoA,3-Hydroxypropanal,Acyl phosphate,UDP-glucose,Glycerol,Acyl1-monogalactosyl-diacylglycerol,Glycerone,Lipoteichoic acid,1,2-Diacyl-3-beta-D-galactosyl-sn-glycerol,1-Acylglycerol,Acyl-[acyl-carrier protein],Diglucosyldiacylglycerol,3-Phospho-D-glycerate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycerolipid metabolism. This is supported by the alterations in several genes and compounds directly associated with this pathway. The genes MBOAT2, LPIN2, PNLIPRP2, DGKB, TKFC, and LIPG are all involved in the synthesis, degradation, or regulation of glycerolipids. The presence of compounds such as UDP-glucose, Acyl-CoA, Glycerol, Acyl1-monogalactosyl-diacylglycerol, and Diglucosyldiacylglycerol further strengthens this identification, as these are key intermediates in glycerolipid metabolism. Additionally, the alteration in AKR1A1, involved in the metabolism of aldehydes, may be linked to the presence of 3-Hydroxypropanal, a byproduct of glycerolipid metabolism. The changes in these genes and compounds strongly suggest that Glycerolipid metabolism is a central pathway affected in the given conditions."}], "target": "Glycerolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ,GAA,,HK1,GYS1,G6PC3,UGP2,G6PC1,PGM2L1,PYGB,AMY1C,GANC,PGM1,ENPP3,PYGM,GBA3,GPI,GYS2,PYGL >>>\nList of compounds : <<< D-Fructose 6-phosphate,beta-D-Glucoside,D-Fructose,alpha-Maltose 1-phosphate,3-Ketosucrose,D-Glucose,D-Glucose 6-phosphate,GDP-glucose,alpha,alpha-Trehalose,D-Glucose 6-phosphate,D-Glucose,Maltose 6'-phosphate,(2,1-beta-D-Fructosyl)n,D-Glucose 6-phosphate,Cellodextrin,1,3-beta-D-Glucan,Sucrose 6-phosphate,ADP-glucose,D-Glucose 6-phosphate,Starch,D-Fructose >>>"}, {"role": "assistant", "content": "Based on the list of altered genes and compounds, it is apparent that the metabolic pathway involved is Starch and Sucrose Metabolism. The presence of genes such as GAA (Lysosomal alpha-glucosidase), GYS1 (Glycogen synthase 1), G6PC3 (Glucose-6-phosphatase catalytic subunit 3), and PGM2L1 (Phosphoglucomutase-2-like 1) indicate the involvement of glycogen metabolism, which is a part of starch and sucrose metabolism.\n\nThe altered compounds such as D-Fructose 6-phosphate, D-Glucose 6-phosphate, GDP-glucose, ADP-glucose, Maltose 6'-phosphate, and Sucrose 6-phosphate are intermediates in this pathway. The presence of compounds like Starch, Sucrose, and D-Fructose further supports the involvement of Starch and Sucrose Metabolism.\n\nTherefore, the altered genes and compounds suggest that the Starch and Sucrose Metabolism pathway is significantly affected in the given conditions."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SULT2B1,CYP1A1,UGT1A1,UGT2B4,UGT1A9,HSD3B1,CYP2E1,UGT2B10,DHRS11,UGT2B28,SRD5A2,HSD11B1L,UGT2B7,HSD17B1 >>>\nList of compounds : <<< Allotetrahydrodeoxycorticosterone,2-Methoxy-17beta-estradiol,11beta,17alpha,21-Trihydroxypregnenolone,20alpha,22beta-Dihydroxycholesterol,17alpha,20alpha-Dihydroxypregn-4-en-3-one,Androstan-3alpha,17beta-diol,Pregnanolone,2-Hydroxyestradiol,22(R)-Hydroxycholesterol,2-Methoxyestrone,2-Methoxyestrone 3-glucuronide,19-Oxotestosterone,5alpha-Dihydrodeoxycorticosterone,11-Dehydrocorticosterone,17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione,Cholesterol sulfate,11beta,21-Dihydroxy-5beta-pregnane-3,20-dione >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes and compounds is the Steroid Hormone Biosynthesis pathway. This conclusion is supported by the presence of several key genes involved in this pathway such as SULT2B1, CYP1A1, UGT1A1, UGT2B4, UGT1A9, HSD3B1, CYP2E1, UGT2B10, DHRS11, UGT2B28, SRD5A2, HSD11B1L, UGT2B7, and HSD17B1. These genes encode enzymes that catalyze various steps in the biosynthesis of steroid hormones from cholesterol.\n\nFurthermore, the identified compounds such as Allotetrahydrodeoxycorticosterone, 2-Methoxy-17beta-estradiol, 11beta,17alpha,21-Trihydroxypregnenolone, 20alpha,22beta-Dihydroxycholesterol, and others, are intermediates or end products of the Steroid Hormone Biosynthesis pathway. The presence of these compounds provides additional evidence for the involvement of this pathway in the specific condition."}], "target": "Steroid hormone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSTA5,UGT2B7,UGT2B11,,ADH5,CYP3A4,UGT2A1,MAOB >>>\nList of compounds : <<< 5-Hydroxyvalproic acid,Aldoifosfamide,Carboxyphosphamide,Chloroacetaldehyde >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Drug metabolism - cytochrome P450. This conclusion is supported by the altered genes and compounds observed. The genes GSTA5, UGT2B7, UGT2B11, ADH5, CYP3A4, UGT2A1, and MAOB are all known to be involved in drug metabolism, specifically in Phase I and Phase II metabolic reactions. The compounds 5-Hydroxyvalproic acid, Aldoifosfamide, Carboxyphosphamide, and Chloroacetaldehyde are metabolites or substrates of these enzymes, further indicating involvement in this pathway. The presence of CYP3A4, a major P450 enzyme, strengthens the conclusion that the cytochrome P450 pathway is significantly altered in this condition."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADH1B,DLD,ADH4,PCK1,LDHAL6A,ME1,ACAT2,LDHA,PDHA2,ACACB,GRHPR,LDHB,ADH6,ADH1C,DLAT,PDHB,FH,ACACA,ACSS1,LDHAL6B,ME2,ACAT1 >>>\nList of compounds : <<< Methylglyoxal,Acetaldehyde,Phosphoenolpyruvate,Thiamin diphosphate,(R)-Lactate,(S)-Lactate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Acetate,Oxaloacetate,2-Propylmalate,Succinate,(S)-Lactaldehyde,Malonyl-CoA,(S)-Malate,(R)-2-Hydroxybutane-1,2,4-tricarboxylate,alpha-Isopropylmalate,Acetyl phosphate,2-(alpha-Hydroxyethyl)thiamine diphosphate,(R)-2-Ethylmalate,Enzyme N6-(dihydrolipoyl)lysine,Acetyl-CoA,Enzyme N6-(lipoyl)lysine,Acetyl adenylate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given experiment is Pyruvate metabolism. This is supported by the alterations in multiple genes associated with this pathway, including ADH1B, DLD, PCK1, LDHAL6A, PDHA2, LDHB, PDHB, and FH. These genes are known to play crucial roles in the conversion of pyruvate to acetyl-CoA, a key step in energy production. The changes in compounds like Methylglyoxal, Acetaldehyde, Phosphoenolpyruvate, (R)-Lactate, (S)-Lactate, Acetate, Oxaloacetate, and Acetyl-CoA further reinforce the involvement of Pyruvate metabolism in the observed condition. The presence of compounds like Thiamin diphosphate and 2-(alpha-Hydroxyethyl)thiamine diphosphate, cofactors involved in pyruvate metabolism, also lends credence to this conclusion."}], "target": "Pyruvate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HK3,HAO1,PDHA2,CS,CAT,IDH3B,IDH3G,TKTL1,HK2,PKLR,PDHB,ACOX1,CPS1,AGXT,PC >>>\nList of compounds : <<< D-Fructose 6-phosphate,D-Glucono-1,5-lactone,beta-D-Glucose 6-phosphate,L-erythro-3-Methylmalyl-CoA,(S)-Methylmalonyl-CoA,Methylamine,2-Dehydro-3-deoxy-D-gluconate,D-Glucono-1,5-lactone 6-phosphate,5,10-Methylenetetrahydrofolate,Isocitrate,Propenoyl-CoA,D-Ribulose 5-phosphate,2-Phospho-D-glycerate,Fumarate,2-Phosphoglycolate,5,10-Methylenetetrahydromethanopterin,5-Methyl-5,6,7,8-tetrahydromethanopterin,2-(Methylthio)ethanesulfonate,Tetrahydrofolate,D-Fructose 1,6-bisphosphate,Tetrahydrosarcinapterin,Hydrogen sulfide,Butanoyl-CoA,3-Hydroxypropionyl-CoA >>>"}, {"role": "assistant", "content": "The analysis of the altered genes and compounds in the experiment suggests that the Carbon metabolism pathway is significantly involved. This conclusion is based on the presence of genes such as HK3, HK2, PDHA2, PDHB, IDH3B, and IDH3G, which are all associated with glycolysis, the TCA cycle, and the oxidative phosphorylation, key processes in carbon metabolism. The compounds D-Fructose 6-phosphate, beta-D-Glucose 6-phosphate, Isocitrate, and Fumarate, among others, are also intermediates in these pathways, further supporting this conclusion. The alteration in these genes and compounds indicates a potential disruption or modification in the carbon metabolism pathway in the specific condition under study."}], "target": "Carbon metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< FAH,MIF,TH,ADH1C,ALDH3A1,HGD,DDC,ADH1B,HPD,ADH7,PNMT,COMT,GSTZ1,AOC2,ADH4,TAT,ADH5,LRTOMT >>>\nList of compounds : <<< 2-Hydroxy-3-(4-hydroxyphenyl)propenoate,Succinate semialdehyde,Pyruvate,4-Fumarylacetoacetate,Maleic acid,2,5-Dihydroxybenzoate,Dopamine,5-Carboxy-2-oxohept-3-enedioate,L-Metanephrine,3-Methoxy-4-hydroxymandelate,5-Carboxymethyl-2-hydroxymuconate,Phenol,3-(4-Hydroxyphenyl)pyruvate,4-Hydroxyphenylacetylglutamic acid,3,4-Dihydroxyphenylethyleneglycol,L-Normetanephrine,3-Methoxytyramine,4-Chlorophenylacetate,2,4-Dihydroxyhept-2-enedioate,Dopaquinone,3-Iodo-L-tyrosine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Tyrosine metabolism pathway. This is supported by the alterations in several genes associated with this pathway, including FAH (fumarylacetoacetate hydrolase), HGD (homogentisate 1,2-dioxygenase), HPD (4-hydroxyphenylpyruvate dioxygenase), and COMT (catechol-O-methyltransferase), among others. These genes play crucial roles in the degradation of tyrosine.\n\nFurthermore, the alteration in various compounds such as 2-Hydroxy-3-(4-hydroxyphenyl)propenoate, 4-Fumarylacetoacetate, Maleic acid, Dopamine, and L-Metanephrine, among others, also indicate the involvement of the Tyrosine metabolism pathway. These compounds are intermediates or end products in the tyrosine metabolism pathway. Therefore, the changes observed in these genes and compounds strongly suggest that the Tyrosine metabolism pathway is significantly affected under the given conditions."}], "target": "Tyrosine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SCD5,ELOVL5,ACOT7,ACOX3,SCD,HACD2,ACOT4,HACD3,ACOT2,ELOVL2,HACD1,ELOVL3,ELOVL7,ELOVL6,ACOT1,ACAA1,ACOX1,ELOVL4,HSD17B12,TECR,HACD4,SCP2,HSD17B4 >>>\nList of compounds : <<< Docosanoic acid,(13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA,Tetracosenoyl-CoA,(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA,Palmitoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Unsaturated Fatty Acids. This conclusion is supported by the alterations in multiple genes and compounds associated with this pathway. The genes include SCD5, ELOVL5, ACOT7, ACOX3, SCD, HACD2, ACOT4, HACD3, ACOT2, ELOVL2, HACD1, ELOVL3, ELOVL7, ELOVL6, ACOT1, ACAA1, ACOX1, ELOVL4, HSD17B12, TECR, HACD4, SCP2, and HSD17B4, which are all known to play crucial roles in the synthesis and regulation of unsaturated fatty acids. The compounds that were altered, such as Docosanoic acid, (13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA, Tetracosenoyl-CoA, (9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA, and Palmitoyl-CoA, are intermediates or products in this pathway. Therefore, the findings suggest a significant involvement of the Biosynthesis of Unsaturated Fatty Acids pathway in the specific condition under investigation."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< PCYT2,PCYT1A >>>\nList of compounds : <<< 3-Phosphinomethylmalate,Lipophosphonoglycan,L-Phosphinothricin,Formate,2-Phosphinomethylmalate,N-Trimethyl-2-aminoethylphosphonate,Ciliatocholate,2-Aminoethylphosphonate,FR 900098,N-Acetyldemethylphosphinothricin,Methylphosphonate,Rhizocticin B,Phosphonoacetate,N-Acetylbialaphos,2-Acetamidoethylphosphonate,Deamino-alpha-keto-demethylphosphinothricin,D-Ribose 5-phosphate,Phosphonoformyl-CMP,Pyruvate,Glycine,Phosphoenolpyruvate,Hydroxymethylphosphonate,Rhizocticin D,N-Monomethyl-2-aminoethylphosphonate,Phosphonoacetaldehyde >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Phosphonate and phosphinate metabolism. This conclusion is supported by the presence of numerous genes and compounds associated with this pathway. The PCYT2 and PCYT1A genes, which are involved in the synthesis of phosphatidylcholine, a key phospholipid, may be affected due to the alterations in this pathway. The presence of compounds such as 3-Phosphinomethylmalate, L-Phosphinothricin, N-Trimethyl-2-aminoethylphosphonate, and others, which are intermediates or products of this pathway, further strengthens this identification. The alteration in the levels of these compounds suggests disruptions or alterations in the normal functioning of the Phosphonate and phosphinate metabolism pathway."}], "target": "Phosphonate and phosphinate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< KL,AKR1A1,UGT1A7,ALDH3A2,UGT1A5,UGT2B11,MIOX,UGT2A3,UGT2B28,RGN,UGT1A10,UGDH,UGT2B15 >>>\nList of compounds : <<< Dehydro-D-arabinono-1,4-lactone,L-xylo-Hexulonolactone,2-Dehydro-3-deoxy-L-arabinonate,2,5-Dioxopentanoate,L-Arabinono-1,4-lactone,Pyruvate,beta-L-Galactose 1-phosphate,2-Dehydro-3-deoxy-D-glucarate,L-Xylonate,L-Gulose,L-Ascorbate 6-phosphate,UDP-D-galacturonate,5-Dehydro-4-deoxy-D-glucarate,L-Arabinose,UDP-glucose,Threonate,D-Xylulose 5-phosphate,L-Galactono-1,5-lactone,GDP-L-galactose,D-Galactaro-1,5-lactone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Ascorbate and aldarate metabolism pathway. This is supported by the alteration of several genes and compounds associated with this pathway. Genes such as AKR1A1, ALDH3A2, UGT1A5, UGT1A7, UGT2A3, UGT2B11, UGT2B15, UGT2B28, and UGDH are known to be involved in this pathway. The compounds L-Arabinono-1,4-lactone, 2-Dehydro-3-deoxy-L-arabinonate, L-Xylonate, L-Gulose, L-Ascorbate 6-phosphate, 5-Dehydro-4-deoxy-D-glucarate, L-Arabinose, D-Xylulose 5-phosphate, L-Galactono-1,5-lactone, and UDP-D-galacturonate are also components of this pathway. Therefore, the alteration of these genes and compounds suggests that the Ascorbate and aldarate metabolism pathway is involved in the specific condition studied."}], "target": "Ascorbate and aldarate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ENPP1,ACP5,RFK,FLAD1,BLVRB,ENPP3,ACP1 >>>\nList of compounds : <<< D-Ribulose 5-phosphate,2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,Riboflavin,L-3,4-Dihydroxybutan-2-one 4-phosphate,FADH2,Dimethylbenzimidazole,Prenol,5-Amino-6-(5'-phosphoribosylamino)uracil >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Riboflavin metabolism. This conclusion is supported by the alterations observed in several genes and compounds directly involved in this pathway. The genes ENPP1, ACP5, RFK, FLAD1, and ENPP3 are all associated with riboflavin metabolism. ENPP1 and ENPP3 are involved in the hydrolysis of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), respectively. RFK encodes riboflavin kinase, which is responsible for the phosphorylation of riboflavin to FMN. FLAD1 encodes flavin adenine dinucleotide synthase, an enzyme that catalyzes the final step in the biosynthesis of FAD. The altered compounds also support this conclusion. D-Ribulose 5-phosphate and 5-Amino-6-(5'-phosphoribosylamino)uracil are intermediates in the synthesis of riboflavin. FADH2, Riboflavin, and Dimethylbenzimidazole are all forms of riboflavin or its derivatives. L-3,4-Dihydroxybutan-2-one 4-phosphate and Prenol are not directly related to riboflavin metabolism, but their alteration could indirectly affect this pathway. The identification of BLVRB, which is not directly involved in riboflavin metabolism, suggests that this pathway may be affected by or affect other metabolic processes."}], "target": "Riboflavin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ASNS,PRPS2,MAT1A,GPT,ABHD14A-ACY1,IDH3A,TKTL2,GAPDH,PGK2,IDH1,,PHGDH,SHMT1,CPS1,PKM,RPE,PFKL,PSPH,TKTL1,PGK1,MAT2A >>>\nList of compounds : <<< 5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide,1-(5-Phospho-D-ribosyl)-ATP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Amino Acids. This is supported by the alteration of several genes involved in this pathway. For instance, ASNS is involved in asparagine synthesis, PRPS2 and GPT in purine and glutamine metabolism, respectively. MAT1A and MAT2A are crucial for methionine synthesis, while IDH1, IDH3A, PHGDH, SHMT1, and CPS1 participate in serine, glycine, and arginine metabolism. The alteration of GAPDH, PGK1, PGK2, PFKL, PKM, and TKTL1 suggests changes in glycolysis, a pathway closely linked to amino acid synthesis. The genes ABHD14A-ACY1, RPE, PSPH, and TKTL2 are involved in fatty acid, retinol, and serine metabolism, respectively, which also contribute to amino acid biosynthesis. The altered compounds, 5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide and 1-(5-Phospho-D-ribosyl)-ATP, are intermediates in purine and pyrimidine nucleotide biosynthesis, which are precursors for amino acid synthesis. Therefore, the alterations in these genes and compounds strongly suggest the involvement of the Biosynthesis of Amino Acids pathway."}], "target": "Biosynthesis of amino acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G4B,CYP2J2,PLA2G4F >>>\nList of compounds : <<< Dihomo-gamma-linolenate,12(13)-EpOME,(7S,8S)-DiHODE,(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid,9,10-Epoxy-13-hydroxy-11-octadecenoate,9,10-12,13-Diepoxyoctadecanoate,13-OxoODE,5S,8R-DiHODE,9-OxoODE,9(S)-HODE,12,13-Epoxy-9-hydroxy-10-octadecenoate,(9Z,11E)-12-[(1E)-Hex-1-en-1-yloxy]dodeca-9,11-dienoic acid,(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid,9(S)-HPODE,Rumenic acid,12,13-Epoxy-9-hydroxy-10-octadecenoate,Arachidonate,Crepenynate,9,12,13-TriHOME,Phosphatidylcholine,(6Z,9Z,12Z)-Octadecatrienoic acid,13(S)-HODE,9,10-Dihydroxy-12,13-epoxyoctadecanoate >>>"}, {"role": "assistant", "content": "The analysis of the altered genes and compounds suggests that the Linoleic acid metabolism pathway is significantly involved in the condition studied. The genes PLA2G4B, PLA2G4F, and CYP2J2 are known to play key roles in this pathway. PLA2G4B and PLA2G4F are Phospholipase A2 enzymes that hydrolyze phospholipids to release linoleic acid, while CYP2J2 is a cytochrome P450 enzyme responsible for linoleic acid metabolism.\n\nThe altered compounds, including Dihomo-gamma-linolenate, various EpOMEs, HODEs, and OxoODEs, are all downstream metabolites of linoleic acid, further supporting the involvement of this pathway. The presence of arachidonate, a product of linoleic acid metabolism, and Phosphatidylcholine, a phospholipid that can release linoleic acid, also support this conclusion. The alteration of rumenic acid, a conjugated linoleic acid, and crepenynate, a metabolite of linoleic acid, further strengthens the evidence for the involvement of the Linoleic acid metabolism pathway in the observed condition."}], "target": "Linoleic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BCAT1,DPYS,UPB1,ALDH1B1 >>>\nList of compounds : <<< (R)-Pantoate,Uracil,beta-Alanine,(S)-2-Acetolactate,3-Ureidopropionate,Adenosine 3',5'-bisphosphate,Pantothenate,Pantetheine 4'-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Pantothenate and CoA biosynthesis pathway. This conclusion is based on the alteration of several genes and compounds associated with this pathway. The gene BCAT1 encodes branched-chain amino acid transaminase 1, which is involved in the synthesis of (S)-2-Acetolactate. The presence of this compound in the list supports the involvement of this pathway. The genes DPYS and UPB1 are involved in pyrimidine metabolism, as evidenced by the presence of Uracil and 3-Ureidopropionate. The involvement of these genes and compounds suggests a link between pyrimidine metabolism and the Pantothenate and CoA biosynthesis pathway. The gene ALDH1B1 encodes aldehyde dehydrogenase 1 family member B1, which is involved in the metabolism of beta-Alanine, another compound in the list. The presence of Pantothenate, Pantetheine 4'-phosphate, and (R)-Pantoate further supports the identification of the Pantothenate and CoA biosynthesis pathway."}], "target": "Pantothenate and CoA biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< BCAT1,SDSL,BCAT2 >>>\nList of compounds : <<< 3-Hydroxy-3-methyl-2-oxobutanoic acid,L-Valine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the provided data is the Valine, Leucine, and Isoleucine biosynthesis pathway. This conclusion is drawn from the alterations observed in the genes BCAT1, SDSL, and BCAT2, which are known to be involved in this pathway. BCAT1 and BCAT2 encode branched-chain aminotransferases, enzymes that catalyze the first step in the biosynthesis of branched-chain amino acids, including valine. SDSL, on the other hand, is involved in the synthesis of sulfur-containing amino acids, a process that is closely linked to branched-chain amino acid biosynthesis. The altered compounds, 3-Hydroxy-3-methyl-2-oxobutanoic acid and L-Valine, also support this conclusion. The former is a direct intermediate in the valine biosynthesis pathway, while L-Valine is the end product of this pathway. Therefore, the changes in these genes and compounds strongly suggest alterations in the Valine, Leucine, and Isoleucine biosynthesis pathway."}], "target": "Valine, leucine and isoleucine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< NAT2,CYP2A7,XDH >>>\nList of compounds : <<< 3-Methylxanthine,1,7-Dimethylxanthine,5-Acetylamino-6-amino-3-methyluracil,5-Acetylamino-6-formylamino-3-methyluracil,7-Methylxanthine,Theophylline,Theobromine,1-Methylxanthine,1,3,7-Trimethyl-5-hydroxyisourate,1,7-Dimethyluric acid,N,N'-Dimethylurea,1,3,7-Trimethyluric acid,Xanthine,N-Methylurea,7-Methyluric acid,3,6,8-Trimethylallantoin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes (NAT2, CYP2A7, XDH) and compounds (3-Methylxanthine, 1,7-Dimethylxanthine, 5-Acetylamino-6-amino-3-methyluracil, 5-Acetylamino-6-formylamino-3-methyluracil, 7-Methylxanthine, Theophylline, Theobromine, 1-Methylxanthine, 1,3,7-Trimethyl-5-hydroxyisourate, 1,7-Dimethyluric acid, N,N'-Dimethylurea, 1,3,7-Trimethyluric acid, Xanthine, N-Methylurea, 7-Methyluric acid, 3,6,8-Trimethylallantoin) is the caffeine metabolism pathway. This conclusion is supported by the presence of various xanthine derivatives, which are intermediates in caffeine metabolism. The genes involved, NAT2, CYP2A7, and XDH, are known to play crucial roles in the metabolism of xanthine derivatives, including caffeine. Specifically, NAT2 is involved in the acetylation of caffeine, CYP2A7 participates in the demethylation of caffeine, and XDH is involved in the oxidation of xanthine to uric acid. The alteration of these genes and the presence of xanthine derivatives suggest that the caffeine metabolism pathway is significantly affected in the given condition."}], "target": "Caffeine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SAT1,ALDH4A1,L3HYPDH,GAMT,ALDH1B1,CARNS1,CKMT1B,ALDH9A1,P4HA3,AOC1 >>>\nList of compounds : <<< 4-Guanidinobutanamide,gamma-Glutamyl-gamma-aminobutyraldehyde,Hydroxyproline,Guanidinoacetate,L-1-Pyrroline-3-hydroxy-5-carboxylate,4-(L-gamma-Glutamylamino)butanoate,trans-3-Hydroxy-L-proline,S-Adenosyl-L-methionine,L-Glutamate,N1-(3-Aminopropyl)agmatine,Carboxyspermidine,L-Glutamate 5-semialdehyde,N-Carbamoylputrescine,S-Adenosylmethioninamine,L-Aspartate 4-semialdehyde,Creatine,Pyruvate,N-Methylhydantoin,Spermine,1-Pyrroline-2-carboxylate,Nopaline,Glyoxylate,4-Aminobutanoate,4-Acetamidobutanoate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Arginine and Proline metabolism. This is supported by the alteration of several genes involved in this pathway, including SAT1, ALDH4A1, L3HYPDH, GAMT, ALDH1B1, CARNS1, CKMT1B, ALDH9A1, P4HA3, and AOC1. These genes are known to play crucial roles in the metabolism of arginine and proline. The observed changes in compounds such as 4-Guanidinobutanamide, gamma-Glutamyl-gamma-aminobutyraldehyde, Hydroxyproline, Guanidinoacetate, L-1-Pyrroline-3-hydroxy-5-carboxylate, and others, which are intermediates or products of this pathway, further reinforce the identification of this pathway."}], "target": "Arginine and proline metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UAP1,UXS1,GNE,HK2,UGP2,GPI,GNPNAT1,PGM1,FCSK >>>\nList of compounds : <<< dTDP-3-methyl-4-oxo-2,6-dideoxy-L-allose,UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose,UDP-D-galacturonate,dTDP-D-angolosamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Biosynthesis of Nucleotide Sugars. This pathway is strongly supported by the altered genes and compounds. The genes UAP1, UXS1, GNE, UGP2, and GPI are directly involved in the nucleotide sugar biosynthesis pathway. UAP1 and UXS1 are involved in the synthesis of UDP-GlcNAc, a key nucleotide sugar. GNE is responsible for the synthesis of sialic acid, another important nucleotide sugar. UGP2 and GPI are involved in the synthesis of UDP-Glc and GDP-Man, respectively, which are also nucleotide sugars. The altered compounds, including dTDP-3-methyl-4-oxo-2,6-dideoxy-L-allose, UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose, UDP-D-galacturonate, and dTDP-D-angolosamine, are all intermediates or end products of the nucleotide sugar biosynthesis pathway. The alteration of these compounds further supports the involvement of this pathway in the condition being studied."}], "target": "Biosynthesis of nucleotide sugars"}
{"messages": [{"role": "user", "content": "List of genes : <<< MTHFD1,ALDH2,VKORC1,COX10,CTPS1,ALAD,SHMT1,ALPG,UGT1A9,MAT2A,ALDH3A2,AK6 >>>\nList of compounds : <<< NAD+,Hydroxymethylbilane,Heme,ADP-5-ethyl-4-methylthiazole-2-carboxylate,Methanofuran,Enoylpimeloyl-[acp] methyl ester,Plastoquinol-9,Retinal,Iminoaspartate,7,8-Dihydroneopterin,Pantetheine 4'-phosphate,Hydrogenobyrinate a,c diamide,Cobyrinate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Cofactors. This conclusion is supported by the alterations in several genes and compounds associated with this pathway. The genes MTHFD1 and SHMT1 are involved in the folate cycle, which is a part of the one-carbon metabolism and contributes to cofactor biosynthesis. ALDH2, ALDH3A2, and ALAD are associated with the heme biosynthesis pathway, which involves the compound Hydroxymethylbilane. COX10 is involved in heme A biosynthesis, which also aligns with the identified pathway. CTPS1, a key enzyme in the synthesis of cytidine triphosphate, is a precursor for cofactor biosynthesis. The presence of compounds like NAD+, ADP-5-ethyl-4-methylthiazole-2-carboxylate, Methanofuran, Enoylpimeloyl-[acp] methyl ester, Plastoquinol-9, Retinal, Iminoaspartate, 7,8-Dihydroneopterin, Pantetheine 4'-phosphate, Hydrogenobyrinate a,c diamide, and Cobyrinate further support the involvement of the Biosynthesis of Cofactors pathway."}], "target": "Biosynthesis of cofactors"}
{"messages": [{"role": "user", "content": "List of genes : <<< SGMS1,CERS4,SMPD3,SMPD1 >>>\nList of compounds : <<< Ethanolamine phosphate,Ceramide 1-phosphate,GM4,N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide,D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide,Sphingomyelin,Sphinganine,Psychosine,Lactosylceramide,Sphingosine,N-Acylsphingosine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Sphingolipid metabolism. This conclusion is supported by the alterations in the genes SGMS1, CERS4, SMPD3, and SMPD1, all of which are directly involved in the synthesis and degradation of sphingolipids. The altered compounds, including Ethanolamine phosphate, Ceramide 1-phosphate, GM4, N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide, D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide, Sphingomyelin, Sphinganine, Psychosine, Lactosylceramide, Sphingosine, and N-Acylsphingosine, are all intermediates or end products of the sphingolipid metabolism pathway. Therefore, the observed changes in these genes and compounds strongly suggest the involvement of the Sphingolipid metabolism pathway in the specific condition under investigation."}], "target": "Sphingolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< EXTL2,NDST1,HS6ST1,HS3ST2,B3GAT3,EXTL1,NDST4,HS2ST1,B4GALT7 >>>\nList of compounds : <<< [Protein]-L-serine,3'-Phosphoadenylyl sulfate,Adenosine 3',5'-bisphosphate,Acetate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is Glycosaminoglycan biosynthesis - heparan sulfate/heparin. This conclusion is drawn from the observed alterations in genes and compounds directly involved in this pathway. The genes EXTL2, NDST1, HS6ST1, HS3ST2, B3GAT3, EXTL1, NDST4, and HS2ST1 are all known to play essential roles in the biosynthesis of heparan sulfate and heparin. The presence of 3'-Phosphoadenylyl sulfate, a crucial cofactor in the sulfation steps of heparan sulfate synthesis, further supports this finding. The involvement of Adenosine 3',5'-bisphosphate, a molecule important in energy transfer, suggests an energy requirement for this pathway's processes. Lastly, the altered levels of Acetate might indicate changes in the acetylation steps during heparan sulfate biosynthesis. Overall, the collective evidence points towards the Glycosaminoglycan biosynthesis - heparan sulfate/heparin pathway being significantly affected in the given conditions."}], "target": "Glycosaminoglycan biosynthesis - heparan sulfate / heparin"}
{"messages": [{"role": "user", "content": "List of genes : <<< OCRL,PLCB2,INPPL1,ITPKA,INPP5A,IMPA2,PLCD4,PIKFYVE,INPP1,PIP5K1B,CDIPT,PIP4K2A,PTEN,PI4K2B,PLCB4,INPP5J,SYNJ1,PLCZ1,INPP4A,PLCG1,PI4KB,PLCH1,MTMR4,SACM1L >>>\nList of compounds : <<< Glycerone phosphate,D-Tagaturonate,1-Keto-D-chiro-inositol,1D-myo-Inositol 1,4-bisphosphate,1D-myo-Inositol 3-phosphate,1D-myo-Inositol 1,3,4,5-tetrakisphosphate,3-Dehydro-scyllo-inosose,1-Phosphatidyl-D-myo-inositol,1D-myo-Inositol 1,4,5,6-tetrakisphosphate,Phosphatidylinositol-3,4,5-trisphosphate,Inositol 1,2,3,5,6-pentakisphosphate,D-myo-Inositol 1,2,4,5,6-pentakisphosphate,1-Phosphatidyl-1D-myo-inositol 4-phosphate,3-Oxopropanoate,scyllo-Inositol,5-Dehydro-L-gluconate,1,2-Diacyl-sn-glycerol,CDP-1L-myo-inositol >>>"}, {"role": "assistant", "content": "The analysis of the altered genes and compounds strongly indicates the involvement of the Inositol phosphate metabolism pathway. This conclusion is supported by the presence of multiple genes associated with this pathway, such as OCRL, PLCB2, INPPL1, ITPKA, INPP5A, IMPA2, PLCD4, PIKFYVE, INPP1, PIP5K1B, CDIPT, PIP4K2A, PTEN, PI4K2B, PLCB4, INPP5J, SYNJ1, PLCZ1, INPP4A, PLCG1, PI4KB, PLCH1, MTMR4, and SACM1L. These genes are known to regulate the synthesis, degradation, and signaling of inositol phosphates. Furthermore, the list of compounds includes various forms of inositol phosphates, such as 1D-myo-Inositol 1,4-bisphosphate, 1D-myo-Inositol 3-phosphate, 1D-myo-Inositol 1,3,4,5-tetrakisphosphate, Phosphatidylinositol-3,4,5-trisphosphate, and Inositol 1,2,3,5,6-pentakisphosphate, among others. Therefore, the data suggest that the Inositol phosphate metabolism pathway is significantly affected in the experimental conditions."}], "target": "Inositol phosphate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A9,RDH10,CYP3A7,CYP2A7,UGT2B28,UGT2B4,DHRS3,UGT2A1,UGT2A3,AWAT2 >>>\nList of compounds : <<< Rhodopsin,beta-Carotene,9-cis-Retinoic acid >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, the altered genes and compounds suggest that the Retinol metabolism pathway is significantly involved. This is supported by the presence of several genes associated with this pathway, such as UGT1A9, RDH10, CYP3A7, CYP2A7, UGT2B28, UGT2B4, DHRS3, UGT2A1, UGT2A3, and AWAT2. These genes are known to play crucial roles in the metabolism of retinoids, which are derivatives of vitamin A. The identification of compounds like Rhodopsin, beta-Carotene, and 9-cis-Retinoic acid further reinforces this, as they are key components in the Retinol metabolism pathway. Rhodopsin is a protein involved in vision that contains retinal, a derivative of vitamin A, while beta-Carotene is a precursor to vitamin A. 9-cis-Retinoic acid is a form of vitamin A that plays a crucial role in cell growth and differentiation. Therefore, the alterations in these genes and compounds strongly suggest that the Retinol metabolism pathway is significantly involved in the conditions being studied."}], "target": "Retinol metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GPAM,PHOSPHO1,PLD4,PLA2G4E,PLA2G12B,DGKH,PLA2G2A,PLA2G4D,PLA2G1B,LPGAT1,CDS2,AGPAT4,LCLAT1,PLAAT2,CRLS1,PTDSS1,DGKA,ETNK1,PLA2G3 >>>\nList of compounds : <<< CDP-choline,Monolysocardiolipin,Phosphatidylethanolamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Glycerophospholipid metabolism. This conclusion is supported by the alterations in multiple genes and compounds associated with this pathway. The genes GPAM, PHOSPHO1, PLD4, PLA2G4E, PLA2G12B, DGKH, PLA2G2A, PLA2G4D, PLA2G1B, LPGAT1, CDS2, AGPAT4, LCLAT1, PLAAT2, CRLS1, PTDSS1, DGKA, ETNK1, and PLA2G3 are all involved in the synthesis, degradation, or regulation of glycerophospholipids. The altered compounds, CDP-choline, Monolysocardiolipin, and Phosphatidylethanolamine, are intermediates or products of this pathway. Therefore, the changes observed in these genes and compounds suggest a disruption in Glycerophospholipid metabolism."}], "target": "Glycerophospholipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< POMGNT2,MGAT5B,LARGE2,B4GALT2,FUT9,POMT1,FKTN,B4GALT1,B3GAT1,B3GALNT2 >>>\nList of compounds : <<< O-Mannose core M1,[Protein]-L-serine,O-mannose core M3,O-Mannose core M2,Phospho-core M3,CTP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Mannose type O-glycan biosynthesis. This conclusion is supported by the alterations observed in the genes and compounds associated with this pathway. Specifically, the genes POMGNT2, MGAT5B, LARGE2, B4GALT2, FUT9, POMT1, FKTN, B4GALT1, B3GAT1, and B3GALNT2 are all known to play crucial roles in the synthesis of O-glycans, which are sugars attached to proteins. The altered compounds, including O-Mannose core M1, M2, and M3, and Phospho-core M3, are intermediates in this pathway. Furthermore, the presence of [Protein]-L-serine and CTP (Cytidine Triphosphate), a key substrate in glycan biosynthesis, further supports the involvement of this pathway."}], "target": "Mannose type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< SELENOI,PCYT1A >>>\nList of compounds : <<< N-Acetyldemethylphosphinothricin tripeptide,2-Oxo-4-phosphonobutanoate,D-Ribose 1,5-bisphosphate,Methane,Formate,alpha-D-Ribose 1-methylphosphonate 5-triphosphate,Methylphosphonate,2-Acetamidoethylphosphonate,2-Hydroxyethylphosphonate,3-(Hydrohydroxyphosphoryl)pyruvate,Bialaphos,Ciliatocholate,Diacylglyceryl-N-trimethyl-2-aminoethylphosphonate,FR 900098,Formylphosphonate,Lipophosphonoglycan,Pyruvate,N-Monomethyl-2-aminoethylphosphonate,Glycine,N-Trimethyl-2-aminoethylphosphonate,(2-Amino-1-hydroxyethyl)phosphonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Phosphonate and Phosphinate Metabolism. This conclusion is supported by the alterations in the genes SELENOI and PCYT1A, as well as the significant changes in various phosphonate and phosphinate compounds.\n\nSELENOI is involved in selenoprotein biosynthesis which can indirectly affect the metabolism of phosphonates. On the other hand, PCYT1A is a key enzyme in the Kennedy pathway, which is responsible for the biosynthesis of phospholipids. However, it's not directly involved in phosphonate metabolism, but changes in its activity can indirectly affect the pathway.\n\nThe significant alterations in the compounds such as N-Acetyldemethylphosphinothricin tripeptide, 2-Oxo-4-phosphonobutanoate, alpha-D-Ribose 1-methylphosphonate 5-triphosphate, and Methylphosphonate, among others, are key components of the Phosphonate and Phosphinate Metabolism pathway, further supporting the identification of this pathway."}], "target": "Phosphonate and phosphinate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HK3,HK1,HKDC1 >>>\nList of compounds : <<< Ribostamycin,6'''-Deamino-6'''-hydroxyparomomycin II,6'-Oxokanamycin C,Gentamicin C2a,6'''-Deamino-6'''-oxoparomomycin II,6'-Oxokanamycin X,Gentamicin A2,2-Deoxystreptamine,2'-Deamino-2'-hydroxy-6'-dehydroparomamine,UDP-kanosamine,L-Glutamate,6''-O-Carbamoylkanamycin A,Paromamine,UDP-N-acetyl-alpha-D-glucosamine,Acyl-carrier protein,4-(gamma-L-Glutamylamino)-(2S)-2-hydroxybutanoyl-[acp],Neamine,UDP-glucose,UDP-N-acetyl-alpha-D-glucosamine,Lividamine,6'-Oxogentamicin X2,Gentamicin C1 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the \"Neomycin, kanamycin, and gentamicin biosynthesis\" pathway. This pathway involves the production of aminoglycoside antibiotics, which are derived from the amino sugars glucosamine and kanosamine. The presence of genes such as HK3, HK1, and HKDC1, which are involved in hexokinase activity and glycolysis, suggests a role in providing energy for this biosynthetic process. The altered compounds, including Ribostamycin, Paromamine, L-Glutamate, and various derivatives of Neamine, Gentamicin, and Kanamycin, are direct intermediates or related compounds in this pathway. The presence of UDP-glucose, UDP-N-acetyl-alpha-D-glucosamine, and Acyl-carrier protein further support this identification, as they are essential for the biosynthesis of aminoglycosides."}], "target": "Neomycin, kanamycin and gentamicin biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDOA,PKM,PSAT1,DLD,PHGDH,GLUD1,TKT,G6PD,MMUT,OGDH,GLUD2,IDNK,GPT,TKTL2,HAO1,CPS1 >>>\nList of compounds : <<< (2R)-Ethylmalonyl-CoA,6-Phospho-D-gluconate,(S)-Malate,2-Phosphoglycolate,(2S)-Ethylmalonyl-CoA >>>"}, {"role": "assistant", "content": "The analysis of the given list of genes and compounds suggests that the Carbon metabolism pathway is significantly altered in the compared conditions. The genes ALDOA, PKM, PSAT1, DLD, PHGDH, GLUD1, TKT, G6PD, MMUT, OGDH, GLUD2, IDNK, GPT, TKTL2, and HAO1 are all involved in various aspects of carbon metabolism, including glycolysis, the citric acid cycle, the pentose phosphate pathway, and amino acid metabolism. The presence of (2R)-Ethylmalonyl-CoA, 6-Phospho-D-gluconate, (S)-Malate, 2-Phosphoglycolate, and (2S)-Ethylmalonyl-CoA further supports this conclusion, as these compounds are intermediates in carbon metabolism pathways. The alteration of these genes and compounds could lead to disruptions in energy production, amino acid synthesis, and redox balance, which are all crucial for cellular function."}], "target": "Carbon metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< TXNRD2,SEPSECS,KYAT1,PAPSS1,TXNRD3,TXNRD1,MTR,INMT,MARS2,SEPHS1 >>>\nList of compounds : <<< Selenohomocysteine,Methaneselenol,gamma-Glutamyl-Se-methylselenocysteine,Methylselenopyruvate,L-Selenocysteine,Adenylylselenate,O-Phosphoseryl-tRNA(Sec),Methylselenic acid,Methylselenocysteine Se-oxide,Trimethylselenonium,L-Alanine,Selenite,Se-Methyl-L-selenocysteine,L-Seryl-tRNA(Sec) >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Selenocompound metabolism. This conclusion is supported by the alterations observed in multiple genes and compounds associated with this pathway. The genes TXNRD1, TXNRD2, TXNRD3, MTR, and SEPHS1 are involved in selenium metabolism, while KYAT1, SEPSECS, and MARS2 are involved in the biosynthesis of selenoproteins. The observed changes in these genes suggest a disturbance in selenocompound metabolism. The altered compounds, including Selenohomocysteine, Methaneselenol, gamma-Glutamyl-Se-methylselenocysteine, Methylselenopyruvate, L-Selenocysteine, Adenylylselenate, O-Phosphoseryl-tRNA(Sec), Methylselenic acid, Methylselenocysteine Se-oxide, Trimethylselenonium, L-Alanine, Selenite, Se-Methyl-L-selenocysteine, and L-Seryl-tRNA(Sec), are all products or intermediates of selenocompound metabolism, further supporting the involvement of this pathway."}], "target": "Selenocompound metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MGLL,DGKD,DGAT2,GPAT2,GLYCTK >>>\nList of compounds : <<< Glycerophosphoglycoglycerolipid,3-D-Glucosyl-1,2-diacylglycerol,1-Acyl-sn-glycerol 3-phosphate,UDP-6-sulfoquinovose,Digalactosyl-diacylglycerol,1,2-Diacyl-sn-glycerol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycerolipid metabolism. This conclusion is supported by the alterations in several key genes and compounds associated with this pathway. The genes MGLL, DGKD, DGAT2, and GPAT2 are directly involved in the synthesis, degradation, and regulation of glycerolipids. The altered compounds, including Glycerophosphoglycoglycerolipid, 3-D-Glucosyl-1,2-diacylglycerol, 1-Acyl-sn-glycerol 3-phosphate, UDP-6-sulfoquinovose, Digalactosyl-diacylglycerol, and 1,2-Diacyl-sn-glycerol, are intermediates or products of this pathway. Therefore, the changes observed in these genes and compounds suggest that the Glycerolipid metabolism pathway is significantly affected in the studied conditions."}], "target": "Glycerolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GAD1,CNDP1 >>>\nList of compounds : <<< Propanoyl-CoA,L-Aspartate,beta-Alanyl-L-lysine,Propynoate,Spermidine,beta-Alanine,beta-Alanyl-CoA,3-Oxopropanoate,4-Aminobutanoate,3-Aminopropiononitrile,3-Hydroxypropionyl-CoA,Propenoyl-CoA,beta-Alanyl-N(pi)-methyl-L-histidine,Acetyl-CoA,beta-Alanyl-L-arginine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the provided data is the beta-Alanine metabolism. This conclusion is supported by the presence of several key genes and compounds associated with this pathway. The genes GAD1 and CNDP1 are involved in the synthesis of beta-Alanine and its derivative compounds. The compounds listed, such as beta-Alanine, beta-Alanyl-CoA, and beta-Alanyl-L-lysine, are direct products or intermediates in the beta-Alanine metabolism pathway. Other compounds like Propanoyl-CoA, 3-Oxopropanoate, and Acetyl-CoA, are closely related metabolites in this pathway. The presence of these genes and compounds strongly indicates that the beta-Alanine metabolism pathway is significantly altered in the compared conditions."}], "target": "beta-Alanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADH1B,ADH1C >>>\nList of compounds : <<< (R)-2-Hydroxybutane-1,2,4-tricarboxylate,Acetyl adenylate,(R)-Lactate,Thiamin diphosphate,(S)-Malate,Ethanol,2-(alpha-Hydroxyethyl)thiamine diphosphate,alpha-Isopropylmalate,Formate,Enzyme N6-(lipoyl)lysine,2-Propylmalate,Oxaloacetate,Methylglyoxal,(S)-Lactaldehyde,(R)-2-Ethylmalate,Enzyme N6-(dihydrolipoyl)lysine,Acetyl phosphate,Acetylenedicarboxylate,Malonyl-CoA,Pyruvate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Acetyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Pyruvate Metabolism. This conclusion is supported by the alteration in several genes and compounds directly involved in this pathway. The genes ADH1B and ADH1C encode alcohol dehydrogenases, enzymes that catalyze the conversion of ethanol to acetaldehyde, a key step in pyruvate metabolism. The presence of compounds such as ethanol, acetyl-CoA, pyruvate, and lactate also indicate involvement in this pathway. Additionally, the presence of thiamin diphosphate and its derivative, 2-(alpha-Hydroxyethyl)thiamine diphosphate, suggest the involvement of the pyruvate dehydrogenase complex, a key enzyme in pyruvate metabolism. Furthermore, the altered levels of compounds like oxaloacetate, malate, and acetyl adenylate, which are intermediates in the TCA cycle, into which pyruvate feeds, also support this conclusion."}], "target": "Pyruvate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ATP6V1G2,ATP5PF,MT-ND1,NDUFA4,MT-CO3,COX17,ATP6V1G1,ATP6V1A,NDUFB7,ATP5F1A >>>\nList of compounds : <<< H+,H2O,H+,ATP,Orthophosphate,H+,NAD+,H+,Succinate,ADP,Diphosphate,Triphosphate,Oxygen,H+ >>>"}, {"role": "assistant", "content": "The identified metabolic pathway involved in this condition is oxidative phosphorylation. This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes ATP6V1G2, ATP5PF, MT-ND1, NDUFA4, MT-CO3, COX17, ATP6V1G1, ATP6V1A, NDUFB7, and ATP5F1A all play crucial roles in the electron transport chain and ATP synthesis, which are key processes in oxidative phosphorylation. The presence of compounds such as H+, H2O, ATP, Orthophosphate, NAD+, Succinate, ADP, Diphosphate, Triphosphate, and Oxygen further corroborates this, as these are all involved in the redox reactions and energy transfer that characterize oxidative phosphorylation."}], "target": "Oxidative phosphorylation"}
{"messages": [{"role": "user", "content": "List of genes : <<< INPP4A,IMPA1,PIK3CA,PI4K2B,MTMR3,INPP5B,ITPKB,PLCD3,PLCB2,PIP4K2B,PIP5K1C,PI4KA,INPP5D,CDIPT,INPP5F,INPP5A,FIG4 >>>\nList of compounds : <<< Bis(1L-myo-inositol)-3,1'-phosphate 1-phosphate,D-myo-Inositol 1,2,4,5,6-pentakisphosphate,D-Glyceraldehyde 3-phosphate,Acetyl-CoA,D-myo-Inositol 3,4-bisphosphate,D-Tagaturonate,1D-myo-Inositol 1,3,4,5-tetrakisphosphate,1-Phosphatidyl-1D-myo-inositol 3-phosphate,1D-myo-Inositol 3,4,5,6-tetrakisphosphate,3-Oxopropanoate,D-myo-Inositol 1,4,5-trisphosphate,1D-myo-Inositol 1,3,4,6-tetrakisphosphate,myo-Inositol 4-phosphate,Inositol 1,2,3,5,6-pentakisphosphate,1D-myo-Inositol 1,4,5,6-tetrakisphosphate,1-Keto-D-chiro-inositol,D-myo-Inositol 1,3-bisphosphate,2-Deoxy-5-keto-D-gluconic acid,2-Deoxy-5-keto-D-gluconic acid 6-phosphate,L-Bornesitol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Inositol Phosphate Metabolism pathway. This conclusion is supported by the observed alterations in numerous genes and compounds associated with this pathway. Specifically, the genes INPP4A, IMPA1, PIK3CA, PI4K2B, MTMR3, INPP5B, ITPKB, PLCD3, PLCB2, PIP4K2B, PIP5K1C, PI4KA, INPP5D, CDIPT, INPP5F, INPP5A, and FIG4 are all involved in this pathway, either in the synthesis, degradation, or regulation of inositol phosphates. Similarly, the altered compounds such as Bis(1L-myo-inositol)-3,1'-phosphate 1-phosphate, D-myo-Inositol 1,2,4,5,6-pentakisphosphate, and various other inositol phosphates, are key intermediates or products of this pathway. The alterations in these genes and compounds suggest that the Inositol Phosphate Metabolism pathway plays a significant role in the specific condition under investigation."}], "target": "Inositol phosphate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DDOST,TMEM258,ALG14,FUT8,MGAT2,B4GALT3,MGAT1,MAN1A1,TUSC3,DAD1,MOGS,ALG13 >>>\nList of compounds : <<< N,N'-Chitobiosyldiphosphodolichol,Dolichyl phosphate D-mannose,GDP-mannose,N-Acetyl-D-glucosaminyldiphosphodolichol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is N-Glycan biosynthesis. This conclusion is supported by the alterations in multiple genes and compounds directly involved in this pathway. Genes such as DDOST, TMEM258, ALG14, FUT8, MGAT2, B4GALT3, MGAT1, MAN1A1, TUSC3, DAD1, MOGS, and ALG13 are all known to play crucial roles in N-Glycan biosynthesis. The altered compounds, including N,N'-Chitobiosyldiphosphodolichol, Dolichyl phosphate D-mannose, GDP-mannose, and N-Acetyl-D-glucosaminyldiphosphodolichol, are key intermediates in this pathway, further confirming the involvement of N-Glycan biosynthesis in the observed condition."}], "target": "N-Glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< HLCS,OXSM >>>\nList of compounds : <<< Pimeloyl-[acyl-carrier protein] methyl ester,Malonyl-[acp] methyl ester,Pimeloyl-CoA,Enoylglutaryl-[acp] methyl ester,Tetranorbiotin,Pimelate,Malonyl-[acyl-carrier protein],3-Hydroxypimeloyl-[acp] methyl ester,Urea,3-Hydroxyglutaryl-[acp] methyl ester,Glutaryl-[acp] methyl ester,Bisnorbiotin,Pimeloyl-[acyl-carrier protein],Long-chain acyl-[acyl-carrier protein],Biotinyl-5'-AMP,Biotin sulfone,3-Ketopimeloyl-[acp] methyl ester,Holo-[carboxylase],Enoylpimeloyl-[acp] methyl ester >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experimental comparison is the Biotin metabolism pathway. This conclusion is based on the alterations observed in the genes HLCS (Holocarboxylase synthetase) and OXSM (3-Methylcrotonyl-CoA carboxylase), both of which are directly involved in biotin metabolism.\n\nThe altered compounds, such as Pimeloyl-[acyl-carrier protein] methyl ester, Malonyl-[acp] methyl ester, Pimeloyl-CoA, and Biotinyl-5'-AMP, among others, are intermediates or derivatives in the biotin metabolism pathway. The presence of Tetranorbiotin and Bisnorbiotin, which are degradation products of biotin, further supports the involvement of the biotin metabolism pathway.\n\nThe identification of compounds like Urea and 3-Ketopimeloyl-[acp] methyl ester, which are not directly linked to biotin metabolism, may suggest potential crosstalk or secondary effects on other metabolic pathways due to the alterations in the biotin metabolism pathway."}], "target": "Biotin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SLC33A1,ST3GAL5,HEXA,ST3GAL2,ST8SIA5,ST6GALNAC6,ST6GALNAC5,ST3GAL1,ST6GALNAC4,ST8SIA1,B3GALT4,ST6GALNAC3 >>>\nList of compounds : <<< GQ1c,GQ1b,GM1alpha,GM1,GD3,Lactosylceramide,9-O-Acetylated GD3,GD1beta >>>"}, {"role": "assistant", "content": "Based on the given list of genes and compounds, the identified metabolic pathway is the Glycosphingolipid biosynthesis - ganglio series. This pathway involves the synthesis of complex glycosphingolipids, a type of lipid found in cell membranes, particularly in the nervous system.\n\nThe genes listed, such as SLC33A1, HEXA, and ST3GAL1, are known to be involved in the synthesis of various glycosphingolipids. For instance, SLC33A1 is involved in the transfer of ceramide, a key component in glycosphingolipid synthesis. HEXA encodes an enzyme involved in the degradation of gangliosides, which are a type of glycosphingolipid. ST3GAL1 is responsible for the synthesis of sialylated glycolipids, a subclass of glycosphingolipids.\n\nThe compounds listed, including GM1alpha, GD3, and Lactosylceramide, are intermediates or products of the ganglio series of glycosphingolipid biosynthesis. Therefore, the alteration of these compounds and genes suggests that the Glycosphingolipid biosynthesis - ganglio series pathway is affected in the given condition."}], "target": "Glycosphingolipid biosynthesis - ganglio series"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACSF3,ACSL6,ACSBG2,ACSL3,FASN,ACSL1,ACACA,ACSL4,OXSM >>>\nList of compounds : <<< 3-Oxostearoyl-[acp],Palmitoyl-CoA,Oleoyl-[acyl-carrier protein],Malonyl-CoA,Long-chain acyl-CoA,Hexadecanoyl-[acp],Long-chain fatty acid,3-Oxooctanoyl-[acp],Decanoyl-[acp],Acyl-carrier protein,Decanoic acid,Long-chain acyl-[acyl-carrier protein],Acetyl-CoA,Acetoacetyl-[acp],(9Z)-Hexadecenoic acid,trans-Hexadec-2-enoyl-[acp],Hexadecanoic acid,Acetyl-[acyl-carrier protein],Acyl-[acyl-carrier protein],trans-Dodec-2-enoyl-[acp],Malonyl-CoA,Malonate,Malonyl-[acyl-carrier protein] >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is Fatty Acid Biosynthesis. This is supported by the alterations in multiple genes and compounds associated with this pathway. The genes ACSF3, ACSL6, ACSBG2, ACSL3, FASN, ACSL1, ACACA, and ACSL4 are all involved in fatty acid synthesis, activation, or transport. The presence of compounds such as Palmitoyl-CoA, Malonyl-CoA, Long-chain acyl-CoA, and Acetyl-CoA, which are key intermediates in fatty acid biosynthesis, further supports this identification. Additionally, the presence of compounds like 3-Oxostearoyl-[acp], Oleoyl-[acyl-carrier protein], and (9Z)-Hexadecenoic acid suggest the involvement of the pathway in the synthesis of unsaturated fatty acids. Therefore, the data strongly indicates that the Fatty Acid Biosynthesis pathway is involved in the specific condition under study."}], "target": "Fatty acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< MGAT5B,POMT1,B4GAT1,ST3GAL3,POMT2 >>>\nList of compounds : <<< [Protein]-L-serine,Dolichyl phosphate D-mannose,O-Mannose core M1,O-mannose core M3,CDP-ribitol,O-Mannose core M2,Phospho-core M3 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Mannose type O-glycan biosynthesis. This pathway was deduced based on the altered genes and compounds. The genes MGAT5B, POMT1, POMT2, B4GAT1, and ST3GAL3 are all involved in the synthesis and modification of O-glycans. MGAT5B and B4GAT1 are specifically involved in the formation of core M1 and M3 structures, respectively. POMT1 and POMT2 are responsible for the initial transfer of mannose to serine or threonine residues, a crucial step in O-glycan biosynthesis. ST3GAL3 is a sialyltransferase that adds sialic acid to the O-glycan structure. The compounds identified - [Protein]-L-serine, Dolichyl phosphate D-mannose, O-Mannose core M1, O-mannose core M3, CDP-ribitol, O-Mannose core M2, and Phospho-core M3 - are all intermediates or products in the Mannose type O-glycan biosynthesis pathway. Therefore, the data strongly suggests that this pathway is affected in the experimental conditions."}], "target": "Mannose type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< MAOB,UROC1,HDC,CNDP2,CARNS1,ALDH3A1,CNDP1,AMDHD1,ALDH7A1,ALDH1B1,ALDH3B2,ALDH3A2,HAL,HNMT,ASPA,FTCD,CARNMT1,ALDH2,ALDH9A1,AOC1,MAOA,ALDH3B1 >>>\nList of compounds : <<< Hydantoin-5-propionate,L-Histidinal,Urocanate,(1-Ribosylimidazole)-4-acetate,5-Phospho-alpha-D-ribose 1-diphosphate,L-Histidinol,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate,5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide,Methylimidazole acetaldehyde,N-Carbamyl-L-glutamate,Methylimidazoleacetic acid,N-Formyl-L-glutamate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the provided list of genes and compounds is the Histidine metabolism pathway. This is supported by the presence of several key genes involved in this pathway, such as MAOB, UROC1, HDC, CNDP2, and CARNS1. The altered compounds, including L-Histidinal, Urocanate, L-Histidinol, and several intermediates like 5-Phospho-alpha-D-ribose 1-diphosphate and 5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide, are also indicative of changes in histidine metabolism. Additionally, the presence of genes like ALDH3A1, ALDH7A1, and ALDH3B2, which are involved in the metabolism of aldehydes and ketones, suggest a potential link to the catabolism of histidine."}], "target": "Histidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT2,BHMT2,CBS,GCLM,TAT,AHCY,KYAT3 >>>\nList of compounds : <<< S-Adenosyl-L-methionine,S-Adenosyl-L-homocysteine,L-Alanine,L-Cysteate,D-Cysteine,gamma-L-Glutamyl-L-2-aminobutyrate,Aminoacyl-L-methionine,S-Glutathionyl-L-cysteine,S-Methyl-1-thio-D-xylulose 5-phosphate,N-Acyl-L-homoserine lactone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Cysteine and Methionine Metabolism. This conclusion is supported by the alterations observed in several genes and compounds directly involved in this pathway. The genes include GOT2 (involved in amino acid metabolism), BHMT2 and CBS (both participating in the transsulfuration pathway converting methionine to cysteine), GCLM (a key enzyme in glutathione synthesis from cysteine), TAT (a transporter of amino acids including cysteine and methionine), AHCY (involved in the methionine cycle), and KYAT3 (a lysine catabolic enzyme interacting with cysteine and methionine metabolism). The altered compounds, such as S-Adenosyl-L-methionine, S-Adenosyl-L-homocysteine, L-Cysteate, D-Cysteine, S-Glutathionyl-L-cysteine, and S-Methyl-1-thio-D-xylulose 5-phosphate, are intermediates or products of this metabolic pathway, further supporting its involvement in the observed condition."}], "target": "Cysteine and methionine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GFUS,TGDS,GMPPB,GMDS,GMPPA,HK3,GFPT2,NAGK,GALE,GFPT1 >>>\nList of compounds : <<< CMP-N-acetylneuraminate,D-Glucosamine 6-phosphate,dTDP-D-fucose >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, the metabolic pathway identified to be significantly altered is the biosynthesis of nucleotide sugars. This is supported by the changes observed in several genes and compounds associated with this pathway. The genes GFUS, TGDS, GMPPB, GMDS, GMPPA, and HK3 are involved in the synthesis of nucleotide sugars, specifically GDP-fucose and CMP-N-acetylneuraminic acid. The alteration in these genes suggests an impact on the production of these nucleotide sugars. Furthermore, the increased levels of CMP-N-acetylneuraminate and D-Glucosamine 6-phosphate, which are intermediates in this pathway, provide additional evidence for the involvement of this pathway. The alteration in the levels of dTDP-D-fucose, another nucleotide sugar, also supports this conclusion. The changes in these genes and compounds suggest a disruption in the biosynthesis of nucleotide sugars, which could have implications for various biological processes, including glycosylation and cell signaling."}], "target": "Biosynthesis of nucleotide sugars"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYB5RL,NANP,GALK1,CHIA,GMDS,CHIT1,GNE,GFUS,HK3,UAP1,GALK2,HEXA,GPI,CMAS,GMPPA,PGM2,GFPT1,GMPPB,HEXB,NAGK,UGDH,GFPT2,UGP2,PGM1, >>>\nList of compounds : <<< D-Mannose,UDP-N-acetylmuramate,D-Mannose,CDP-3,6-dideoxy-D-mannose,N-Acetyl-D-mannosamine,N-Acetylneuraminate 9-phosphate,UDP-L-Ara4O,N-Acetyl-D-glucosamine,UDP-L-Ara4FN,D-Fructose,alpha-D-Glucose 6-phosphate,CDP-3,6-dideoxy-D-glucose,D-Glucose,UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate,Chitin,D-Mannose >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the metabolic pathway identified is Amino sugar and nucleotide sugar metabolism. This pathway is involved in the biosynthesis of amino sugars, nucleotide sugars, and their derivatives, which are crucial for the glycosylation of proteins and lipids. The presence of genes such as GNE, NANP, and CHIT1, which are directly involved in the metabolism of amino sugars, supports this identification.\n\nFurthermore, the compounds listed, including N-Acetyl-D-glucosamine, UDP-L-Ara4O, and UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate, are key intermediates in this pathway. The recurrence of D-Mannose and its derivatives also suggests involvement in this pathway, as they are precursors for the synthesis of various amino sugars. Therefore, the alterations in these genes and compounds point towards the Amino sugar and nucleotide sugar metabolism pathway."}], "target": "Amino sugar and nucleotide sugar metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HK3,GCK,HK2,HKDC1,HK1 >>>\nList of compounds : <<< Apramycin,Kanamycin C,UDP-3-ketoglucose,6'-Dehydro-6'-oxoparomamine,6'''-Deamino-6'''-oxoneomycin C,Gentamicin C2a,6'-Oxo-G418,Nebramine,Lividomycin A,Gentamicin A2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Neomycin, kanamycin, and gentamicin biosynthesis pathway. This is primarily due to the presence of multiple genes related to hexokinase enzymes (HK3, GCK, HK2, HKDC1, HK1) and the altered compounds that are directly associated with this pathway, such as Apramycin, Kanamycin C, Gentamicin C2a, and 6'-Oxo-G418. The other compounds like UDP-3-ketoglucose, 6'-Dehydro-6'-oxoparomamine, 6'''-Deamino-6'''-oxoneomycin C, Nebramine, and Lividomycin A are also known to be involved in this pathway or have structural similarities with the known compounds in this pathway. Therefore, it is reasonable to conclude that the Neomycin, kanamycin, and gentamicin biosynthesis pathway is significantly involved in the observed condition."}], "target": "Neomycin, kanamycin and gentamicin biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< SDHA,PDHA2,PDHA1,ACO1,IDH2,DLAT,DLD,OGDHL,IDH3B,ACO2,ACLY,PDHB,SUCLG2,OGDH,SDHB,PCK2,SUCLA2,PC,SDHC,MDH1,SDHD,DLST,FH,SUCLG1,IDH3G >>>\nList of compounds : <<< Citrate,Succinyl-CoA,Pyruvate,cis-Aconitate,Phosphoenolpyruvate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Citrate cycle (TCA cycle). This conclusion is supported by the altered genes and compounds observed. The genes SDHA, SDHB, SDHC, SDHD, DLAT, DLD, ACO1, and ACO2 are all associated with the TCA cycle, indicating its involvement. The altered genes PDHA1, PDHA2, PDHB, and PCK2 are involved in pyruvate metabolism, which feeds into the TCA cycle. The genes IDH2, IDH3B, and IDH3G are associated with the NADP+ dependent step of the oxidative decarboxylation of isocitrate, a key reaction in the TCA cycle. The compound changes further support this conclusion. The increase/decrease in Citrate, Succinyl-CoA, Pyruvate, cis-Aconitate, and Phosphoenolpyruvate are all intermediates or closely related to intermediates in the TCA cycle."}], "target": "Citrate cycle (TCA cycle)"}
{"messages": [{"role": "user", "content": "List of genes : <<< GADL1,FMO4,GAD1,CDO1,FMO5,CSAD,FMO2,GGT6,GGT5 >>>\nList of compounds : <<< 2-Hydroxyethanesulfonate,Sulfoacetate,Pyruvate,Taurocholate,Cysteamine,L-Cysteate,Sulfoacetaldehyde >>>"}, {"role": "assistant", "content": "Based on the altered genes and compounds, the metabolic pathway identified is the Taurine and hypotaurine metabolism. This conclusion is drawn due to the presence of multiple genes involved in this pathway, such as GADL1, GAD1, and CDO1, which are involved in the synthesis of taurine and its precursor cysteinesulfonic acid. The altered compounds, including 2-Hydroxyethanesulfonate, Sulfoacetate, Pyruvate, Taurocholate, Cysteamine, L-Cysteate, and Sulfoacetaldehyde, are intermediates or products of this pathway. The involvement of FMO (Flavin-containing monooxygenase) genes further supports this, as they are known to metabolize taurine conjugates."}], "target": "Taurine and hypotaurine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AK9,UCK2 >>>\nList of compounds : <<< dUDP,P1,P4-Bis(5'-uridyl) tetraphosphate,UDP,beta-Alanine,Aminoacrylate,Carbamate,2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate,2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate,(R)-5,6-Dihydrothymine,Uridine,Urea,3',5'-Cyclic UMP,Orotate,CMP,Orotidine 5'-phosphate,CTP,dTDP,2',3'-Cyclic CMP,3-Oxopropanoate,RNA,Methylmalonate >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the metabolic pathway identified is pyrimidine metabolism. The altered genes, AK9 and UCK2, are directly involved in this pathway. AK9 encodes for adenylate kinase 9, which plays a role in maintaining the balance of nucleotides, including pyrimidines. UCK2 encodes for uridine-cytidine kinase 2, a key enzyme in the pyrimidine salvage pathway. The presence of various pyrimidine-related compounds such as dUDP, UDP, Uridine, Orotate, CMP, Orotidine 5'-phosphate, and CTP further supports this identification. The alteration of these compounds suggests disturbances in the synthesis, degradation, or salvage of pyrimidines. Additionally, the presence of compounds like beta-Alanine, Aminoacrylate, and Methylmalonate could indicate potential crosstalk with other pathways, but their primary connection here appears to be through their relationship with pyrimidine metabolism."}], "target": "Pyrimidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MVD,GGPS1,ZMPSTE24,IDI2,PDSS1,PMVK,HMGCS2,IDI1,FNTB,HMGCR,PCYOX1 >>>\nList of compounds : <<< Isoprene,(R)-Mevalonate 3,5-bisphosphate,2-C-Methyl-D-erythritol 4-phosphate,S-Farnesyl protein,Protein C-terminal S-farnesyl-L-cysteine,(S)-3-Hydroxy-3-methylglutaryl-CoA,(R)-Mevalonate,trans,trans-Farnesyl diphosphate,trans-Anhydromevalonate phosphate,Polyprenol,Geranyl diphosphate,all-trans-Heptaprenyl diphosphate,ditrans,polycis-Polyprenyl diphosphate,(2E,6E)-Farnesol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Terpenoid backbone biosynthesis. This conclusion is supported by the altered genes and compounds observed. The genes MVD, GGPS1, PDSS1, PMVK, HMGCS2, HMGCR, and IDI1/2 are all involved in this pathway, responsible for the synthesis of isoprenoids, which are crucial building blocks for terpenoids. The presence of Isoprene, (R)-Mevalonate 3,5-bisphosphate, 2-C-Methyl-D-erythritol 4-phosphate, (S)-3-Hydroxy-3-methylglutaryl-CoA, (R)-Mevalonate, trans,trans-Farnesyl diphosphate, and (2E,6E)-Farnesol, all intermediates or products of this pathway, further strengthens this conclusion. Additionally, the presence of S-Farnesyl protein and Protein C-terminal S-farnesyl-L-cysteine, which are products of protein prenylation using farnesyl diphosphate from this pathway, also supports this identification."}], "target": "Terpenoid backbone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ABO,ST8SIA1,A4GALT,B3GALNT1,B3GALT2,B4GALNT2,FUT7,ST3GAL3,B3GNT2,B3GALT5,B4GALT2,B4GALT1,GCNT2,B3GNT5,ST3GAL4,B4GALT3 >>>\nList of compounds : <<< Lc4Cer,Type IIIA glycolipid,nLc6Cer,Sialyl-3-paragloboside,IV2Fuc-nLc4Cer,VI3NeuAc-nLc6Cer,PX2,Sialyl-6-paragloboside,3',8'-LD1,iso-nLc8Cer,III3,IV2Fuca,IV3Gala-nLc4-Cer,VI2Fuc-nLc6,IV4Gala-nLc4-Cer,Type II A antigen,nLc8Cer,Type IA glycolipid,Fuc-Lc4Cer,III3,IV2Fuca,IV3GalNAca-nLc4-Cer,nLc7Cer,nLc5Cer,III3Fuc-nLc6Cer,BLeb glycolipid,ALeb glycolipid,Paragloboside,IV2Fuc,III4Fuc-Lc4Cer >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosphingolipid biosynthesis - lacto and neolacto series. This conclusion is supported by the observed alterations in multiple genes and compounds associated with this pathway. The genes listed, such as ABO, ST8SIA1, A4GALT, B3GALNT1, B3GALT2, B4GALNT2, FUT7, ST3GAL3, B3GNT2, B3GALT5, B4GALT2, B4GALT1, GCNT2, B3GNT5, ST3GAL4, and B4GALT3, are known to be involved in the biosynthesis of glycosphingolipids, specifically the lacto and neolacto series. Similarly, the altered compounds, including Lc4Cer, Type IIIA glycolipid, nLc6Cer, Sialyl-3-paragloboside, and others, are intermediates or end products of this pathway. Therefore, the data strongly suggests that the Glycosphingolipid biosynthesis - lacto and neolacto series pathway is significantly affected in the condition under investigation."}], "target": "Glycosphingolipid biosynthesis - lacto and neolacto series"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSTT2,G6PD,GSS,GSTO1,GSTM4,GGT6,CHAC1 >>>\nList of compounds : <<< L-Cysteine,Bis(glutathionyl)spermine disulfide,NADPH,5-Oxoproline,NADP+,Spermine,Homotrypanothione,Tryparedoxin,NADP+,L-Amino acid,Bis(glutathionyl)spermine,Ascorbate,Glutathionylaminopropylcadaverine,Spermidine,Glutathionylspermine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glutathione metabolism. This conclusion is supported by the altered genes and compounds observed. The genes GSTT2, G6PD, GSS, GSTO1, GSTM4, GGT6, and CHAC1 are all involved in glutathione metabolism. G6PD (Glucose-6-phosphate dehydrogenase) and NADPH, for instance, are crucial for the production of reduced glutathione (GSH), a key antioxidant in the cell. The altered compounds, such as L-Cysteine, Bis(glutathionyl)spermine disulfide, NADP+, 5-Oxoproline, Spermine, Homotrypanothione, Tryparedoxin, L-Amino acid, Bis(glutathionyl)spermine, Ascorbate, Glutathionylaminopropylcadaverine, Spermidine, and Glutathionylspermine, are all directly involved or are byproducts of this pathway, further supporting the identification of Glutathione metabolism as the affected pathway."}], "target": "Glutathione metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ELOVL4,ELOVL2,ELOVL6,HSD17B12,ELOVL7 >>>\nList of compounds : <<< Ximenoyl-CoA,cis-Vaccenoyl-CoA,Icosadienoic acid,(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA,Eicosanoyl-CoA,Docosanoyl-CoA,(11Z,14Z)-Icosadienoyl-CoA,(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA,Adrenic acid,Dihomo-gamma-linolenate,(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA,(9Z)-Octadecenoic acid,Docosanoyl-CoA,(8Z,11Z,14Z,17Z,20Z)-Hexacosapentaenoyl-CoA,Palmitoyl-CoA,Ximenoyl-CoA,Oleoyl-CoA,(10Z,13Z,16Z,19Z,22Z)-Octacosapentaenoyl-CoA,Tetracosanoyl-CoA,Docosenoyl-CoA,Docosanoic acid,Tetracosanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Unsaturated Fatty Acids. This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes ELOVL4, ELOVL2, ELOVL6, and ELOVL7 are elongases involved in fatty acid elongation, a key process in unsaturated fatty acid biosynthesis. HSD17B12 is a key enzyme in the beta-oxidation of fatty acids, which is closely linked to fatty acid biosynthesis. The altered compounds, including various CoA-linked unsaturated fatty acids and their intermediates, are direct products of this pathway, further supporting this identification."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< PGM1,TREH,AGL,GPI,GBE1,GAA,PGM2,,PGM2L1,HK3,HK1,G6PC2,PYGB,HK2,AMY1B >>>\nList of compounds : <<< Maltose 6'-phosphate,alpha,alpha-Trehalose,Starch,D-Glucose,Amylose,UDP-glucose,(2,1-beta-D-Fructosyl)n,Sucrose,Dextran,D-Glucose 6-phosphate,1,3-beta-D-Glucan,GDP-glucose,Maltose,Levan,6-Phospho-beta-D-glucosyl-(1,4)-D-glucose,beta-D-Glucoside,3-Ketosucrose,ADP-glucose,Isomaltose >>>"}, {"role": "assistant", "content": "In the comparison between two conditions, the starch and sucrose metabolism pathway was identified as being significantly altered. This pathway is central to carbohydrate metabolism, and the observed alterations in genes such as PGM1, TREH, AGL, GPI, GBE1, GAA, PGM2, PGM2L1, HK3, HK1, G6PC2, PYGB, HK2, and AMY1B, together with changes in compounds like Maltose 6'-phosphate, alpha,alpha-Trehalose, Starch, D-Glucose, Amylose, UDP-glucose, (2,1-beta-D-Fructosyl)n, Sucrose, Dextran, D-Glucose 6-phosphate, 1,3-beta-D-Glucan, GDP-glucose, Maltose, Levan, 6-Phospho-beta-D-glucosyl-(1,4)-D-glucose, beta-D-Glucoside, 3-Ketosucrose, ADP-glucose, and Isomaltose, strongly suggest that this pathway is implicated in the observed condition. These metabolites and enzymes are key components of the starch and sucrose metabolism pathway, playing roles in the breakdown and synthesis of these major carbohydrates."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B15,UGT2B7,UGDH,GUSB,UGT1A9,RGN,UGT2B4,UGT1A3,AKR1A1,UGT1A6,KL,UGT2B11,UGT2A3,UGT1A7,UGT1A10,UGT2B17,ALDH7A1,UGT2A1,ALDH3A2,UGT2B10,ALDH1B1,ALDH2,UGT1A5,UGT1A1 >>>\nList of compounds : <<< beta-D-Glucuronoside,3-Dehydro-L-gulonate,2-Dehydro-3-deoxy-D-glucarate,UDP-D-galacturonate,GDP-L-galactose,myo-Inositol,D-Glucuronate,L-Gulonate,D-Arabinono-1,4-lactone,L-Gulono-1,4-lactone,L-Galactono-1,5-lactone,D-Glucuronate 1-phosphate,Ascorbate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Ascorbate and aldarate metabolism. This conclusion is supported by the altered genes and compounds observed. The genes UGT2B15, UGT2B7, UGDH, GUSB, UGT1A9, RGN, UGT2B4, UGT1A3, AKR1A1, UGT1A6, KL, UGT2B11, UGT2A3, UGT1A7, UGT1A10, UGT2B17, ALDH7A1, UGT2A1, ALDH3A2, UGT2B10, ALDH1B1, ALDH2, UGT1A5, and UGT1A1 are all involved in the metabolism of sugars, including those in the Ascorbate and aldarate metabolism pathway. The compounds beta-D-Glucuronoside, 3-Dehydro-L-gulonate, 2-Dehydro-3-deoxy-D-glucarate, UDP-D-galacturonate, GDP-L-galactose, myo-Inositol, D-Glucuronate, L-Gulonate, D-Arabinono-1,4-lactone, L-Gulono-1,4-lactone, L-Galactono-1,5-lactone, D-Glucuronate 1-phosphate, and Ascorbate are all intermediates or products of this pathway, further supporting the identification of Ascorbate and aldarate metabolism as the affected pathway."}], "target": "Ascorbate and aldarate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ST8SIA1,B3GALT5,B3GALNT1,ABO,GBGT1 >>>\nList of compounds : <<< Globotriaosylceramide,IV4-alpha-Gal-Gb4Cer,Monosialylgalactosylgloboside,Globo-B,V3(NeuAc)2-Gb5Cer,NORint,IV3GalNAcb-Gb4Cer,Lactosylceramide,Forssman antigen, IV3GalNAca-Gb4Cer,GalGb3Cer,iGb3-Cer,Galactosylgloboside,NOR2 antigen >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosphingolipid biosynthesis - globo and isoglobo series. This conclusion is supported by the alterations in genes such as ST8SIA1, B3GALT5, B3GALNT1, ABO, and GBGT1, which are all known to be involved in this pathway. These genes contribute to the synthesis of various glycosphingolipids, including Globotriaosylceramide, Monosialylgalactosylgloboside, Globo-B, V3(NeuAc)2-Gb5Cer, Lactosylceramide, Galactosylgloboside, and others. The presence of these compounds further strengthens the identification of this pathway. The alterations in these genes and compounds suggest a disruption in the normal synthesis of glycosphingolipids, which are crucial for cell recognition, signaling, and adhesion processes."}], "target": "Glycosphingolipid biosynthesis - globo and isoglobo series"}
{"messages": [{"role": "user", "content": "List of genes : <<< AOX1,KMO >>>\nList of compounds : <<< Indole-3-ethanol,5-Hydroxyindoleacetaldehyde,L-Tryptophan,5-Hydroxyindoleacetate,5-Methoxytryptamine,2-Aminomuconate semialdehyde,Indole,5-(3'-Carboxy-3'-oxopropenyl)-4,6-dihydroxypicolinate,5-Hydroxy-N-formylkynurenine,2-Amino-3-carboxymuconate semialdehyde,2-Oxoadipate,4-Hydroxy-2-quinolinecarboxylic acid,4,8-Dihydroxyquinoline,4-(2-Amino-5-hydroxyphenyl)-2,4-dioxobutanoate,5-Hydroxyindolepyruvate,Formyl-N-acetyl-5-methoxykynurenamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Tryptophan metabolism pathway. This is evident from the altered genes, AOX1 and KMO, which are known to be involved in this pathway. AOX1, or aldehyde oxidase 1, is an enzyme that catalyzes the oxidation of various aldehydes, including those derived from tryptophan metabolism. KMO, or kynurenine 3-monooxygenase, is another enzyme in the tryptophan metabolism pathway that converts kynurenine to 3-hydroxykynurenine.\n\nFurthermore, the list of altered compounds also supports this conclusion. Many of these compounds, such as L-Tryptophan, Indole, 5-Hydroxyindoleacetate, and 5-Hydroxyindolepyruvate, are direct intermediates or products of the tryptophan metabolism pathway. Others, like 2-Aminomuconate semialdehyde, 2-Amino-3-carboxymuconate semialdehyde, and 2-Oxoadipate, are downstream products of this pathway. The presence of these compounds indicates that the tryptophan metabolism pathway is indeed active and altered under the conditions of this experiment."}], "target": "Tryptophan metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ASMTL,AMPD2,ADSS2,PNP >>>\nList of compounds : <<< GMP,Inosine,N6-(1,2-Dicarboxyethyl)-AMP,5-Phospho-alpha-D-ribose 1-diphosphate,dCDP,XDP,CTP,Deoxyadenosine,ADP,Thymidine,UMP,ITP,Deoxyuridine,L-Glutamine,Deoxyinosine,UDP >>>"}, {"role": "assistant", "content": "The experiment revealed alterations in genes ASMTL, AMPD2, ADSS2, and PNP, along with various compounds including GMP, Inosine, N6-(1,2-Dicarboxyethyl)-AMP, 5-Phospho-alpha-D-ribose 1-diphosphate, dCDP, XDP, CTP, Deoxyadenosine, ADP, Thymidine, UMP, ITP, Deoxyuridine, L-Glutamine, Deoxyinosine, and UDP. These findings point towards the involvement of the Nucleotide metabolism pathway.\n\nASMTL and PNP are involved in purine metabolism, a sub-pathway of nucleotide metabolism. AMPD2 and ADSS2 are involved in pyrimidine metabolism, another sub-pathway. The altered compounds, such as GMP, Inosine, and UMP, are intermediates in these sub-pathways, further supporting the identification of the nucleotide metabolism pathway. The presence of L-Glutamine, a precursor for nucleotide synthesis, and Deoxyadenosine and Deoxyuridine, derivatives of nucleotides, also reinforce this conclusion."}], "target": "Nucleotide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PIGV,PIGP,PIGK,PIGC >>>\nList of compounds : <<< Phosphatidylethanolamine,UDP-N-acetyl-D-glucosamine,6-(alpha-D-glucosaminyl)-1D-myo-inositol,Ethanolamine phosphate,1-Phosphatidyl-D-myo-inositol,Phosphatidylethanolamine,Dolichyl phosphate D-mannose,Phosphatidylethanolamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycosylphosphatidylinositol (GPI)-anchor biosynthesis. This conclusion is supported by the alteration of genes PIGV, PIGP, PIGK, and PIGC, which are all directly involved in the GPI-anchor biosynthesis pathway. The presence of compounds such as Phosphatidylethanolamine, UDP-N-acetyl-D-glucosamine, 6-(alpha-D-glucosaminyl)-1D-myo-inositol, Ethanolamine phosphate, 1-Phosphatidyl-D-myo-inositol, Dolichyl phosphate D-mannose, and Phosphatidylethanolamine further corroborate this finding, as these are all intermediates or related compounds in the GPI-anchor biosynthesis pathway."}], "target": "Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< BCKDHA,GOT1L1,BCKDHB,BCAT2,IDH2,OGDH,DHTKD1,NAGS,GPT,ABHD14A-ACY1,DLD,ACY1,CS,PDHA2,PDHA1,GPT2,GOT2,IDH1,DBT,BCAT1,OGDHL,AADAT,ACO2,AGXT,ACO1 >>>\nList of compounds : <<< (-)-threo-Iso(homo)3-citrate,7-Methylthioheptyl glucosinolate,L-Glutamate,Phenylacetothiohydroximate,3-Methyl-2-oxobutanoic acid,LysW-L-glutamate,S-(Indolylmethylthiohydroximoyl)-L-cysteine,Sinalbin,4-Methyl-2-oxopentanoate,3-(5'-Methylthio)pentylmalic acid,(R)-2,3-Dihydroxy-3-methylbutanoate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the 2-Oxocarboxylic acid metabolism. This pathway involves the conversion of 2-oxocarboxylic acids into other compounds, which is crucial for energy production and amino acid synthesis.\n\nSeveral genes associated with this pathway, such as BCKDHA, BCKDHB, BCAT2, and IDH2, were altered. These genes are involved in the breakdown of branched-chain amino acids and the conversion of isocitrate to alpha-ketoglutarate, both of which are part of the 2-Oxocarboxylic acid metabolism.\n\nMoreover, the altered compounds such as L-Glutamate, 3-Methyl-2-oxobutanoic acid, and 4-Methyl-2-oxopentanoate, are intermediates or products of this pathway. The presence of these compounds further supports the involvement of the 2-Oxocarboxylic acid metabolism in the given condition."}], "target": "2-Oxocarboxylic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADH7,LDHA,PDHA2 >>>\nList of compounds : <<< Acetate,2-Phospho-D-glycerate,beta-D-Glucose 6-phosphate,Phosphoenolpyruvate,Enzyme N6-(lipoyl)lysine,D-Glucose,Acetaldehyde,Arbutin 6-phosphate,beta-D-Glucose,Salicin 6-phosphate,Salicin,Acetyl-CoA,Pyruvate,D-Glucose 1-phosphate,Ethanol,Enzyme N6-(dihydrolipoyl)lysine,alpha-D-Glucose >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycolysis/Gluconeogenesis. This conclusion is supported by the alteration of several key genes and compounds involved in these pathways. The genes ADH7 (Alcohol Dehydrogenase 7), LDHA (Lactate Dehydrogenase A), and PDHA2 (Pyruvate Dehydrogenase E1 Subunit Alpha 2) play crucial roles in glycolysis and gluconeogenesis. ADH7 is involved in ethanol metabolism, which is a byproduct of glycolysis. LDHA converts pyruvate to lactate, a step in anaerobic glycolysis. PDHA2 is a component of the pyruvate dehydrogenase complex, which links glycolysis to the citric acid cycle. The presence of compounds such as Acetaldehyde, Ethanol, Pyruvate, and Acetyl-CoA further supports the involvement of these pathways. The alteration of these genes and compounds suggests that glycolysis and/or gluconeogenesis may be dysregulated in the specific condition being studied."}], "target": "Glycolysis / Gluconeogenesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2A3,COX10,COX15,CPOX,BLVRA >>>\nList of compounds : <<< Precorrin 3A,Divinylprotochlorophyllide,Sirohydrochlorin,Coenzyme F430,Peroxidase,(S)-4-Amino-5-oxopentanoate,alpha-Ribazole,Porphobilinogen,Precorrin 3B,Bilirubin beta-diglucuronide,12,18-Didecarboxysiroheme,Siroheme,Heme A,8,12-Diethyl-3-vinylbacteriochlorophyllide d,Precorrin 8X,Chlorophyllide,L-Glutamyl-tRNA(Glu),5-Methoxybenzimidazole,3-Hydroxyethylbacteriochlorophyllide a,Pyropheophorbide a >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Porphyrin metabolism. This conclusion is supported by the alterations observed in several genes and compounds associated with this pathway. The genes UGT2A3, COX10, COX15, CPOX, and BLVRA are all involved in Porphyrin metabolism. UGT2A3 is responsible for the glucuronidation of bilirubin, a key compound in this pathway. COX10 and COX15 are involved in heme biosynthesis, a subpathway of Porphyrin metabolism. CPOX and BLVRA are also involved in heme biosynthesis, specifically in the conversion of protoporphyrinogen IX to protoporphyrin IX. The observed alterations in compounds such as Precorrin 3A, Divinylprotochlorophyllide, Sirohydrochlorin, Coenzyme F430, Porphobilinogen, Precorrin 3B, Bilirubin beta-diglucuronide, 12,18-Didecarboxysiroheme, Siroheme, Heme A, Precorrin 8X, Chlorophyllide, L-Glutamyl-tRNA(Glu), 5-Methoxybenzimidazole, 3-Hydroxyethylbacteriochlorophyllide a, and Pyropheophorbide a further support the identification of Porphyrin metabolism as the affected pathway."}], "target": "Porphyrin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PCYT1A,PLA2G2F,PLAAT2,LPGAT1,PLA2G10,,LPCAT3,CDIPT,DGKB,AGPAT1,CDS1,ETNK1,PLA2G2D,GPAT4,PLA2G1B,CEPT1 >>>\nList of compounds : <<< 1-Acyl-sn-glycerol 3-phosphate,Phosphatidylglycerophosphate,L-Serine,Heptaprenylglycerol,1-Acyl-sn-glycero-3-phosphoglycerol,sn-Glycero-3-phosphoethanolamine,1,2-Diacyl-sn-glycerol,Phosphatidyl-N-dimethylethanolamine,1-Acyl-sn-glycero-3-phosphoethanolamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycerophospholipid metabolism. This conclusion is supported by the observed alterations in several genes and compounds directly involved in this pathway. Genes such as PCYT1A, PLA2G2F, PLAAT2, LPGAT1, PLA2G10, LPCAT3, CDIPT, DGKB, AGPAT1, CDS1, ETNK1, PLA2G2D, GPAT4, PLA2G1B, and CEPT1 all play crucial roles in the synthesis, degradation, and remodeling of glycerophospholipids. The altered compounds, including 1-Acyl-sn-glycerol 3-phosphate, Phosphatidylglycerophosphate, L-Serine, Heptaprenylglycerol, 1-Acyl-sn-glycero-3-phosphoglycerol, sn-Glycero-3-phosphoethanolamine, 1,2-Diacyl-sn-glycerol, Phosphatidyl-N-dimethylethanolamine, and 1-Acyl-sn-glycero-3-phosphoethanolamine, are key intermediates or products of this pathway. Therefore, the changes observed in these genes and compounds strongly suggest the involvement of the Glycerophospholipid metabolism in the studied condition."}], "target": "Glycerophospholipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HTD2,ACSF3,ACACB,FASN,ACACA,OXSM,ACSL1,ACSL3,ACSBG2,HSD17B8,OLAH,MECR,CBR4,MCAT,ACSBG1,ACSL5,ACSL4,ACSL6 >>>\nList of compounds : <<< Malonate,Acetyl-CoA,trans-Hexadec-2-enoyl-[acp],Hexadecanoyl-[acp],Acyl-carrier protein,Dodecanoic acid,Long-chain fatty acid,trans-Oct-2-enoyl-[acp],3-Oxoacyl-[acyl-carrier protein],Butyryl-[acp],(2E)-Octadecenoyl-[acp],Acetoacetyl-[acp],(3R)-3-Hydroxypalmitoyl-[acyl-carrier protein],(3R)-3-Hydroxybutanoyl-[acyl-carrier protein] >>>"}, {"role": "assistant", "content": "The analysis of the provided list of genes and compounds suggests that the metabolic pathway involved is Fatty Acid Biosynthesis. This conclusion is supported by the presence of several key genes in this pathway, including FASN (Fatty Acid Synthase), ACACA and ACACB (Acetyl-CoA Carboxylase Alpha and Beta), ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6 (Acyl-CoA Synthetase Long-chain Family Members), and OXSM (3-Oxoacyl-[Acyl-Carrier-Protein] Synthase). These genes play crucial roles in the synthesis of long-chain fatty acids.\n\nAdditionally, the identified compounds, such as Acetyl-CoA, Acyl-carrier protein, Long-chain fatty acid, and various intermediates like trans-Hexadec-2-enoyl-[acp] and (3R)-3-Hydroxypalmitoyl-[acyl-carrier protein], are also characteristic of the fatty acid biosynthesis pathway. Therefore, it is highly likely that this pathway is significantly altered in the specific condition under investigation."}], "target": "Fatty acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ELOVL1,SCD5,ACOT2,SCD,ELOVL6,ELOVL5,HSD17B4,HACD3,ELOVL7,HACD1,BAAT,ELOVL4,HACD4,HSD17B12,FADS1,ACAA1,FADS2,ACOX3 >>>\nList of compounds : <<< Docosanoyl-CoA,(7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA,Tetracosenoyl-CoA,(8Z,11Z,14Z,17Z)-Icosatetraenoyl-CoA,Docosanoic acid,Ximenoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the \"Biosynthesis of unsaturated fatty acids\". This conclusion is drawn based on the altered genes and compounds. The genes listed, such as ELOVL1, ELOVL5, ELOVL6, and ELOVL7, are known to be involved in the elongation of very long-chain fatty acids. SCD5 and SCD are stearoyl-CoA desaturases, enzymes that introduce double bonds into saturated fatty acids. HACD1, HACD3, and HACD4 are involved in the hydroxyacyl-CoA dehydratase pathway, which is part of the unsaturated fatty acid biosynthesis. HSD17B4 and HSD17B12 are involved in steroid metabolism, but they can also act on fatty acids. FADS1 and FADS2 are delta-5 and delta-6 desaturases, respectively, which are crucial for the biosynthesis of polyunsaturated fatty acids. The compounds listed, such as Docosanoyl-CoA, (7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA, and Tetracosenoyl-CoA, are intermediates in the biosynthesis of unsaturated fatty acids. Therefore, the alteration of these genes and compounds strongly suggests the involvement of the biosynthesis of unsaturated fatty acids pathway in the given condition."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< MGAT3,SRD5A3,MGAT4A,B4GALT2,ST6GAL2,ALG12,MAGT1,MAN1A2,STT3B,ST6GAL1,ALG8,STT3A,B4GALT3,DPM2,MAN1C1,ALG13,MGAT2,ALG9,B4GALT1,TMEM258,DOLPP1,MGAT1,DOLK,MAN2A1,MGAT4D >>>\nList of compounds : <<< GDP-mannose,Dolichyl phosphate D-mannose,N-Acetyl-D-glucosaminyldiphosphodolichol,Dolichol >>>"}, {"role": "assistant", "content": "The experiment revealed that the N-Glycan biosynthesis pathway was significantly altered in the two conditions. This conclusion is supported by the alteration of multiple genes directly involved in this pathway, including MGAT1, MGAT2, MGAT3, MGAT4A, MGAT4D, ALG12, ALG13, ALG8, ALG9, B4GALT1, B4GALT2, B4GALT3, DPM2, MAN1A2, MAN1C1, MAN2A1, SRD5A3, ST6GAL1, ST6GAL2, STT3A, and STT3B. Additionally, the compounds GDP-mannose, Dolichyl phosphate D-mannose, N-Acetyl-D-glucosaminyldiphosphodolichol, and Dolichol, which are key intermediates in the N-Glycan biosynthesis pathway, were also found to be altered. These findings strongly suggest that the N-Glycan biosynthesis pathway plays a crucial role in the observed conditions."}], "target": "N-Glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACOT7,ACAA1,ELOVL6,FADS1,ELOVL2,ACOT2,BAAT,ELOVL4,ACOT1,TECR,ELOVL3,ACOT4,ELOVL7,ACOX1,FADS2 >>>\nList of compounds : <<< Icosadienoic acid,Linoleoyl-[acyl-carrier protein],Tetracosanoyl-CoA,Tetracosenoyl-CoA,Docosenoyl-CoA,Stearoyl-CoA,Oleoyl-CoA,(5Z,8Z,11Z)-Icosatrienoyl-CoA,(6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA,Ximenoyl-CoA,(9Z,12Z,15Z)-Octadecatrienoic acid,Montanoyl-CoA,Montanoyl-CoA,(13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA,(7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA,(9Z,12Z,15Z)-Octadecatrienoyl-CoA,Palmitoyl-CoA,Docosenoyl-CoA,(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA,(11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA,(6Z,9Z)-Hexadecadienoyl-CoA,Docosanoyl-CoA,Eicosanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Unsaturated Fatty Acids. This is evident from the alterations in genes such as ACOT7, ACAA1, ELOVL6, FADS1, ELOVL2, ACOT2, BAAT, ELOVL4, ACOT1, TECR, ELOVL3, ACOT4, ELOVL7, ACOX1, FADS2, which are all known to be involved in this pathway. The changes in compounds like Icosadienoic acid, Linoleoyl-[acyl-carrier protein], Tetracosanoyl-CoA, Tetracosenoyl-CoA, Docosenoyl-CoA, Stearoyl-CoA, Oleoyl-CoA, and others, which are intermediates or products of this pathway, further support this identification. The alterations in these genes and compounds suggest that the Biosynthesis of Unsaturated Fatty Acids pathway is significantly affected in the specific condition under study."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< AKR1B1,QDPR,CBR1,MOCS2 >>>\nList of compounds : <<< Glycolaldehyde,6-Lactoyl-5,6,7,8-tetrahydropterin,4-(beta-D-Ribofuranosyl)phenol 5'-phosphate,7,8-Dihydroneopterin,Tetrahydrobiopterin,7,8-Dihydroneopterin 3'-triphosphate,THF-polyglutamate,7,8-Dihydromonapterin,GTP,2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine,(8S)-3',8-Cyclo-7,8-dihydroguanosine 5'-triphosphate,5,6,7,8-Tetrahydromethanopterin,7,8-Dihydroneopterin 2'-phosphate,4-Aminobenzoate,Thio-molybdenum cofactor >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes and compounds is Folate biosynthesis. This conclusion is supported by several pieces of evidence. The gene MOCS2 is involved in the biosynthesis of molybdenum cofactor, a crucial component in the conversion of guanidinoacetate to creatine, a process that requires folate. The presence of 7,8-Dihydroneopterin, Tetrahydrobiopterin, and 7,8-Dihydroneopterin 3'-triphosphate, which are intermediates in the folate biosynthesis pathway, further supports this identification. Additionally, the presence of THF-polyglutamate, a form of folate, and 5,6,7,8-Tetrahydromethanopterin, a compound structurally similar to folate, provides additional support. The altered genes AKR1B1, QDPR, and CBR1, while not directly involved in folate biosynthesis, have been implicated in related pathways such as glucose metabolism and pteridine metabolism, which can indirectly affect folate levels."}], "target": "Folate biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< FUT1,GBGT1,B3GALT5,ST3GAL2,HEXB,ABO,FUT2,ST8SIA1,A3GALT2,NAGA,FUT9,HEXA,GLA,B3GALNT1,A4GALT >>>\nList of compounds : <<< Globo-A,Forssman antigen, IV3GalNAca-Gb4Cer,IV3GalNAcb-Gb4Cer,NORint,Disialosylglobopentaosylceramide,Globo-H,Globoside >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the metabolic pathway identified is the Glycosphingolipid biosynthesis - globo and isoglobo series. This pathway is characterized by the synthesis of complex glycosphingolipids, such as Globo-A, Forssman antigen, IV3GalNAca-Gb4Cer, IV3GalNAcb-Gb4Cer, NORint, Disialosylglobopentaosylceramide, Globo-H, and Globoside. The genes listed, including FUT1, GBGT1, B3GALT5, ST3GAL2, HEXB, ABO, FUT2, ST8SIA1, A3GALT2, NAGA, FUT9, HEXA, GLA, B3GALNT1, and A4GALT, encode for enzymes involved in the biosynthesis of these glycosphingolipids. The alterations in these genes and compounds suggest a dysregulation in this pathway, which may contribute to the specific condition being studied."}], "target": "Glycosphingolipid biosynthesis - globo and isoglobo series"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADH4,HADHB,EHHADH,CPT1B,ACSL1,HADHA,ACADS,ACSL3,ALDH3A2,ADH5,ACSL5,ACSBG1,ADH1B,ALDH7A1,GCDH,ALDH9A1 >>>\nList of compounds : <<< (S)-Hydroxyhexanoyl-CoA,Acyl-carrier protein,CoA,trans-Hexadec-2-enoyl-CoA,CoA >>>"}, {"role": "assistant", "content": "The data from the experiment indicates that the Fatty Acid Degradation pathway is significantly involved in the observed conditions. This conclusion is supported by the alterations in multiple genes associated with this pathway, including ADH4, HADHB, EHHADH, CPT1B, ACSL1, HADHA, ACADS, ACSL3, ALDH3A2, ADH5, ACSL5, ACSBG1, ADH1B, ALDH7A1, and GCDH. These genes encode enzymes that catalyze various steps in fatty acid degradation, such as oxidation, hydration, and dehydrogenation.\n\nFurthermore, the observation of altered compounds such as (S)-Hydroxyhexanoyl-CoA, Acyl-carrier protein, CoA, and trans-Hexadec-2-enoyl-CoA also supports this conclusion. These compounds are key intermediates in the fatty acid degradation pathway, and their alteration indicates a disruption in this pathway. The presence of CoA in the list of altered compounds is particularly notable, as it is a crucial cofactor in many enzymatic reactions involved in fatty acid degradation."}], "target": "Fatty acid degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALPI,ACP1,ALPP,ALPL,NTPCR,AK8,AK2,AK7,THTPA,AK4,NFS1,TPK1 >>>\nList of compounds : <<< 5-(2-Hydroxyethyl)-4-methylthiazole,Glycine,2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate,4-Methyl-5-(2-phosphooxyethyl)thiazole,Adenylyl-[sulfur-carrier protein],Thiamine aldehyde,[Enzyme]-S-sulfanylcysteine,ADP-5-ethyl-4-methylthiazole-2-carboxylate,2-(2-Carboxy-4-methylthiazol-5-yl)ethyl phosphate,Glycine,Thiamin diphosphate,Iminoglycine,4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate,4-Amino-5-aminomethyl-2-methylpyrimidine,Pyruvate,Thiamin triphosphate,Thiamine acetic acid,D-Glyceraldehyde 3-phosphate,L-Tyrosine,Thiamine,L-Cysteine,[Enzyme]-cysteine,Sulfur-carrier protein,Thiocarboxy-[sulfur-carrier protein] >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Thiamine metabolism, based on the alterations observed in both genes and compounds. The genes ALPI, ACP1, ALPP, and ALPL are involved in alkaline phosphatase activity, which is crucial in the release of free thiamine from its phosphorylated forms. The AK family genes (AK8, AK2, AK7, AK4) encode Adenylate Kinases, enzymes that participate in adenosine nucleotide metabolism and can interact with thiamin-containing compounds. NFS1 and TPK1 are associated with iron-sulfur cluster biosynthesis, which plays a role in thiamine-dependent enzymes.\n\nThe compound alterations further support the involvement of Thiamine metabolism. The presence of compounds such as Thiamine aldehyde, Thiamin diphosphate, Thiamin triphosphate, Thiamine acetic acid, and Thiamine indicate a disruption in Thiamine synthesis and metabolism. Additionally, the alteration of compounds like Adenylyl-[sulfur-carrier protein], [Enzyme]-S-sulfanylcysteine, and Sulfur-carrier protein, which are involved in thiamine-dependent enzymes, further suggests a disruption in Thiamine metabolism."}], "target": "Thiamine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NNMT,NMNAT1,SIRT6,NT5C1A,SIRT4,NMRK1 >>>\nList of compounds : <<< Nicotine,NAD+,Blue pigment,4-Aminobutanoate,N1-Methyl-4-pyridone-5-carboxamide,2,3-Dimethylmaleate,(2R,3S)-2,3-Dimethylmalate,L-Aspartate,Succinate,Fumarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Nicotinate and Nicotinamide metabolism. This is supported by the alterations in genes NNMT, NMNAT1, SIRT6, and NMRK1, which are all known to be involved in this pathway. NNMT is responsible for the methylation of nicotinamide, while NMNAT1 is involved in the synthesis of Nicotinamide Adenine Dinucleotide (NAD+). SIRT6 and NMRK1 also play roles in the NAD+ metabolism. The altered compounds, including Nicotine, NAD+, and N1-Methyl-4-pyridone-5-carboxamide, a metabolite of Nicotinamide, further confirm the involvement of this pathway. The other compounds, such as 4-Aminobutanoate, Succinate, and Fumarate, may indicate secondary effects on other metabolic pathways due to the disruption of Nicotinate and Nicotinamide metabolism."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SDS,BHMT,DNMT3B,LDHB,CTH,DNMT3A,ENOPH1,MTAP,ADI1,CDO1,MAT1A,SMS,AMD1,LDHAL6A,KYAT1,AGXT2,GSS,GOT1L1 >>>\nList of compounds : <<< gamma-L-Glutamyl-L-2-aminobutyrate,Aminoacyl-L-methionine,2,3-Diketo-5-methylthiopentyl-1-phosphate,N-Acyl-L-homoserine lactone,2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate,L-Methionine S-oxide,L-Methionine,L-Aspartate 4-semialdehyde,L-Homoserine,3-Sulfopyruvate,S-Adenosylmethioninamine,L-Cysteate,S-Inosyl-L-homocysteine,Sulfate,3-Phosphonooxypyruvate,3-Mercaptolactate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Cysteine and Methionine Metabolism. This conclusion is supported by the alterations in several key genes and compounds associated with this pathway. Genes such as SDS, BHMT, MAT1A, ADI1, and AMD1 are directly involved in the metabolism of cysteine and methionine. The altered compounds, including L-Methionine, L-Methionine S-oxide, L-Homoserine, L-Cysteate, and S-Adenosylmethioninamine, are intermediates or products of this pathway. Other genes like DNMT3A and DNMT3B, while not directly involved in this pathway, play a role in DNA methylation, which can influence gene expression in this pathway. Similarly, compounds like 3-Sulfopyruvate and Sulfate are related to sulfur metabolism, which is a key aspect of cysteine and methionine metabolism. Therefore, the evidence strongly suggests that the Cysteine and Methionine Metabolism pathway is involved in the condition under study."}], "target": "Cysteine and methionine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ASRGL1,GPT >>>\nList of compounds : <<< N-Acetylaspartylglutamylglutamate,Carbamoyl phosphate,N-Carbamoyl-L-aspartate,Pyruvate,Oxaloacetate,beta-Citryl-L-glutamate,N-Acetylaspartylglutamate,4-Aminobutanoate,D-Glucosamine 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Alanine, Aspartate, and Glutamate metabolism. This is supported by the alteration of two key genes, ASRGL1 and GPT, both of which are involved in this pathway. ASRGL1 encodes an enzyme that plays a role in the synthesis of N-Acetylaspartylglutamate, a compound that was found to be altered in this experiment. GPT, on the other hand, encodes an enzyme that catalyzes the interconversion of alanine and pyruvate and the interconversion of aspartate and oxaloacetate, which are also among the altered compounds. Furthermore, the presence of compounds such as N-Carbamoyl-L-aspartate and beta-Citryl-L-glutamate, which are intermediates in this pathway, further supports the identification of this metabolic pathway."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< COQ7,COQ2 >>>\nList of compounds : <<< 2-Phytyl-1,4-naphthoquinone,Geranylhydroquinone,2-Polyprenyl-6-hydroxyphenol,2-Methoxy-6-all-trans-polyprenyl-1,4-benzoquinol,Dihydroechinofuran,alpha-Tocotrienol,Dihydroshikonofuran,Phytyl diphosphate,(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate,3''-Hydroxy-geranylhydroquinone,delta-Tocotrienol,Phylloquinone,4-Hydroxy-3-polyprenylbenzoate,Geranyl diphosphate,L-Tyrosine,Geranylgeranyl diphosphate,2-Succinylbenzoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the given information is the Ubiquinone and other terpenoid-quinone biosynthesis pathway. This conclusion is supported by the presence of altered genes COQ7 and COQ2, which are both directly involved in this pathway. COQ7 is essential for the synthesis of coenzyme Q (ubiquinone), while COQ2 is involved in the early stages of ubiquinone biosynthesis. The observed changes in compounds such as 2-Phytyl-1,4-naphthoquinone, Geranylhydroquinone, and Phytyl diphosphate, among others, also align with this pathway as they are intermediates or analogs in the terpenoid-quinone biosynthesis process."}], "target": "Ubiquinone and other terpenoid-quinone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B4,ADH6,CYP3A4,ALDH3B1,GSTA2,ADH7,FMO1,GSTT1 >>>\nList of compounds : <<< Citalopram aldehyde,Carboxyphosphamide,Tamoxifen N-oxide,4-Ketoifosfamide,Morphine-6-glucuronide,Aldoifosfamide,3-Hydroxylidocaine,Morphine-3-glucuronide,Acrolein,Cyclophosphamide (INN) >>>"}, {"role": "assistant", "content": "Based on the genes and compounds provided, the metabolic pathway identified is Drug Metabolism - Cytochrome P450. This conclusion is supported by the presence of several key genes involved in this pathway, such as CYP3A4, ADH6, ADH7, FMO1, and UGT2B4. CYP3A4 is a major enzyme in drug metabolism, while UGT2B4 is involved in glucuronidation, a phase II detoxification process. ADH6 and ADH7 are alcohol dehydrogenases, and FMO1 is a flavin-containing monooxygenase, both of which are involved in phase I metabolism.\n\nThe compounds listed, such as Citalopram aldehyde, Carboxyphosphamide, Tamoxifen N-oxide, 4-Ketoifosfamide, Morphine-6-glucuronide, Aldoifosfamide, 3-Hydroxylidocaine, Morphine-3-glucuronide, Acrolein, and Cyclophosphamide, are known substrates or metabolites of the Cytochrome P450 enzyme system. Therefore, the alteration of these genes and compounds strongly suggests the involvement of the Drug Metabolism - Cytochrome P450 pathway."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALPL,ALPI,AK4,ALPG,NTPCR,AK8,AK5,NFS1,AK1,ALPP >>>\nList of compounds : <<< Thiocarboxy-[sulfur-carrier protein],Thiamine,1-Deoxy-D-xylulose 5-phosphate,5-(2-Hydroxyethyl)-4-methylthiazole,4-Methyl-5-(2-phosphooxyethyl)thiazole,2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate,Glycine,L-Cysteine,N-Formyl-4-amino-5-aminomethyl-2-methylpyrimidine,Thiamine aldehyde,Thiamin diphosphate,4-Amino-5-hydroxymethyl-2-methylpyrimidine,D-Glyceraldehyde 3-phosphate,L-Tyrosine,Thiamin monophosphate,Thiamine acetic acid,Adenylyl-[sulfur-carrier protein],4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate,4-Amino-5-aminomethyl-2-methylpyrimidine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Thiamine metabolism. This is supported by the presence of several key genes and compounds associated with this pathway. The genes ALPL, ALPI, AK4, ALPG, NTPCR, AK8, AK5, AK1, and ALPP are all involved in various aspects of cellular metabolism, including phosphate metabolism, nucleotide metabolism, and thiamine metabolism. The compounds Thiamine, Thiamine aldehyde, Thiamin diphosphate, Thiamin monophosphate, Thiamine acetic acid, and 4-Amino-5-hydroxymethyl-2-methylpyrimidine are all direct or indirect products of thiamine metabolism. Additionally, the presence of compounds like 1-Deoxy-D-xylulose 5-phosphate, 5-(2-Hydroxyethyl)-4-methylthiazole, 4-Methyl-5-(2-phosphooxyethyl)thiazole, and 2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, which are involved in the biosynthesis of thiamine, further supports this conclusion."}], "target": "Thiamine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PGM1,G6PC1,AGL,HK1,GYS2 >>>\nList of compounds : <<< D-Glucose 6-phosphate,D-Fructose,(2,1-beta-D-Fructosyl)n,Sucrose 6'-phosphate,Cellodextrin,1,3-beta-D-Glucan,alpha,alpha'-Trehalose 6-phosphate,6-Phospho-beta-D-glucosyl-(1,4)-D-glucose,Cyclomaltodextrin,D-Glucose,D-Fructose 6-phosphate,Maltodextrin,beta-D-Glucoside,D-Fructose 6-phosphate,alpha,alpha-Trehalose,D-Glucose >>>"}, {"role": "assistant", "content": "The identified metabolic pathway based on the given list of genes and compounds is the \"Starch and Sucrose Metabolism\" pathway. This is primarily due to the presence of genes directly involved in this pathway such as PGM1 (Phosphoglucomutase 1), G6PC1 (Glucose-6-Phosphatase, Catalytic Subunit 1), GYS2 (Glycogen Synthase 2), and HK1 (Hexokinase 1). These genes play crucial roles in the conversion and storage of glucose, fructose, and their phosphorylated forms. The altered compounds, including D-Glucose, D-Glucose 6-phosphate, D-Fructose, D-Fructose 6-phosphate, Sucrose 6'-phosphate, and various forms of glucans and maltodextrins, are key intermediates in this pathway, further supporting the identification of the Starch and Sucrose Metabolism pathway."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< G6PC3,GBE1,PGM2L1,HKDC1,,,,MGAM2,GYS1,GAA,PYGB,HK1,HK2,PYGL >>>\nList of compounds : <<< Sucrose,D-Glucose 6-phosphate,D-Glucose,D-Glucose,1-alpha-D-[(1-&gt;4)-alpha-D-Glucosyl](n-1)-alpha-D-glucopyranoside,alpha,alpha-Trehalose,UDP-glucose,(2,1-beta-D-Fructosyl)n,Dextran,D-Fructose,Cyclomaltodextrin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Starch and Sucrose Metabolism. This conclusion is drawn from the altered genes and compounds observed. Several genes involved in this pathway, such as G6PC3, GBE1, PGM2L1, HKDC1, MGAM2, GYS1, GAA, PYGB, HK1, HK2, and PYGL, were found to be altered. These genes play crucial roles in the breakdown and synthesis of carbohydrates, including starch and sucrose. The compounds identified, such as Sucrose, D-Glucose 6-phosphate, D-Glucose, alpha,alpha-Trehalose, UDP-glucose, (2,1-beta-D-Fructosyl)n, Dextran, D-Fructose, and Cyclomaltodextrin, are all intermediates or products in the Starch and Sucrose Metabolism pathway. Therefore, the alteration of these genes and compounds strongly suggests the involvement of the Starch and Sucrose Metabolism pathway in the observed condition."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP1A2,CYP2A7,NAT2,NAT1,XDH,CYP2A6 >>>\nList of compounds : <<< Glyoxylate,1,3,7-Trimethyluric acid,N,N'-Dimethylurea,Xanthine,3,6,8-Trimethylallantoin,5-Acetylamino-6-amino-3-methyluracil,Caffeine,1-Methylxanthine,7-Methyluric acid,3,7-Dimethyluric acid,7-Methylxanthine,Xanthosine,N-Methylurea,Theophylline,1,3,7-Trimethyl-5-hydroxyisourate,5-Acetylamino-6-formylamino-3-methyluracil,1-Methyluric acid,1,7-Dimethyluric acid,1,7-Dimethylxanthine,Theobromine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Caffeine metabolism pathway. This conclusion is supported by the presence of several genes and compounds involved in this process. The genes CYP1A2, CYP2A6, and CYP2A7, which are known to be responsible for the metabolism of caffeine and other xenobiotics, were altered. Furthermore, the presence of caffeine and its metabolites, such as 1-methylxanthine, 7-methylxanthine, theophylline, and theobromine, among other compounds, suggest that this pathway is indeed active. The altered compounds like 1,3,7-Trimethyluric acid, 3,6,8-Trimethylallantoin, and 1,3,7-Trimethyl-5-hydroxyisourate, are also related to caffeine metabolism, indicating a disturbance in this pathway."}], "target": "Caffeine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DHFR2,UGT2B28,HAAO,GPHN,DHRS3,GCLC,ALDH2,AKR1A1,PHOSPHO2,AK5,TPK1,MOCS2,UGT2B17,NME1-NME2,RFK,ADSL,AK1,COQ5,UGT2A1,NADK2,PANK3,MTHFD1,UGT1A10 >>>\nList of compounds : <<< Dehypoxanthine futalosine,Cobalt-precorrin 5A,gamma-L-Glutamyl-L-cysteine,Dihydrolipoylprotein,Coenzyme F420-1,8-Amino-7-oxononanoate,4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate,Chorismate,5,6,7,8-Tetrahydromethanopterin,Pimelate,3-Demethylubiquinol,Uroporphyrinogen III,Homogentisate,3-Aminopropanal,Nickel-sirohydrochlorin a,c-diamide >>>"}, {"role": "assistant", "content": "The altered genes and compounds in this experiment suggest that the metabolic pathway involved is the Biosynthesis of Cofactors. Several genes such as GCLC, COQ5, and MTHFD1 are involved in the production of cofactors like glutathione, CoQ10, and folate, respectively. The presence of compounds such as Cobalt-precorrin 5A, Coenzyme F420-1, and Nickel-sirohydrochlorin a, which are intermediates or final products in cofactor biosynthesis, further supports this. Additionally, the alteration in genes like DHFR2, ALDH2, and AK1, which are involved in redox reactions utilizing cofactors, also indicates a direct link to this pathway."}], "target": "Biosynthesis of cofactors"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP46A1,AKR1D1,AMACR,HSD17B4,CYP27A1,CYP7B1,AKR1C4,CYP8B1,ACOT8,CYP39A1,ACOX2,SLC27A5,CYP7A1,BAAT,HSD3B7 >>>\nList of compounds : <<< 3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA,Chenodeoxycholoyl-CoA,Cholic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is primary bile acid biosynthesis. This pathway is characterized by the conversion of cholesterol to primary bile acids, cholic acid and chenodeoxycholic acid, in the liver. The altered genes in this study, such as CYP7A1, CYP27A1, CYP8B1, CYP7B1, CYP46A1, and CYP39A1, are known to be involved in the biosynthesis and metabolism of bile acids. Additionally, the enzymes encoded by these genes, such as cholesterol 7-alpha-hydroxylase (CYP7A1), sterol 27-hydroxylase (CYP27A1), and 12-alpha-hydroxylase (CYP8B1), are responsible for the conversion of cholesterol to primary bile acids. Furthermore, the altered compounds in this study, such as 3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA and Chenodeoxycholoyl-CoA, are intermediates in the primary bile acid biosynthesis pathway. Therefore, it is likely that the altered genes and compounds in this study are related to changes in the primary bile acid biosynthesis pathway."}], "target": "Primary bile acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< TIGAR,HKDC1,MPI,SORD,ENOSF1,PFKFB4,GMPPA,PFKP,GMPPB,TPI1,ALDOB,AKR1B1,FPGT,FBP1,PMM2,PMM1,AKR1B15,GMDS,TKFC,FCSK,PFKL,PFKFB2 >>>\nList of compounds : <<< D-Fructose 6-phosphate,beta-D-Fructose 2-phosphate,Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,2-Dehydro-3-deoxy-L-fuconate,alpha-D-Glucose,D-Mannitol 1-phosphate,L-Fuculose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Fructose and Mannose Metabolism pathway. This conclusion is supported by the alterations observed in multiple genes and compounds directly involved in this pathway. The genes include TIGAR, HKDC1, MPI, SORD, PFKP, TPI1, ALDOB, and PFKL, which are all key enzymes in the fructose metabolism process. The compounds D-Fructose 6-phosphate, beta-D-Fructose 2-phosphate, and alpha-D-Glucose also provide direct evidence for this pathway's involvement. The presence of D-Mannitol 1-phosphate and L-Fuculose 1-phosphate further suggest a connection to mannose metabolism. Therefore, the altered genes and compounds strongly indicate that the Fructose and Mannose Metabolism pathway is involved in the condition under study."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NAT8L,ASL,ADSS2,NIT2 >>>\nList of compounds : <<< Ammonia,Oxaloacetate,N-Acetylaspartylglutamate,L-Alanine,D-Aspartate,L-Aspartate,Fumarate,L-Glutamate,L-Asparagine,Citrate,(S)-1-Pyrroline-5-carboxylate,N-Acetylaspartylglutamylglutamate,4-Aminobutanoate,D-Glucosamine 6-phosphate,2-Oxoglutarate,Pyruvate,2-Oxosuccinamate,5-Phosphoribosylamine,N-(L-Arginino)succinate,N6-(1,2-Dicarboxyethyl)-AMP,Carbamoyl phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Alanine, Aspartate, and Glutamate Metabolism pathway. This conclusion is supported by the alterations in several key genes and compounds associated with this pathway. The genes NAT8L, ASL, ADSS2, and NIT2 are all involved in this pathway. NAT8L is involved in the synthesis of N-acetylaspartylglutamate, a compound that was altered in the experiment. ASL and ADSS2 are involved in the synthesis of aspartate and N-acetylaspartate, respectively, both of which were also altered. NIT2 is involved in the conversion of nitrite to ammonia, which was also found to be altered. Furthermore, the compounds L-Alanine, D-Aspartate, L-Aspartate, L-Glutamate, L-Asparagine, and 2-Oxoglutarate, all key components of this pathway, were also found to be altered. Therefore, it is reasonable to conclude that the Alanine, Aspartate, and Glutamate Metabolism pathway is significantly affected in this experiment."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GLS,DGLUCY >>>\nList of compounds : <<< Glycine,Oxaloacetate,Bacitracin,5-D-Glutamyl-D-glutamyl-peptide,L-Arginine,L-Proline,5-Amino-2-oxopentanoic acid,D-Alanyl-alanyl-poly(glycerolphosphate),(2S)-2-Amino-4-{[(1R)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}butanoate,Pyruvate,2-Amino-4-oxopentanoic acid,D-Cysteine,2-Oxo-4-hydroxy-5-aminovalerate,D-Alanine,L-Ornithine,LL-2,6-Diaminoheptanedioate,2-Oxoglutarate,N-Acetyl-D-phenylalanine,2,5-Dioxopentanoate,D-Serine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is D-Amino acid metabolism. This identification is supported by the altered genes and compounds. The genes GLS (Glutaminase) and DGLUCY (D-glucosamine-6-phosphate deaminase) are involved in amino acid metabolism, particularly glutamine and D-glucosamine-6-phosphate respectively. The presence of D-amino acids such as D-Alanine, D-Cysteine, and D-Serine, as well as the compound D-Alanyl-alanyl-poly(glycerolphosphate), further indicates alterations in D-Amino acid metabolism. Additionally, the compound LL-2,6-Diaminoheptanedioate, a derivative of D-amino acids, also supports this conclusion. The involvement of these genes and compounds suggests that the D-Amino acid metabolism pathway is significantly affected in the specific condition being studied."}], "target": "D-Amino acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HYAL1,GNS,HYAL3,GUSB,HYAL4,SPAM1,IDS,HEXB,HGSNAT,NAGLU,HPSE,ARSB,HYAL2 >>>\nList of compounds : <<< Chondroitin 4-sulfate,Dermatan sulfate,Hyaluronic acid,DWA-2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycosaminoglycan (GAG) degradation. This conclusion is supported by the altered genes and compounds observed. The genes HYAL1, HYAL2, HYAL3, and HYAL4 are hyaluronidases, enzymes responsible for degrading hyaluronic acid, a type of GAG. GUSB, IDS, ARSB, and HEXB are lysosomal enzymes involved in the degradation of various GAGs. GNS, SPAM1, HGSNAT, and NAGLU are involved in the synthesis and modification of GAGs, suggesting a potential feedback mechanism in response to altered GAG levels. The compounds Chondroitin 4-sulfate, Dermatan sulfate, and Hyaluronic acid are all GAGs, further supporting the identification of this pathway. The presence of DWA-2, a compound used in the study of GAG degradation, further strengthens this conclusion."}], "target": "Glycosaminoglycan degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP2A6,CYP1A2,CYP2A7,NAT2,XDH,NAT1 >>>\nList of compounds : <<< 1,7-Dimethylxanthine,Glyoxylate,N-Methylurea,3,7-Dimethyluric acid,5-Acetylamino-6-amino-3-methyluracil,1,3,7-Trimethyluric acid,Xanthine,7-Methylxanthine,7-Methylxanthosine,7-Methyluric acid,1-Methyluric acid,Xanthosine,N,N'-Dimethylurea,5-Acetylamino-6-formylamino-3-methyluracil,1,7-Dimethyluric acid,Caffeine,1-Methylxanthine,1,3,7-Trimethyl-5-hydroxyisourate,3-Methylxanthine,Theophylline >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Caffeine metabolism pathway. This conclusion is based on the altered genes and compounds observed. The genes, including CYP2A6, CYP1A2, CYP2A7, NAT2, and XDH, are known to be involved in caffeine metabolism. CYP2A6 and CYP1A2 are primarily responsible for the metabolism of caffeine, while CYP2A7, NAT2, and XDH play secondary roles. The presence of compounds such as caffeine, 1,7-Dimethylxanthine, Glyoxylate, and various methylated and acetylated derivatives of xanthine and uric acid further supports this conclusion. These compounds are intermediate products in the caffeine metabolism pathway, and their alteration suggests a dysfunction in this pathway."}], "target": "Caffeine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DPM2,PIGS,PIGZ,PIGF,PIGN,PIGU,PIGP,PIGM,GPAA1,PIGQ,PIGC,PIGH,PIGB,PIGX,PIGW,PIGA,PIGK,PIGV,PIGG,MPPE1,GPLD1,PIGO,PIGL,PGAP1 >>>\nList of compounds : <<< Palmitoyl-CoA,Dolichyl phosphate D-mannose,1-Phosphatidyl-D-myo-inositol,UDP-N-acetyl-D-glucosamine,Phosphatidylethanolamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway. This conclusion is based on the significant alterations observed in multiple genes and compounds directly involved in this pathway. Genes such as DPM2, PIGS, PIGZ, PIGF, PIGN, PIGU, PIGP, PIGM, GPAA1, PIGQ, PIGC, PIGH, PIGB, PIGX, PIGW, PIGA, PIGK, PIGV, PIGG, MPPE1, GPLD1, PIGO, PIGL, and PGAP1 are all known to play crucial roles in the GPI-anchor biosynthesis process. Furthermore, the observed changes in the compounds, including Palmitoyl-CoA, Dolichyl phosphate D-mannose, 1-Phosphatidyl-D-myo-inositol, UDP-N-acetyl-D-glucosamine, and Phosphatidylethanolamine, are all key intermediates or substrates in this pathway. Therefore, the alterations in these genes and compounds strongly suggest that the GPI-anchor biosynthesis pathway is significantly affected in the given condition."}], "target": "Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PIGS,PIGL,PIGU,PIGB,GPLD1,GPAA1,PIGV,PIGG,PIGZ >>>\nList of compounds : <<< Ethanolamine phosphate,Dolichyl phosphate D-mannose >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway. This pathway is characterized by the alteration of genes such as PIGS, PIGL, PIGU, PIGB, PIGV, PIGG, and PIGZ, all of which encode enzymes involved in the synthesis of the GPI anchor. The altered compounds, Ethanolamine phosphate and Dolichyl phosphate D-mannose, are key intermediates in this pathway. Ethanolamine phosphate is a precursor for the synthesis of the GPI anchor's core glycan, while Dolichyl phosphate D-mannose is involved in the transfer of mannose residues during GPI anchor biosynthesis. The alteration of these genes and compounds suggests a disruption in the GPI-anchor biosynthesis pathway."}], "target": "Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACOT1,ELOVL3,HACD1,ACOX3,ACOT7,FADS1,HACD2,SCD5,ELOVL6,ELOVL7,HACD3,FADS2,ELOVL4,HSD17B4 >>>\nList of compounds : <<< Ximenoyl-CoA,Adrenic acid,(5Z,8Z,11Z)-Icosatrienoyl-CoA,Docosenoyl-CoA,Tetracosenoyl-CoA,Stearoyl-CoA,8,11,14-Eicosatrienoyl-CoA,Arachidonyl-CoA,(6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA,Octadecanoyl-[acyl-carrier protein],(7Z,10Z,13Z)-Docosatrienoyl-CoA,Tetracosanoyl-CoA,Oleoyl-CoA,Palmitoyl-CoA,Sapienoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Unsaturated Fatty Acids. This conclusion is supported by the alteration of multiple genes and compounds associated with this pathway. The genes ACOT1, ACOX3, ACOT7, FADS1, FADS2, SCD5, ELOVL3, ELOVL4, ELOVL6, ELOVL7, HACD1, HACD2, and HACD3 are all involved in the synthesis, elongation, or desaturation of unsaturated fatty acids. Similarly, the compounds Ximenoyl-CoA, Adrenic acid, (5Z,8Z,11Z)-Icosatrienoyl-CoA, Docosenoyl-CoA, Tetracosenoyl-CoA, Stearoyl-CoA, 8,11,14-Eicosatrienoyl-CoA, Arachidonyl-CoA, (6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA, Octadecanoyl-[acyl-carrier protein], (7Z,10Z,13Z)-Docosatrienoyl-CoA, Tetracosanoyl-CoA, Oleoyl-CoA, Palmitoyl-CoA, and Sapienoyl-CoA are intermediates or products in this pathway. Therefore, the alteration of these genes and compounds strongly suggests the involvement of the Biosynthesis of Unsaturated Fatty Acids pathway in the condition under study."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH5A1,GFPT1,GLUL,NAT8L,GLUD2,RIMKLB,GLS2,GFPT2,GLUD1,ADSS2,ABAT,ASS1,FOLH1,GAD1,GAD2,ASNS,CAD,AGXT,ASRGL1 >>>\nList of compounds : <<< Succinate semialdehyde,L-Alanine,Fumarate,D-Glucosamine 6-phosphate,N-Acetylaspartylglutamate,N-Acetyl-L-aspartate,Succinate,L-Glutamate,4-Aminobutanoate,N-(L-Arginino)succinate,L-Aspartate,N6-(1,2-Dicarboxyethyl)-AMP,beta-Citryl-L-glutamate,(S)-1-Pyrroline-5-carboxylate,Pyruvate,Citrate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Alanine, Aspartate, and Glutamate Metabolism pathway. This conclusion is based on the observation of altered metabolic genes and compounds associated with this pathway. The genes ALDH5A1, GFPT1, GLUL, NAT8L, GLUD2, RIMKLB, GLS2, GFPT2, GLUD1, ADSS2, ABAT, ASS1, FOLH1, GAD1, GAD2, ASNS, CAD, AGXT, and ASRGL1 are all involved in this pathway, with roles in amino acid synthesis, transportation, and degradation.\n\nThe altered compounds further support this identification. Succinate semialdehyde, L-Alanine, Fumarate, D-Glucosamine 6-phosphate, N-Acetylaspartylglutamate, N-Acetyl-L-aspartate, Succinate, L-Glutamate, 4-Aminobutanoate, N-(L-Arginino)succinate, L-Aspartate, N6-(1,2-Dicarboxyethyl)-AMP, beta-Citryl-L-glutamate, (S)-1-Pyrroline-5-carboxylate, Pyruvate, and Citrate are all intermediates or products of this pathway. Therefore, the changes in these genes and compounds suggest that the Alanine, Aspartate, and Glutamate Metabolism pathway is significantly affected in the experimental conditions."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP11A1,CYP7B1,UGT1A3,SRD5A1,UGT1A6,UGT2A2,AKR1C1,HSD11B1,HSD3B1,AKR1D1,UGT2A1,AKR1C2,UGT2B17,CYP1B1,UGT2A3,UGT2B15,UGT1A1 >>>\nList of compounds : <<< 16alpha-Hydroxyestrone,20alpha-Hydroxy-4-pregnen-3-one,7alpha-Hydroxytestosterone,Aldosterone,11beta-Hydroxyandrost-4-ene-3,17-dione,Cortisone,Progesterone,2-Methoxy-17beta-estradiol,5alpha-Pregnane-3alpha,20alpha-diol,11beta-Hydroxyandrost-4-ene-3,17-dione,5alpha-Dihydrodeoxycorticosterone,Testosterone,Androsterone glucuronide,11beta,17alpha,21-Trihydroxypregnenolone,Allopregnanolone,5alpha-Pregnane-3,20-dione,Androstenedione,7alpha-Hydroxypregnenolone,19-Hydroxytestosterone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Steroid hormone biosynthesis pathway. This conclusion is supported by the significant alterations observed in genes associated with steroid hormone synthesis, metabolism, and signaling, such as CYP11A1, CYP7B1, HSD11B1, HSD3B1, and AKR1C1, among others. Additionally, the changes in compounds like 16alpha-Hydroxyestrone, Aldosterone, Cortisone, Progesterone, Testosterone, and Androstenedione, which are key intermediates or final products in this pathway, further substantiate the involvement of steroid hormone biosynthesis in the observed condition. The alterations in these genes and compounds provide strong evidence for the role of the Steroid hormone biosynthesis pathway in the specific condition under study."}], "target": "Steroid hormone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACADSB,ELOVL2,HACD3,ACOX1,ACSL4,HADH,FADS2 >>>\nList of compounds : <<< (3R,6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosapentaenoyl-CoA,(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA,Hexanoyl-[acp],3-Oxooctanoyl-CoA,(11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA,(11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA,(S)-3-Hydroxyhexadecanoyl-CoA,Eicosanoyl-CoA,(S)-3-Hydroxyoctanoyl-CoA,trans-Dodec-2-enoyl-[acp],Stearoyl-CoA,But-2-enoyl-[acyl-carrier protein],trans-Oct-2-enoyl-[acp],3-Oxooctanoyl-[acp],Malonyl-[acyl-carrier protein],(3R)-3-Hydroxydodecanoyl-[acyl-carrier protein],8,11,14-Eicosatrienoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the given list of genes and compounds is Fatty Acid Metabolism. This conclusion is drawn from the presence of several key genes involved in this pathway, such as ACADSB (medium-chain acyl-CoA dehydrogenase), ACOX1 (acyl-CoA oxidase 1), HADH (hydroxyacyl-CoA dehydrogenase), and ACSL4 (acyl-CoA synthetase long-chain family member 4). These genes play crucial roles in the breakdown (beta-oxidation), synthesis, and transport of fatty acids.\n\nMoreover, the altered compounds, which include various acyl-CoAs and fatty acids, are intermediates or products of fatty acid metabolism. For instance, (3R,6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosapentaenoyl-CoA and (2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA are long-chain fatty acids, while Malonyl-[acyl-carrier protein] is a key intermediate in fatty acid synthesis. Therefore, the changes in these compounds further support the involvement of fatty acid metabolism in the given condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT1,PAH,TAT,IL4I1 >>>\nList of compounds : <<< N-(5-Phospho-D-ribosyl)anthranilate,Anthranilate,Chorismate,D-Erythrose 4-phosphate,2-Benzylmalic acid,2-Amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid,3-Dehydroshikimate,Indoleglycerol phosphate,L-Phenylalanine,6-Deoxy-5-ketofructose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Phenylalanine, tyrosine, and tryptophan biosynthesis\" pathway, based on the alterations observed in the genes and compounds. The genes GOT1 (Glutamic-oxaloacetic transaminase 1), PAH (Phenylalanine hydroxylase), and TAT (Tyrosine aminotransferase) are directly involved in this pathway. PAH is responsible for converting phenylalanine to tyrosine, while TAT converts tyrosine to 4-hydroxyphenylpyruvate. GOT1, although not directly involved in this pathway, can indirectly influence amino acid metabolism, including phenylalanine metabolism. The altered compounds, such as N-(5-Phospho-D-ribosyl)anthranilate, Anthranilate, Chorismate, and Indoleglycerol phosphate, are intermediates in this pathway, further supporting its involvement. The presence of L-Phenylalanine and its derivatives also suggests perturbations in this pathway. Therefore, the observed changes in genes and compounds strongly indicate an alteration in the phenylalanine, tyrosine, and tryptophan biosynthesis pathway."}], "target": "Phenylalanine, tyrosine and tryptophan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< HK2,HKDC1 >>>\nList of compounds : <<< 6'-Oxokanamycin X,6'''-Deamino-6'''-hydroxyparomomycin II,6'''-Deamino-6'''-oxoneomycin C,Xylostasin,Kanamycin D,Tobramycin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Neomycin, kanamycin, and gentamicin biosynthesis\" pathway. This conclusion is supported by the alterations in the genes HK2 and HKDC1, and the compounds 6'-Oxokanamycin X, 6'''-Deamino-6'''-hydroxyparomomycin II, 6'''-Deamino-6'''-oxoneomycin C, Xylostasin, Kanamycin D, and Tobramycin. These compounds are intermediates or derivatives of the neomycin, kanamycin, and gentamicin biosynthesis pathway. The genes HK2 and HKDC1, which encode hexokinase enzymes, are involved in the initial steps of this pathway by phosphorylating the substrate glucose. Therefore, alterations in these genes could potentially affect the flux through the biosynthesis pathway."}], "target": "Neomycin, kanamycin and gentamicin biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< GUSB,TYMP,RRM2B,GSTT1,CES2,UGT1A8,GSTA5,XDH,NME7,ITPA >>>\nList of compounds : <<< Isonicotinylglycine,5'-Deoxy-5-fluorocytidine,6-Mercaptopurine ribonucleoside triphosphate,5-Fluorouridine,Hepatotoxins,alpha-Fluoro-beta-alanine,6-Thioxanthine 5'-monophosphate,Doxifluridine (JP18/INN),Fluorouracil (JP18/USP/INN),APC,N,N'-Diacetylhydrazine,Isoniazid alpha-ketoglutaric acid,6-Thiourate,Carmofur (JP18/INN),Thioguanine,5-Fluorouridine triphosphate,NPC,5-Fluorouridine monophosphate,5-Fluorodeoxyuridine triphosphate,Hydrazine,5-Fluorodeoxyuridine diphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Drug metabolism - other enzymes.\" This is supported by the alterations in several genes and compounds associated with this pathway. The genes GUSB, TYMP, RRM2B, GSTT1, CES2, UGT1A8, GSTA5, and XDH are known to be involved in the metabolism of various drugs, including enzymatic reactions such as glucuronidation, sulfation, and glutathione conjugation. The altered compounds, such as Isonicotinylglycine, 5'-Deoxy-5-fluorocytidine, 6-Mercaptopurine ribonucleoside triphosphate, and Fluorouracil, are substrates for these enzymes and are metabolized through this pathway. The presence of hepatotoxins, N,N'-Diacetylhydrazine, and Hydrazine suggest potential toxicity and disruption of this pathway. Overall, these findings indicate that the \"Drug metabolism - other enzymes\" pathway is involved in the specific condition under investigation."}], "target": "Drug metabolism - other enzymes"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLPP2,PLD2,PEDS1-UBE2V1,PEDS1,PLA2G10,PLD4 >>>\nList of compounds : <<< 1-(1-Alkenyl)-sn-glycerol,O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine,2-Acetyl-1-alkyl-sn-glycero-3-phosphate,sn-Glycero-3-phosphocholine,2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine,1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine,O-Alkylglycerone phosphate,2-Acyl-1-alkyl-sn-glycero-3-phosphate,1-Alkenyl-2-acylglycerol,1-Alkyl-sn-glycerol,Seminolipid,1-Alkyl-sn-glycero-3-phosphate,1-Radyl-2-acyl-sn-glycero-3-phosphocholine,1-(1-Alkenyl)-sn-glycero-3-phosphate,1-Alkyl-2-acetyl-sn-glycerol,sn-Glycero-3-phosphoethanolamine,1-Organyl-2-lyso-sn-glycero-3-phosphocholine,1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol,Galactosyl-1-alkyl-2-acylglycerol,1-Alkyl-2-acylglycerol,Plasmenylcholine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Ether Lipid Metabolism. This conclusion is supported by the alterations in multiple genes and compounds associated with this pathway. The genes PLPP2, PLD2, PLA2G10, and PLD4 are involved in the synthesis and degradation of ether lipids. The compounds, such as 1-(1-Alkenyl)-sn-glycerol, O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine, and Plasmenylcholine, are intermediate or final products of the ether lipid metabolism. The alterations in these genes and compounds suggest a dysregulation in this pathway, which could be a significant factor in the observed condition."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< INPP4A,PI4K2B,PI4K2A,INPPL1,INPP5B,CDIPT,PLCH2,PLCZ1,TPI1,PLCD1,SYNJ1,INPP5F >>>\nList of compounds : <<< D-myo-Inositol 1,3-bisphosphate,D-myo-Inositol 1,4,5-trisphosphate,D-Glucose 6-phosphate,3-Oxopropanoate,2,4,6/3,5-Pentahydroxycyclohexanone,D-Tagaturonate,1,2-Diacyl-sn-glycerol,3D-3,5/4-Trihydroxycyclohexane-1,2-dione,1-Phosphatidyl-1D-myo-inositol 5-phosphate,2-Deoxy-5-keto-D-gluconic acid,Acetyl-CoA,CDP-1L-myo-inositol,1D-myo-Inositol 1,3,4,5,6-pentakisphosphate,1D-myo-Inositol 1,4,5,6-tetrakisphosphate,D-Glyceraldehyde 3-phosphate,1-Keto-D-chiro-inositol,1D-myo-Inositol 3-phosphate,scyllo-Inositol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Inositol phosphate metabolism pathway, based on the altered genes and compounds. The involvement of this pathway is evident from the presence of several genes that regulate inositol phosphate metabolism, such as INPP4A, PI4K2B, PI4K2A, INPPL1, INPP5B, SYNJ1, and INPP5F. These genes are involved in the synthesis and degradation of various inositol phosphate compounds.\n\nThe altered compounds further support this conclusion, as many of them are intermediates or products of the Inositol phosphate metabolism pathway, including D-myo-Inositol 1,3-bisphosphate, D-myo-Inositol 1,4,5-trisphosphate, CDP-1L-myo-inositol, 1D-myo-Inositol 1,3,4,5,6-pentakisphosphate, 1D-myo-Inositol 1,4,5,6-tetrakisphosphate, and 1D-myo-Inositol 3-phosphate. The presence of these compounds suggests an active and potentially dysregulated inositol phosphate metabolism in the given condition."}], "target": "Inositol phosphate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PTGS2,PLA2G1B,CYP4F8,CYP2C19,PTGR2,GGT1,PLA2G10,JMJD7-PLA2G4B,AKR1C3,PTGES2,TBXAS1,PTGES,CYP2C8,GPX4,ALOX12,CYP2J2,ALOX12B,PLAAT2 >>>\nList of compounds : <<< 11(R)-HETE,9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid,Prostaglandin B2,Lipoxin B4,Delta-12-Prostaglandin J2,8,9-EET,5(S)-HPETE,12-OxoETE >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes and compounds is the Arachidonic Acid Metabolism pathway. The genes listed, such as PTGS2, PLA2G1B, CYP4F8, CYP2C19, PTGR2, and ALOX12, are all involved in the metabolism of arachidonic acid. These genes encode enzymes that convert arachidonic acid into various bioactive lipids, including prostaglandins, leukotrienes, and thromboxanes. The identified compounds, such as 11(R)-HETE, Prostaglandin B2, and Lipoxin B4, are products of this metabolism, further supporting the involvement of this pathway. Therefore, the alterations in these genes and compounds suggest a significant role for the Arachidonic Acid Metabolism pathway in the observed condition."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GLDC,RPIA,RPEL1,SHMT2,ME1,PGAM2,GPI,ME3,IDH3G,ENO3,RGN,HAO1,H6PD,ACOX1,ALDOA,PGK2,PRPS2 >>>\nList of compounds : <<< (S)-3-Hydroxybutanoyl-CoA,Succinate semialdehyde,3-Phospho-D-glyceroyl phosphate,2-Dehydro-3-deoxy-D-gluconate,Oxaloacetate,L-Serine,CO,5,10-Methenyltetrahydromethanopterin,Pyruvate,D-Xylulose 5-phosphate,3-Methylfumaryl-CoA,Coenzyme B,2-Phosphoglycolate,3-Phospho-D-glycerate,D-Glyceraldehyde,D-Gluconic acid,(R)-Methylmalonyl-CoA,Coenzyme M >>>"}, {"role": "assistant", "content": "Based on the list of altered genes and compounds, the metabolic pathway identified is Carbon metabolism. This pathway involves the breakdown and synthesis of various carbon molecules, including sugars, amino acids, and fatty acids.\n\nThe genes GLDC, RPIA, SHMT2, ME1, PGAM2, ENO3, ALDOA, and PGK2 are involved in glycolysis and the pentose phosphate pathway, which are key components of carbon metabolism. The genes ME3, IDH3G, and ACOX1 are associated with the tricarboxylic acid (TCA) cycle and fatty acid oxidation, also part of carbon metabolism.\n\nThe compounds (S)-3-Hydroxybutanoyl-CoA, Succinate semialdehyde, 3-Phospho-D-glyceroyl phosphate, 2-Dehydro-3-deoxy-D-gluconate, Oxaloacetate, Pyruvate, D-Xylulose 5-phosphate, 3-Methylfumaryl-CoA, 2-Phosphoglycolate, 3-Phospho-D-glycerate, D-Glyceraldehyde, D-Gluconic acid, and (R)-Methylmalonyl-CoA are all intermediates or products in the various processes of carbon metabolism.\n\nTherefore, the alteration of these genes and compounds strongly suggests involvement in the Carbon metabolism pathway."}], "target": "Carbon metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SELENBP1,BPNT1,PAPSS1 >>>\nList of compounds : <<< Sulfate,L-Cysteine,Adenosine 3',5'-bisphosphate,Succinate,Taurine,Adenylyl sulfate,Sulfate,Polysulfide,3'-Phosphoadenylyl sulfate,Thiosulfate,Sulfur,O-Acetyl-L-serine,Methanesulfonic acid,L-Serine,Dimethyl sulfide,Taurine,3-(Methylthio)propanoyl-CoA,3-(Methylthio)propanoate,Dimethyl sulfoxide,L-Homocysteine,Thiosulfate,Sulfate,Alkanesulfonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is sulfur metabolism. This conclusion is supported by the alterations in several genes and compounds that are directly involved in this pathway. SELENBP1 and BPNT1 are genes associated with the regulation and biosynthesis of sulfur-containing compounds. PAPSS1 is a gene that encodes an enzyme involved in the activation of sulfate, a key compound in sulfur metabolism. The presence of sulfate, adenylyl sulfate, 3'-phosphoadenylyl sulfate, and thiosulfate among the altered compounds further strengthens the connection to sulfur metabolism. Other compounds such as L-Cysteine, L-Serine, L-Homocysteine, Taurine, and sulfur itself are also integral to sulfur metabolism, providing additional evidence for the involvement of this pathway in the observed condition."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ST3GAL2,B3GALT4,HEXB,SLC33A1,ST6GALNAC5,ST6GALNAC6,B4GALNT1,ST6GALNAC4,ST3GAL5,ST8SIA5,GLB1,ST6GALNAC3,HEXA,ST3GAL1,ST8SIA1 >>>\nList of compounds : <<< GD3,Fucosyl-GM1,N-Acetylgalactosaminyl GM1b,GM3,GM2alpha,GM1alpha >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosphingolipid biosynthesis - ganglio series. This conclusion is supported by the alterations in genes and compounds associated with this pathway. Genes such as ST3GAL2, B3GALT4, HEXB, SLC33A1, ST6GALNAC5, ST6GALNAC6, B4GALNT1, ST6GALNAC4, ST3GAL5, ST8SIA5, GLB1, ST6GALNAC3, HEXA, ST3GAL1, and ST8SIA1 are all involved in the synthesis of gangliosides, complex glycosphingolipids found in the outer leaflet of cellular membranes. Similarly, the altered compounds, including GD3, Fucosyl-GM1, N-Acetylgalactosaminyl GM1b, GM3, GM2alpha, and GM1alpha, are all gangliosides, further supporting the involvement of the Glycosphingolipid biosynthesis - ganglio series in the observed condition."}], "target": "Glycosphingolipid biosynthesis - ganglio series"}
{"messages": [{"role": "user", "content": "List of genes : <<< NDUFB2,ATP5F1C,ATP6V0D2,COX4I2,ATP5PF,PPA1,ATP5ME,ATP6V0C,NDUFS1,NDUFB9,NDUFV3,ATP5F1A,NDUFA4L2,NDUFA13,NDUFA2,NDUFA11,COX8C >>>\nList of compounds : <<< H+,H2O,H+,Oxygen,H+,H+,Triphosphate,NADH,H+,NAD+ >>>"}, {"role": "assistant", "content": "The identified metabolic pathway in this experiment is Oxidative Phosphorylation (OXPHOS), which is supported by the alterations in various genes and compounds. The genes listed, including NDUFB2, COX4I2, NDUFS1, and COX8C, are all components of the complexes involved in OXPHOS. These complexes, namely Complex I, III, IV, and V, are responsible for the electron transport chain and ATP synthesis.\n\nThe alterations in compounds such as H+, Oxygen, NADH, and NAD+ further solidify this conclusion. These compounds are integral to the OXPHOS process, with H+ and Oxygen being involved in the electron transport chain, NADH donating electrons, and NAD+ accepting electrons. The presence of Triphosphate (ATP) indicates the successful completion of ATP synthesis, a key function of OXPHOS. Therefore, the data strongly suggests that the Oxidative Phosphorylation pathway is involved in the condition under study."}], "target": "Oxidative phosphorylation"}
{"messages": [{"role": "user", "content": "List of genes : <<< PRPS2,GPI,PRPS1L1,ALDOA,GLYCTK,RPIA,PGLS,IDNK,RPE,DERA,PGD,ALDOC,TKT,RGN,G6PD,H6PD,PFKP,FBP2,RBKS,PGM1,RPEL1,PFKL,TKTL2,TKTL1,PFKM >>>\nList of compounds : <<< 2-Dehydro-3-deoxy-D-gluconate,D-Glucono-1,5-lactone 6-phosphate,Sedoheptulose,2-Amino-2-deoxy-D-gluconate,6-Phospho-D-gluconate,D-Glyceraldehyde 3-phosphate,2-Dehydro-3-deoxy-6-phospho-D-gluconate,3-Phospho-D-glycerate,alpha-D-Glucose 6-phosphate,5-Phospho-alpha-D-ribose 1-diphosphate,Deoxyribose,2-Deoxy-D-ribose 5-phosphate,6-Phospho-2-dehydro-D-gluconate,D-Ribose,D-arabino-Hex-3-ulose 6-phosphate,D-Xylulose 5-phosphate,D-Ribose 5-phosphate,D-Fructose 1,6-bisphosphate,D-Glucosaminate-6-phosphate,2-Phospho-D-glycerate,D-Ribulose 1,5-bisphosphate,D-Glucono-1,5-lactone >>>"}, {"role": "assistant", "content": "The analysis of the provided gene list and associated compounds indicates a strong association with the Pentose Phosphate Pathway (PPP). This pathway is involved in the biosynthesis of nucleotides and aromatic amino acids, and in the production of NADPH for various biosynthetic reactions.\n\nSeveral genes in the list, such as G6PD, H6PD, PGD, RPE, RPIA, TKT, and TKTL1/2, are directly involved in the PPP. The altered compounds, including D-Glucose 6-phosphate, 6-Phospho-D-gluconate, D-Ribose 5-phosphate, D-Xylulose 5-phosphate, and Sedoheptulose, are intermediates in this pathway, further supporting this conclusion. The involvement of other genes like ALDOA, ALDOC, and PGM1, which are part of glycolysis, suggests a possible interplay between glycolysis and the PPP in this specific condition."}], "target": "Pentose phosphate pathway"}
{"messages": [{"role": "user", "content": "List of genes : <<< PYGM,AMY1B,HK3,UGP2,,PGM2L1,PGM1,GYG2,GYS2,GCK,HK2,AMY2A,AMY1A,GBE1,AGL,HKDC1 >>>\nList of compounds : <<< D-Glucose,D-Glucose 6-phosphate,beta-D-Glucoside,D-Glucose,Cellulose,D-Fructose,ADP-glucose,Cellodextrin,Levan,1-alpha-D-[(1-&gt;4)-alpha-D-Glucosyl](n-1)-alpha-D-glucopyranoside,alpha,alpha-Trehalose,CDP-glucose,(2,1-beta-D-Fructosyl)n,D-Glucose 6-phosphate,D-Glucose 6-phosphate,D-Glucose,Dextrin,Amylose,D-Glucose,alpha-D-Glucose 1,6-bisphosphate,GDP-glucose,alpha-Maltose 1-phosphate,1,3-beta-D-Glucan,Starch >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Starch and Sucrose Metabolism pathway. This is evidenced by the alterations in several key genes involved in this pathway, including PYGM (glycogen phosphorylase), AMY1A/AMY1B/AMY2A (alpha-amylases), GBE1 (glycogen branching enzyme), GYG2/GYS2 (glycogen synthases), and PGM1/PGM2L1 (phosphoglucomutases). These genes are responsible for the breakdown and synthesis of glycogen and starch. The altered compounds also support this conclusion, as they include various forms of glucose, glucose derivatives, and polysaccharides such as starch, cellulose, and dextrin, which are central to this pathway."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A10,RDH16,ALDH1A1,UGT2B10,CYP1A1,UGT1A3,UGT2A2,UGT1A6,DHRS4,UGT1A9,UGT2B11,AWAT2,HSD17B6,CYP26A1,UGT1A4,CYP2C8 >>>\nList of compounds : <<< Metarhodopsin,11-cis-Retinal,all-trans-18-Hydroxyretinoic acid,all-trans-13,14-Dihydroretinol,Retinoate,all-trans-5,6-Epoxyretinoic acid,9-cis-Retinal,Iodopsin,Retinal,all-trans-3,4-Didehydroretinol,9-cis-Retinol,all-trans-Retinoyl-beta-glucuronide,Retinyl palmitate,Lumirhodopsin,11-cis-Retinol,11-cis-Retinyl palmitate,Bathorhodopsin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Retinol metabolism. The alteration of genes such as UGT1A10, UGT2B10, UGT1A3, UGT1A6, UGT1A9, UGT2B11, and UGT1A4, which are UDP-glucuronosyltransferases involved in the glucuronidation of retinol and its metabolites, supports this conclusion. Additionally, the alteration of genes like RDH16, ALDH1A1, DHRS4, HSD17B6, and CYP26A1, which are involved in the oxidation and reduction of retinoids, further strengthens the identification of this pathway. The changes in compounds such as Metarhodopsin, 11-cis-Retinal, all-trans-Retinoic acid, Retinal, Retinol, and Retinyl palmitate, which are key intermediates and end products in the Retinol metabolism pathway, provide additional evidence."}], "target": "Retinol metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< TAT,GOT2,GOT1,PAH,IL4I1,GOT1L1 >>>\nList of compounds : <<< L-Arogenate,Indoleglycerol phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Phenylalanine, tyrosine, and tryptophan biosynthesis pathway. This conclusion is based on the alteration of several key genes involved in this pathway, including TAT, GOT2, GOT1, and PAH. TAT encodes a transaminase involved in the conversion of tyrosine to p-hydroxyphenylpyruvate, while GOT1 and GOT2 encode enzymes that convert aspartate to oxaloacetate, which is a precursor for phenylalanine and tyrosine biosynthesis. The alteration of PAH, which encodes phenylalanine hydroxylase, is also indicative of changes in this pathway. The presence of L-Arogenate and indoleglycerol phosphate, compounds involved in the biosynthesis of phenylalanine, tyrosine, and tryptophan, further supports the identification of this pathway as being affected by the experimental conditions."}], "target": "Phenylalanine, tyrosine and tryptophan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< IDH2,PDHA1,CS,SDHB,PDHB,IDH1,SDHC,ACLY,OGDHL,DLST,PCK1,MDH1,PDHA2,IDH3B,PCK2 >>>\nList of compounds : <<< 2-(alpha-Hydroxyethyl)thiamine diphosphate,Acetyl-CoA,Fumarate,3-Carboxy-1-hydroxypropyl-ThPP >>>"}, {"role": "assistant", "content": "The citrate cycle (TCA cycle) has been identified as the primary metabolic pathway involved in the experiment, as multiple genes and compounds associated with this pathway showed alterations. The presence of altered genes such as IDH2, PDHA1, CS, SDHB, PDHB, IDH1, SDHC, DLST, and MDH1, which are all central enzymes in the TCA cycle, provides strong evidence for this pathway's involvement. Additionally, the changes in the levels of compounds like 2-(alpha-Hydroxyethyl)thiamine diphosphate, Acetyl-CoA, Fumarate, and 3-Carboxy-1-hydroxypropyl-ThPP, which are intermediates or cofactors in the TCA cycle, further support this conclusion. The alterations in genes and compounds related to the TCA cycle suggest that it plays a crucial role in the specific condition under investigation."}], "target": "Citrate cycle (TCA cycle)"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLCG1,PIK3C2A,PIK3CD,PLCZ1,INPP5J,IMPA1,INPP5A,PIP5KL1,PLCB4,IPPK,INPP1,MTM1,INPPL1,MTMR8,PLCH1,PLCB3,INPP5K,PLCD3,PIK3C3,PIK3C2B,MTMR3 >>>\nList of compounds : <<< 2-Deoxy-5-keto-D-gluconic acid 6-phosphate,1-Phosphatidyl-1D-myo-inositol 5-phosphate,5-Deoxy-D-glucuronate,1D-myo-Inositol 1,4-bisphosphate,3D-3,5/4-Trihydroxycyclohexane-1,2-dione,1D-myo-Inositol 1,3,4-trisphosphate,1D-myo-Inositol 3-phosphate,1D-myo-Inositol 1,3,4,5,6-pentakisphosphate,1D-myo-Inositol 3,4,5,6-tetrakisphosphate,3-Oxopropanoate,Inositol 1,2,3,5,6-pentakisphosphate,1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate,1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate,Phosphatidylinositol-3,4,5-trisphosphate,D-myo-Inositol 3,4-bisphosphate,D-myo-Inositol 1,3-bisphosphate,1D-myo-Inositol 1,3,4,5-tetrakisphosphate,1D-chiro-Inositol,Acetyl-CoA,myo-Inositol,D-Glucuronate,scyllo-Inositol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Inositol phosphate metabolism. This conclusion is supported by the alterations in multiple genes associated with this pathway, such as PLCG1, PIK3C2A, PIK3CD, PLCZ1, INPP5J, IMPA1, INPP5A, PIP5KL1, PLCB4, IPPK, INPP1, MTM1, INPPL1, MTMR8, PLCH1, PLCB3, INPP5K, PLCD3, PIK3C3, PIK3C2B, and MTMR3. Additionally, the altered compounds, including various inositol phosphates such as 1D-myo-Inositol 1,4-bisphosphate, 1D-myo-Inositol 1,3,4-trisphosphate, 1D-myo-Inositol 3-phosphate, and Phosphatidylinositol-3,4,5-trisphosphate, further support this identification. The presence of other compounds like Acetyl-CoA and D-Glucuronate may indicate crosstalk with other pathways, but the primary pathway involved in this condition is the Inositol phosphate metabolism."}], "target": "Inositol phosphate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACOX2,CYP46A1,AKR1C4,SLC27A5,BAAT,CH25H,ACOT8 >>>\nList of compounds : <<< Choloyl-CoA,7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one,Cholic acid,(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA,Chenodeoxycholate,Cholest-5-ene-3beta,7alpha,25-triol,7alpha,24-Dihydroxy-4-cholesten-3-one,Cerebrosterol,Glycine,Taurochenodeoxycholate,3beta,7alpha-Dihydroxy-5-cholestenoate,(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA,(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA,Taurine,7alpha,25-Dihydroxy-4-cholesten-3-one,4-Cholesten-7alpha,12alpha-diol-3-one,25-Hydroxycholesterol,3alpha,7alpha-Dihydroxy-5beta-cholestanate,3beta-Hydroxy-5-cholestenoate,Chenodeoxycholoyl-CoA,3alpha,7alpha-Dihydroxy-5beta-cholestane,3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane,5beta-Cyprinolsulfate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Primary Bile Acid Biosynthesis pathway. This conclusion is supported by the alterations in genes such as ACOX2, CYP46A1, and AKR1C4, which are known to play crucial roles in this pathway. Furthermore, the changes in compounds like Choloyl-CoA, Cholic acid, and Chenodeoxycholate, which are intermediates and end products of this pathway, also corroborate this finding. Additionally, the presence of BAAT (Bile Acid CoA:amino acid N-acyltransferase), which is involved in bile acid conjugation, and the alteration of bile acid derivatives like Taurochenodeoxycholate and Glycine, further strengthen the hypothesis that the Primary Bile Acid Biosynthesis pathway is significantly affected in the given conditions."}], "target": "Primary bile acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< B4GALT7,CHST3,CHST13,CHPF2,CHST14,CHSY1,CSGALNACT1,XYLT1,DSEL,CSGALNACT2,B3GALT6,UST,CHPF,DSE,XYLT2,CHSY3,CHST11,B3GAT3,CHST15 >>>\nList of compounds : <<< 3'-Phosphoadenylyl sulfate,Dermatan,[Protein]-L-serine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate. This conclusion is supported by the alteration of multiple genes and compounds involved in this pathway. The genes B4GALT7, CHST3, CHST13, CHPF2, CHST14, CHSY1, CSGALNACT1, XYLT1, CSGALNACT2, B3GALT6, UST, CHPF, DSE, XYLT2, CHSY3, CHST11, B3GAT3, and CHST15 all play key roles in the synthesis and modification of chondroitin sulfate and dermatan sulfate, which are types of glycosaminoglycans. The presence of the compounds 3'-Phosphoadenylyl sulfate, a cofactor required for sulfation reactions, and Dermatan, a product of this pathway, further support the involvement of this pathway in the experimental conditions."}], "target": "Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"}
{"messages": [{"role": "user", "content": "List of genes : <<< SELENOI,PCYT1A,CEPT1,CHPT1,PCYT1B,PCYT2 >>>\nList of compounds : <<< Pyruvate,Phosphonoacetate,Diacylglyceryl-2-aminoethylphosphonate,Hydroxymethylphosphonate,Methylphosphonate,Diacylglyceryl-N-trimethyl-2-aminoethylphosphonate,D-Ribose 5-phosphate,N-Trimethyl-2-aminoethylphosphonate,Demethylphosphinothricin,2-Amino-3-phosphonopropanoate,Bialaphos,Phosphonoacetaldehyde,Rhizocticin C,2-Phosphinomethylmalate,2-Acetamidoethylphosphonate,Phosphonoformate,Rhizocticin A,CMP-2-aminoethylphosphonate >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, the identified metabolic pathway was the Phosphonate and phosphinate metabolism. This conclusion is based on the significantly altered genes and compounds associated with this pathway. The genes SELENOI, PCYT1A, CEPT1, CHPT1, PCYT1B, and PCYT2 are involved in the regulation of phospholipid metabolism, which is closely related to phosphonate and phosphinate metabolism.\n\nThe presence of numerous phosphonate and phosphinate compounds such as Pyruvate, Phosphonoacetate, Diacylglyceryl-2-aminoethylphosphonate, Hydroxymethylphosphonate, Methylphosphonate, and others, further supports the involvement of this pathway. These compounds are key intermediates or products of the phosphonate and phosphinate metabolism. Therefore, the alteration in these genes and compounds strongly suggests that the Phosphonate and phosphinate metabolism pathway plays a crucial role in the studied condition."}], "target": "Phosphonate and phosphinate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PMM1,PFKFB4 >>>\nList of compounds : <<< Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,alpha-D-Glucose,GDP-6-deoxy-D-talose,(S)-Lactate,L-Fuculose,D-Allulose 6-phosphate,L-Rhamnulose,D-Mannose,ADP-mannose,GDP-6-deoxy-D-mannose,D-Fructose 1-phosphate,Sorbose 1-phosphate,D-Glyceraldehyde,D-Allose,Sorbitol 6-phosphate,D-Mannose 6-phosphate,beta-D-Fructose 2-phosphate,Mannitol,L-Sorbose,D-Mannitol 1-phosphate,D-Fructose 1,6-bisphosphate,beta-D-Fructose 2,6-bisphosphate >>>"}, {"role": "assistant", "content": "The analysis of the provided genes (PMM1, PFKFB4) and compounds (Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group, alpha-D-Glucose, GDP-6-deoxy-D-talose, (S)-Lactate, L-Fuculose, D-Allulose 6-phosphate, L-Rhamnulose, D-Mannose, ADP-mannose, GDP-6-deoxy-D-mannose, D-Fructose 1-phosphate, Sorbose 1-phosphate, D-Glyceraldehyde, D-Allose, Sorbitol 6-phosphate, D-Mannose 6-phosphate, beta-D-Fructose 2-phosphate, Mannitol, L-Sorbose, D-Mannitol 1-phosphate, D-Fructose 1,6-bisphosphate, beta-D-Fructose 2,6-bisphosphate) indicates that the fructose and mannose metabolism pathway is involved in the specific condition.\n\nPMM1 encodes phosphomannomutase, which converts D-mannose-6-phosphate to D-mannose-1-phosphate in the fructose and mannose metabolism pathway. PFKFB4 is a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase that regulates the glycolytic pathway by controlling the levels of fructose-2,6-bisphosphate, a potent allosteric activator of phosphofructokinase-1 (PFK1) that catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. The presence of D-mannose, D-mannose 6-phosphate, and D-mannitol 1-phosphate in the list of compounds also supports the involvement of the fructose and mannose metabolism pathway in the specific condition."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ARG2,NAGS,ASS1,ASL,GOT1,ARG1,NOS2,GLUL,CAD,GLUD2,GOT1L1,GOT2,ACY1,NOS3,NOS1,GLS,CPS1,GPT2,ABHD14A-ACY1 >>>\nList of compounds : <<< L-Glutamate,N-Acetyl-L-glutamate 5-semialdehyde,L-Arginine,L-Aspartate,2-Oxoglutarate,LysW-L-glutamyl 5-phosphate,CO2,N-Acetyl-L-glutamate,L-Glutamine,Fumarate,LysW-L-ornithine,LysW-L-glutamate 5-semialdehyde,N-Acetyl-L-citrulline,Ammonia,Urea,L-Citrulline,Urea-1-carboxylate,Carbamoyl phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Arginine biosynthesis pathway. This conclusion is supported by the alterations in multiple genes directly involved in this pathway, such as ARG2, NAGS, ASS1, ASL, and ARG1. The involvement of these genes suggests an impact on the conversion of L-Glutamate to L-Ornithine, the primary steps in arginine synthesis.\n\nAdditionally, the presence of compounds like L-Arginine, L-Aspartate, 2-Oxoglutarate, CO2, N-Acetyl-L-glutamate, L-Glutamine, Fumarate, LysW-L-ornithine, LysW-L-glutamate 5-semialdehyde, N-Acetyl-L-citrulline, Ammonia, Urea, L-Citrulline, Urea-1-carboxylate, and Carbamoyl phosphate further corroborates this finding. These compounds are key intermediates in the arginine biosynthesis pathway, indicating a disruption or alteration in this metabolic process."}], "target": "Arginine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDXK,PDXP,PHOSPHO2,PSAT1,AOX1,PNPO >>>\nList of compounds : <<< 2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate,3-Hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate,O-Phospho-4-hydroxy-L-threonine,Isopyridoxal,5-Pyridoxolactone,Glycolaldehyde,Pyridoxine phosphate,3-Hydroxy-2-methylpyridine-4,5-dicarboxylate,4-Pyridoxolactone,Pyridoxamine phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Vitamin B6 metabolism. This conclusion is supported by the altered genes and compounds observed. The genes PDXK, PDXP, PHOSPHO2, PSAT1, AOX1, and PNPO are all involved in the metabolism of Vitamin B6. PDXK and PDXP encode pyridoxal kinase and pyridoxine 5'-phosphate oxidase, respectively, which are key enzymes in the production of active forms of Vitamin B6. PHOSPHO2 and PSAT1 are involved in serine biosynthesis, a process linked to Vitamin B6 metabolism. AOX1 is a flavin-containing oxidoreductase that can metabolize Vitamin B6 derivatives. PNPO encodes pyridox(am)ine 5'-phosphate oxidase, which is involved in the degradation of Vitamin B6. The altered compounds, such as 2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate, 3-Hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate, Isopyridoxal, 5-Pyridoxolactone, Pyridoxine phosphate, Pyridoxamine phosphate, and 4-Pyridoxolactone, are all intermediates or derivatives in the Vitamin B6 metabolism pathway."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DNMT1,AHCY,KYAT1,IL4I1,AMD1,KYAT3,GOT1,MAT2B,PHGDH,GCLM >>>\nList of compounds : <<< 1-Deoxy-D-xylulose 5-phosphate,L-Serine,1,2-Dihydroxy-5-(methylthio)pent-1-en-3-one,L-Serine,3-Mercaptolactate,S-Glutathionyl-L-cysteine,S-Methyl-5-thio-D-ribulose 1-phosphate,N-Acyl-L-homoserine lactone,(S)-2-Aminobutanoate,S-Methyl-5-thio-D-ribose 1-phosphate,S-Sulfo-L-cysteine,3-Sulfopyruvate,L-Alanine,3-Sulfinylpyruvate,L-Homoserine,S-Adenosyl-L-homocysteine,Pyruvate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the given list of genes and compounds is the Cysteine and Methionine metabolism pathway. This conclusion is drawn from the presence of several key genes and compounds associated with this pathway.\n\nGenes such as AHCY (S-adenosylhomocysteine hydrolase), AMD1 (adenosylmethionine decarboxylase 1), and MAT2B (methionine adenosyltransferase 2B) are directly involved in the metabolism of methionine and its derivatives. The altered gene DNMT1 (DNA methyltransferase 1) also indirectly affects this pathway as it uses S-adenosylmethionine as a methyl donor.\n\nThe listed compounds further support this identification. Compounds like S-adenosyl-L-homocysteine, S-Glutathionyl-L-cysteine, and S-Methyl-5-thio-D-ribulose 1-phosphate are intermediates or products in the cysteine and methionine metabolism pathway. The presence of compounds such as L-Serine, L-Alanine, and Pyruvate, which are connected to this pathway, also strengthens the conclusion.\n\nTherefore, the alteration of these genes and compounds suggests that the Cysteine and Methionine metabolism pathway is significantly involved in the specific condition under investigation."}], "target": "Cysteine and methionine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< G6PC1,B4GALT2,SI,G6PC3,PFKL,GAA,MGAM,LCT,G6PC2 >>>\nList of compounds : <<< D-Sorbitol,D-Galactose 6-phosphate,D-Tagatose 1,6-bisphosphate,D-Galactono-1,5-lactone,D-Galactosamine,D-Galactose,Glycerol,2-Dehydro-3-deoxy-D-galactonate,alpha-D-Glucose,Melibiose,D-Fructose 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Galactose metabolism. This conclusion is supported by the alteration of several genes and compounds directly involved in this pathway. The genes G6PC1, G6PC2, and G6PC3, which encode for glucose-6-phosphatases, are crucial in the conversion of galactose-1-phosphate to galactose, a key step in galactose metabolism. The altered B4GALT2 gene, which encodes for beta-1,4-galactosyltransferase, is involved in the synthesis of lactose from galactose and glucose. The altered PFKL gene, encoding phosphofructokinase, is involved in the glycolysis pathway, which interacts with the galactose metabolism. The altered compounds, including D-Galactose, D-Galactose 6-phosphate, D-Galactono-1,5-lactone, and D-Galactosamine, are all intermediates or products of the galactose metabolism pathway. Therefore, the evidence strongly suggests that the Galactose metabolism pathway is involved in the specific condition under investigation."}], "target": "Galactose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP2E1,GSTM3,GSTA5,CYP1B1,UGT1A4,GSTO1,UGT1A7,GSTP1,UGT1A6,EPHX1,CYP2A7,CYP2S1,CYP2D7,UGT1A10,CBR1,ALDH3B2,UGT1A8,GSTM5,AKR7L,ADH4,AKR7A3,UGT1A5 >>>\nList of compounds : <<< 1-Naphthylamine,1,1-Dichloroethylene,(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene,2,2-Dichloroacetaldehyde,2-S-Glutathionyl acetate,9-Hydroxybenzo[a]pyrene,1-(3-Pyridinyl)-1,4-butanediol,trans-3,4-Dihydro-3,4-dihydroxy-7,12-dimethylbenz[a]anthracene,Aflatoxin-M1-8,9-epoxide,Benzo[a]pyrene-4,5-oxide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the metabolism of xenobiotics by cytochrome P450. This conclusion is supported by the alterations in genes such as CYP2E1, CYP1B1, CYP2A7, CYP2S1, CYP2D7, and the presence of compounds like 1-Naphthylamine, 9-Hydroxybenzo[a]pyrene, and Benzo[a]pyrene-4,5-oxide. These genes encode cytochrome P450 enzymes, which are responsible for the metabolism of various xenobiotic substances, including drugs, pollutants, and carcinogens. The altered compounds are known substrates for these enzymes, further supporting the involvement of this pathway in the observed condition."}], "target": "Metabolism of xenobiotics by cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< NAT2,CYP2A6,NAT1,CYP2A7,CYP1A2 >>>\nList of compounds : <<< Xanthine,N,N'-Dimethylurea,7-Methylxanthosine,Xanthosine,7-Methyluric acid,1-Methylxanthine,1,3,7-Trimethyl-5-hydroxyisourate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the caffeine metabolism pathway. This conclusion is supported by the altered genes and compounds observed. The genes NAT2, CYP2A6, NAT1, CYP2A7, and CYP1A2 have known roles in caffeine metabolism. For instance, CYP1A2 is responsible for the primary metabolism of caffeine, while NAT2 and NAT1 are involved in the subsequent metabolism of caffeine metabolites.\n\nThe presence of compounds such as xanthine, N,N'-Dimethylurea, 7-Methylxanthosine, Xanthosine, 7-Methyluric acid, 1-Methylxanthine, and 1,3,7-Trimethyl-5-hydroxyisourate further supports this conclusion. These compounds are either direct metabolites or closely related to metabolites in the caffeine metabolism pathway. Therefore, the changes observed in these genes and compounds suggest that the caffeine metabolism pathway is significantly affected in the experimental conditions studied."}], "target": "Caffeine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OXSM,HLCS >>>\nList of compounds : <<< 3-Ketopimeloyl-[acp] methyl ester,Pimeloyl-[acyl-carrier protein],Biotin,3-Hydroxypimeloyl-[acp] methyl ester,Biotin sulfoxide,Enoylpimeloyl-[acp] methyl ester,Holo-[carboxylase],Malonyl-[acyl-carrier protein],3-Hydroxyglutaryl-[acp] methyl ester >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the metabolic pathway that was identified is Biotin metabolism. This conclusion is supported by the presence of OXSM and HLCS genes, which are known to be involved in biotin metabolism. OXSM encodes for a biotin synthase, a key enzyme in the final step of biotin biosynthesis, while HLCS encodes for holocarboxylase synthetase, which is responsible for activating biotin-dependent carboxylases.\n\nThe altered compounds further corroborate this conclusion. The presence of compounds such as 3-Ketopimeloyl-[acp] methyl ester, Pimeloyl-[acyl-carrier protein], Biotin, 3-Hydroxypimeloyl-[acp] methyl ester, Biotin sulfoxide, Enoylpimeloyl-[acp] methyl ester, Malonyl-[acyl-carrier protein], and 3-Hydroxyglutaryl-[acp] methyl ester are intermediates or derivatives in the biotin metabolic pathway. Therefore, the changes in these compounds suggest an alteration in the biotin metabolism pathway."}], "target": "Biotin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AMPD1,HDDC2,GMPR,UCK1,AK1,NTPCR,NT5C1A,TYMS,NT5C,IMPDH2,ITPA,GMPR2,NT5DC4,CMPK1,DCTD,AK5,ASMTL,NT5C1B-RDH14,GUK1,NME2 >>>\nList of compounds : <<< 2'-Deoxyinosine 5'-phosphate,5-Phospho-alpha-D-ribose 1-diphosphate,Xanthine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Nucleotide Metabolism. Several genes involved in this pathway exhibited alterations, including AMPD1, HDDC2, GMPR, UCK1, AK1, NTPCR, NT5C1A, TYMS, NT5C, IMPDH2, ITPA, GMPR2, NT5DC4, CMPK1, DCTD, AK5, ASMTL, NT5C1B-RDH14, GUK1, and NME2. These genes are associated with various aspects of nucleotide synthesis, degradation, and salvage.\n\nThe altered compounds, 2'-Deoxyinosine 5'-phosphate, 5-Phospho-alpha-D-ribose 1-diphosphate, and Xanthine, are all intermediates or products of nucleotide metabolism. The presence and alteration of these compounds further support the identification of nucleotide metabolism as the affected pathway. The changes in these genes and compounds suggest potential disturbances in nucleotide balance and energy metabolism, which could contribute to the specific condition under investigation."}], "target": "Nucleotide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< KYAT1,ADI1,GOT2,DNMT3A,PSAT1,DNMT3B,TAT,MAT1A,BHMT2,AHCYL1,MRI1,CTH,LDHA >>>\nList of compounds : <<< L-Homoserine,2-Oxobutanoate,Sulfur dioxide,L-Aspartate 4-semialdehyde,S-Adenosylmethioninamine,(S)-3-Sulfolactate,(2R)-3-Sulfolactate,S-Ribosyl-L-homocysteine,Glutathione,L-Cystathionine,(S)-2-Aminobutanoate,5'-Methylthioadenosine,D-Cysteine,L-Homocysteine,2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the given list of genes and compounds is Cysteine and Methionine metabolism. The involvement of this pathway is supported by several pieces of evidence. Firstly, the presence of genes such as MAT1A, BHMT2, AHCYL1, and MRI1, which are known to play crucial roles in this pathway, indicates its activation. Secondly, the altered compounds, including L-Homocysteine, S-Adenosylmethioninamine, 5'-Methylthioadenosine, and D-Cysteine, are direct intermediates or by-products of this pathway. Additionally, the presence of compounds like Sulfur dioxide, Glutathione, and L-Cystathionine, which are associated with the regulation or detoxification processes in this pathway, further supports this conclusion."}], "target": "Cysteine and methionine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SHMT2,ACSS2,PGP,PCCA,AGXT,HAO2,ACAT1,HYI >>>\nList of compounds : <<< L-erythro-3-Methylmalyl-CoA,(2R)-Ethylmalonyl-CoA,meso-Tartaric acid,cis-Aconitate,Oxalyl-CoA,2-Hydroxy-3-oxoadipate,Glycolaldehyde,Glycerone phosphate,(S)-Malate >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the metabolic pathway identified is the Glyoxylate and dicarboxylate metabolism. Several genes are directly involved in this pathway, such as PGP (Phosphoenolpyruvate carboxykinase) and PCCA (Propionyl-CoA carboxylase alpha chain), which are key enzymes in the conversion of phosphoenolpyruvate to oxaloacetate and the metabolism of propionyl-CoA, respectively. SHMT2 (Serine hydroxymethyltransferase 2) is involved in the folate cycle, which is linked to the glyoxylate cycle. ACSS2 (Acyl-CoA synthetase short-chain family member 2) plays a role in fatty acid metabolism, which can be connected to the glyoxylate cycle. The altered compounds, such as L-erythro-3-Methylmalyl-CoA, (2R)-Ethylmalonyl-CoA, Oxalyl-CoA, and 2-Hydroxy-3-oxoadipate, are intermediates in this pathway, further supporting its involvement. The presence of cis-Aconitate, Glycolaldehyde, Glycerone phosphate, and (S)-Malate suggest connections to the TCA cycle and glycolysis, which are closely linked to the glyoxylate cycle."}], "target": "Glyoxylate and dicarboxylate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< TKTL1,RPIA,PFKM,IDNK,ALDOA,PRPS1L1,RPEL1,RPE,PGD,ALDOC,PRPS2,PGLS,SHPK,FBP2,RGN,PFKP,GPI >>>\nList of compounds : <<< alpha-D-Ribose 1-phosphate,2-Dehydro-3-deoxy-6-phospho-D-gluconate,D-Gluconic acid,D-Glucose,D-Ribose 1,5-bisphosphate,beta-D-Glucose,6-Phospho-D-gluconate,2-Amino-2-deoxy-D-gluconate,D-Glyceraldehyde,D-Ribose 5-phosphate,2-Amino-2-deoxy-D-gluconate >>>"}, {"role": "assistant", "content": "The analysis of the provided gene list and altered compounds indicates that the Pentose Phosphate Pathway (PPP) is significantly involved. This conclusion is supported by the presence of several key genes related to PPP, including TKTL1, RPIA, PFKM, IDH, ALDOA, PGD, and GPI. These genes are known to play crucial roles in the oxidative and non-oxidative branches of the PPP. The compounds identified, such as alpha-D-Ribose 1-phosphate, D-Ribose 1,5-bisphosphate, and D-Ribose 5-phosphate, are intermediates in the PPP, further strengthening the association. The presence of D-Glucose, beta-D-Glucose, and D-Gluconic acid suggests that glucose metabolism is also affected, which is consistent with the PPP being the first pathway of glucose metabolism. Overall, the evidence strongly suggests that the Pentose Phosphate Pathway is a primary metabolic pathway affected in the given condition."}], "target": "Pentose phosphate pathway"}
{"messages": [{"role": "user", "content": "List of genes : <<< SQLE,LSS,LBR,EBP,CEL,MSMO1,CYP51A1,DHCR24,NSDHL,FDFT1,SOAT1,DHCR7 >>>\nList of compounds : <<< 4alpha-Methylzymosterol,Episterol,(S)-2,3-Epoxysqualene,Lanosterol,7-Dehydrocholesterol,4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol,Ergosta-5,7,22,24(28)-tetraen-3beta-ol,4alpha-Carboxy-5alpha-cholesta-8,24-dien-3beta-ol,14-Demethyllanosterol,Lathosterol,Secalciferol,24-Methylidenecycloartanol,Desmosterol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Steroid biosynthesis pathway. This conclusion is supported by the alterations in genes such as SQLE, LSS, LBR, EBP, CEL, MSMO1, CYP51A1, DHCR24, NSDHL, FDFT1, SOAT1, and DHCR7, all of which are known to be involved in this pathway. The altered compounds, including 4alpha-Methylzymosterol, Episterol, (S)-2,3-Epoxysqualene, Lanosterol, 7-Dehydrocholesterol, 4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol, Ergosta-5,7,22,24(28)-tetraen-3beta-ol, 4alpha-Carboxy-5alpha-cholesta-8,24-dien-3beta-ol, 14-Demethyllanosterol, Lathosterol, Secalciferol, 24-Methylidenecycloartanol, and Desmosterol, are also intermediates or products of this pathway. Therefore, the data suggest that the Steroid biosynthesis pathway is affected in the specific condition being studied."}], "target": "Steroid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH6A1,MCEE,ECHDC1 >>>\nList of compounds : <<< Propynoate,(S)-Lactate,2-Hydroxybutanoic acid,Propanoate,Lactoyl-CoA,3-Oxopropionyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Propanoate metabolism. The altered genes, ALDH6A1, MCEE, and ECHDC1, are all associated with this pathway. ALDH6A1 encodes an enzyme involved in the metabolism of propionate to succinate. MCEE, or methylcrotonoyl-CoA carboxylase subunit alpha, is a key enzyme in the metabolism of propionate and methylcrotonate. ECHDC1, or enoyl-CoA hydratase domain containing 1, is involved in the metabolism of fatty acids and propanoate.\n\nThe altered compounds, such as Propynoate, (S)-Lactate, 2-Hydroxybutanoic acid, Propanoate, Lactoyl-CoA, and 3-Oxopropionyl-CoA, are all intermediates or products of the Propanoate metabolism pathway. The presence of these compounds further supports the identification of Propanoate metabolism as the affected pathway."}], "target": "Propanoate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< TALDO1,ALDOB,G6PD,ALDOA,PGD,PRPS1L1,PFKL,FBP2,IDNK >>>\nList of compounds : <<< 2-Deoxy-D-ribose 5-phosphate,Pyruvate,2-Deoxy-D-ribose 1-phosphate,D-Glyceraldehyde 3-phosphate,D-Glucosaminate-6-phosphate,Sedoheptulose 7-phosphate,2-Dehydro-3-deoxy-6-phospho-D-gluconate,alpha-D-Ribose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Pentose Phosphate Pathway (PPP). This pathway was implicated due to the alteration of several key genes and compounds associated with it. The genes TALDO1, ALDOB, G6PD, and PGD are directly involved in the PPP, with TALDO1 and ALDOB encoding enzymes in the non-oxidative branch, G6PD being a rate-limiting enzyme in the oxidative branch, and PGD involved in the conversion of 6-phosphogluconate to ribulose 5-phosphate. The alteration of PRPS1L1, PFKL, and FBP2, which are involved in purine metabolism and glycolysis, could indirectly affect the PPP as these pathways are interconnected. The detected compounds, such as 2-Deoxy-D-ribose 5-phosphate, D-Glyceraldehyde 3-phosphate, Sedoheptulose 7-phosphate, and alpha-D-Ribose 1-phosphate, are intermediates or products of the PPP, further supporting the involvement of this pathway in the observed condition."}], "target": "Pentose phosphate pathway"}
{"messages": [{"role": "user", "content": "List of genes : <<< AK7,ACP1,AK2,THTPA,ALPP,NTPCR,ALPG,AK5,AK4,NFS1,ALPL >>>\nList of compounds : <<< 4-Amino-5-aminomethyl-2-methylpyrimidine,Thiamin diphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Thiamine metabolism. This conclusion is supported by the alterations observed in several genes and compounds directly associated with this pathway. The genes AK7, AK2, AK5, and AK4 are Adenylate Kinases, which play a role in energy metabolism and could indirectly affect thiamine metabolism. The gene ACP1, involved in fatty acid metabolism, may also influence thiamine metabolism as thiamine is crucial for energy production in these processes. The presence of the gene THTPA, which encodes Thiamine Triphosphatase, a thiamine metabolizing enzyme, further strengthens the connection. The altered compound 4-Amino-5-aminomethyl-2-methylpyrimidine is a structural analog of thiamine, suggesting a direct involvement in thiamine metabolism. The other altered compound, Thiamin diphosphate, is a key intermediate in thiamine metabolism, confirming the pathway's involvement. The genes ALPP, NTPCR, ALPG, NFS1, and ALPL, although not directly involved in thiamine metabolism, may have indirect effects on the pathway or be secondary consequences of the alterations in the primary pathway."}], "target": "Thiamine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SULT2A1,,UGT2B11,CYP3A4,CYP2B6,UGT2B10,ADH7,AKR1C1,CYP2C9,ADH5,HPGDS,CYP2E1 >>>\nList of compounds : <<< Bromobenzene-3,4-dihydrodiol,1,2-Dihydronaphthalene-1,2-diol,7-Hydroxymethyl-12-methylbenz[a]anthracene,Thiodiacetic acid,S-(2-Hydroxyethyl)-N-acetyl-L-cysteine,7,12-Dimethylbenz[a]anthracene,4-[(Hydroxymethyl)nitrosoamino]-1-(3-pyridinyl)-1-butanone,5-(3-Pyridyl)-2-hydroxytetrahydrofuran,1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene,Trichloroethanol,NNAL-N-glucuronide,Benzo[a]pyrene-4,5-oxide,(1S,2R)-Naphthalene 1,2-oxide,Dichloroacetyl chloride,(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene,2-(S-Glutathionyl)acetyl glutathione >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Metabolism of xenobiotics by cytochrome P450. This pathway involves a series of enzymes, including cytochrome P450 (CYP) enzymes, responsible for metabolizing various exogenous substances, such as drugs and environmental pollutants.\n\nThe altered genes in this experiment, such as CYP3A4, CYP2B6, CYP2C9, and CYP2E1, are all members of the cytochrome P450 family. These genes encode enzymes that catalyze the oxidation of organic substances, which is a crucial step in xenobiotic metabolism.\n\nThe altered compounds, such as Bromobenzene-3,4-dihydrodiol, 1,2-Dihydronaphthalene-1,2-diol, and Benzo[a]pyrene-4,5-oxide, are known metabolites of xenobiotics. The presence of these compounds suggests that the metabolism of xenobiotics by cytochrome P450 is indeed active in the given conditions.\n\nMoreover, the presence of compounds like S-(2-Hydroxyethyl)-N-acetyl-L-cysteine and 1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene, which are conjugation products of phase II metabolism, further supports the involvement of the xenobiotic metabolism pathway.\n\nIn conclusion, the altered genes and compounds suggest that the Metabolism of xenobiotics by cytochrome P450 pathway is significantly involved in the given conditions."}], "target": "Metabolism of xenobiotics by cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< CS,SUCLA2,PDHA2,ACO2,OGDHL,IDH2,SDHC,DLST,ACLY,SUCLG1,ACO1,IDH3A,MDH2 >>>\nList of compounds : <<< 2-Oxoglutarate,Citrate,Enzyme N6-(lipoyl)lysine,Enzyme N6-(dihydrolipoyl)lysine,Succinate,Fumarate,Acetyl-CoA,Enzyme N6-(lipoyl)lysine,Thiamin diphosphate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Isocitrate,3-Carboxy-1-hydroxypropyl-ThPP,Oxaloacetate,Phosphoenolpyruvate,Oxalosuccinate,[Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine,Pyruvate,Succinyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Citrate Cycle (TCA Cycle). This conclusion is supported by the alteration of multiple genes and compounds associated with this pathway. Genes such as CS, SUCLA2, PDHA2, ACO2, OGDHL, IDH2, SDHC, DLST, ACLY, SUCLG1, ACO1, IDH3A, and MDH2 are all involved in the TCA Cycle. Similarly, the altered compounds, including 2-Oxoglutarate, Citrate, Enzyme N6-(lipoyl)lysine, Enzyme N6-(dihydrolipoyl)lysine, Succinate, Fumarate, Acetyl-CoA, Thiamin diphosphate, [Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine, Isocitrate, 3-Carboxy-1-hydroxypropyl-ThPP, Oxaloacetate, Phosphoenolpyruvate, Oxalosuccinate, [Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine, Pyruvate, and Succinyl-CoA, are all intermediates or cofactors in the TCA Cycle. Therefore, the data suggest that the TCA Cycle is significantly affected in the given conditions."}], "target": "Citrate cycle (TCA cycle)"}
{"messages": [{"role": "user", "content": "List of genes : <<< PFKFB3,GMPPB,PFKFB1,FPGT,PFKL,TKFC,ALDOC,TIGAR,TPI1,GFUS >>>\nList of compounds : <<< 2-(alpha-D-Mannosyl)-3-phosphoglycerate,beta-L-Fucopyranose,D-Mannose,D-Fructose 1-phosphate,GDP-4-dehydro-6-deoxy-D-mannose,GDP-D-mannuronate,Fructan,Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,D-Allose 6-phosphate,GDP-6-deoxy-D-mannose,D-Sorbitol,alpha-D-Glucose,L-Rhamnulose,D-Fructose 1,6-bisphosphate,L-Fucose 1-phosphate,D-Allose,D-Fructose 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Fructose and Mannose metabolism. The alterations in genes such as PFKFB3, PFKFB1, PFKL, and TIGAR, which are involved in the regulation of glycolysis and fructose metabolism, provide strong evidence for this. The changes in compounds like D-Fructose 1-phosphate, D-Fructose 6-phosphate, and D-Fructose 1,6-bisphosphate, which are intermediates in this pathway, further support this identification. Additionally, the presence of D-Mannose and its related compounds suggest a connection to mannose metabolism. The alterations in GMPPB and GFUS, which are involved in the synthesis of GDP-mannose derivatives, also support this conclusion."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACOX3,CNDP2,ECHS1,CARNS1,GAD2,ALDH3B2,ALDH3B1 >>>\nList of compounds : <<< L-Histidine,Pantothenate,beta-Nitropropanoate,Acetyl-CoA,Carnosine,3-Aminopropanal,beta-Alanine,beta-Alanyl-L-lysine,Propanoyl-CoA,Malonyl-CoA,Spermidine,beta-Alanyl-L-arginine,3-Ureidopropionate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the beta-Alanine metabolism. This conclusion is supported by the alterations in several genes and compounds directly associated with this pathway. The genes CNDP2, CARNS1, and ALDH3B2 are involved in the synthesis, degradation, and detoxification of carnosine, a dipeptide consisting of beta-alanine and histidine. The increased levels of L-Histidine, Carnosine, beta-Alanine, and beta-Alanyl-L-lysine further corroborate the involvement of this pathway. The presence of ACOX3, ECHS1, GAD2, and ALDH3B1 might indicate secondary effects or crosstalk with other pathways, such as fatty acid oxidation and amino acid metabolism. However, the key findings point towards the beta-Alanine metabolism as the primary pathway affected in this specific condition."}], "target": "beta-Alanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PAFAH1B1,ENPP6,ENPP2,PLAAT2,LPCAT4,SELENOI,PLA2G1B,PLA2G4A,PLA2G4B,PLD2,GAL3ST1,PLA2G12A,PEDS1,PAFAH1B2,GDPD3 >>>\nList of compounds : <<< 1-Alkenyl-2-acylglycerol,sn-Glycero-3-phosphocholine,1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine,2-Acetyl-1-alkyl-sn-glycero-3-phosphate,1-Alkyl-sn-glycerol,2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine,1-Organyl-2-lyso-sn-glycero-3-phosphocholine,1-Radyl-2-acyl-sn-glycero-3-phosphocholine,Seminolipid,1-Alkyl-2-acetyl-sn-glycerol,1-(1-Alkenyl)-sn-glycero-3-phosphocholine,1-(1-Alkenyl)-sn-glycerol,Plasmenylcholine,1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol,1-Alkyl-sn-glycero-3-phosphate,1-(1-Alkenyl)-sn-glycero-3-phosphate,O-Alkylglycerone phosphate,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate,1-Alkyl-2-acylglycerophosphoethanolamine,O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine,2-Acyl-1-alkyl-sn-glycero-3-phosphate,Acylglycerone phosphate,Galactosyl-1-alkyl-2-acylglycerol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is Ether Lipid Metabolism. This conclusion is drawn based on the significant alterations observed in genes and compounds associated with this pathway. Genes such as PAFAH1B1, ENPP6, ENPP2, PLAAT2, LPCAT4, SELENOI, PLA2G1B, PLA2G4A, PLA2G4B, PLD2, GAL3ST1, PLA2G12A, PEDS1, PAFAH1B2, and GDPD3 are all known to play crucial roles in the synthesis, degradation, and regulation of ether lipids. Similarly, the altered compounds, including 1-Alkenyl-2-acylglycerol, sn-Glycero-3-phosphocholine, 1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine, and others, are key intermediates or end products in the ether lipid metabolism pathway. These findings suggest that the observed condition may be related to dysregulation or disruption of ether lipid metabolism."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PNPO,PSAT1,PDXK,PDXP >>>\nList of compounds : <<< Pyridoxal phosphate,3-Hydroxy-2-methylpyridine-5-carboxylate,2-(Acetamidomethylene)succinate,Glycolaldehyde >>>"}, {"role": "assistant", "content": "The comparison between the two conditions led to the identification of the Vitamin B6 metabolism pathway as being significantly altered. This is supported by the changes in genes and compounds associated with this pathway. PNPO, PSAT1, PDXK, and PDXP are all genes involved in the metabolism of Vitamin B6. PNPO is involved in the conversion of pyridoxamine 5'-phosphate to pyridoxal 5'-phosphate, a coenzyme form of Vitamin B6. PSAT1 is involved in the biosynthesis of Vitamin B6 from 3-hydroxy-2-methylpyridine-5-carboxylate. PDXK and PDXP are involved in the conversion of pyridoxine to pyridoxal 5'-phosphate. The observed alterations in the levels of pyridoxal phosphate, 3-Hydroxy-2-methylpyridine-5-carboxylate, 2-(Acetamidomethylene)succinate, and Glycolaldehyde, which are all intermediates or products of the Vitamin B6 metabolism pathway, further support the identification of this pathway as being involved in the condition."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< A4GALT,ST3GAL1,B3GALNT1,ST3GAL2,GLA,NAGA,B3GALT5,HEXA,FUT2,FUT9,ABO,GBGT1,FUT1 >>>\nList of compounds : <<< iGb4-Cer,Monosialylgalactosylgloboside,Disialosylglobopentaosylceramide,Lactosylceramide,Globo-H,Globoside,Globo-A,Galactosylgloboside,Globotriaosylceramide,NORint,iGb3-Cer,Globo-B,NOR2 antigen,IV3GalNAcb-Gb4Cer,Forssman antigen, IV3GalNAca-Gb4Cer >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycosphingolipid biosynthesis - globo and isoglobo series. This pathway was identified due to the alterations in multiple genes and compounds associated with this process. The genes A4GALT, ST3GAL1, B3GALNT1, ST3GAL2, GLA, NAGA, B3GALT5, HEXA, FUT2, FUT9, ABO, GBGT1, and FUT1 are all involved in the biosynthesis of glycosphingolipids, specifically in the globo and isoglobo series. The altered compounds, such as iGb4-Cer, Monosialylgalactosylgloboside, Disialosylglobopentaosylceramide, Lactosylceramide, Globo-H, Globoside, Globo-A, Galactosylgloboside, Globotriaosylceramide, NORint, iGb3-Cer, Globo-B, NOR2 antigen, IV3GalNAcb-Gb4Cer, Forssman antigen, and IV3GalNAca-Gb4Cer, are all intermediates or final products in this pathway, further supporting the identification of this pathway."}], "target": "Glycosphingolipid biosynthesis - globo and isoglobo series"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A8,ALDH9A1,ALDH1B1,UGT2B7,UGT1A7,UGT1A10,UGT2B28,UGDH,ALDH3A2,UGT1A3,AKR1A1,KL,UGT2A1,UGT1A9 >>>\nList of compounds : <<< D-Galacturonate,UDP-glucuronate,(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate,D-Arabinono-1,4-lactone,L-Arabinonate,2-Dehydro-3-deoxy-L-arabinonate,GDP-L-gulose,beta-L-Galactose 1-phosphate,UDP-D-galacturonate,myo-Inositol,2-Dehydro-3-deoxy-D-glucarate,Pyruvate,D-Galactaro-1,5-lactone >>>"}, {"role": "assistant", "content": "The identified metabolic pathway is Ascorbate and aldarate metabolism. This pathway is characterized by the interconversion of various aldarate sugars, including uronates, galactonates, and glucuronates. The altered genes, such as UGT1A8, UGT2B7, UGT1A7, and UGDH, encode enzymes involved in the glucuronidation process, which is a key step in this pathway. Additionally, the altered compounds, including D-Galacturonate, UDP-glucuronate, and UDP-D-galacturonate, are direct participants in this metabolic pathway. The presence of ALDH9A1, ALDH1B1, and ALDH3A2, which are involved in aldehyde metabolism, also supports the involvement of the Ascorbate and aldarate metabolism pathway, as aldehydes are intermediate products in this pathway."}], "target": "Ascorbate and aldarate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OXSM,BTD >>>\nList of compounds : <<< Pimeloyl-[acyl-carrier protein],Tetranorbiotin,Biocytin,Biotin sulfoxide,7,8-Diaminononanoate,Pimeloyl-[acyl-carrier protein] methyl ester,Urea,Bisnorbiotin,3-Hydroxypimeloyl-[acp] methyl ester,Pimelate,Biotin,Enoylglutaryl-[acp] methyl ester,Malonyl-[acyl-carrier protein],Dethiobiotin,Biotin sulfone,3-Ketopimeloyl-[acp] methyl ester,8-Amino-7-oxononanoate,3-Hydroxyglutaryl-[acp] methyl ester,Long-chain acyl-[acyl-carrier protein],Glutaryl-[acp] methyl ester,Biotinyl-5'-AMP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Biotin metabolism. This is supported by the alteration of several genes and compounds directly involved in this pathway. The genes OXSM and BTD are known to play crucial roles in biotin metabolism. OXSM encodes the enzyme 7,8-diaminopelargonic acid synthase, which is involved in the final step of biotin biosynthesis. BTD, on the other hand, encodes biotinidase, the enzyme responsible for recycling biotin. The altered compounds, including Pimeloyl-[acyl-carrier protein], Biocytin, Biotin sulfoxide, and Biotinyl-5'-AMP, are intermediates or derivatives in the biotin metabolism pathway. Therefore, the collective alteration of these genes and compounds suggests that the Biotin metabolism pathway is significantly affected in the compared conditions."}], "target": "Biotin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A4,ALDH2,UGT1A8,UGT2B4 >>>\nList of compounds : <<< D-Arabinono-1,4-lactone,2,5-Dioxopentanoate,UDP-glucose,L-Ascorbate 6-phosphate,L-Galactose,5-Dehydro-4-deoxy-D-glucarate,L-Xylulose 5-phosphate,L-Galactono-1,4-lactone,1-Phospho-alpha-D-galacturonate,D-Arabinose,L-Arabinono-1,4-lactone,D-Galacturonate,Dehydro-D-arabinono-1,4-lactone,Dehydroascorbate,Ascorbate,2-Hydroxy-3-oxopropanoate,Pyruvate,UDP-D-galacturonate,D-Glucuronate 1-phosphate,L-Xylonate,D-Arabinonate,L-Galactonate,GDP-mannose,beta-L-Galactose 1-phosphate,L-Galactono-1,5-lactone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the altered genes and compounds is the Ascorbate and aldarate metabolism. This pathway is primarily involved in the metabolism of vitamin C (ascorbate) and its derivatives (aldarates). The genes UGT1A4, UGT1A8, and UGT2B4, which are involved in the glucuronidation of various compounds, suggest an involvement in the metabolism of ascorbate and its derivatives. The presence of compounds such as L-Ascorbate 6-phosphate, Dehydroascorbate, and Ascorbate directly implicates this pathway. The ALDH2 gene, which encodes an enzyme involved in the metabolism of aldehydes, may also play a role in this pathway, particularly in the metabolism of aldarates. The presence of compounds such as D-Arabinono-1,4-lactone, L-Galactono-1,4-lactone, and Dehydro-D-arabinono-1,4-lactone further supports this conclusion."}], "target": "Ascorbate and aldarate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< IL4I1,GPT2,NAT8L,GOT2,GLS,GPT,ADSS2,GFPT1,FOLH1,ALDH5A1,PPAT >>>\nList of compounds : <<< N-Acetylaspartylglutamate,2-Oxosuccinamate,N-(L-Arginino)succinate,beta-Citryl-L-glutamate,N-Acetylaspartylglutamylglutamate,Citrate,Fumarate,L-Asparagine,L-Alanine,L-Glutamine,N-Carbamoyl-L-aspartate,2-Oxoglutaramate,5-Phosphoribosylamine,L-Aspartate,D-Glucosamine 6-phosphate,Pyruvate,Ammonia,Succinate,2-Oxoglutarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Alanine, Aspartate, and Glutamate Metabolism pathway. This conclusion is supported by the alterations in several genes and compounds associated with this pathway. Genes such as GPT2, GOT2, GLS, GPT, and GFPT1 are directly involved in this pathway, regulating the conversion of amino acids like L-Alanine, L-Aspartate, and L-Glutamine. The presence of compounds like L-Alanine, L-Aspartate, L-Glutamine, Ammonia, Pyruvate, and 2-Oxoglutarate further strengthens this identification. Additionally, other genes like IL4I1, NAT8L, ADSS2, FOLH1, and ALDH5A1, along with compounds like N-Acetylaspartylglutamate, 2-Oxosuccinamate, and 2-Oxoglutaramate, are indirectly related to this pathway, supporting its involvement in the observed condition."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< B3GAT3,NDST3,EXT2,EXTL1,HS2ST1,XYLT2,HS6ST3 >>>\nList of compounds : <<< [Protein]-L-serine,Acetate,Adenosine 3',5'-bisphosphate,3'-Phosphoadenylyl sulfate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosaminoglycan biosynthesis - heparan sulfate / heparin pathway. This conclusion is supported by the altered genes and compounds observed. The genes B3GAT3, NDST3, EXT2, EXTL1, HS2ST1, XYLT2, and HS6ST3 are all involved in the biosynthesis of heparan sulfate and heparin, which are complex carbohydrates found in the extracellular matrix. The presence of [Protein]-L-serine, a precursor in this pathway, further supports this identification. Additionally, the compounds Acetate and Adenosine 3',5'-bisphosphate are known to regulate various steps in this pathway. Lastly, the presence of 3'-Phosphoadenylyl sulfate, a sulfate donor in the sulfation steps of this pathway, provides additional evidence for the involvement of this pathway in the observed condition."}], "target": "Glycosaminoglycan biosynthesis - heparan sulfate / heparin"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDXK,PSAT1,PNPO,PHOSPHO2 >>>\nList of compounds : <<< 2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate,5-Pyridoxolactone,2-(Acetamidomethylene)succinate,D-Glyceraldehyde 3-phosphate,4-Hydroxy-L-threonine,Pyridoxine phosphate,Pyridoxamine phosphate,Glycolaldehyde,2-Oxo-3-hydroxy-4-phosphobutanoate,2-(Hydroxymethyl)-4-oxobutanoate,3-Hydroxy-2-methylpyridine-4,5-dicarboxylate,3-Amino-2-oxopropyl phosphate,2-Amino-3-oxo-4-phosphonooxybutyrate,4-Pyridoxolactone,Pyridoxine,O-Phospho-4-hydroxy-L-threonine,2-(Hydroxymethyl)-3-(acetamidomethylene)succinate,Isopyridoxal,L-Glutamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Vitamin B6 metabolism. This conclusion is supported by the alterations in genes PDXK, PSAT1, PNPO, and PHOSPHO2, which are all involved in different steps of this pathway. PDXK is responsible for the synthesis of pyridoxal 5'-phosphate, the active form of vitamin B6, while PSAT1 and PNPO are involved in serine biosynthesis and tryptophan degradation, respectively, both of which are closely linked to vitamin B6 metabolism. PHOSPHO2 encodes a phosphatase that plays a role in maintaining intracellular pyridoxal 5'-phosphate levels. The altered compounds, including various forms of vitamin B6 (pyridoxine, pyridoxine phosphate, pyridoxamine phosphate, and pyridoxolactone), as well as intermediates in related pathways (serine and glutamine metabolism), further support this conclusion."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADSS1,GAD1,RIMKLB,NAT8L,RIMKLA,FOLH1,CAD,GFPT1,AGXT,GLUD2,ADSS2,GOT2,GPT2,GLUD1,ASPA,ASNS,GPT,ALDH5A1,GLUL,ABAT,GFPT2,ASL,ASRGL1,AGXT2,GLS >>>\nList of compounds : <<< 5-Phosphoribosylamine,beta-Citryl-L-glutamate >>>"}, {"role": "assistant", "content": "The experiment identified the Alanine, Aspartate and Glutamate Metabolism pathway as being significantly altered. This pathway involves the interconversion of these three amino acids, which are essential for protein synthesis and nitrogen metabolism. The altered genes, including ADSS1, GAD1, RIMKLB, NAT8L, GLUD1, GLS, and others, are directly involved in this pathway. For instance, GAD1 encodes glutamic acid decarboxylase, which catalyzes the conversion of glutamate to GABA, and GLUD1 encodes glutamate dehydrogenase, which catalyzes the reversible oxidative deamination of glutamate. The altered compounds, 5-Phosphoribosylamine and beta-Citryl-L-glutamate, are intermediates in this pathway, further supporting the involvement of this pathway in the observed condition."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< COX10,UGT2A3,UGT1A3,HEPH,UGT2B17,MMAB,COX15,FTMT,UROD,FTH1,UGT2A1,GUSB,UGT1A9,FTL,FXN,HCCS,UGT2B15,HEPHL1,BLVRB,BLVRA,UGT1A10,UGT2B10,EARS2,ALAD >>>\nList of compounds : <<< Pheophytin a,Fe-coproporphyrin III,Geranylgeranyl bacteriochlorophyllide a,Uroporphyrinogen III,Cytochrome a,Bacteriochlorophyll d,Bacteriochlorophyll b,8-Ethyl-12-methylbacteriochlorophyllide d,Hemoglobin,Magnesium protoporphyrin,Magnesium protoporphyrin monomethyl ester,Precorrin 3B,3-Hydroxyethylbacteriochlorophyllide a,Cob(II)alamin,Bilirubin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Porphyrin metabolism pathway. This conclusion is supported by the alteration of multiple genes and compounds directly involved in this pathway. Genes such as COX10, COX15, UROD, and ALAD are known to play crucial roles in porphyrin biosynthesis and metabolism. The altered compounds, including Uroporphyrinogen III, Precorrin 3B, and Bilirubin, are intermediates and end products in the Porphyrin metabolism pathway. Additionally, the presence of Hemoglobin and Cytochrome a, both of which contain heme, a product of porphyrin metabolism, further supports this identification. Therefore, the data suggest that the Porphyrin metabolism pathway is significantly affected in the compared conditions."}], "target": "Porphyrin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SGPP2,SPHK1,ARSA,CERS4,NEU1,SGMS2,PLPP2,ACER3,UGCG,ASAH1,ENPP7,NEU4,B4GALNT1,SMPD2,SMPD3,B4GALT6,SPTLC1,KDSR,SPTLC2,CERS1 >>>\nList of compounds : <<< Psychosine,L-Serine,Globoside,Glucosylceramide,alpha-D-Galactosyl-(1-&gt;4)-beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(1&lt;-&gt;1)-ceramide,Digalactosylceramide,Gangliotriaosylceramide-II3 sulfate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Sphingolipid metabolism pathway. This is consistent with the altered genes and compounds observed. The genes SGPP2, SPHK1, ARSA, CERS4, NEU1, SGMS2, PLPP2, ACER3, UGCG, ASAH1, ENPP7, NEU4, B4GALNT1, SMPD2, SMPD3, B4GALT6, SPTLC1, KDSR, SPTLC2, and CERS1 are all involved in the biosynthesis, degradation, and regulation of sphingolipids. Similarly, the altered compounds, including Psychosine, L-Serine, Globoside, Glucosylceramide, Digalactosylceramide, and Gangliotriaosylceramide-II3 sulfate, are intermediates or end products of the sphingolipid metabolism pathway. Therefore, the changes in these genes and compounds suggest that the Sphingolipid metabolism pathway is affected in the specific condition studied."}], "target": "Sphingolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH1B1,ADH6,ACADVL,ACSL4,EHHADH >>>\nList of compounds : <<< (S)-Hydroxydecanoyl-CoA,CoA,Fatty acid,Aldehyde,3-Oxohexanoyl-CoA,Primary alcohol,(S)-3-Hydroxyoctanoyl-CoA,Palmitoyl-CoA,3-Oxodecanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is fatty acid degradation. This is supported by the alterations observed in several genes and compounds associated with this pathway. The genes ALDH1B1, ADH6, ACADVL, ACSL4, and EHHADH are all involved in fatty acid metabolism. ALDH1B1 and ADH6 are associated with the oxidation of alcohols and aldehydes, steps in fatty acid degradation. ACADVL and EHHADH are involved in the beta-oxidation of fatty acids, a process that breaks down fatty acids into acetyl-CoA. ACSL4 activates long-chain fatty acids for beta-oxidation. The altered compounds, including (S)-Hydroxydecanoyl-CoA, 3-Oxohexanoyl-CoA, and 3-Oxodecanoyl-CoA, are intermediates in the beta-oxidation pathway, further supporting the identification of fatty acid degradation as the affected pathway."}], "target": "Fatty acid degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< SDS,SDSL,BCAT2,BCAT1 >>>\nList of compounds : <<< (R)-3-Hydroxy-3-methyl-2-oxopentanoate,(S)-2-Acetolactate,3-Hydroxy-3-methyl-2-oxobutanoic acid,4-Methyl-2-oxopentanoate,alpha-Isopropylmalate,(R)-2,3-Dihydroxy-3-methylbutanoate,D-erythro-3-Methylmalate,2-Oxobutanoate,(S)-2-Aceto-2-hydroxybutanoate,L-Valine,Pyruvate,3-Methyl-2-oxobutanoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Valine, Leucine and Isoleucine Biosynthesis pathway. This is supported by the alterations in the genes SDS, SDSL, BCAT2, and BCAT1, which are directly involved in this pathway. SDS and SDSL encode subunits of the acetohydroxyacid synthase complex, the first committed step in the biosynthesis of these branched-chain amino acids. BCAT2 and BCAT1 encode branched-chain amino acid transaminases, which catalyze the final step in the biosynthesis of valine and the initial step in the catabolism of all three branched-chain amino acids. The altered compounds, including (R)-3-Hydroxy-3-methyl-2-oxopentanoate, (S)-2-Acetolactate, and L-Valine, are intermediates or end products of this pathway, further supporting the involvement of this pathway in the observed condition."}], "target": "Valine, leucine and isoleucine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< COX6A2,MT-CYB,COX7A2,ATP5F1E,NDUFB2,MT-CO1,NDUFB11,COX10,MT-CO3,ATP4A,UQCRFS1,NDUFB7,PPA1,NDUFA3,NDUFV2 >>>\nList of compounds : <<< H+,H+,H+,NAD+ >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Oxidative Phosphorylation, a process that occurs in the inner mitochondrial membrane to generate ATP. This pathway was implicated due to the alterations in genes such as COX6A2, MT-CYB, COX7A2, ATP5F1E, NDUFB2, MT-CO1, NDUFB11, COX10, MT-CO3, ATP4A, UQCRFS1, NDUFB7, NDUFA3, and NDUFV2, which are all key components of the electron transport chain and ATP synthase complexes in oxidative phosphorylation. Moreover, the altered compounds H+ and NAD+ are directly involved in this pathway. Protons (H+) are pumped across the membrane to create a proton gradient, which drives ATP synthesis, and NAD+ is a coenzyme that accepts electrons during the electron transport chain, ultimately contributing to the generation of ATP. Therefore, the observed alterations in these genes and compounds strongly suggest a role for oxidative phosphorylation in the condition under investigation."}], "target": "Oxidative phosphorylation"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH1B1,LPIN2,MGLL,GPAT4,PLPP2,AGPAT2,PNLIPRP2,DGKZ >>>\nList of compounds : <<< 1,2-Diacyl-3-alpha-D-glucosyl-sn-glycerol,Glycerol,1-Acyl-sn-glycerol 3-phosphate,1,2-Diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol,1-Acylglycerol,Fatty acid,1,2-Diacyl-3-beta-D-galactosyl-sn-glycerol,UDP-6-sulfoquinovose,3-Hydroxypropanal,Glycerophosphoglycoglycerolipid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Glycerolipid metabolism. This pathway was implicated due to the alterations observed in several genes and compounds associated with it. The genes ALDH1B1, MGLL, GPAT4, AGPAT2, and DGKZ are directly involved in the synthesis and degradation of glycerolipids. The altered compounds, including Glycerol, 1-Acyl-sn-glycerol 3-phosphate, Fatty acid, and Glycerophosphoglycoglycerolipid, are key intermediates in this pathway. The presence of 1,2-Diacyl-3-alpha-D-glucosyl-sn-glycerol and 1,2-Diacyl-3-beta-D-galactosyl-sn-glycerol suggest the involvement of glycerolipid glycosylation. Therefore, the observed changes in genes and compounds strongly support the implication of the Glycerolipid metabolism pathway in the studied condition."}], "target": "Glycerolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ELOVL3,ACOT4,HACD1,ELOVL1,ELOVL5,ACOX3,ACOT2,ACOX1,ACAA1 >>>\nList of compounds : <<< (11Z,14Z,17Z)-Icosatrienoyl-CoA,Hexadecanoic acid,(15Z)-Tetracosenoic acid,Docosanoyl-CoA,Linoleoyl-[acyl-carrier protein],(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA,Docosanoic acid,Eicosanoyl-CoA,Icosatrienoic acid,(11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA,Docosenoyl-CoA,Eicosanoyl-CoA,(11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA,(6Z,9Z,12Z)-Octadecatrienoic acid,Ximenoyl-CoA,Eicosanoyl-CoA,Palmitoyl-CoA,Palmitoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Biosynthesis of Unsaturated Fatty Acids. This conclusion aligns with the alterations observed in genes and compounds. The gene list includes ELOVL3, ELOVL1, ELOVL5, HACD1, ACOT4, ACOX3, ACOX1, ACOT2, and ACAA1, which are all known to be involved in the biosynthesis and degradation of unsaturated fatty acids. The compound list also supports this finding, as it includes various unsaturated fatty acids and their intermediate forms, such as (11Z,14Z,17Z)-Icosatrienoyl-CoA, (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA, and (11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA, among others. The presence of these compounds indicates active biosynthesis and metabolism of unsaturated fatty acids."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< B3GAT3,DSE,CHST15,CHSY3,DSEL,XYLT1,CSGALNACT1,CHST13 >>>\nList of compounds : <<< Adenosine 3',5'-bisphosphate,3'-Phosphoadenylyl sulfate,Adenosine 3',5'-bisphosphate >>>"}, {"role": "assistant", "content": "The experiment identified the Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate pathway as the affected metabolic pathway. This is supported by the altered genes and compounds observed. The genes B3GAT3, DSE, CHST15, CHSY3, DSEL, XYLT1, and CSGALNACT1 are all directly involved in the synthesis of chondroitin sulfate and dermatan sulfate, which are key components of this pathway. The compounds Adenosine 3',5'-bisphosphate and 3'-Phosphoadenylyl sulfate are crucial cofactors in the sulfation reactions required for the biosynthesis of these glycosaminoglycans. Therefore, the changes in these genes and compounds strongly suggest that the Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate pathway is affected in the specific condition under study."}], "target": "Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADO,FMO1,GAD2,GADL1,FMO5,GGT5,GGT1,FMO4,FMO2,CSAD,BAAT >>>\nList of compounds : <<< Acetyl-CoA,Acetyl phosphate,Cysteamine,N-Phosphotaurocyamine,Acetaldehyde,2-Hydroxyethanesulfonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Taurine and Hypotaurine Metabolism pathway. This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes ADO, FMO1, FMO5, FMO4, FMO2, CSAD, and BAAT are all involved in the metabolism of taurine and hypotaurine. The compound N-Phosphotaurocyamine is a direct intermediate in this pathway, while Cysteamine is a precursor to taurine synthesis. The presence of Acetyl-CoA and Acetaldehyde may suggest a link with other pathways, but their role in this context is likely related to the conversion of cysteamine to hypotaurine. The altered levels of 2-Hydroxyethanesulfonate, a byproduct of taurine catabolism, further supports the involvement of this pathway."}], "target": "Taurine and hypotaurine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< FDPS,NUS1,IDI2,ICMT,IDI1,CHURC1-FNTB >>>\nList of compounds : <<< (R)-5-Diphosphomevalonate,Geranylgeranyl diphosphate,trans-Anhydromevalonate phosphate,Acetoacetyl-CoA,all-trans-Hexaprenyl diphosphate,(R)-Mevalonate,Isopentenyl phosphate,all-trans-Heptaprenyl diphosphate,(R)-Mevalonate 3,5-bisphosphate,all-trans-Nonaprenyl diphosphate,1-Deoxy-D-xylulose 5-phosphate,(2E,6E)-Farnesol,2-trans,6-trans-Farnesal,2-cis,6-cis-Farnesyl diphosphate,2-C-Methyl-D-erythritol 4-phosphate,cis-1,4-Polyisoprene,trans,octacis-Decaprenyl diphosphate,S-Farnesyl protein,(R)-Mevalonate 3-phosphate,Acetyl-CoA,trans,trans-Farnesyl phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Terpenoid backbone biosynthesis. This pathway was implicated due to the alterations in genes such as FDPS, NUS1, IDI2, ICMT, IDI1, and CHURC1-FNTB, which are all known to be involved in this pathway. The changes in these genes directly impact the production of terpenoids, which are a large and diverse class of organic compounds produced by a variety of organisms.\n\nThe list of altered compounds further supports this finding. Compounds such as (R)-5-Diphosphomevalonate, Geranylgeranyl diphosphate, and Isopentenyl phosphate are key intermediates in the Terpenoid backbone biosynthesis pathway. Additionally, the presence of prenyl diphosphates like Heptaprenyl diphosphate and Decaprenyl diphosphate, as well as the final products Farnesol, Farnesal, and Farnesyl diphosphate, indicate active terpenoid synthesis. Therefore, the data suggest that alterations in the Terpenoid backbone biosynthesis pathway are associated with the observed condition."}], "target": "Terpenoid backbone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< MAT1A,ACY1,PGAM2,BCAT2,TPI1,ABHD14A-ACY1,PFKM,CTH,ARG1,ASNS,TALDO1,MAT2A,ACO2,MTR,GPT >>>\nList of compounds : <<< D-Erythrose 4-phosphate,Glycerone phosphate,L-Glutamate 5-semialdehyde,3-Dehydroquinate,D-Fructose 1,6-bisphosphate,1-(5-Phospho-D-ribosyl)-ATP,(S)-2-Acetolactate,S-Sulfo-L-cysteine,L-Proline,Homoisocitrate,Isocitrate,2,3,4,5-Tetrahydrodipicolinate,L-Lysine,LysW-L-glutamate,S-Adenosyl-L-methionine,3-Dehydroshikimate,L-2-Aminoadipate,S-Adenosyl-L-homocysteine,L-Aspartate 4-semialdehyde,L-Cystathionine,(S)-1-Pyrroline-5-carboxylate,D-Fructose 6-phosphate,(2R,3S)-3-Isopropylmalate,2-Oxoglutarate,3-(4-Hydroxyphenyl)pyruvate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the \"Biosynthesis of amino acids.\" This pathway was inferred based on the alterations in multiple genes and compounds associated with amino acid metabolism. Genes such as MAT1A, MAT2A, MTR, and CTH are involved in the synthesis of methionine, arginine, and cysteine, respectively. The presence of intermediate compounds like S-Adenosyl-L-methionine, L-Cystathionine, and L-Aspartate 4-semialdehyde further supports this pathway. Additionally, the altered genes BCAT2, ASNS, and ACO2, which are involved in the synthesis of branched-chain amino acids, asparagine, and citrate, respectively, and the presence of compounds such as L-Glutamate 5-semialdehyde and Homoisocitrate, suggest the involvement of this pathway. Therefore, the data indicates that the \"Biosynthesis of amino acids\" pathway is significantly affected in the given condition."}], "target": "Biosynthesis of amino acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< HDC,ALDH7A1,ALDH2 >>>\nList of compounds : <<< L-Glutamate,N-Carbamyl-L-glutamate,4-Imidazolone-5-acetate,N-(5'-Phospho-D-1'-ribulosylformimino)-5-amino-1-(5''-phospho-D-ribosyl)-4-imidazolecarboxamide,Phosphoribosyl-AMP,Formylisoglutamine,gamma-L-Glutamyl-S-(hercyn-2-yl)-L-cysteine S-oxide,4-(beta-Acetylaminoethyl)imidazole,Methylimidazole acetaldehyde,Carnosine,L-Aspartate,N(pi)-Methyl-L-histidine,1-(5-Phospho-D-ribosyl)-ATP,Imidazol-5-yl-pyruvate,Hydantoin-5-propionate,N-Formimino-L-glutamate,4-Oxoglutaramate,N-Formyl-L-aspartate,Thiourocanic acid,N-Methylhistamine,Histamine,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate,1-(5-Phosphoribosyl)imidazole-4-acetate,L-Histidinol phosphate >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, the histidine metabolism pathway was identified as being significantly altered. This is supported by the changes observed in the genes HDC (Histidine decarboxylase), ALDH7A1 (Antiquitin), and ALDH2 (Aldehyde dehydrogenase 2). These genes are known to be involved in the catabolism of histidine. Furthermore, the altered compounds, such as histamine, N-Formimino-L-glutamate, and 4-Imidazolone-5-acetate, are intermediates or products of this pathway. These findings suggest that the histidine metabolism pathway plays a crucial role in the condition under study."}], "target": "Histidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BPNT2,ETHE1,SELENBP1,BPNT1,SUOX >>>\nList of compounds : <<< Hydrogen sulfide,Acetate,L-Homoserine,S,S-Dimethyl-beta-propiothetin,Acetaldehyde,Taurine,3-(Methylthio)propanoate,Sulfite,Sulfite,Tetrathionate,Methanethiol,Adenosine 3',5'-bisphosphate,Polysulfide,Succinate,Sulfur,S-Sulfanylglutathione,L-Cysteine,Adenylyl sulfate,Hydrogen sulfide,Alkanesulfonate,Sulfate,Thiosulfate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is sulfur metabolism. This conclusion is supported by the alterations in genes and compounds involved in this pathway. The genes BPNT2, BPNT1, SELENBP1, ETHE1, and SUOX are all associated with sulfur metabolism. BPNT2 and BPNT1 are involved in the biosynthesis of thiamine, a coenzyme crucial for sulfur metabolism. SELENBP1 plays a role in selenium metabolism, which is interconnected with sulfur metabolism. ETHE1 and SUOX are involved in the detoxification of sulfur compounds. The altered compounds, including Hydrogen sulfide, Sulfite, Tetrathionate, Methanethiol, Sulfur, S-Sulfanylglutathione, L-Cysteine, Adenylyl sulfate, Sulfate, and Thiosulfate, are all key intermediates or products of sulfur metabolism. Therefore, the changes observed in these genes and compounds strongly suggest that sulfur metabolism is the affected pathway in the given condition."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PIGL,PIGZ,PIGB,PIGV,PIGW,DPM2,PIGS,PIGH,GPLD1,GPAA1 >>>\nList of compounds : <<< Palmitoyl-CoA,Dolichyl phosphate D-mannose,Phosphatidylethanolamine,6-(alpha-D-glucosaminyl)-1D-myo-inositol,Ethanolamine phosphate,Phosphatidylethanolamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway. This pathway was implicated due to the alterations observed in multiple genes and compounds directly involved in its process. The list of genes includes PIGL, PIGZ, PIGB, PIGV, PIGW, DPM2, PIGS, PIGH, GPLD1, and GPAA1, all of which are known to play crucial roles in GPI-anchor biosynthesis. The altered compounds, such as Dolichyl phosphate D-mannose, 6-(alpha-D-glucosaminyl)-1D-myo-inositol, and Phosphatidylethanolamine, are key intermediates in this pathway. The presence of Palmitoyl-CoA and Ethanolamine phosphate, although not directly involved in GPI-anchor biosynthesis, can influence lipid and carbohydrate metabolism, further supporting the identified pathway. Therefore, the data suggest that the GPI-anchor biosynthesis pathway is likely involved in the observed condition."}], "target": "Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PCYT1B,CHPT1,SELENOI,CEPT1 >>>\nList of compounds : <<< N-Dimethyl-2-aminoethylphosphonate,D-Ribose 2,5-bisphosphate,Lipophosphonoglycan,Demethylphosphinothricin,2-Hydroxyethylphosphonate,Phosphoenolpyruvate,D-Ribose 1,5-bisphosphate,Formylphosphonate,Phosphonoacetaldehyde,1-Carboxyvinyl carboxyphosphonate,(R)-2-(Phosphonomethyl)malate,2-Amino-3-phosphonopropanoate,Methane,Phosphonoformate,Methylphosphonate,alpha-D-Ribose 1,2-cyclic phosphate 5-phosphate,Acetate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Phosphonate and Phosphinate Metabolism. This pathway is closely linked to the alterations observed in the genes and compounds. The genes PCYT1B, CHPT1, SELENOI, and CEPT1 are involved in phospholipid and phosphate metabolism, which intersects with the phosphonate pathway. The presence of numerous phosphonate and phosphinate compounds, such as N-Dimethyl-2-aminoethylphosphonate, Phosphoenolpyruvate, and (R)-2-(Phosphonomethyl)malate, further supports the involvement of this pathway. These compounds are intermediates or products of the Phosphonate and Phosphinate Metabolism. Therefore, the observed alterations in these genes and compounds suggest a significant role for this metabolic pathway in the condition under investigation."}], "target": "Phosphonate and phosphinate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HAL,ASPA,ALDH3A2,ALDH3B1,FTCD,CARNS1,CNDP1,CNDP2,CARNMT1,AOC1,ALDH3B2 >>>\nList of compounds : <<< N-Formyl-L-glutamate,beta-Alanyl-N(pi)-methyl-L-histidine,Carnosine,Imidazole lactate,Hydantoin-5-propionate,Imidazole-4-acetate,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate,4-Imidazolone-5-acetate,Phosphoribosyl-AMP,L-Glutamate,(1-Ribosylimidazole)-4-acetate >>>"}, {"role": "assistant", "content": "The experiment identified the Histidine metabolism pathway as being significantly altered in the comparison of the two conditions. This is supported by the altered genes and compounds observed. The genes HAL, ASPA, ALDH3A2, ALDH3B1, AOC1, and ALDH3B2 are known to be involved in the Histidine metabolism pathway. HAL encodes histidine ammonia-lyase, which is the first enzyme in the catabolism of histidine. ASPA, ALDH3A2, ALDH3B1, and ALDH3B2 are involved in the breakdown of intermediates in this pathway. AOC1 encodes amine oxidase copper containing 1, which is involved in the degradation of histamine, a product of histidine metabolism. The altered compounds, such as N-Formyl-L-glutamate, beta-Alanyl-N(pi)-methyl-L-histidine, Carnosine, Imidazole lactate, and others, are direct products or intermediates in the Histidine metabolism pathway, further supporting this identification."}], "target": "Histidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CNDP2,AOC3,ALDH9A1,ALDH2,EHHADH,ACADS,ECHS1,MLYCD,ALDH1B1,UPB1,HADHA,ALDH6A1,GAD2,SMOX,ALDH3A1,CSAD,ALDH7A1,ALDH3B2,HIBCH,ACOX1,ALDH3B1 >>>\nList of compounds : <<< beta-Nitropropanoate,beta-Alanyl-CoA,N-Acetyl-beta-alanine,beta-Alanyl-L-lysine,Malonyl-CoA,L-Histidine,Spermine,beta-Alanyl-L-arginine,Propanoyl-CoA,Acetyl-CoA,3-Ureidopropionate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the beta-Alanine metabolism pathway, which is supported by the alterations observed in multiple genes and compounds. Several genes involved in this pathway were affected, including CNDP2, AOC3, ALDH2, EHHADH, ECHS1, MLYCD, ALDH1B1, ALDH3A1, ALDH3B1, and ALDH3B2. These genes encode enzymes that catalyze reactions in the beta-Alanine metabolism pathway, such as the conversion of beta-Alanine to propionate and acetyl-CoA.\n\nFurthermore, several compounds related to this pathway were also altered, including beta-Alanine derivatives such as beta-Alanyl-CoA, N-Acetyl-beta-alanine, beta-Alanyl-L-lysine, and beta-Alanyl-L-arginine. Additionally, changes in the levels of Malonyl-CoA, Acetyl-CoA, and 3-Ureidopropionate further support the involvement of the beta-Alanine metabolism pathway in the observed condition. Overall, the alterations in both genes and compounds suggest that the beta-Alanine metabolism pathway plays a key role in the condition under investigation."}], "target": "beta-Alanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSTZ1,ALDH3B2,TH,FAH,IL4I1,DCT,MAOB,MAOA,GOT1,TPO,AOX1,ADH5,LRTOMT,HGD,ALDH3A1,COMT,TAT,TYR,DDC,GOT1L1,ALDH3B1,AOC2,ADH7 >>>\nList of compounds : <<< Salidroside,5-Carboxy-2-oxohept-3-enedioate,Cysteinyldopa,3,4-Dihydroxyphenylacetaldehyde,5-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde,2-Oxohept-3-enedioate,3-Fumarylpyruvate,4-Coumarate,3,5-Diiodo-L-tyrosine,3-Methoxy-4-hydroxyphenylacetaldehyde,4-Hydroxyphenylacetate,Phaeomelanin,3,4-Dihydroxy-L-phenylalanine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Tyrosine metabolism. This pathway was implicated due to the significant alterations in several genes and compounds directly associated with it. Genes such as TH (Tyrosine Hydroxylase), TYR (Tyrosinase), DDC (Dopa Decarboxylase), MAOA and MAOB (Monoamine Oxidase A and B), COMT (Catechol-O-Methyltransferase), and GOT1 and GOT1L1 (Aspartate Aminotransferase) are all key enzymes in this pathway. The altered compounds, including 3,4-Dihydroxyphenylalanine (L-DOPA), 3-Methoxy-4-hydroxyphenylacetaldehyde, 4-Hydroxyphenylacetate, and Phaeomelanin, are intermediates or products of the Tyrosine metabolism. The changes in these genes and compounds suggest that this pathway is significantly involved in the condition under study."}], "target": "Tyrosine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BLVRA,UGT2A2,UGT1A3,FXN,ALAS2,EPRS1,UGT1A5,BLVRB,FTL,UGT1A8,MMAB,UGT2B10,UGT2B7,HCCS,UGT1A9,FECH,HEPHL1,ALAD,UGT2B11,UGT2B17 >>>\nList of compounds : <<< alpha-Ribazole,Oxyhemoglobin,13(1)-Hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester >>>"}, {"role": "assistant", "content": "The experiment identified the Porphyrin metabolism pathway as being significantly altered. This is supported by the changes observed in several genes associated with this pathway, including FECH, ALAS2, ALAD, and HCCS, which are involved in the synthesis and modification of heme. The compound 13(1)-Hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester is a direct intermediate in the porphyrin pathway, further supporting this finding. The presence of altered UGT genes, which are involved in the glucuronidation of porphyrins and heme, also aligns with this pathway. The presence of Oxyhemoglobin, a product of heme metabolism, further supports the involvement of the Porphyrin metabolism pathway. Alpha-Ribazole, while not directly linked to porphyrin metabolism, can affect heme synthesis indirectly by influencing folate metabolism."}], "target": "Porphyrin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PCYT2,PLD4,PLA2G12A,LPIN2,PLA2G6,LYPLA1,LCAT,GPD1,PNPLA6,GPAT2,PCYT1A,CRLS1,PCYT1B,,PLA2G1B,PLA2G2C,PLD1 >>>\nList of compounds : <<< Triethanolamine,sn-Glycerol 3-phosphate,Cardiolipin,Phosphatidylcholine,CDP-ethanolamine,Aminoacyl-phosphatidylglycerol,Diacylglyceryl-N,N,N-trimethylhomoserine,2,3-Bis-(O-geranylgeranyl)-sn-glycero-1-phospho-L-serine >>>"}, {"role": "assistant", "content": "The experiment identified the Glycerophospholipid metabolism pathway as being significantly altered. This pathway involves the synthesis, degradation, and modification of glycerophospholipids, which are major components of cellular membranes. The alteration of several genes involved in this pathway, including PCYT2, PLD4, PLA2G12A, LPIN2, PLA2G6, LYPLA1, LCAT, GPAT2, PCYT1A, CRLS1, PCYT1B, PLA2G1B, and PLA2G2C, supports this finding. These genes encode enzymes that play key roles in the biosynthesis, hydrolysis, and remodeling of glycerophospholipids. Additionally, the observed changes in various glycerophospholipid compounds, such as sn-Glycerol 3-phosphate, Phosphatidylcholine, CDP-ethanolamine, and Aminoacyl-phosphatidylglycerol, further corroborate the involvement of this pathway. Therefore, the Glycerophospholipid metabolism pathway is likely to be a key player in the condition under study."}], "target": "Glycerophospholipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< RGN,PFKP,PGM2,DERA,FBP2,ALDOA,PRPS2,ALDOB,GPI,RPIA,PRPS1L1,PGD,ALDOC,FBP1,PFKM,PGLS,SHPK,G6PD,PRPS1,PGM1 >>>\nList of compounds : <<< 6-Phospho-2-dehydro-D-gluconate,D-Erythrose 4-phosphate,D-Ribulose 1,5-bisphosphate,Deoxyribose,alpha-D-Glucose 6-phosphate,D-Glucose,3-Phospho-D-glycerate,beta-D-Glucose 6-phosphate,D-Ribose 5-phosphate,D-Glucono-1,5-lactone,D-Glycerate,2-Deoxy-D-ribose 1-phosphate,2-Dehydro-3-deoxy-6-phospho-D-gluconate,D-arabino-Hex-3-ulose 6-phosphate,2-Amino-2-deoxy-D-gluconate,6-Phospho-D-gluconate,alpha-D-Ribose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Pentose Phosphate Pathway (PPP). This pathway was deduced from the alterations in multiple genes and compounds. The genes involved, such as G6PD, PGD, and PGLS, are key enzymes in the PPP, which is responsible for the synthesis of ribose-5-phosphate and NADPH. The altered compounds, including D-Glucose 6-phosphate, D-Ribose 5-phosphate, and D-Erythrose 4-phosphate, are intermediates in the PPP, further supporting the identification of this pathway. The changes in these genes and compounds suggest an increased flux through the PPP, potentially due to an increased demand for nucleotides or NADPH, or a decreased demand for glycolytic intermediates."}], "target": "Pentose phosphate pathway"}
{"messages": [{"role": "user", "content": "List of genes : <<< DLAT,GLO1,PC,ACAT2,ALDH7A1,ADH4,ME2,ADH1B,ACOT12,LDHC,FH,ACACA,LDHB,PKLR,ME1,ALDH9A1,ADH1A,DLD >>>\nList of compounds : <<< 2-(alpha-Hydroxyethyl)thiamine diphosphate,Enzyme N6-(lipoyl)lysine,Enzyme N6-(dihydrolipoyl)lysine,Acetyl adenylate,Acetyl-CoA,Fumarate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Acetaldehyde,(R)-Lactaldehyde,Ethanol,(S)-Lactate,Succinate,Acetyl phosphate,Pyruvate,(R)-2-Ethylmalate,2-Propylmalate,Thiamin diphosphate,Methylglyoxal,(R)-Lactate,Acetate,Acetoacetyl-CoA,alpha-Isopropylmalate >>>"}, {"role": "assistant", "content": "The experiment identified alterations in the Pyruvate metabolism pathway. Several genes involved in this pathway were found to be altered, including DLAT, DLD, and LDHB, which are associated with the pyruvate dehydrogenase complex and lactate dehydrogenase, respectively. These enzymes play crucial roles in converting pyruvate to acetyl-CoA and lactate. The altered compounds, such as pyruvate, acetyl-CoA, lactate, and acetaldehyde, are direct intermediates or products of this pathway. Additionally, the presence of compounds like thiamin diphosphate and its derivative, 2-(alpha-Hydroxyethyl)thiamine diphosphate, further supports the involvement of pyruvate metabolism, as thiamin diphosphate is a cofactor for pyruvate dehydrogenase. Therefore, the changes in these genes and compounds suggest that the Pyruvate metabolism pathway is significantly involved in the condition under study."}], "target": "Pyruvate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PC,TKFC,ACSS1,PHGDH,ENO4,IDH2,ADH5,PRPS1,RPIA,G6PD,HK2,H6PD,ACSS2,SHMT1,IDH3A >>>\nList of compounds : <<< (R)-Methylmalonyl-CoA,CO2,Acetate,Acetyl phosphate,Malonyl-CoA,5-Methyl-H4SPT,D-Glyceraldehyde,L-threo-3-Methylaspartate,Tetrahydrosarcinapterin,4-Hydroxybutanoic acid,D-Ribose 5-phosphate,Butanoyl-CoA,Trimethylamine,Ammonia,Glycerone,(S)-Malate,Coenzyme B,5,10-Methylenetetrahydromethanopterin,D-Glucono-1,5-lactone,Propenoyl-CoA,Propanoyl-CoA,3-Hydroxypropanoate,Glyoxylate,D-Glucono-1,5-lactone 6-phosphate >>>"}, {"role": "assistant", "content": "The experiment revealed that the Carbon metabolism pathway was significantly affected. This is supported by the observed alterations in several genes involved in this pathway, such as PC (Pyruvate carboxylase), ENO4 (Enolase 4), HK2 (Hexokinase 2), and G6PD (Glucose-6-phosphate dehydrogenase). These genes play crucial roles in glucose metabolism, glycolysis, and the pentose phosphate pathway. The altered compounds, including CO2, Acetate, D-Glyceraldehyde, and D-Ribose 5-phosphate, further corroborate this finding. These compounds are intermediates in the Carbon metabolism pathway, indicating changes in the flux through this pathway. Therefore, the data suggest that the Carbon metabolism pathway is likely involved in the condition under investigation."}], "target": "Carbon metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACY1,OTC,NOS1,GPT,GOT2,ARG2,GLS2,GLUL >>>\nList of compounds : <<< L-Ornithine,Ammonia,N-(L-Arginino)succinate,N-Acetyl-L-glutamate 5-semialdehyde,2-Oxoglutarate,L-Citrulline,LysW-L-glutamate,N-Acetyl-L-citrulline,LysW-L-glutamate 5-semialdehyde,N-Acetyl-L-glutamate 5-phosphate,Urea >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Arginine biosynthesis. This conclusion is supported by the altered genes and compounds observed in the two conditions. The genes ACY1, OTC, NOS1, ARG2, GLS2, and GLUL are all involved in this pathway. ACY1 and GLUL are involved in the synthesis of L-Ornithine and L-Glutamate, respectively, which are precursors in the Arginine biosynthesis pathway. OTC, NOS1, and ARG2 are directly involved in the conversion of L-Ornithine to L-Citrulline and L-Citrulline to L-Arginine. GLS2, which produces L-Glutamate, is also essential for this pathway. The altered compounds, such as L-Ornithine, L-Citrulline, N-(L-Arginino)succinate, and Urea, are intermediates or products of the Arginine biosynthesis pathway, further supporting this conclusion."}], "target": "Arginine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< CKB,GOT1L1,AZIN2,PRODH2,SMS,CKMT2,P4HA2,NOS1,GATM,ALDH18A1,CARNS1,SAT2,ALDH3A2,CKM,GAMT,HOGA1,AOC1,GOT1,ALDH2,AMD1,AGMAT,P4HA3,LAP3,MAOB >>>\nList of compounds : <<< Nopaline,Phosphocreatine,Carboxyspermidine,N(omega)-Hydroxyarginine,L-1-Pyrroline-3-hydroxy-5-carboxylate,L-Glutamyl 5-phosphate,(4R)-4-Hydroxy-2-oxoglutarate,5-Amino-2-oxopentanoic acid,Nitric oxide,Hydroxyproline,N-Acetylputrescine,N-Acetyl-L-glutamate 5-semialdehyde,N-Succinyl-L-glutamate,Pyruvate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Arginine and Proline metabolism. This conclusion is supported by the alteration in several genes and compounds directly related to this pathway. The genes include PRODH2 and ALDH18A1, which are involved in the conversion of proline to glutamate and arginine biosynthesis respectively. The compound list further corroborates this, with the presence of Nopaline, a derivative of arginine, L-Glutamyl 5-phosphate, an intermediate in glutamate metabolism, and L-1-Pyrroline-3-hydroxy-5-carboxylate, a precursor in proline biosynthesis. Thus, the findings suggest a significant role of the Arginine and Proline metabolism in the given condition."}], "target": "Arginine and proline metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NDUFA7,LHPP,MT-ND4,MT-ATP6,NDUFA13,NDUFA4,ATP5MC3,ATP6V1B1,NDUFS8,NDUFB10,ATP6V0E1,NDUFA1,NDUFV2,ATP6V1F,MT-ND3,MT-ATP8,ATP6V0B,ATP5MC1,COX7A2L,COX6A1,ATP5ME, >>>\nList of compounds : <<< Fumarate,H+,Diphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is oxidative phosphorylation. This pathway was implicated due to the significant alterations observed in multiple genes associated with it. These genes include NDUFA7, NDUFA13, NDUFA4, NDUFA1, NDUFV2, MT-ND3, MT-ND4, MT-ATP6, MT-ATP8, ATP5MC1, ATP5MC3, ATP6V1B1, ATP6V0E1, ATP6V1F, ATP6V0B, ATP5ME, COX7A2L, and COX6A1. These genes encode subunits of complexes I, III, IV, and V of the electron transport chain, and the ATP synthase, all of which are crucial components of oxidative phosphorylation. The altered compounds, fumarate and diphosphate, also support this conclusion. Fumarate is a key intermediate in the citric acid cycle, which feeds electrons into the electron transport chain for oxidative phosphorylation. Diphosphate is a byproduct of ATP synthesis in oxidative phosphorylation. The presence of H+ ions further indicates proton gradient changes, a fundamental process in this pathway. Therefore, the data suggest a significant role of oxidative phosphorylation in the observed condition."}], "target": "Oxidative phosphorylation"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSTM2,GSTP1,CYP2E1,UGT2B11,ADH5,UGT2A2,UGT1A1,FMO2,UGT1A10,ADH6,CYP3A5,GSTA2,CYP2A7,UGT1A4,CYP2D6,ADH1B,UGT2A1,FMO5,GSTO2,UGT2B4,ADH7,GSTM3,UGT1A8,GSTT1 >>>\nList of compounds : <<< Atropaldehyde,2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline,2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine,3-Hydroxymonoethylglycinexylidide,Glycinexylidide,Citalopram,3-Hydroxycarbamazepine,2-n-Propyl-3-pentenoic acid,5-Phenyl-1,3-oxazinane-2,4-dione,2-Amino-3-methylbenzoate,Codeine,Felbamate,2-n-Propyl-2-pentenoic acid,4-Hydroxyvalproic acid,Oxcarbazepine,Alcoifosfamide,3-Oxovalproic acid,4-Hydroxyifosfamide,Tamoxifen N-oxide,Dechloroethylcyclophosphamide,Codeine (USP) >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Drug metabolism - cytochrome P450\". This pathway fits with the altered genes and compounds as many of the listed genes (CYP2E1, CYP3A5, CYP2A7, CYP2D6) are cytochrome P450 enzymes, which are involved in the metabolism of a wide range of drugs and other xenobiotics. Similarly, many of the listed compounds (Citalopram, 3-Hydroxycarbamazepine, Codeine, Felbamate, Oxcarbazepine, Tamoxifen N-oxide, Dechloroethylcyclophosphamide) are known substrates of these cytochrome P450 enzymes. Other genes and compounds listed are also involved in the phase II metabolism (conjugation) of drugs, which often follows cytochrome P450-mediated phase I metabolism, further supporting the involvement of this pathway."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< PSAT1,PDXK >>>\nList of compounds : <<< Pyridoxine,Succinate semialdehyde,2-(Hydroxymethyl)-4-oxobutanoate,2-(Acetamidomethylene)succinate,Pyridoxamine phosphate,2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate,D-Erythrose 4-phosphate,O-Phospho-4-hydroxy-L-threonine,L-Glutamine,4-Pyridoxate,4-Hydroxy-L-threonine,Pyridoxal phosphate,Isopyridoxal,Glycolaldehyde,Pyridoxine phosphate,5-Pyridoxolactone,3-Amino-2-oxopropyl phosphate,4-Phospho-D-erythronate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Vitamin B6 metabolism. This is supported by the alterations in the genes PSAT1 and PDXK, which are known to be involved in this pathway. PSAT1 encodes phosphoserine aminotransferase 1, an enzyme that uses pyridoxal phosphate, the active form of vitamin B6, as a cofactor. PDXK encodes pyridoxal kinase, which is responsible for the production of pyridoxal phosphate. The presence of various forms of vitamin B6 and its metabolites, such as pyridoxine, pyridoxal phosphate, and pyridoxamine phosphate, in the list of compounds further strengthens the identification of the Vitamin B6 metabolism pathway. Additionally, the altered compounds are intermediates or products of reactions in this pathway, further supporting this conclusion."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NOS1,GOT2,CAD,NOS2 >>>\nList of compounds : <<< N-(L-Arginino)succinate,N-Acetyl-L-glutamate 5-phosphate,LysW-L-glutamyl 5-phosphate,N-Acetylornithine,N-Acetyl-L-glutamate 5-semialdehyde,L-Glutamate,Urea-1-carboxylate,Ammonia,L-Arginine,Urea,2-Oxoglutarate,CO2,LysW-L-glutamate 5-semialdehyde,Carbamoyl phosphate,L-Aspartate,LysW-L-glutamate,Fumarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Arginine biosynthesis pathway. This is supported by the alteration of several genes and compounds directly involved in this pathway. The genes NOS1 and NOS2, which encode nitric oxide synthases, are involved in the conversion of L-arginine to citrulline and nitric oxide. The gene GOT2, which encodes glutamic-oxaloacetic transaminase, and the gene CAD, which encodes carbamoyl phosphate synthetase, are involved in the production of L-glutamate and carbamoyl phosphate, respectively, both of which are precursors in the arginine biosynthesis pathway. The altered compounds, including L-arginine, N-(L-Arginino)succinate, L-glutamate, and carbamoyl phosphate, are intermediates in the arginine biosynthesis pathway, further supporting the identification of this pathway."}], "target": "Arginine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< STT3A,ALG2,ALG6,DPM3,MOGS >>>\nList of compounds : <<< N,N'-Chitobiosyldiphosphodolichol,Dolichyl phosphate D-mannose,Dolichol,Protein asparagine,Dolichyl phosphate,N-Acetyl-D-glucosaminyldiphosphodolichol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is N-Glycan biosynthesis. This pathway involves the synthesis and attachment of N-linked glycans to proteins, which is crucial for proper protein folding and function. The altered genes, including STT3A, ALG2, ALG6, DPM3, and MOGS, are all key enzymes in this pathway. STT3A is an oligosaccharyltransferase that transfers the N-glycan to the protein, while ALG2, ALG6, and DPM3 are involved in the formation of the N-glycan precursor, and MOGS is necessary for the final steps of N-glycan maturation. The altered compounds, such as N,N'-Chitobiosyldiphosphodolichol, Dolichyl phosphate D-mannose, Dolichyl phosphate, and N-Acetyl-D-glucosaminyldiphosphodolichol, are intermediates in the N-Glycan biosynthesis pathway. The presence of Protein asparagine, which is the site of N-glycosylation, further supports the involvement of this pathway. Therefore, the changes in these genes and compounds are consistent with an alteration in the N-Glycan biosynthesis pathway."}], "target": "N-Glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< POMT2,B4GAT1,POMGNT1,B4GALT3 >>>\nList of compounds : <<< Dolichyl phosphate D-mannose,O-mannose core M3,[Protein]-L-serine,D-Ribitol 5-phosphate,CDP-ribitol,Phospho-core M3,CTP >>>"}, {"role": "assistant", "content": "The experiment identified the Mannose type O-glycan biosynthesis pathway as being affected in the two conditions. This pathway was implicated due to the alterations in multiple genes and compounds associated with it. The genes POMT2, B4GAT1, POMGNT1, and B4GALT3 are all involved in the synthesis and transfer of mannose residues to proteins, a key step in this pathway. The altered compounds, including Dolichyl phosphate D-mannose, O-mannose core M3, and Phospho-core M3, are intermediates in this pathway. The presence of [Protein]-L-serine suggests that the O-glycosylation of proteins is affected, as serine is a common site for this modification. Furthermore, the altered levels of D-Ribitol 5-phosphate, CDP-ribitol, and CTP, which are involved in other glycan biosynthesis pathways, may indicate cross-talk or regulation between these pathways and the Mannose type O-glycan biosynthesis pathway."}], "target": "Mannose type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< AOC2,FAHD1,MAOA >>>\nList of compounds : <<< Pyruvate,Eumelanin,2,5-Dihydroxybenzoate,3-Amino-3-(4-hydroxyphenyl)propanoate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Tyrosine metabolism. This conclusion is supported by the alteration of several genes and compounds associated with this pathway. The genes AOC2 and FAHD1 are involved in the metabolism of tyrosine to produce various compounds, including melanin and certain neurotransmitters. MAOA, on the other hand, is involved in the degradation of neurotransmitters derived from tyrosine. The compounds Pyruvate and 3-Amino-3-(4-hydroxyphenyl)propanoate (L-DOPA) are intermediates in the Tyrosine metabolism pathway, while Eumelanin and 2,5-Dihydroxybenzoate are end products. The alteration of these genes and compounds suggests a disruption in the Tyrosine metabolism pathway, making it a likely candidate for the observed condition."}], "target": "Tyrosine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GPX5,GPX2,GSTT2B,RRM1,GGT1,GSTT1,PRDX6,GPX3,ANPEP,SMS,GPX6,CHAC1 >>>\nList of compounds : <<< Glycine,Tryparedoxin disulfide,NADP+,Trypanothione,S-Substituted N-acetyl-L-cysteine,NADPH,Tryparedoxin,R-S-Cysteinylglycine,Spermine,L-Amino acid,L-Ornithine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glutathione metabolism. This pathway was implicated due to the alteration of several genes directly involved in glutathione metabolism, including GPX2, GPX3, GPX5, GPX6, GSTT1, GSTT2B, and PRDX6. These genes encode for enzymes such as glutathione peroxidases and glutathione S-transferases, which are key players in the detoxification of reactive oxygen species and xenobiotics through the reduction of glutathione. The alterations in compounds such as Glycine, NADP+, NADPH, and S-Substituted N-acetyl-L-cysteine further support this, as these compounds are essential cofactors or precursors in glutathione metabolism. The identification of Tryparedoxin and Tryparedoxin disulfide, which are involved in a similar redox system in trypanosomatids, may suggest potential crosstalk or compensation mechanisms between the two systems."}], "target": "Glutathione metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B11,GMPPA,ALPL,KMO,IDO1,COQ7,PHOSPHO2 >>>\nList of compounds : <<< (R)-(Homo)2-citrate,L-Galactonate,Coproporphyrin III,1,4-Dihydroxy-2-naphthoyl-CoA,Glutaryl-[acp] methyl ester,N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole,Coenzyme F420-1,(R)-4-Phosphopantoate,3-Methyl-2-oxobutanoic acid >>>"}, {"role": "assistant", "content": "Based on the experiment, the metabolic pathway identified is the \"Biosynthesis of cofactors\". The alterations in genes such as COQ7 and N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole, which are directly involved in the biosynthesis of coenzyme Q and F420 respectively, support this finding. The changes in compounds like Coproporphyrin III, a precursor in heme biosynthesis, and Coenzyme F420-1 further corroborate this. Additionally, alterations in genes like UGT2B11 and IDO1, which indirectly affect cofactor biosynthesis via their roles in detoxification and tryptophan metabolism, respectively, provide additional evidence. The observed changes in (R)-(Homo)2-citrate, a compound involved in energy metabolism, and other intermediates suggest a possible link between energy metabolism and cofactor biosynthesis in the specific condition under investigation."}], "target": "Biosynthesis of cofactors"}
{"messages": [{"role": "user", "content": "List of genes : <<< BPNT2,SELENBP1,TST,SUOX,PAPSS1,PAPSS2,SQOR >>>\nList of compounds : <<< L-Serine,Sulfur,Dimethyl sulfoxide,2-(Methylthio)ethanesulfonate,Tetrathionate,Sulfate,Adenosine 3',5'-bisphosphate,O-Succinyl-L-homoserine,Methanesulfonic acid,L-Homoserine,L-Cysteine,3-(Methylthio)propanoyl-CoA,Sulfate,Taurine,Acetaldehyde,Trithionate,Sulfate,Alkanesulfonate,Thiosulfate,Sulfite,3'-Phosphoadenylyl sulfate,Polysulfide,Sulfate,Protein-trisulfide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Sulfur metabolism. This conclusion is supported by the alterations observed in the genes and compounds associated with this pathway. The genes BPNT2, SELENBP1, TST, SUOX, PAPSS1, PAPSS2, and SQOR are all involved in various aspects of sulfur metabolism. For instance, SUOX and SQOR are involved in the oxidation of sulfite and sulfide, respectively. PAPSS1 and PAPSS2 are crucial for sulfate activation. The list of compounds, including L-Cysteine, Tetrathionate, Thiosulfate, and Sulfite, are all key intermediates in sulfur metabolism. Therefore, the observed alterations in these genes and compounds strongly suggest that the Sulfur metabolism pathway is involved in the condition under study."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GLYCTK,GLDC,GNMT,SARDH,PSPH,SHMT2,AGXT,CHDH,AOC3,CTH >>>\nList of compounds : <<< Lipoylprotein,L-Serine,Ammonia >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Glycine, Serine, and Threonine Metabolism. This conclusion is supported by the alterations observed in several genes and compounds associated with this pathway. The genes GLYCTK, GLDC, GNMT, SARDH, and SHMT2 are directly involved in this pathway, with GLYCTK and GLDC involved in glycine metabolism, GNMT in methionine metabolism interconnected with glycine, serine, and threonine metabolism, SARDH in serine metabolism, and SHMT2 in serine and one-carbon metabolism. The alteration in L-Serine, a key compound in this pathway, further supports this finding. Additionally, the presence of Ammonia and Lipoylprotein, which are byproducts and cofactors in this pathway respectively, provide additional evidence. Therefore, the data suggest that the Glycine, Serine, and Threonine Metabolism pathway is significantly affected in the compared conditions."}], "target": "Glycine, serine and threonine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GRHPR,SRR,ALAS2 >>>\nList of compounds : <<< CO2,Creatine,Guanidinoacetate,2-Oxobutanoate,1,3-Diaminopropane,D-Glycerate,Methylglyoxal,N,N-Dimethylglycine,L-Homoserine,L-Tryptophan,Hydroxypyruvate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Glycine, serine and threonine metabolism\" pathway. This conclusion is supported by the alteration of several genes and compounds in the experiment. The genes GRHPR, SRR, and ALAS2 are involved in this pathway. GRHPR encodes glyoxylate reductase/hydroxypyruvate reductase, an enzyme that plays a role in glycine metabolism. SRR encodes serine racemase, an enzyme that catalyzes the conversion of L-serine to D-serine. ALAS2 encodes delta-aminolevulinate synthase 2, which is involved in the synthesis of heme, a process that requires glycine. The altered compounds, including CO2, Creatine, Guanidinoacetate, 2-Oxobutanoate, 1,3-Diaminopropane, D-Glycerate, Methylglyoxal, N,N-Dimethylglycine, L-Homoserine, L-Tryptophan, and Hydroxypyruvate, are intermediates or products of reactions in this pathway. Therefore, the alteration of these genes and compounds suggests that the glycine, serine and threonine metabolism pathway is affected in the experimental conditions."}], "target": "Glycine, serine and threonine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GNPNAT1,FCSK,CHIA,HEXB,GFPT1,GALK1,MPI,UAP1L1,CYB5R2,FPGT >>>\nList of compounds : <<< CDP-glucose,CDP-abequose,D-Galactosamine 6-phosphate,Arabinan,D-Mannose,1,6-Anhydro-N-acetyl-beta-muramate,alpha-D-Glucose 6-phosphate,GDP-6-deoxy-D-talose,CMP-pseudaminic acid,N-Acetyl-alpha-D-glucosamine 1-phosphate,N-Acetyl-D-glucosamine,CDP-3,6-dideoxy-D-glucose,GDP-D-arabinopyranose,CMP-3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate,UDP-6-sulfoquinovose,N-Acetyl-D-glucosamine,D-Fructose 6-phosphate,N-Acetyl-D-mannosamine,UDP-L-Ara4O >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is \"Amino sugar and nucleotide sugar metabolism\". This pathway was indicated by the alterations in multiple genes and compounds associated with this metabolic process. The genes GNPNAT1, HEXB, GFPT1, GALK1, MPI, UAP1L1, and FPGT are involved in the synthesis and metabolism of nucleotide sugars, which are key components in this pathway. The compounds CDP-glucose, CDP-abequose, D-Galactosamine 6-phosphate, alpha-D-Glucose 6-phosphate, N-Acetyl-alpha-D-glucosamine 1-phosphate, N-Acetyl-D-glucosamine, D-Fructose 6-phosphate, and N-Acetyl-D-mannosamine are all intermediates or products in this pathway. Furthermore, the presence of compounds such as CMP-pseudaminic acid and UDP-L-Ara4O, which are involved in the biosynthesis of specific glycans, further supports the involvement of the amino sugar and nucleotide sugar metabolism pathway."}], "target": "Amino sugar and nucleotide sugar metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< B4GALT2,LALBA,PFKM,GCK,HKDC1,GAA,HK1,GLB1 >>>\nList of compounds : <<< D-Mannose,UDP-alpha-D-galactofuranose,alpha-D-Glucose 6-phosphate,D-Glyceraldehyde,3-beta-D-Galactosyl-sn-glycerol,alpha-D-Glucose,myo-Inositol,D-Galactosamine,Raffinose,Galactan,D-Galactono-1,5-lactone,D-Tagatose 6-phosphate,D-Gal alpha 1-&gt;6D-Gal alpha 1-&gt;6D-Glucose,UDP-glucose >>>"}, {"role": "assistant", "content": "The experiment identified the Galactose metabolism pathway as the primary pathway affected. This is supported by the alteration of several genes directly involved in this pathway. B4GALT2 and LALBA are involved in the synthesis of lactose, a primary disaccharide in galactose metabolism. GAA encodes for lysosomal acid alpha-glucosidase, an enzyme that catalyzes the hydrolysis of glycogen and glycogen-derived oligosaccharides to glucose, which can then be metabolized to galactose. The alteration of PFKM, GCK, HKDC1, and HK1, which are involved in glycolysis, further supports this, as glucose and galactose share this pathway. The altered compounds, including D-Mannose, D-Galactose, and UDP-glucose, are all intermediates or byproducts of the galactose metabolism pathway."}], "target": "Galactose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDXK,PHOSPHO2,PDXP,AOX1,PSAT1 >>>\nList of compounds : <<< Isopyridoxal,2-(Hydroxymethyl)-4-oxobutanoate,3-Hydroxy-2-methylpyridine-4,5-dicarboxylate,Pyridoxal phosphate,O-Phospho-4-hydroxy-L-threonine,Pyridoxamine,Glycolaldehyde,5-Pyridoxolactone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Vitamin B6 metabolism. This conclusion is supported by the alterations observed in the genes and compounds associated with this pathway. The genes PDXK, PHOSPHO2, PDXP, and PSAT1 are involved in the metabolism of Vitamin B6, with PDXK and PDXP encoding pyridoxal kinase and pyridoxine 5'-phosphate oxidase respectively, which are essential for the conversion of Vitamin B6 to its active form, pyridoxal phosphate. The compounds Isopyridoxal, Pyridoxal phosphate, Pyridoxamine, and 5-Pyridoxolactone are intermediates or derivatives of Vitamin B6, further supporting the involvement of this pathway. The alterations in the other compounds, such as 2-(Hydroxymethyl)-4-oxobutanoate and O-Phospho-4-hydroxy-L-threonine, may be downstream effects of the changes in the Vitamin B6 metabolism."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HEXA,ST3GAL1,ST8SIA1,ST8SIA5,B4GALNT1,ST6GALNAC3,B3GALT4,ST6GALNAC6 >>>\nList of compounds : <<< GT1b,GM1,GP1c,GM1alpha,GT2,GD1c,N-Acetylgalactosaminyl GM1b,GQ1balpha,GT3,GT1c,GA2,GM1b,Fucosyl-GM1,GM2alpha,GQ1c,9-O-Acetylated GT3,GD1beta,GT1aalpha,GT1a,GD2,GD1b,N-Acetylgalactosaminyl GD1a,GD1a,GM2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Glycosphingolipid biosynthesis - ganglio series. This pathway was chosen due to the significant alterations observed in genes and compounds directly involved in this process. The list of genes includes HEXA, ST3GAL1, ST8SIA1, ST8SIA5, B4GALNT1, ST6GALNAC3, B3GALT4, and ST6GALNAC6, all of which are known to play crucial roles in the synthesis of gangliosides, a type of glycosphingolipid. The altered compounds, such as GT1b, GM1, GP1c, GD1b, and GD1a, are also specific products of this pathway. The presence of N-Acetylgalactosaminyl GM1b and N-Acetylgalactosaminyl GD1a further supports the involvement of this pathway, as they are modified forms of gangliosides. Therefore, the evidence strongly suggests that the Glycosphingolipid biosynthesis - ganglio series pathway is implicated in the condition under investigation."}], "target": "Glycosphingolipid biosynthesis - ganglio series"}
{"messages": [{"role": "user", "content": "List of genes : <<< ELOVL6,TECR,ACOT1,HACD4,ELOVL2,HACD3,PPT2,PPT1,HSD17B12,HADHB >>>\nList of compounds : <<< Hexadecanoic acid,3-Oxododecanoyl-CoA,(S)-3-Hydroxydodecanoyl-CoA,(S)-Hydroxyhexanoyl-CoA,3-Oxodecanoyl-CoA,Very-long-chain acyl-CoA,3-Oxohexanoyl-CoA,Very-long-chain 3-oxoacyl-CoA,Hexadecanoic acid,trans-Hex-2-enoyl-CoA,Palmitoyl-CoA,Octanoyl-CoA,2,3-Dehydroacyl-CoA,Tetradecanoyl-CoA,Decanoyl-CoA,(3S)-3-Hydroxyacyl-CoA,Long-chain fatty acid,3-Oxoacyl-CoA,(S)-3-Hydroxyhexadecanoyl-CoA,Acetyl-CoA,Acyl-CoA,Long-chain acyl-CoA,Butanoyl-CoA,Acyl-CoA,trans-Oct-2-enoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Fatty acid elongation pathway. This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes ELOVL6, ELOVL2, HACD3, and HACD4 are known to be involved in the elongation of very long chain fatty acids. The compounds such as Very-long-chain acyl-CoA, Very-long-chain 3-oxoacyl-CoA, Tetradecanoyl-CoA, and Palmitoyl-CoA are intermediates in the fatty acid elongation process. Furthermore, the presence of compounds like Acetyl-CoA, Acyl-CoA, and Long-chain acyl-CoA, which serve as substrates for fatty acid elongation, also supports this conclusion. Therefore, the alterations in these genes and compounds suggest that the Fatty acid elongation pathway is involved in the condition under investigation."}], "target": "Fatty acid elongation"}
{"messages": [{"role": "user", "content": "List of genes : <<< SDHB,DLST,MDH1,SDHA,DLAT,PDHA2,PC,SUCLG2,SUCLG1 >>>\nList of compounds : <<< Succinate,Phosphoenolpyruvate,2-Oxoglutarate,Enzyme N6-(lipoyl)lysine,Oxaloacetate,Enzyme N6-(dihydrolipoyl)lysine,Citrate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Acetyl-CoA,Succinyl-CoA,2-(alpha-Hydroxyethyl)thiamine diphosphate,Fumarate,(S)-Malate,3-Carboxy-1-hydroxypropyl-ThPP,Enzyme N6-(lipoyl)lysine,cis-Aconitate,Pyruvate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Citrate cycle (TCA cycle). This conclusion is drawn based on the alterations observed in the genes and compounds associated with this pathway. The genes SDHB, DLST, MDH1, SDHA, DLAT, PC, SUCLG2, and SUCLG1 are all involved in the TCA cycle, with roles in electron transport, decarboxylation, and substrate level phosphorylation. The presence of compounds such as succinate, 2-oxoglutarate, citrate, fumarate, malate, and pyruvate, which are intermediates in the TCA cycle, further supports this identification. Additionally, the presence of enzyme cofactors like N6-(lipoyl)lysine, N6-(dihydrolipoyl)lysine, and 2-(alpha-Hydroxyethyl)thiamine diphosphate, which are crucial for the activity of TCA cycle enzymes, further substantiates the involvement of this pathway."}], "target": "Citrate cycle (TCA cycle)"}
{"messages": [{"role": "user", "content": "List of genes : <<< NAPRT,NAMPT,NADK,SIRT6,SIRT2,NT5C1A,NT5M >>>\nList of compounds : <<< NADP+,Nicotinate D-ribonucleoside,(R)-6-Hydroxynicotine,Pyruvate,(S)-6-Hydroxynicotine,NAD+,Deamino-NAD+,6-Hydroxypseudooxynicotine,Nicotinamide-beta-riboside,3-Succinoylpyridine,2,6-Dihydroxynicotinate >>>"}, {"role": "assistant", "content": "The experiment identified the Nicotinate and nicotinamide metabolism pathway as the main pathway involved in the condition. This is supported by the alterations in genes NAPRT, NAMPT, NADK, SIRT6, SIRT2, NT5C1A, and NT5M, all of which are known to play crucial roles in this pathway. NAPRT and NAMPT are involved in the synthesis of nicotinamide adenine dinucleotide (NAD+) and NADP+ from nicotinate and nicotinamide, respectively. NADK is responsible for the conversion of NAD+ to NADP+. SIRT6 and SIRT2 are NAD+-dependent deacetylases. NT5C1A and NT5M are involved in the salvage pathway of nucleotide metabolism, which includes nicotinate and nicotinamide metabolism. The altered compounds, such as NAD+, NADP+, nicotinate D-ribonucleoside, and nicotinamide-beta-riboside, are also direct participants in this pathway, providing further evidence for its involvement."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A9,UGT2B4,KL,ALDH1B1,UGT1A4,UGT2B17,UGT1A10,ALDH7A1,UGT1A3,UGT2A2,UGT1A1,UGT1A8,UGT2B10,UGDH,UGT2B28,ALDH9A1,ALDH3A2,AKR1A1,UGT2A1,UGT2B15,UGT1A5,UGT2A3,MIOX >>>\nList of compounds : <<< L-Gulono-1,4-lactone,D-Glucuronate 1-phosphate,GDP-mannose >>>"}, {"role": "assistant", "content": "The experiment identified the Ascorbate and aldarate metabolism pathway as being involved in the condition. This is supported by the alterations in multiple genes and compounds associated with this pathway. For instance, UGT1A9, UGT2B4, UGT1A4, and UGT1A1 are UDP-glucuronosyltransferases that are involved in the metabolism of ascorbate. The presence of D-Glucuronate 1-phosphate and GDP-mannose, intermediates in the pathway, further strengthens this association. Additionally, ALDH1B1, ALDH7A1, and ALDH3A2, which are aldehyde dehydrogenases involved in this pathway, were also altered. The involvement of L-Gulono-1,4-lactone, a key precursor in ascorbate biosynthesis, further supports the implication of the Ascorbate and aldarate metabolism pathway in the condition."}], "target": "Ascorbate and aldarate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< POMT2,LARGE1,FKTN,POMGNT2,B3GALNT2,B4GALT1,MGAT5B,POMK,CRPPA,FUT4,FKRP,B4GAT1 >>>\nList of compounds : <<< D-Ribitol 5-phosphate,[Protein]-L-serine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Mannose type O-glycan biosynthesis. This pathway was implicated due to the alterations observed in multiple genes involved in this process, including POMT2, LARGE1, FKTN, POMGNT2, B3GALNT2, B4GALT1, MGAT5B, POMK, FUT4, FKRP, and B4GAT1. These genes encode enzymes that are critical for the synthesis and attachment of mannose-type O-glycans to proteins. The alteration in the [Protein]-L-serine compound further supports this finding as L-serine is a key substrate in the initiation of O-glycan biosynthesis. The identification of D-Ribitol 5-phosphate, a compound involved in other metabolic pathways, does not contradict the primary identification of the Mannose type O-glycan biosynthesis pathway."}], "target": "Mannose type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PTGES3,ALOX12B,PLB1,GPX4,LTC4S,CYP4F2,PLA2G2C,JMJD7-PLA2G4B,CYP2C19,PLA2G1B >>>\nList of compounds : <<< Prostaglandin A2,Delta-12-Prostaglandin J2,(5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate,12(S)-HPETE,11H-14,15-EETA,Leukotriene E4,12-Keto-leukotriene B4,11(R)-HETE,(5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate,Arachidonate,(5Z,13E)-6,9alpha-Epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate,9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid,Lipoxin A4,5,6-DHET,11,12-EET,11,14,15-THETA,14,15-DHET,Prostaglandin E2,5,6-EET,20-OH-Leukotriene B4,8(R)-HETE,11-Dehydro-thromboxane B2,11(R)-HPETE,16(R)-HETE >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given experiment is the Arachidonic acid metabolism pathway. This is supported by the alterations observed in the genes and compounds associated with this pathway. The genes listed, including PTGES3, ALOX12B, PLA2G2C, and CYP4F2, are known to encode enzymes that catalyze various steps in the metabolism of arachidonic acid. The compounds listed, such as Prostaglandin A2, Leukotriene E4, and Lipoxin A4, are all metabolites derived from arachidonic acid. Therefore, the alterations in these genes and compounds suggest that the Arachidonic acid metabolism pathway is involved in the specific condition under investigation."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G4E,ALOX15B,PTGES,PLAAT3,CYP2E1,LTA4H,LTC4S,CBR1,HPGDS,PLA2G1B,CYP2C9,PTGS2,PLA2G3,PLA2G2F >>>\nList of compounds : <<< Prostaglandin D2,16(R)-HETE,15H-11,12-EETA,20-HETE,12-OxoETE,Prostaglandin C2,15-OxoETE,(5Z,13E)-6,9alpha-Epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate,11(R)-HPETE,11,12-EET,11-epi-Prostaglandin F2alpha,20-COOH-Leukotriene B4,Trioxilin A3,Trioxilin B3,2,3-Dinor-8-iso prostaglandin F2alpha,Arachidonate,6-Keto-prostaglandin F1alpha,Leukotriene F4 >>>"}, {"role": "assistant", "content": "The experiment identified the Arachidonic acid metabolism pathway as being significantly altered. This is supported by the observed changes in several genes and compounds directly involved in this pathway. Genes such as PLA2G4E, ALOX15B, PTGES, CYP2E1, LTA4H, LTC4S, CBR1, HPGDS, PLA2G1B, CYP2C9, PTGS2, PLA2G3, and PLA2G2F are all associated with the metabolism of arachidonic acid. The altered compounds, including Prostaglandin D2, 16(R)-HETE, 15H-11,12-EETA, 20-HETE, 12-OxoETE, Prostaglandin C2, 15-OxoETE, and others, are known intermediates or end products of this pathway. Therefore, it is likely that changes in the Arachidonic acid metabolism pathway are contributing to the observed condition."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACSS2,MLYCD,DLD,SUCLA2,MMUT,ALDH6A1,SUCLG1,LDHAL6A,ACADS,ECHDC1,ACOX3,ACOX1,MCEE,EHHADH,SUCLG2 >>>\nList of compounds : <<< 3-Oxopropionyl-CoA,Enzyme N6-(S-propyldihydrolipoyl)lysine,(S)-Methylmalonyl-CoA,2-Oxobutanoate,Methylmalonate,Hydroxyacetone,Propane-1-ol,3-Oxopropanoate,Propanal,Propanoate,Acetyl-CoA,Methylglyoxal,beta-Alanyl-CoA,(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate,(Z)-But-2-ene-1,2,3-tricarboxylate,Enzyme N6-(lipoyl)lysine,Malonyl-CoA,Succinate,2-Hydroxybutanoic acid,Enzyme N6-(dihydrolipoyl)lysine,Acrylic acid,Propanoyl phosphate,3-Hydroxypropanoate,2-(alpha-Hydroxypropyl)thiamine diphosphate,Propanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Propanoate metabolism. This pathway is supported by the alterations in the genes ACSS2, MLYCD, DLD, SUCLA2, MMUT, ALDH6A1, SUCLG1, LDHAL6A, ACADS, ECHDC1, ACOX3, ACOX1, MCEE, EHHADH, and SUCLG2. These genes are involved in various steps of propanoate metabolism, including propionate activation, conversion to succinyl-CoA, and subsequent entry into the citric acid cycle. The altered compounds, such as 3-Oxopropionyl-CoA, Propanoate, and Succinate, are key intermediates in this pathway, further supporting the identification of Propanoate metabolism as the affected pathway."}], "target": "Propanoate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OXSM,HLCS >>>\nList of compounds : <<< Biotinyl-CoA,Biotin,Pimeloyl-[acyl-carrier protein],Long-chain acyl-[acyl-carrier protein],Holo-[carboxylase],Pimeloyl-[acyl-carrier protein] methyl ester,Glutaryl-[acp] methyl ester,Enoylpimeloyl-[acp] methyl ester,L-Lysine,Biotin sulfoxide,Tetranorbiotin,Enoylglutaryl-[acp] methyl ester,Malonyl-[acyl-carrier protein],Dethiobiotin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Biotin metabolism. The list of altered genes, OXSM and HLCS, are directly involved in this pathway. OXSM, or 3-methylcrotonyl-CoA carboxylase alpha chain, is an enzyme that catalyzes the carboxylation of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the leucine degradation pathway, which requires biotin as a cofactor. HLCS, or holocarboxylase synthetase, is an enzyme responsible for the attachment of biotin to specific carboxylases, including OXSM, which is essential for their activity.\n\nThe altered compounds also support the involvement of Biotin metabolism. These compounds include various forms of biotin (Biotinyl-CoA, Biotin, Biotin sulfoxide, Tetranorbiotin, Dethiobiotin), biotin intermediates (Pimeloyl-[acyl-carrier protein], Long-chain acyl-[acyl-carrier protein], Holo-[carboxylase]), and metabolites involved in biotin-dependent reactions (L-Lysine, Enoylpimeloyl-[acp] methyl ester, Enoylglutaryl-[acp] methyl ester, Malonyl-[acyl-carrier protein]). Therefore, the alterations in these genes and compounds suggest that the Biotin metabolism pathway is significantly affected in the given condition."}], "target": "Biotin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PFKP,ALDOB,ADH1B,G6PC1,PGAM2,ALDH2,PGM1,HKDC1,HK1,GPI,ADH6,PDHB,ALDOC,ADH7,DLAT,AKR1A1,ENO4,ADH5,HK2,FBP1,ALDH3A2,PGM2,PDHA1,ADH4 >>>\nList of compounds : <<< Arbutin 6-phosphate,2,3-Bisphospho-D-glycerate,Enzyme N6-(dihydrolipoyl)lysine,beta-D-Glucose,2-(alpha-Hydroxyethyl)thiamine diphosphate,Glycerone phosphate,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Oxaloacetate,(S)-Lactate,3-Phospho-D-glyceroyl phosphate,Arbutin,D-Fructose 6-phosphate,alpha-D-Glucose 6-phosphate,Acetaldehyde,3-Phospho-D-glycerate,Acetyl-CoA,beta-D-Glucose 6-phosphate,D-Glucose,Enzyme N6-(lipoyl)lysine,Salicin 6-phosphate,Thiamin diphosphate,alpha-D-Glucose,Acetate,D-Glucose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Glycolysis / Gluconeogenesis. This pathway was implicated due to the alterations observed in several genes and compounds associated with this metabolic process. The genes PFKP, ALDOB, ADH1B, PGAM2, ENO4, HKDC1, HK1, GPI, HK2, FBP1, and PGM2 are involved in glycolysis or gluconeogenesis. Similarly, the compounds such as beta-D-Glucose, D-Fructose 6-phosphate, alpha-D-Glucose 6-phosphate, D-Glucose 1-phosphate, and 2,3-Bisphospho-D-glycerate are intermediates in these pathways. The presence of Acetyl-CoA and Acetate suggests the link to the subsequent pyruvate metabolism. Therefore, the alterations in these genes and compounds indicate a significant role of Glycolysis / Gluconeogenesis in the observed condition."}], "target": "Glycolysis / Gluconeogenesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< FBP1,PFKFB3,GMPPA,PFKP,KHK,GMDS,PFKM,FBP2,HK2,FPGT,TPI1,TIGAR,HKDC1,HK1,PFKFB2,FCSK,GFUS,GMPPB,PFKL,ALDOB >>>\nList of compounds : <<< L-Fucose 1-phosphate,(S)-Lactaldehyde,D-Allulose 6-phosphate,L-Rhamnulose,(S)-Lactate,Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,beta-D-Fructose 2-phosphate,L-Rhamnono-1,4-lactone,D-Sorbitol,L-Rhamnofuranose,D-Glyceraldehyde >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Fructose and Mannose metabolism pathway. This is supported by the alterations observed in several genes involved in this pathway, including Fructose-bisphosphatase 1 and 2 (FBP1, FBP2), Hexokinase 1 and 2 (HK1, HK2), Phosphofructokinase P (PFKP), Phosphofructokinase L (PFKL), and Glucose-6-phosphate dehydrogenase (G6PD). These genes are key regulators of fructose metabolism, converting fructose-6-phosphate to fructose-1,6-bisphosphate (PFKP, PFKL) and vice versa (FBP1, FBP2). The alterations in the levels of compounds such as D-Fructose 2-phosphate, L-Rhamnose, and D-Glyceraldehyde further support this, as these are intermediates in the fructose and mannose metabolism pathway. The presence of L-Fucose 1-phosphate and L-Rhamnofuranose could suggest a link to related pathways such as fructose and mannose degradation and L-fucose metabolism."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B11,UGT2A2,UGT1A8,ALDH7A1 >>>\nList of compounds : <<< L-Galactono-1,4-lactone,D-Glucuronate 1-phosphate,UDP-glucose,L-Galactose,2-Dehydro-3-deoxy-L-arabinonate,2,5-Dioxopentanoate,L-Gulonate,UDP-glucuronate,L-Xylonate,L-Ascorbate 6-phosphate,Ascorbate,L-Xylulose 5-phosphate,3-Dehydro-L-gulonate 6-phosphate,D-Galactaro-1,4-lactone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Ascorbate and Aldarate metabolism. This pathway was implicated due to the alteration of several genes and compounds associated with it. The genes UGT2B11, UGT2A2, and UGT1A8 are UDP-glucuronosyltransferases, enzymes involved in the glucuronidation of ascorbate and various aldarates. ALDH7A1 encodes an aldehyde dehydrogenase that plays a role in the conversion of L-gulonate to L-xylulose. The altered compounds, such as L-Galactono-1,4-lactone, D-Glucuronate 1-phosphate, UDP-glucose, L-Galactose, L-Ascorbate 6-phosphate, Ascorbate, and others, are key intermediates in the Ascorbate and Aldarate metabolism. Therefore, the observed changes in these genes and compounds suggest a significant impact on the Ascorbate and Aldarate metabolism pathway."}], "target": "Ascorbate and aldarate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SMYD2,PRDM16,NSD3,MECOM,PHYKPL,KMT2B,ECHS1,ALDH2,COLGALT1,PRDM6,DLST,SETMAR,HYKK,KMT5C,EHMT1,PIPOX,HADH,ASH1L,EZH1,EHMT2 >>>\nList of compounds : <<< Enzyme N6-(dihydrolipoyl)lysine,[Dihydrolipoyllysine-residue succinyltransferase] S-glutaryldihydrolipoyllysine,Protein lysine,Protein N6,N6,N6-trimethyl-L-lysine,Crotonoyl-CoA,N6-(L-1,3-Dicarboxypropyl)-L-lysine,(S)-3-Hydroxybutanoyl-CoA,6-Amino-2-oxohexanoate,Glycine,5-Aminopentanal,Acetoacetate,Procollagen 5-hydroxy-L-lysine,Protein N6-methyl-L-lysine,5-Acetamidopentanoate,2-Oxoglutarate,Protein N6,N6-dimethyl-L-lysine,Thiamin diphosphate,L-Hydroxylysine,(3S)-3,6-Diaminohexanoate,(3S)-3-Hydroxy-N6,N6,N6-trimethyl-L-lysine,N6,N6,N6-Trimethyl-L-lysine,4-Trimethylammoniobutanal,5-Aminopentanamide,(S)-5-Amino-3-oxohexanoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Lysine degradation pathway. This pathway was implicated due to the alterations observed in various genes and compounds associated with lysine metabolism. The gene list includes ECHS1 and ALDH2, which are involved in the catabolism of lysine, and SETMAR, KMT2B, KMT5C, EHMT1, and EHMT2, which are involved in lysine methylation. The compound list includes various forms of lysine, such as Protein N6-methyl-L-lysine, Protein N6,N6-dimethyl-L-lysine, and Protein N6,N6,N6-trimethyl-L-lysine, as well as intermediates in lysine degradation, such as (S)-3-Hydroxybutanoyl-CoA and Acetoacetate. These findings suggest that the Lysine degradation pathway is dysregulated in the condition being studied."}], "target": "Lysine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP2A13,CYP1A1,UGT2A2,UGT2A1,CYP2S1,UGT1A10,CYP2C9,UGT1A6,ADH1A,UGT2B11,UGT2B15,ALDH3B1,AKR7A3 >>>\nList of compounds : <<< 1-Nitronaphthalene-5,6-oxide,2-Bromophenol,4-(Methylnitrosamino)-1-(1-oxido-3-pyridinyl)-1-butanone,1-Nitronaphthalene,Trichloroacetate,Aflatoxin M1,4-(Nitrosoamino)-1-(3-pyridinyl)-1-butanone,1,1-Dichloroethylene epoxide,2-Naphthol,2-Bromoacetaldehyde,7,12-Dimethylbenz[a]anthracene 5,6-oxide,alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde,Nicotine,Dichloroacetate,N-Hydroxy-1-aminonaphthalene,Benzo[a]pyrene-7,8-dihydrodiol,Bromobenzene-3,4-dihydrodiol >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the metabolic pathway involved is the \"Metabolism of xenobiotics by cytochrome P450\". This pathway is primarily responsible for the detoxification of a wide variety of foreign chemical substances, known as xenobiotics, in the body. The genes listed, such as CYP2A13, CYP1A1, CYP2S1, CYP2C9, and others, are all members of the cytochrome P450 superfamily, which are known to encode enzymes involved in this pathway. These enzymes catalyze the oxidation, reduction, and hydroxylation reactions of the listed compounds, such as 1-Nitronaphthalene-5,6-oxide, Aflatoxin M1, and Benzo[a]pyrene-7,8-dihydrodiol, thereby facilitating their elimination from the body. The alterations in these genes and compounds suggest changes in this metabolic pathway, which could have implications for the body's ability to detoxify xenobiotics."}], "target": "Metabolism of xenobiotics by cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP1B1,HADHA,ALDH3A2,DHTKD1,KMO,ACAT1,AANAT,ASMT,CYP1A2,AADAT,ACMSD,ALDH7A1,IDO1,AFMID,DLD,HAAO,HADH,ALDH8A1,CAT,TPH2,ALDH2 >>>\nList of compounds : <<< 2,3-Dihydroxyindole,2-Amino-3-carboxymuconate semialdehyde,Formylanthranilate,Indolylmethylthiohydroximate,5-Hydroxy-N-formylkynurenine,4,6-Dihydroxyquinoline,4,8-Dihydroxyquinoline,4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate,3-Hydroxyanthranilate,4-(2-Amino-5-hydroxyphenyl)-2,4-dioxobutanoate,gamma-Oxalocrotonate,Indole-3-ethanol,4-(2-Aminophenyl)-2,4-dioxobutanoate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Tryptophan metabolism. This conclusion is supported by the altered genes and compounds observed. Many of the genes listed, such as CYP1A2, CYP1B1, IDO1, TPH2, AANAT, ASMT, and ALDH2, are known to be involved in the metabolism of tryptophan. Similarly, the compounds identified, including 2,3-Dihydroxyindole, 3-Hydroxyanthranilate, and Indole-3-ethanol, are intermediates or end products in the tryptophan metabolic pathway. Therefore, the changes in these genes and compounds suggest that the Tryptophan metabolic pathway is significantly affected in the experimental conditions."}], "target": "Tryptophan metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OGDH,PDHA2,AADAT >>>\nList of compounds : <<< 2-Isopropylmaleate,L-Valine,3-Hydroxy-3-methyl-2-oxobutanoic acid,Indolylmethyl-desulfoglucosinolate,8-Methylthiooctanaldoxime,2-(5'-Methylthio)pentylmalic acid,S-(Hydroxyphenylacetothiohydroximoyl)-L-cysteine,3-Methylbutyraldehyde oxime,(R)-2,3-Dihydroxy-3-methylpentanoate,Glucoberteroin,2-(2'-Methylthio)ethylmalic acid,4-Methylthio-2-oxobutanoic acid,L-Aspartate 4-semialdehyde,4-Phospho-L-aspartate,2-(7'-Methylthio)heptylmalic acid,LysW-L-ornithine,9-Methylthiononanaldoxime >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the 2-Oxocarboxylic acid metabolism. This pathway is involved in the breakdown of various amino acids and the production of energy in the form of ATP. The altered genes OGDH, PDHA2, and AADAT are all key enzymes in this pathway. OGDH is involved in the oxidative decarboxylation of 2-oxoglutarate, PDHA2 is a component of the pyruvate dehydrogenase complex that converts pyruvate to acetyl-CoA, and AADAT is involved in the catabolism of branched-chain amino acids. The altered compounds, such as 2-Isopropylmaleate, L-Valine, and 3-Hydroxy-3-methyl-2-oxobutanoic acid, are intermediates or products of the 2-Oxocarboxylic acid metabolism pathway. The changes in these genes and compounds suggest that this pathway is dysregulated in the specific condition studied."}], "target": "2-Oxocarboxylic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G2C,PLA2G5,PLA2G4C,PLA2G10,PLA2G4F,PLA2G6,CYP2E1,CYP2C19,PLA2G1B,PLA2G12B,PLA2G2E >>>\nList of compounds : <<< 9,10-Epoxy-13-hydroxy-11-octadecenoate,13(S)-HODE,9,10,13-TriHOME,(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid,9,10-DHOME,12,13-DHOME,(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid,Dihomo-gamma-linolenate,9,12,13-TriHOME,9-OxoODE,(7S,8S)-DiHODE,Linoleate,12(13)-EpOME,13-OxoODE,(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate,(6Z,9Z,12Z)-Octadecatrienoic acid,9,10-12,13-Diepoxyoctadecanoate,8(R)-HPODE,(9Z,11E)-12-[(1E)-Hex-1-en-1-yloxy]dodeca-9,11-dienoic acid,5S,8R-DiHODE,Arachidonate,Crepenynate,Rumenic acid >>>"}, {"role": "assistant", "content": "The experiment identified the Linoleic acid metabolism pathway as being significantly altered. This is supported by the changes in multiple genes involved in this pathway, including PLA2G2C, PLA2G5, PLA2G4C, PLA2G10, PLA2G4F, PLA2G6, PLA2G1B, PLA2G12B, and PLA2G2E, which are phospholipase A2 enzymes that catalyze the release of linoleic acid from membrane phospholipids. Additionally, changes in CYP2E1 and CYP2C19, which are involved in the oxidation of linoleic acid, further support this finding. The alterations in various compounds derived from linoleic acid metabolism, such as 13(S)-HODE, 9,10-Epoxy-13-hydroxy-11-octadecenoate, and Dihomo-gamma-linolenate, further strengthen the identification of this pathway."}], "target": "Linoleic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NOS2,P4HA3,CNDP2,AOC1,CKMT1A,L3HYPDH >>>\nList of compounds : <<< 1-Pyrroline-2-carboxylate,4-Guanidinobutanoate,Putrescine,S-Adenosylmethioninamine,L-Ornithine,L-4-Hydroxyglutamate semialdehyde,Hydroxyproline,L-Arginine phosphate,Guanidinoacetate,(S)-1-Pyrroline-5-carboxylate,Peptide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Arginine and Proline metabolism. This pathway was suggested due to the alterations observed in several genes and compounds directly associated with this pathway. The genes NOS2, AOC1, and CKMT1A, which are involved in the conversion of Arginine to Citrulline, Nitric Oxide, and Ornithine, respectively, were altered. Similarly, changes were observed in compounds such as L-Arginine phosphate, L-Ornithine, Putrescine, and 1-Pyrroline-2-carboxylate, which are intermediates in this pathway. Additionally, the presence of Hydroxyproline, a metabolite of Proline, further supports the involvement of this pathway. These findings suggest that the Arginine and Proline metabolism pathway is significantly impacted in the given condition."}], "target": "Arginine and proline metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PHGDH,GATM,PSAT1,GLDC,SHMT1,PSPH >>>\nList of compounds : <<< L-Threonine,Guanidinoacetate,L-2,4-Diaminobutanoate,3-Phospho-D-glycerate,D-Serine,2-Phospho-D-glycerate,Hydroxypyruvate,Phosphatidylserine,L-Tryptophan,Creatine,Ectoine,2-Oxobutanoate,L-Cystathionine,L-Serine,L-Aspartate 4-semialdehyde >>>"}, {"role": "assistant", "content": "The experiment identified the Glycine, Serine and Threonine metabolism pathway as being significantly altered. This is consistent with the changes observed in the genes and compounds. The genes PHGDH, PSAT1, and PSPH are directly involved in the serine synthesis pathway, while GATM and SHMT1 are involved in the interconversion between serine and glycine. The alterations in these genes suggest a disruption in serine and glycine metabolism. The changes in compounds such as L-Threonine, L-Serine, D-Serine, 3-Phospho-D-glycerate, and 2-Phospho-D-glycerate, which are intermediates in this pathway, further support this conclusion. Additionally, the alterations in compounds like L-Cystathionine, L-Aspartate 4-semialdehyde, and L-Tryptophan, which are linked to this pathway, suggest a broader impact on amino acid metabolism."}], "target": "Glycine, serine and threonine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OLAH,ACACA,ACSBG2,FASN,ACSL3,MECR,CBR4,HSD17B8,ACSL1,ACACB,HTD2,ACSL4,ACSL6,ACSL5 >>>\nList of compounds : <<< Palmitoyl-CoA,trans-Hex-2-enoyl-[acp],Acyl-[acyl-carrier protein],Acetyl-CoA,Acetoacetyl-[acp],trans-Dodec-2-enoyl-[acp],(3R)-3-Hydroxypalmitoyl-[acyl-carrier protein],trans-Hexadec-2-enoyl-[acp],Acetyl-CoA,Acetyl-[acyl-carrier protein],(3R)-3-Hydroxyhexanoyl-[acyl-carrier protein],Long-chain acyl-CoA,(9Z)-Hexadecenoic acid,3-Oxodecanoyl-[acp],trans-Dec-2-enoyl-[acp],Acyl-carrier protein,Tetradecanoic acid,Malonate,Malonyl-[acyl-carrier protein],(3R)-3-Hydroxyacyl-[acyl-carrier protein],3-Oxohexanoyl-[acp],Long-chain fatty acid,Long-chain fatty acid,Acyl-carrier protein,(3R)-3-Hydroxyacyl-[acyl-carrier protein] >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is fatty acid biosynthesis. This conclusion is supported by the altered genes and compounds. The genes OLAH, ACACA, FASN, MECR, HSD17B8, and ACSL1-6 are all involved in fatty acid biosynthesis. OLAH and ACACA are involved in the initial steps of fatty acid synthesis, while FASN and MECR are involved in elongation and desaturation. HSD17B8 is involved in the reduction of 3-ketoacyl-ACP to 3-hydroxyacyl-ACP during fatty acid synthesis. The ACSL genes are involved in the activation of long-chain fatty acids. The altered compounds, such as Palmitoyl-CoA, Acetyl-CoA, and various acyl-ACP intermediates, are all key components of the fatty acid biosynthesis pathway. Additionally, the presence of compounds like Malonyl-ACP and 3-Oxoacyl-ACP further supports this conclusion, as they are direct intermediates in the fatty acid synthesis pathway."}], "target": "Fatty acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< DGAT2,GPAT4,TKFC,AKR1B1,MBOAT2,LPIN2,GPAT2,PNPLA2,AGK,LIPG,DGKB,LCLAT1,LIPC,DGKA,CEL >>>\nList of compounds : <<< Propane-1,3-diol,Diglucosyldiacylglycerol,UDP-glucose,3-D-Glucosyl-1,2-diacylglycerol,Acyl-CoA,alpha-Kojibiosyldiacylglycerol,Glycerone phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is Glycerolipid metabolism. This conclusion is supported by the alterations observed in numerous genes and compounds associated with this pathway. The genes DGAT2, GPAT4, MBOAT2, LPIN2, GPAT2, AGK, DGKB, LCLAT1, and CEL are all involved in the synthesis and degradation of glycerolipids. The presence of compounds such as Diglucosyldiacylglycerol, 3-D-Glucosyl-1,2-diacylglycerol, alpha-Kojibiosyldiacylglycerol, Glycerone phosphate, and Acyl-CoA further corroborates this finding, as they are intermediates or substrates in the glycerolipid metabolism pathway. The observed alterations in the genes and compounds suggest perturbations in this pathway, which could be linked to the specific condition under investigation."}], "target": "Glycerolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PTGR1,CYP2U1,EPHX2,PLA2G2F,PLA2G12B,PTGES2,CBR3,ALOX12B,PLA2G2A,CYP4F3,CYP2J2,GGT5,CYP2C9,PLA2G4E,PTGS1,JMJD7-PLA2G4B,PLA2G4A,CYP2C8,AKR1C3,PLA2G12A,ALOX12 >>>\nList of compounds : <<< (5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate,11-Dehydro-thromboxane B2,8(S)-HETE,Thromboxane B2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Arachidonic Acid Metabolism pathway. This pathway involves the oxidation of arachidonic acid, a polyunsaturated fatty acid, into various bioactive lipids, including prostaglandins, thromboxanes, and leukotrienes. The identified genes, such as PTGS1 (Cyclooxygenase-1), CYP2U1, CYP2J2, and ALOX12B (Arachidonate 12-Lipoxygenase), are known to be involved in this pathway. They encode enzymes that catalyze the conversion of arachidonic acid into various metabolites. The altered compounds, including (5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate, 11-Dehydro-thromboxane B2, 8(S)-HETE, and Thromboxane B2, are direct products of this pathway, further supporting its involvement in the condition."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ASS1,GLS,NOS3,CPS1,GLUD1,ACY1,ARG2 >>>\nList of compounds : <<< Carbamoyl phosphate,L-Citrulline,L-Ornithine,LysW-L-glutamyl 5-phosphate,Ammonia,L-Glutamine,N-Acetyl-L-glutamate,N-Acetyl-L-glutamate 5-semialdehyde,LysW-L-glutamate,N-Acetyl-L-citrulline,CO2,Fumarate,Urea,N-(L-Arginino)succinate,L-Aspartate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Arginine biosynthesis. This pathway was inferred based on the alterations observed in the associated genes and compounds. The genes ASS1, GLS, NOS3, CPS1, GLUD1, ACY1, and ARG2 are all involved in the Arginine biosynthesis pathway. ASS1 and CPS1 are critical for the synthesis of carbamoyl phosphate, an essential precursor for Arginine. GLS and GLUD1 are involved in the production of glutamate, which is converted to ornithine by the enzymes encoded by the genes ACY1 and ARG2. The presence of compounds such as carbamoyl phosphate, L-citrulline, L-ornithine, L-glutamine, and N-acetyl-L-citrulline further supports this conclusion, as they are intermediates in the Arginine biosynthesis pathway. Additionally, the detection of urea and N-(L-Arginino)succinate, by-products of this pathway, further corroborates this identification."}], "target": "Arginine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PIGP,PIGY,PIGU,PIGX,PIGW,PIGC,PIGA,PIGG,PIGV,PGAP1,GPLD1,PIGO,PIGB,DPM2,PIGQ,PIGL,GPAA1,PIGS,PIGH >>>\nList of compounds : <<< Palmitoyl-CoA,Dolichyl phosphate D-mannose,Ethanolamine phosphate,Phosphatidylethanolamine,6-(alpha-D-glucosaminyl)-1D-myo-inositol,UDP-N-acetyl-D-glucosamine,1-Phosphatidyl-D-myo-inositol,Phosphatidylethanolamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycosylphosphatidylinositol (GPI)-anchor biosynthesis. This pathway was implicated due to the alteration of several genes directly involved in this process, including PIGA-PIGQ, PIGG, GPAA1, PIGS, and PIGH. These genes encode proteins that catalyze various steps in the biosynthesis of GPI anchors, which are glycolipids that attach proteins to the cell surface. The altered compounds, such as Dolichyl phosphate D-mannose, UDP-N-acetyl-D-glucosamine, and 1-Phosphatidyl-D-myo-inositol, are intermediates in this pathway, further supporting the involvement of GPI-anchor biosynthesis in the observed condition. The alterations in Palmitoyl-CoA and Phosphatidylethanolamine, while not direct intermediates, may suggest potential secondary effects or regulatory mechanisms related to this pathway."}], "target": "Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< NT5C1B-RDH14,ENTPD2,DCTD,DUT,AK6,NT5M,NT5C1A,RRM2B,AK3,PNP,NT5C3B,DCTPP1,AK1,AK2,ADA,HDDC2,CMPK1,DGUOK,LACC1,ENTPD5,AMPD1 >>>\nList of compounds : <<< Xanthine,Hypoxanthine,5-Phospho-alpha-D-ribose 1-diphosphate,Uridine,UDP,Thymine,dTTP,dCMP,Inosine,L-Glutamine,AMP,GTP,CDP,Cytosine,dADP,Deoxyadenosine,ITP,Deoxyinosine,XDP,UTP,Cytidine,dTMP,dGTP,IMP,dTDP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is nucleotide metabolism. This is supported by the significant alterations in genes associated with this pathway, including NT5C1B-RDH14, ENTPD2, DCTD, DUT, AK6, NT5M, NT5C1A, RRM2B, AK3, PNP, NT5C3B, DCTPP1, AK1, AK2, ADA, HDDC2, CMPK1, DGUOK, LACC1, ENTPD5, and AMPD1. These genes are involved in various aspects of nucleotide synthesis, degradation, and salvage. The altered compounds, such as Xanthine, Hypoxanthine, Uridine, UDP, Thymine, dTTP, dCMP, AMP, GTP, CDP, Cytosine, dADP, Deoxyadenosine, ITP, Deoxyinosine, XDP, UTP, Cytidine, dTMP, dGTP, IMP, and dTDP, are intermediates and products of nucleotide metabolism, further supporting the involvement of this pathway in the condition under study."}], "target": "Nucleotide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT1L1,GOT2,GOT1,IL4I1,PAH,TAT >>>\nList of compounds : <<< 1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,D-Fructose 1,6-bisphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Phenylalanine, tyrosine and tryptophan biosynthesis. This is supported by the alterations in the genes GOT1L1, GOT2, GOT1, PAH, and TAT, which are all involved in this pathway. GOT1 and GOT2 are glutamate-oxaloacetate transaminases involved in amino acid metabolism, PAH encodes phenylalanine hydroxylase, a key enzyme in phenylalanine metabolism, and TAT encodes tyrosine aminotransferase. The alteration in the compound 1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate, a derivative of phenylalanine, further supports this finding. The alteration in D-Fructose 1,6-bisphosphate, a glycolysis intermediate, may suggest a link between carbohydrate metabolism and the identified amino acid pathway."}], "target": "Phenylalanine, tyrosine and tryptophan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< COQ2,NQO1,VKORC1L1,HPD,COQ7 >>>\nList of compounds : <<< 3-(4-Hydroxyphenyl)pyruvate,Ubiquinol,6-Methoxy-3-methyl-2-all-trans-polyprenyl-1,4-benzoquinol,2-Methoxy-6-all-trans-polyprenyl-1,4-benzoquinol,6-Geranylgeranyl-2-methylbenzene-1,4-diol,1,4-Dihydroxy-2-naphthoyl-CoA,Dehypoxanthine futalosine,alpha-Tocotrienol,Geranylgeranyl diphosphate,4-(beta-D-Glucosyloxy)benzoate,2-Methyl-6-solanyl-1,4-benzoquinol,all-trans-Polyprenyl diphosphate,Menaquinone,trans-Cinnamate,p-Coumaroyl-CoA,3-Demethylubiquinol,4-Hydroxy-3-polyprenylbenzoate,2,3-Epoxymenaquinone,Isochorismate,gamma-Tocopherol,alpha-Tocopherol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Ubiquinone and other terpenoid-quinone biosynthesis pathway. This conclusion is supported by the alterations observed in several genes and compounds involved in this pathway. The genes COQ2 and COQ7 are directly involved in the biosynthesis of ubiquinone, also known as coenzyme Q10. The alterations in these genes would likely affect the production of ubiquinone and its derivatives, such as ubiquinol and 3-demethylubiquinol, which were found to be altered in the experiment. Additionally, changes in the NQO1 gene, which encodes an enzyme involved in the reduction of quinones, further support the involvement of this pathway. The alterations in various prenylated benzoquinones and polyprenyl diphosphate, a key intermediate in the pathway, also provide strong evidence for the involvement of the Ubiquinone and other terpenoid-quinone biosynthesis pathway."}], "target": "Ubiquinone and other terpenoid-quinone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PGD,GGCT,GSTO1,GGT5,GSTM1,SRM,CHAC1,RRM2,IDH2,GPX8,NAT8,CHAC2,RRM2B,MGST1,GSTM4,LAP3,GSTM3,GPX3,GPX1,IDH1,ODC1,GSTM5 >>>\nList of compounds : <<< Cadaverine,Glutathione disulfide,Dehydroascorbate,Homotrypanothione disulfide,L-Glutamate,R-S-Glutathione,NADPH,L-Amino acid,Tryparedoxin,gamma-L-Glutamyl-L-cysteine,Glycine,Trypanothione disulfide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is Glutathione metabolism. This pathway was implicated due to the significant alterations in several genes and compounds directly involved in this process. The genes PGD, GGCT, GSTO1, GGT5, GSTM1, GPX8, NAT8, MGST1, GSTM3, GPX1, IDH1, and GSTM5 are all associated with Glutathione metabolism. Glutathione, Glutathione disulfide, Dehydroascorbate, Homotrypanothione disulfide, L-Glutamate, R-S-Glutathione, Trypanothione disulfide, gamma-L-Glutamyl-L-cysteine, and Glycine are key compounds in this pathway, and their alterations further support the involvement of Glutathione metabolism in the condition under study. The Glutathione metabolism pathway is crucial for maintaining cellular homeostasis and protecting cells from oxidative stress, and its disruption could potentially contribute to the observed condition."}], "target": "Glutathione metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< FUT1,HEXA,HEXB,FUT2,ST3GAL2,B3GALNT1,A4GALT,FUT9,ABO,ST3GAL1,B3GALT5,NAGA,ST8SIA1,A3GALT2 >>>\nList of compounds : <<< Globotriaosylceramide,NORint,Globo-H,Galactosylgloboside,NOR2 antigen,Globo-A,Disialosylglobopentaosylceramide,IV3GalNAcb-Gb4Cer,Lactosylceramide,Forssman antigen, IV3GalNAca-Gb4Cer >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosphingolipid biosynthesis - globo and isoglobo series. This pathway was found to be significantly altered based on the changes observed in the genes and compounds. The genes FUT1, FUT2, ST3GAL1, ST3GAL2, B3GALNT1, A4GALT, A3GALT2, and ST8SIA1 are all involved in the synthesis of glycosphingolipids, specifically in the globo and isoglobo series. The altered compounds, such as Globotriaosylceramide, Globo-H, Galactosylgloboside, and Disialosylglobopentaosylceramide, are also products of this pathway. Therefore, the changes in these genes and compounds provide strong evidence for the involvement of the Glycosphingolipid biosynthesis - globo and isoglobo series in the condition under investigation."}], "target": "Glycosphingolipid biosynthesis - globo and isoglobo series"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP4F2,JMJD7-PLA2G4B,CYP2C8,AKR1C3,PLA2G12A,PLA2G2D,CYP4F3,PLA2G2C,PLA2G2A,PLAAT2,PLAAT3,PLA2G6,PLA2G4A,CBR1,PTGR1,PTGES,ALOX15B,PTGS1,GGT1,PLA2G2E,EPHX2,PLA2G4B,PLA2G3,ALOX12B >>>\nList of compounds : <<< 16(R)-HETE,12(S)-HPETE,15-Keto-prostaglandin F2alpha,9(S)-HETE,Trioxilin B3,11,12-EET,Prostaglandin C2,Leukotriene F4,Delta-12-Prostaglandin J2,Lipoxin A4,12-OxoETE,11-epi-Prostaglandin F2alpha,11,14,15-THETA,5(S)-HPETE,2,3-Dinor-8-iso prostaglandin F2alpha >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Arachidonic Acid Metabolism. This pathway was implicated due to the alterations observed in multiple genes and compounds associated with it. The genes listed, such as CYP4F2, CYP2C8, AKR1C3, PLA2G2A, and PTGS1, are known to encode enzymes involved in the metabolism of arachidonic acid. The compounds, including 16(R)-HETE, 12(S)-HPETE, Prostaglandin C2, and Leukotriene F4, are metabolites produced through this pathway. Therefore, the changes in these genes and compounds suggest a significant role of the Arachidonic Acid Metabolism in the observed condition."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PHOSPHO2,PNPO,PDXK,AOX1 >>>\nList of compounds : <<< D-Glyceraldehyde 3-phosphate,2-Oxo-3-hydroxy-4-phosphobutanoate,Pyridoxine,4-Pyridoxate,Pyridoxine phosphate,Succinate semialdehyde,Pyridoxamine phosphate,2-(Hydroxymethyl)-3-(acetamidomethylene)succinate,O-Phospho-4-hydroxy-L-threonine,Pyridoxal phosphate,2-Amino-3-oxo-4-phosphonooxybutyrate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Vitamin B6 metabolism. This conclusion is based on the alteration of genes PHOSPHO2, PNPO, PDXK, and AOX1, which are all directly involved in Vitamin B6 metabolism. PHOSPHO2 encodes an enzyme that converts pyridoxine to pyridoxal phosphate, the active form of Vitamin B6. PNPO is involved in the conversion of pyridoxamine phosphate to pyridoxal phosphate. PDXK is responsible for the phosphorylation of pyridoxine and pyridoxal to their respective phosphate forms. AOX1 encodes an aldehyde oxidase that can oxidize pyridoxal to pyridoxate. Furthermore, the altered compounds, such as Pyridoxine, Pyridoxate, Pyridoxine phosphate, Pyridoxal phosphate, Pyridoxamine phosphate, and Succinate semialdehyde, are all intermediates or byproducts in the Vitamin B6 metabolism pathway. Therefore, the changes in these genes and compounds suggest a significant role of Vitamin B6 metabolism in the observed condition."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MAT2A,TKT,MAT2B,GOT1L1,PKLR >>>\nList of compounds : <<< L-Glutamate 5-semialdehyde,2-Phospho-D-glycerate,Pyruvate,L-Tryptophan,L-Aspartate 4-semialdehyde,L-Homocysteine,4-Phospho-L-aspartate,4-Methyl-2-oxopentanoate,L-Methionine,N-Acetylornithine,L-Lysine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Amino Acids. This conclusion is supported by the altered genes and compounds. The genes MAT2A and MAT2B are involved in the synthesis of S-adenosylmethionine (SAM), a key methyl donor in amino acid biosynthesis. GOT1L1 is involved in the interconversion of aspartate and alpha-ketoglutarate, which are precursors for several amino acids. PKLR is involved in glycolysis, which provides carbon skeletons for amino acid biosynthesis. The altered compounds, such as L-Glutamate 5-semialdehyde, 4-Phospho-L-aspartate, L-Homocysteine, L-Methionine, and L-Lysine, are intermediates or products of amino acid biosynthesis pathways. Therefore, the changes observed in these genes and compounds suggest an alteration in the Biosynthesis of Amino Acids pathway."}], "target": "Biosynthesis of amino acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< G6PC2,GANC,GCK,GALM,HK3,HK2,MGAM,AKR1B1,GLB1,G6PC1,GAA,PGM2,G6PC3,PFKL,GALE >>>\nList of compounds : <<< Glycerone phosphate,Galactitol,D-Galactose,Galactitol 1-phosphate,Lactose 6'-phosphate,D-Gal alpha 1-&gt;6D-Gal alpha 1-&gt;6D-Glucose,Raffinose,alpha-D-Glucose 6-phosphate,D-Glyceraldehyde,alpha-D-Galactosyl-(1-&gt;3)-1D-myo-inositol,alpha-D-Galactose 1-phosphate,myo-Inositol,Sucrose,3-beta-D-Galactosyl-sn-glycerol,alpha-D-Galactose,N-Acetyl-D-galactosamine 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Galactose metabolism pathway. This conclusion is supported by the alteration of multiple genes and compounds associated with this pathway. The altered genes include GALM, GALE, and GLB1, which are directly involved in the metabolism of galactose. The presence of compounds such as D-Galactose, Galactitol, Galactitol 1-phosphate, and alpha-D-Galactose 1-phosphate further supports this finding, as these are key intermediates in the galactose metabolism pathway. The alteration of other genes such as G6PC2, GCK, and HK3, which are involved in glucose metabolism, may indicate a crosstalk between the two pathways due to the structural similarity between glucose and galactose."}], "target": "Galactose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BTD,HLCS >>>\nList of compounds : <<< Biotinyl-CoA,8-Amino-7-oxononanoate,Pimeloyl-[acyl-carrier protein] methyl ester,Dethiobiotin,Malonyl-[acyl-carrier protein],Biocytin,Biotin,Glutaryl-[acp] methyl ester,Urea,3-Ketopimeloyl-[acp] methyl ester,Long-chain acyl-[acyl-carrier protein] >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Biotin metabolism. This conclusion is supported by the alterations in the genes BTD and HLCS, both of which are directly involved in this pathway. BTD encodes biotinidase, an enzyme responsible for recycling biotin, while HLCS encodes holocarboxylase synthetase, which activates biotin by attaching it to specific enzymes. The altered compounds, including Biotinyl-CoA, Biocytin, Dethiobiotin, and Biotin, are intermediates in the Biotin metabolism pathway. Additionally, the presence of compounds like 8-Amino-7-oxononanoate, Pimeloyl-[acyl-carrier protein] methyl ester, Malonyl-[acyl-carrier protein], and Glutaryl-[acp] methyl ester, which are involved in fatty acid synthesis and are dependent on biotin-containing enzymes, further supports the involvement of the Biotin metabolism pathway in the observed condition."}], "target": "Biotin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GALNTL6,GALNT1,GALNTL5,ST6GALNAC2,GALNT5,B3GNT6,GALNT11,ST6GALNAC1,C1GALT1C1,GALNT7,GCNT4 >>>\nList of compounds : <<< Tn antigen,UDP-N-acetyl-D-galactosamine,[Protein]-L-serine,T antigen,Sialyl-Tn antigen >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Mucin type O-glycan biosynthesis pathway. This pathway involves the addition of carbohydrates to proteins, particularly mucins, which are heavily glycosylated proteins found on the surface of epithelial cells. The altered genes in this experiment, including GALNTL6, GALNT1, GALNTL5, ST6GALNAC2, GALNT5, B3GNT6, GALNT11, ST6GALNAC1, C1GALT1C1, GALNT7, and GCNT4, are all involved in the initiation and elongation steps of O-glycan biosynthesis. The altered compounds, such as UDP-N-acetyl-D-galactosamine, [Protein]-L-serine, T antigen, and Sialyl-Tn antigen, are intermediates or end products of this pathway. The presence of the Tn antigen and its sialylated form, Sialyl-Tn antigen, suggests truncation or aberrant glycosylation in the pathway, which fits with the alterations in the genes involved in this pathway."}], "target": "Mucin type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< SELENOI,PCYT2,CHPT1,CEPT1 >>>\nList of compounds : <<< alpha-D-Ribose 1,2-cyclic phosphate 5-phosphate,Phosphonoformate,FR 900098,(2-Amino-1-hydroxyethyl)phosphonate,Rhizocticin A >>>"}, {"role": "assistant", "content": "The experiment identified the phosphonate and phosphinate metabolism pathway as being altered in the given conditions. This pathway is involved in the metabolism of compounds containing phosphorus-carbon bonds, which are not commonly found in biological systems but are present in certain drugs and toxins. The alterations in genes SELENOI, PCYT2, CHPT1, and CEPT1, which are involved in phospholipid metabolism, phosphatidylcholine biosynthesis, and fatty acid metabolism, suggest a link to phosphonate metabolism due to the shared use of phosphorus-containing compounds. The significant changes in compounds such as alpha-D-Ribose 1,2-cyclic phosphate 5-phosphate, Phosphonoformate, FR 900098, (2-Amino-1-hydroxyethyl)phosphonate, and Rhizocticin A, which are phosphonate or phosphinate-containing compounds, further support the involvement of the phosphonate and phosphinate metabolism pathway in the observed condition."}], "target": "Phosphonate and phosphinate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH1B1,CYP1A2,DLST,IDO1,DLD,KMO,AOC1,ALDH8A1 >>>\nList of compounds : <<< 4-(2-Amino-5-hydroxyphenyl)-2,4-dioxobutanoate,4,8-Dihydroxyquinoline,3-Hydroxykynurenamine,5-Hydroxyindolepyruvate,5-Methoxytryptamine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Tryptophan metabolism. This conclusion is supported by the altered genes and compounds observed. Several genes involved in this pathway were impacted, including ALDH1B1, CYP1A2, DLST, IDO1, DLD, KMO, AOC1, and ALDH8A1. These genes are known to participate in different steps of the Tryptophan metabolism, such as conversion to kynurenine, serotonin, and other metabolites. The altered compounds, including 4-(2-Amino-5-hydroxyphenyl)-2,4-dioxobutanoate, 4,8-Dihydroxyquinoline, 3-Hydroxykynurenamine, 5-Hydroxyindolepyruvate, and 5-Methoxytryptamine, are intermediates or end products of this pathway. Therefore, the changes in these genes and compounds provide strong evidence for the involvement of the Tryptophan metabolism in the observed condition."}], "target": "Tryptophan metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACADL,HSD17B8,ACACA,FADS2,HACD1,PPT1,ACSL6,HACD4,ECHS1,ACSL5,ACSBG2,HADHA,ELOVL2,ACSL1,ELOVL5,CPT2,HTD2 >>>\nList of compounds : <<< (S)-Hydroxydecanoyl-CoA,Acetyl-CoA,(11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA,Eicosanoyl-CoA,Acetoacetyl-CoA,2-trans-Dodecenoyl-CoA,trans-Hexadec-2-enoyl-[acp],(2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA,(3R)-3-Hydroxyoctanoyl-[acyl-carrier protein],trans-Hex-2-enoyl-[acp],(6Z,9Z,12Z,15Z,18Z,21Z)-3-Oxotetracosahexaenoyl-CoA,Dodecanoyl-[acyl-carrier protein],Hexadecanoic acid,(S)-3-Hydroxytetradecanoyl-CoA,Ximenoyl-CoA,(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA,Acetoacetyl-[acp],(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA,Decanoyl-[acp],alpha-Linolenoyl-ACP,Octanoyl-CoA,3-Oxohexanoyl-CoA >>>"}, {"role": "assistant", "content": "The analysis of the gene and compound alterations in the experiment points to the involvement of the fatty acid metabolism pathway. Several genes identified, such as ACADL, ACACA, HADHA, CPT2, and ELOVL2, are known to play crucial roles in this pathway. ACADL and HADHA are involved in fatty acid beta-oxidation, ACACA in fatty acid synthesis, CPT2 in the transport of fatty acids into the mitochondria for oxidation, and ELOVL2 in elongation of very long chain fatty acids. The altered compounds, including various acyl-CoA intermediates and fatty acids, are also directly involved in fatty acid metabolism processes such as synthesis, elongation, desaturation, and beta-oxidation. Therefore, the data suggests that the fatty acid metabolism pathway is significantly affected in the given condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DPYS,GSTO1,GSTP1,NAT1,CYP3A4,GSTT2B,GSTM4 >>>\nList of compounds : <<< Acetylhydrazine,Isoniazid pyruvate,alpha-Fluoro-beta-ureidopropionic acid,Irinotecan,Doxifluridine (JP18/INN),5'-Deoxy-5-fluorocytidine,6-Thiourate,6-Mercaptopurine ribonucleoside triphosphate,6-Methylmercaptopurine,alpha-Fluoro-beta-alanine,6-Mercaptopurine,5-Fluorodeoxyuridine diphosphate,1-Methyl-4-nitroimidazole,Isoniazid (JP18/USP/INN),5'-Deoxy-5-fluorouridine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Drug metabolism - other enzymes\". This pathway was implicated due to the alterations in genes such as DPYS, GSTO1, GSTP1, NAT1, CYP3A4, GSTT2B, and GSTM4, which are all known to be involved in drug metabolism. These genes encode for enzymes that play a role in the metabolism of various drugs, including oxidation, reduction, and conjugation reactions. The altered compounds, including Acetylhydrazine, Isoniazid pyruvate, Irinotecan, and 5'-Deoxy-5-fluorouridine, among others, are also known substrates or metabolites of these enzymes. Therefore, the changes observed in these genes and compounds suggest that the \"Drug metabolism - other enzymes\" pathway is significantly affected in the given condition."}], "target": "Drug metabolism - other enzymes"}
{"messages": [{"role": "user", "content": "List of genes : <<< ATP6V0A1,NDUFA5,ATP6V1D,ATP6V1C1,ATP5MGL,SDHD,NDUFS6,ATP5MF,ATP6V1A,MT-ND5,NDUFB7,COX8C,NDUFB8,NDUFA12,NDUFB3,UQCRHL,ATP5F1D,COX5B,SDHA,ATP6V0B,COX7B2,ATP6V1E1,NDUFA9,MT-CO3 >>>\nList of compounds : <<< H+,H+,Fumarate,Diphosphate,H+,NAD+,H2O,H2O,H+,ADP,ATP,H+,H+,Oxygen,H+ >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Oxidative Phosphorylation. This conclusion is supported by the altered genes and compounds. The genes listed, such as NDUFA5, NDUFB7, NDUFS6, and NDUFA12, are subunits of Complex I in the electron transport chain, a crucial component of Oxidative Phosphorylation. SDHA and COX7B2 are involved in Complex II and Complex IV, respectively, further implicating this pathway. The compounds H+, NAD+, ADP, ATP, and Oxygen are all key players in Oxidative Phosphorylation, where protons (H+) are pumped across a membrane to generate a proton motive force, which is then used to synthesize ATP from ADP and inorganic phosphate. The presence of Fumarate, a TCA cycle intermediate, suggests a link between this pathway and the Krebs cycle, which feeds into Oxidative Phosphorylation."}], "target": "Oxidative phosphorylation"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACACB,PDHA1,ALDH2,FH,MDH1,PKM,HAGH,ACOT12,LDHA,PDHA2,PKLR,PDHB,ADH1C,ACACA,ALDH9A1,ADH6,ADH4,ADH1B,DLAT,ALDH3A2,ME3,LDHD,DLD,ACSS2,LDHAL6A >>>\nList of compounds : <<< 2-(alpha-Hydroxyethyl)thiamine diphosphate,(R)-2-Hydroxybutane-1,2,4-tricarboxylate,(R)-2-Ethylmalate,2-Propylmalate,(S)-Lactate,Methylglyoxal,2-Hydroxyethylenedicarboxylate,(R)-S-Lactoylglutathione,(S)-Lactaldehyde,Acetylenedicarboxylate,Acetaldehyde,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Acetoacetyl-CoA,(R)-Lactate,Acetate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Pyruvate metabolism. This is supported by the alterations in the genes and compounds associated with this pathway. For instance, genes such as PDHA1, PDHA2, PDHB are involved in the pyruvate dehydrogenase complex, which converts pyruvate to acetyl-CoA. The presence of compounds like (R)-Lactate, Acetyl-CoA, and Acetate further corroborates this finding. Additionally, genes like ALDH2, HAGH, and ADH1C, involved in alcohol metabolism, were also altered, which is a subpathway of pyruvate metabolism. The presence of compounds such as Acetaldehyde and Methylglyoxal, intermediates in alcohol metabolism, strengthens this conclusion. Therefore, the data suggests that the Pyruvate metabolism pathway, particularly its alcohol metabolism subpathway, is significantly impacted in the given condition."}], "target": "Pyruvate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PHOSPHO2,PDXK,PDXP,AOX1,PNPO >>>\nList of compounds : <<< Pyridoxal phosphate,2-Oxo-3-hydroxy-4-phosphobutanoate,Pyridoxine phosphate,2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate,4-Phospho-D-erythronate,2-(Acetamidomethylene)succinate,Pyridoxal,4-Pyridoxate,3-Hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate,3-Hydroxy-2-methylpyridine-5-carboxylate,O-Phospho-4-hydroxy-L-threonine,Pyridoxine,2-Amino-3-oxo-4-phosphonooxybutyrate,5-Pyridoxolactone,3-Amino-2-oxopropyl phosphate,L-Glutamine,D-Ribose 5-phosphate,Pyridoxamine,D-Glyceraldehyde 3-phosphate,Isopyridoxal,D-Erythrose 4-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Vitamin B6 metabolism. This pathway was selected based on the alterations observed in genes and compounds associated with it. The genes PHOSPHO2, PDXK, PDXP, and PNPO, which are involved in the metabolism of Vitamin B6, were found to be altered. The compounds affected include various forms of Vitamin B6, such as Pyridoxal phosphate, Pyridoxine phosphate, and Pyridoxine, as well as intermediates in the pathway like 2-Oxo-3-hydroxy-4-phosphobutanoate and 4-Phospho-D-erythronate. The alterations in these genes and compounds suggest a disruption in the Vitamin B6 metabolism pathway, which is crucial for amino acid metabolism and neurotransmitter synthesis."}], "target": "Vitamin B6 metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MPI,PFKP,FPGT,AKR1B10,ALDOB,ALDOC,ALDOA,PFKL,PFKFB2,GMPPA,TIGAR,FBP1,HK1,AKR1B1,ENOSF1,KHK,PMM1,AKR1B15,PFKM,PFKFB3,PFKFB4,GMDS >>>\nList of compounds : <<< D-Mannose,2-Dehydro-3-deoxy-L-fuconate,1,4-beta-D-Mannan,L-Fuconate,L-Fuculose,2-Dehydro-3-deoxy-L-rhamnonate,L-Sorbose,L-Rhamnose,L-Rhamnono-1,4-lactone,D-Allose,2-O-(alpha-D-Mannosyl)-D-glycerate,Sorbitol 6-phosphate,beta-D-Fructose 2,6-bisphosphate,Sorbose 1-phosphate,2-(alpha-D-Mannosyl)-3-phosphoglycerate,GDP-L-fucose,L-Fucono-1,5-lactone,Fructan,D-Sorbitol,Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,D-Sorbitol,D-Allulose 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is \"Fructose and mannose metabolism\". This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes MPI, PFKP, ALDOB, ALDOC, ALDOA, PFKL, PFKFB2, FBP1, HK1, KHK, PMM1, and PFKM are involved in the metabolism of fructose and mannose, providing strong evidence for this pathway's involvement. The compounds D-Mannose, 1,4-beta-D-Mannan, D-Allose, D-Allulose 6-phosphate, and D-Sorbitol are all intermediates or products of this pathway, further supporting this identification. Additionally, the presence of compounds such as 2-Dehydro-3-deoxy-L-fuconate and L-Fuconate, which are related to fructose metabolism, further solidifies the involvement of this pathway."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MAN2A2,RPN1,DPM2,OSTC >>>\nList of compounds : <<< Dolichyl diphosphate,N,N'-Chitobiosyldiphosphodolichol,GDP-mannose,DS 3,Dolichyl phosphate,Polyprenol,Protein asparagine,Dolichyl beta-D-glucosyl phosphate,N-Acetyl-D-glucosaminyldiphosphodolichol,Dolichyl phosphate D-mannose >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is N-Glycan biosynthesis. This pathway was implicated due to the alterations in genes and compounds that are directly involved in its processes. The genes MAN2A2, RPN1, DPM2, and OSTC are known to play crucial roles in N-glycan biosynthesis. MAN2A2 encodes an alpha-mannosidase involved in glycoprotein processing, RPN1 is a component of the oligosaccharyltransferase complex, DPM2 is involved in dolichyl-phosphate mannose biosynthesis, and OSTC is an oligosaccharyltransferase. The altered compounds, including Dolichyl diphosphate, N,N'-Chitobiosyldiphosphodolichol, GDP-mannose, Dolichyl phosphate, Polyprenol, Protein asparagine, Dolichyl beta-D-glucosyl phosphate, N-Acetyl-D-glucosaminyldiphosphodolichol, and Dolichyl phosphate D-mannose, are all intermediates or products in the N-Glycan biosynthesis pathway. Therefore, the alterations in these genes and compounds suggest a disruption in N-Glycan biosynthesis, which fits with the identified pathway."}], "target": "N-Glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< AKR1B15,CRPPA,SORD,UGT1A3,UGT2B28,UGP2,UGT2B11,GUSB,UGT2B4,UGT2B15,RPE,XYLB,UGT1A1,KL,UGT2A1,RPEL1,CRYL1,UGT2B7,UGT1A10,FGGY,AKR1B10,UGT1A5,UGT1A7,UGT1A8 >>>\nList of compounds : <<< (4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate,L-Arabinose,L-Xylonate,Glycerone phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Pentose and glucuronate interconversions\". This pathway was inferred based on the alterations observed in multiple genes and compounds. The genes involved, such as UGT1A1, UGT1A3, UGT1A5, UGT1A7, UGT1A8, UGT1A10, UGT2A1, UGT2B11, UGT2B15, UGT2B28, UGT2B4, and UGT2B7, are primarily UDP-glucuronosyltransferases, enzymes that catalyze the transfer of glucuronic acid from UDP-glucuronic acid to various substrates. This is a key process in the pentose and glucuronate interconversions pathway. The altered compounds, including (4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate, L-Arabinose, L-Xylonate, and Glycerone phosphate, are intermediates or products of this pathway. Therefore, the observed changes in these genes and compounds strongly suggest that the pentose and glucuronate interconversions pathway is significantly affected in the studied condition."}], "target": "Pentose and glucuronate interconversions"}
{"messages": [{"role": "user", "content": "List of genes : <<< GFUS,HK1,GFPT1,UAP1L1,PGM3,GALK2,NAGK >>>\nList of compounds : <<< dTDP-D-angolosamine,dTDP-4-oxo-5-C-methyl-L-rhamnose,UDP-D-xylose,dTDP-4-dehydro-beta-L-rhamnose,GDP-4-dehydro-3,6-dideoxy-alpha-D-mannose,UDP-kanosamine,UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucose,alpha-D-Galactose,CDP-3,6-dideoxy-D-mannose,CMP-N,N'-diacetyllegionaminate,D-Arabinose 5-phosphate,2,4-Diacetamido-2,4,6-trideoxy-beta-L-gulose >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of nucleotide sugars. This pathway involves the conversion of simple sugars into nucleotide sugars, which are essential for the synthesis of glycans, glycoproteins, and glycolipids. The altered genes GFUS, HK1, GFPT1, UAP1L1, PGM3, GALK2, and NAGK are all involved in various steps of this pathway. For instance, GFUS is involved in the synthesis of UDP-glucose, HK1 in the conversion of glucose to glucose-6-phosphate, and NAGK in the synthesis of UDP-N-acetylglucosamine. The altered compounds, such as UDP-D-xylose, UDP-kanosamine, and CDP-3,6-dideoxy-D-mannose, are all nucleotide sugars produced in this pathway. Therefore, the changes in these genes and compounds suggest an alteration in the Biosynthesis of nucleotide sugars pathway."}], "target": "Biosynthesis of nucleotide sugars"}
{"messages": [{"role": "user", "content": "List of genes : <<< BCAT2,SDS >>>\nList of compounds : <<< D-erythro-3-Methylmalate,(2R,3S)-3-Isopropylmalate,L-Leucine,(R)-2,3-Dihydroxy-3-methylbutanoate,(R)-2-Methylmalate,2-Methylmaleate,(2S)-2-Isopropyl-3-oxosuccinate,(S)-3-Methyl-2-oxopentanoic acid,Pyruvate,(S)-2-Aceto-2-hydroxybutanoate,Acetyl-CoA,2-Isopropylmaleate,L-Valine,4-Methyl-2-oxopentanoate,(S)-2-Acetolactate,L-Isoleucine,(R)-2,3-Dihydroxy-3-methylpentanoate,3-Methyl-2-oxobutanoic acid >>>"}, {"role": "assistant", "content": "Based on the provided list of genes and compounds, the metabolic pathway identified is the Valine, Leucine, and Isoleucine Biosynthesis. This pathway is supported by the presence of BCAT2, which encodes branched-chain amino acid transaminase 2, and SDS, which encodes succinyl-diaminopimelinate desuccinylase, both of which are involved in the biosynthesis of these amino acids. The altered compounds, including D-erythro-3-Methylmalate, (2R,3S)-3-Isopropylmalate, L-Leucine, L-Valine, and L-Isoleucine, are intermediates or end products of this pathway, further supporting its involvement. Additionally, changes in compounds such as Pyruvate, Acetyl-CoA, and 2-Aceto-2-hydroxybutanoate suggest a connection to energy metabolism, which is closely linked to amino acid biosynthesis. Therefore, the Valine, Leucine, and Isoleucine Biosynthesis pathway is likely to be significantly affected in the given condition."}], "target": "Valine, leucine and isoleucine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< COLGALT2,ACAT1,BBOX1,NSD2,KMT5C,KMT2C,EHHADH,PRDM16,SETD2,PIPOX,DLD,SUV39H1,EZH1,ASH1L,GCDH,SETD7,KMT2E,ALDH3A2,AADAT >>>\nList of compounds : <<< Succinate,D-Lysine,Protein N6-methyl-L-lysine,N6,N6,N6-Trimethyl-L-lysine,Glutarate,4-Carboxy-1-hydroxybutyryl-ThPP,5-(D-Galactosyloxy)-L-lysine-procollagen,D-Lysopine,5-Aminopentanamide,Protein N6,N6,N6-trimethyl-L-lysine,(2R,5S)-2,5-Diaminohexanoate,6-Amino-2-oxohexanoate,Thiamin diphosphate,4-Trimethylammoniobutanal,N6-Acetyl-L-lysine,Glycine,(3S)-3-Hydroxy-N6,N6,N6-trimethyl-L-lysine,Enzyme N6-(lipoyl)lysine,L-3-Aminobutyryl-CoA,Procollagen 5-hydroxy-L-lysine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the \"Lysine degradation\" pathway. This conclusion is supported by the alterations in genes and compounds associated with lysine metabolism. Genes such as COLGALT2, involved in collagen lysine hydroxylation, PIPOX, associated with pipecolate oxidation, and GCDH, involved in glutaryl-CoA dehydrogenase activity, all have roles in lysine metabolism. The altered compounds further substantiate this finding. These include various forms of lysine (D-Lysine, Protein N6-methyl-L-lysine, N6,N6,N6-Trimethyl-L-lysine), intermediates of lysine degradation (Glutarate, 6-Amino-2-oxohexanoate), and compounds related to lysine modification (5-(D-Galactosyloxy)-L-lysine-procollagen, Enzyme N6-(lipoyl)lysine). Therefore, the data suggest that the Lysine degradation pathway is significantly affected in the compared conditions."}], "target": "Lysine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< HIBCH,HADHA,MLYCD,ACOX3,ECHS1,GAD1,DPYD,ALDH2,ALDH3A1,ALDH9A1,GAD2,DPYS >>>\nList of compounds : <<< Carnosine,beta-Alanyl-L-arginine,4-Aminobutyraldehyde,3-Hydroxypropanoate,3-Aminopropanal,N-Acetyl-beta-alanine,Propenoyl-CoA,Quinolinate,3-Aminopropiononitrile,D-4'-Phosphopantothenate,Uracil,Propynoate,L-Histidine,1,3-Diaminopropane,Acetyl-CoA,beta-Alanine,3-Hydroxypropionyl-CoA,Propanoyl-CoA >>>"}, {"role": "assistant", "content": "The experiment identified the beta-Alanine metabolism pathway as being significantly altered. This is supported by the observation of multiple genes involved in this pathway being affected, including HIBCH, HADHA, MLYCD, ECHS1, GAD1, GAD2, and DPYS. These genes encode enzymes involved in the synthesis and degradation of beta-Alanine. Additionally, several compounds associated with this pathway were also altered, including beta-Alanine, Carnosine, and N-Acetyl-beta-alanine. These findings suggest that changes in the beta-Alanine metabolism pathway may play a role in the observed condition."}], "target": "beta-Alanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SDS,MAOA,,ALDH7A1,SARDH,DAO,ALAS2,CBS,MAOB,PSPH,PGAM4,SRR,DMGDH,GAMT,CHDH,SDSL,GATM,BPGM, >>>\nList of compounds : <<< Guanidinoacetate,Glyoxylate,Ectoine,2-Oxobutanoate,[Protein]-S8-aminomethyldihydrolipoyllysine,2-Phospho-D-glycerate,L-2,4-Diaminobutanoate,Lipoylprotein,Aminoacetone,O-Phospho-L-serine,Pyruvate,Choline,L-Aspartate 4-semialdehyde >>>"}, {"role": "assistant", "content": "The experiment identified the Glycine, Serine and Threonine metabolism pathway as being significantly altered. This is supported by the alterations in several genes associated with this pathway, including Serine Dehydratase (SDS), Serine Racemase (SARDH), Dimethylglycine Dehydrogenase (DMGDH), and Guanidinoacetate Methyltransferase (GAMT). Additionally, the altered compounds such as Glyoxylate, 2-Oxobutanoate, Aminoacetone, L-Aspartate 4-semialdehyde, and Guanidinoacetate, are intermediates or products of this pathway. These findings suggest that the Glycine, Serine and Threonine metabolism pathway plays a key role in the condition being studied."}], "target": "Glycine, serine and threonine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ELOVL3,ACOT4,ELOVL7,HACD2,ELOVL5,HACD4,ACOX1,TECR,ACOT2 >>>\nList of compounds : <<< (6Z,9Z)-Octadecadienoyl-CoA,(11Z,14Z)-Icosadienoyl-CoA,Montanoyl-CoA,Tetracosenoyl-CoA,Stearoyl-CoA,Tetracosanoyl-CoA,(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid,Icosenoyl-CoA,Docosanoyl-CoA,(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA,8,11,14-Eicosatrienoyl-CoA,(8Z,11Z)-Icosadienoyl-CoA,Linoleoyl-[acyl-carrier protein],Docosanoyl-CoA,Stearoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the biosynthesis of unsaturated fatty acids. This conclusion is supported by the altered genes and compounds observed. The genes ELOVL3, ELOVL5, ELOVL7, HACD2, and HACD4 are all involved in the elongation and desaturation of fatty acids, key steps in unsaturated fatty acid biosynthesis. The ACOT2, ACOX1, and TECR genes are involved in fatty acid beta-oxidation, which can provide substrates for unsaturated fatty acid synthesis. The altered compounds, including various unsaturated CoA-esters and free fatty acids, are intermediates and products of this pathway, further supporting its involvement in the observed condition."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< MPI,PFKP,ENOSF1,ALDOC,GFUS,HKDC1,GMDS,HK1,PMM1,ALDOB,PFKFB4,FPGT,PFKL,PFKFB1,TIGAR,TPI1,GMPPB,ALDOA,AKR1B10,HK3,PFKFB3 >>>\nList of compounds : <<< L-Fuculose,D-Glyceraldehyde,2-O-(alpha-D-Mannosyl)-D-glycerate,GDP-D-mannuronate >>>"}, {"role": "assistant", "content": "The metabolic pathway implicated in the experiment is the Fructose and Mannose Metabolism. This conclusion is supported by the alterations in numerous genes involved in this pathway, including Mannose-6-Phosphate Isomerase (MPI), Phosphofructokinase Platelet (PFKP), Aldolase C (ALDOC), Hexokinase Domain Containing 1 (HKDC1), and several others. These genes play crucial roles in the conversion of fructose-6-phosphate to mannose-6-phosphate and vice versa, as well as in the subsequent steps of glycolysis. The identified compounds, such as L-Fuculose, D-Glyceraldehyde, and 2-O-(alpha-D-Mannosyl)-D-glycerate, are intermediates in this pathway, further supporting the involvement of Fructose and Mannose Metabolism in the observed condition."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BTD,HLCS >>>\nList of compounds : <<< Biotinyl-5'-AMP,Pimelate,Biocytin,Glutaryl-[acp] methyl ester,Biotin sulfoxide,Dethiobiotin,8-Amino-7-(carboxyamino)nonanoate,Malonyl-[acp] methyl ester,Pimeloyl-[acyl-carrier protein] >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Biotin metabolism pathway. This conclusion is supported by the alterations observed in the genes BTD and HLCS, and the compounds Biotinyl-5'-AMP, Pimelate, Biocytin, Glutaryl-[acp] methyl ester, Biotin sulfoxide, Dethiobiotin, 8-Amino-7-(carboxyamino)nonanoate, Malonyl-[acp] methyl ester, and Pimeloyl-[acyl-carrier protein]. These genes and compounds are all directly involved in the biotin metabolism pathway, which is responsible for the synthesis, recycling, and degradation of biotin, an essential coenzyme for several carboxylase enzymes. The alterations suggest that there may be disruptions in the normal functioning of this pathway, leading to the specific condition observed."}], "target": "Biotin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< RRM2B,AK9,PDE6D,PDE10A,AK8 >>>\nList of compounds : <<< Xanthine,Acetyl adenylate,P1,P3-Bis(5'-adenosyl) triphosphate,D-Ribose 5-phosphate,Guanosine 3'-diphosphate 5'-triphosphate,dATP,Ammonia,ATP,dGMP,dGDP,(S)-Allantoin,ADP,5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole,GMP,8-Hydroxyadenine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Purine metabolism. This conclusion is supported by the alterations in several genes and compounds associated with this pathway. The genes RRM2B and AK8 are involved in nucleotide biosynthesis, which is a key process in Purine metabolism. The compounds Xanthine, Guanosine 3'-diphosphate 5'-triphosphate, dATP, dGMP, dGDP, Ammonia, ATP, ADP, and 5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole are all intermediates or products of Purine metabolism. Furthermore, the presence of (S)-Allantoin and 8-Hydroxyadenine, which are breakdown products of purines, further supports the involvement of Purine metabolism in the observed condition."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< RIMKLA,CAD,GAD1,ASS1,GPT,ASPA,ABAT,AGXT,CPS1,NAT8L,ALDH4A1,GFPT1,GOT1,DDO,IL4I1,ADSS1,GPT2,ASL,ASRGL1 >>>\nList of compounds : <<< N-(L-Arginino)succinate,4-Aminobutanoate,Oxaloacetate,5-Phosphoribosylamine,Ammonia,L-Glutamine,Fumarate,Carbamoyl phosphate,L-Aspartate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Alanine, Aspartate and Glutamate Metabolism. This pathway was implicated due to the altered genes and compounds observed in the two conditions. Genes such as GPT (Glutamic-Pyruvic Transaminase), GPT2 (Glutamic-Pyruvic Transaminase 2), ASL (Argininosuccinate Lyase), ASS1 (Argininosuccinate Synthase 1), and CAD (Carbamoyl-Phosphate Synthase 1) are directly involved in this pathway. The presence of the compounds N-(L-Arginino)succinate, L-Aspartate, L-Glutamine, and Ammonia further supports this finding, as they are key intermediates in this pathway. The alteration of GAD1 (Glutamate Decarboxylase 1), ABAT (4-Aminobutyrate Aminotransferase), and ALDH4A1 (Succinic Semialdehyde Dehydrogenase) suggests potential crosstalk with the GABA shunt. Therefore, the data suggests a significant role of the Alanine, Aspartate and Glutamate Metabolism in the observed conditions."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDOC,KHK,PMM1,MPI,PFKFB4,FCSK,TPI1,GMPPB,TIGAR,AKR1B15,HK2,AKR1B1,PFKFB2,PFKM,GMDS,ALDOB,SORD,FPGT,PFKFB3,ENOSF1,PFKL,PFKFB1,HKDC1,ALDOA,AKR1B10 >>>\nList of compounds : <<< Mannitol,D-Fructose 1,6-bisphosphate,D-Glyceraldehyde 3-phosphate,D-Sorbitol,GDP-mannose,(S)-Lactate,D-Fructose,L-Fuconate,D-Sorbitol,L-Rhamnono-1,4-lactone,D-Allulose 6-phosphate,L-Fuculose 1-phosphate,1,4-beta-D-Mannan,Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,(beta-D-Mannuronate)n,2-Dehydro-3-deoxy-L-rhamnonate,L-Fucono-1,5-lactone,L-Fuculose,L-Rhamnulose 1-phosphate,L-Rhamnonate,L-Sorbose >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Fructose and mannose metabolism\" pathway. This conclusion is supported by the alterations in multiple genes and compounds associated with this pathway. Genes such as ALDOA, ALDOB, ALDOC, HK2, KHK, PFKFB1-4, PFKL, PFKM, and TPI1 are involved in the fructose and mannose metabolism pathway, which includes the conversion of fructose to fructose-1,6-bisphosphate and ultimately to glyceraldehyde 3-phosphate, a key intermediate in glycolysis. The altered compounds, including D-Fructose, D-Fructose 1,6-bisphosphate, D-Mannitol, D-Sorbitol, GDP-mannose, and D-Allulose 6-phosphate, are also indicative of this pathway. These findings suggest that changes in this pathway may be contributing to the observed condition."}], "target": "Fructose and mannose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SRM,GATM,MAOA,ALDH4A1,PYCR1,CARNS1,CKMT1A,P4HA3,GOT2,ARG1,PYCR2,CKMT1B,P4HA2,PYCR3,MAOB,ALDH3A2,DAO,CKM,ALDH9A1,GOT1,ODC1,PRODH2,SMOX,NOS3,SAT1 >>>\nList of compounds : <<< Guanidinoacetate,(4R)-4-Hydroxy-2-oxoglutarate,trans-3-Hydroxy-L-proline,Spermine,5-Aminopentanoate,Agmatine,p-Coumaroylputrescine,Glyoxylate,4-Guanidinobutanoate,L-Arginine phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Arginine and Proline Metabolism. This pathway was implicated due to the alterations observed in several genes and compounds directly involved in this metabolic process. The genes SRM, GATM, MAOA, ALDH4A1, ARG1, DAO, ODC1, PRODH2, and NOS3 are all known to play crucial roles in Arginine and Proline Metabolism. Furthermore, the presence of Guanidinoacetate, (4R)-4-Hydroxy-2-oxoglutarate, trans-3-Hydroxy-L-proline, Spermine, 5-Aminopentanoate, Agmatine, L-Arginine phosphate, which are intermediates or products of this pathway, further supports this identification. This suggests that dysregulation in the Arginine and Proline Metabolism pathway may contribute to the condition being studied."}], "target": "Arginine and proline metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CHPT1,PCYT1B,PCYT1A,PCYT2,CEPT1,SELENOI >>>\nList of compounds : <<< (2-Amino-1-hydroxyethyl)phosphonate,Phosphoenolpyruvate,Lipophosphonoglycan,Ciliatocholate,N-Dimethyl-2-aminoethylphosphonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in our comparison experiment is the Phosphonate and phosphinate metabolism pathway. This pathway was pinpointed due to the alterations observed in several genes and compounds that are directly involved in phosphonate metabolism. The genes CHPT1, PCYT1B, PCYT1A, PCYT2, and CEPT1 are all associated with phospholipid metabolism, which is closely linked to phosphonate metabolism. The altered compounds, including (2-Amino-1-hydroxyethyl)phosphonate, N-Dimethyl-2-aminoethylphosphonate, and Lipophosphonoglycan, are direct products or intermediates of the phosphonate and phosphinate metabolism pathway. The presence of Phosphoenolpyruvate and Ciliatocholate may suggest interplay with other pathways, such as glycolysis and bile acid synthesis, respectively. Overall, the evidence supports the implication of the Phosphonate and phosphinate metabolism pathway in the observed condition."}], "target": "Phosphonate and phosphinate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< G6PC2,ENPP1,HK3,GYS1,,PYGB,TREH,HK2,AMY1C,ENPP3,HKDC1,AMY2A,SI,G6PC3,GPI,AMY2B,PGM2,AGL,G6PC1,HK1,GCK >>>\nList of compounds : <<< 3-Ketosucrose,(2,1-beta-D-Fructosyl)n,D-Glucose 6-phosphate,6-Phospho-beta-D-glucosyl-(1,4)-D-glucose,Maltose 6'-phosphate,D-Glucose 6-phosphate,D-Fructose,alpha-Maltose 1-phosphate,alpha-D-Glucose 1,6-bisphosphate,D-Glucose,D-Fructose 6-phosphate,beta-D-Glucoside,Maltose,D-Glucose,Maltose,UDP-glucose,alpha,alpha-Trehalose,Levanbiose,alpha,alpha-Trehalose,Sucrose,D-Glucose 6-phosphate,Amylose,Cellobiose,Dextran >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Starch and Sucrose Metabolism. This pathway was suggested by the alterations in genes and compounds associated with carbohydrate metabolism. The genes G6PC1, G6PC2, G6PC3, GCK, HK1, HK2, HK3, HKDC1, PGM2, and GYS1 are involved in glucose metabolism, while AMY1C, AMY2A, AMY2B, GPI, and SI are involved in starch and sucrose degradation. The identified compounds, such as D-Glucose, D-Fructose, Maltose, Sucrose, and various phosphorylated glucose intermediates, are key components of this pathway. The alteration in these genes and compounds suggests a dysregulation in the Starch and Sucrose Metabolism pathway, leading to the specific condition observed in the experiment."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACAA1,SCP2,ACOT1,HACD3,TECR >>>\nList of compounds : <<< Icosenoyl-CoA,Ximenoyl-CoA,Montanoyl-CoA,Eicosanoyl-CoA,gamma-Linolenoyl-CoA,Montanoyl-CoA,(15Z)-Tetracosenoic acid,Palmitoleoyl-CoA,(13Z,16Z)-Docosadienoic acid,Paullinoyl-CoA,Stearoyl-CoA,(8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosahexaenoyl-CoA,Icosenoyl-CoA,Stearoyl-CoA,(11Z,14Z)-Icosadienoyl-CoA,Hexadecanoic acid,(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA,Cerotoyl-CoA,(7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA,(7Z,10Z,13Z)-Docosatrienoyl-CoA,Icosenoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Biosynthesis of unsaturated fatty acids.\" This conclusion is supported by the altered genes and compounds observed. The genes ACAA1, SCP2, ACOT1, HACD3, and TECR are all known to be involved in this pathway. They play roles in various steps such as fatty acid activation, elongation, desaturation, and oxidation. The list of compounds, which includes various unsaturated fatty acids and their corresponding CoA derivatives, further corroborates this finding. These compounds are intermediates and products in the biosynthesis of unsaturated fatty acids pathway. Therefore, the alterations in these genes and compounds suggest that this pathway is significantly affected in the condition being studied."}], "target": "Biosynthesis of unsaturated fatty acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< AGXT,CS,PCCB,MDH2,PCCA,HYI,MDH1,HOGA1,MMUT,ACAT2,GLDC,AMT,GCSH,MCEE,SHMT1,CAT,ACO2,GLUL >>>\nList of compounds : <<< 3-Oxalomalate,3-Phospho-D-glycerate,L-Glutamine,Mesaconate,Oxygen,L-threo-3-Methylaspartate,Propanoyl-CoA,CO2,L-Serine,D-Ribulose 1-phosphate,3-Propylmalate,cis-Aconitate,Butanoyl-CoA,Ammonia,Glycolate,D-Glycerate,Glycolaldehyde,Acetyl-CoA,Dihydroxyfumarate,(2R)-Ethylmalonyl-CoA,Oxalate,D-Ribulose 1,5-bisphosphate,Hydroxypyruvate,2-Hydroxy-3-oxosuccinate,(R,R)-Tartaric acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Glyoxylate and dicarboxylate metabolism. This pathway was found to be altered based on the changes observed in the genes and compounds. Several genes involved in this pathway, such as AGXT, CS, PCCB, PCCA, and MUTM, were altered. These genes are known to be involved in the conversion of glyoxylate to other compounds, such as malate and succinate. Additionally, several compounds associated with this pathway, such as 3-Oxalomalate, Mesaconate, cis-Aconitate, Oxalate, and (R,R)-Tartaric acid, were also altered, further supporting the involvement of this pathway. The alterations in these genes and compounds suggest that the Glyoxylate and dicarboxylate metabolism pathway may be playing a key role in the condition being studied."}], "target": "Glyoxylate and dicarboxylate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AKR1B10,LCT,MGAM2,HK3,LALBA,MGAM,HK1,PFKL,HK2,GALT,SI,B4GALT1,GLA,PGM2,GALM,G6PC1,G6PC3,G6PC2,GAA,GALE,HKDC1,GANC,GLB1 >>>\nList of compounds : <<< D-Glyceraldehyde,Stachyose,UDP-alpha-D-galactofuranose,D-Tagatose,Galactan,D-Tagatose 1,6-bisphosphate,D-Galactono-1,4-lactone,alpha-D-Glucose,D-Tagatose 6-phosphate,D-Fructose 6-phosphate,D-Galactono-1,5-lactone,myo-Inositol,N-Acetyl-D-galactosamine 6-phosphate,D-Galactosamine,D-Galactonate,2-Dehydro-3-deoxy-D-galactonate,Glycerol,Lactose 6'-phosphate,D-Sorbitol,alpha-D-Galactosyl-(1-&gt;3)-1D-myo-inositol >>>"}, {"role": "assistant", "content": "The experiment identified the Galactose metabolism pathway as being significantly altered based on the changes observed in multiple genes and compounds. The genes AKR1B10, LCT, MGAM2, HK3, GALT, SI, B4GALT1, GALE, and GALM are directly involved in this pathway. The alterations in these genes likely affected the metabolism of galactose, leading to changes in the levels of compounds such as D-Galactose, D-Galactono-1,4-lactone, D-Galactono-1,5-lactone, and D-Galactosamine. Additionally, the changes in compounds such as Lactose 6'-phosphate and alpha-D-Galactosyl-(1-&gt;3)-1D-myo-inositol further support the involvement of the Galactose metabolism pathway. The alterations in this pathway could be linked to the specific condition being studied."}], "target": "Galactose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALOX5,PTGR1,PLA2G4C,PTGES3,LTA4H,PLA2G3,PLA2G4F,CYP2C9,CYP4F3,AKR1C3,CBR1,PTGR2 >>>\nList of compounds : <<< Prostaglandin J2,11H-14,15-EETA,2,3-Dinor-8-iso prostaglandin F2alpha,8(S)-HETE,(5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate,15-Keto-prostaglandin F2alpha,5,6-DHET,Leukotriene F4,11,12-EET >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Arachidonic Acid Metabolism pathway. This pathway was selected based on the alterations observed in multiple genes and compounds associated with this metabolic process. The genes ALOX5, PTGR1, PLA2G4C, PTGES3, LTA4H, PLA2G3, PLA2G4F, CYP2C9, CYP4F3, AKR1C3, CBR1, and PTGR2 are all involved in the metabolism of arachidonic acid. Similarly, the identified compounds, such as Prostaglandin J2, 11H-14,15-EETA, 2,3-Dinor-8-iso prostaglandin F2alpha, 8(S)-HETE, (5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate, 15-Keto-prostaglandin F2alpha, 5,6-DHET, and Leukotriene F4, are known metabolites of arachidonic acid. Therefore, the changes observed in these genes and compounds suggest that the Arachidonic Acid Metabolism pathway is likely involved in the specific condition being studied."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AOC3,MAOB,ALDH3A1,DDC,PAH,GOT1,TAT,IL4I1,MAOA >>>\nList of compounds : <<< alpha-Oxo-benzeneacetic acid,Pyruvate,Phenylacetylglutamine,2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate,Phenethylamine,3-(2-Hydroxyphenyl)propanoate,3-Oxo-5,6-dehydrosuberyl-CoA,cis-3-(3-Carboxyethenyl)-3,5-cyclohexadiene-1,2-diol,3-Hydroxyphenylacetate,Fumarate,Acetyl-CoA,Acetaldehyde,3-(3-Hydroxyphenyl)propanoic acid,2-Hydroxyphenylacetate,Phenylacetaldehyde,D-Phenylalanine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Phenylalanine metabolism. This conclusion is supported by the altered genes and compounds observed. Several genes involved in this pathway were affected, including PAH (Phenylalanine hydroxylase), DDC (Dopa decarboxylase), AOC3 (Amine oxidase copper containing 3), MAOA and MAOB (Monoamine oxidase A and B), and ALDH3A1 (Aldehyde dehydrogenase 3 family member A1). These genes are known to play crucial roles in the metabolism of phenylalanine. Additionally, the altered compounds, such as D-Phenylalanine, Phenylacetaldehyde, 3-(3-Hydroxyphenyl)propanoic acid, and 3-Hydroxyphenylacetate, are intermediates or products of the phenylalanine metabolism pathway. Therefore, the changes in these genes and compounds suggest that the Phenylalanine metabolism pathway is significantly involved in the condition under study."}], "target": "Phenylalanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP7B1,CYP8B1,HSD17B4,AKR1D1,ACOX2,BAAT,CYP7A1,AKR1C4,SLC27A5,HSD3B7 >>>\nList of compounds : <<< 4-Cholesten-7alpha,12alpha-diol-3-one,7alpha-Hydroxy-5beta-cholestan-3-one,Chenodeoxycholoyl-CoA,Taurine,3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane,7alpha,27-Dihydroxycholesterol,Cerebrosterol,3beta,7alpha-Dihydroxy-5-cholestenoate,5beta-Cyprinolsulfate,Choloyl-CoA,Cholic acid,Cholic acid,3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate,(24S)-Cholest-5-ene-3beta,7alpha,24-triol,(25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA,(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA,(24E)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA,Glycocholate,3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is Primary bile acid biosynthesis. This pathway fits with the altered genes and compounds as many of the listed genes are directly involved in this pathway. Genes such as CYP7A1, CYP7B1, CYP8B1, ACOX2, HSD3B7, and HSD17B4 are known to play significant roles in the synthesis and metabolism of primary bile acids. Additionally, the altered compounds are intermediates and end products of this pathway, including Cholic acid, Chenodeoxycholoyl-CoA, and Glycocholate. These findings suggest that changes in the Primary bile acid biosynthesis pathway may be a significant factor in the condition being studied."}], "target": "Primary bile acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< CA8,CA13,CA1,CA5A,CA3,CA7,CA2,CA6,GLUD1,CA5B,CA9,CA4,CA14,GLUD2 >>>\nList of compounds : <<< Hydrazine,Nitrate,Hydroxylamine,Ammonia,Cyanate,Nitroalkane,Ammonia,Formamide,HCO3-,Ammonia,Nitrile,Nitrogen,Ammonia,Nitric oxide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Nitrogen metabolism. This is supported by the alterations in genes and compounds associated with this pathway. The genes listed, such as CA8, CA9, and GLUD1, are involved in carbonic anhydrase activity and glutamate dehydrogenase activity, respectively, both of which play crucial roles in nitrogen metabolism. The compounds, including Ammonia, Nitrate, Nitric oxide, and Nitrile, are key intermediates and end products in nitrogen metabolism. Therefore, the changes observed in these genes and compounds strongly suggest that the Nitrogen metabolism pathway is significantly affected in the given conditions."}], "target": "Nitrogen metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GCH1,GCLC,UGT2A1,ALDH2,SPR,ALAS1,GMPPA,UMPS,AK7,SHMT2,MOCS2,UGT1A8,NFS1,AK5,CPOX,LIPT1,ALAD,CTPS2,MMAB,NME4,PMM2 >>>\nList of compounds : <<< Reduced FMN,Tetrahydrobiopterin,7,8-Dihydroneopterin,D-Ribose 5-phosphate,2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate,D-Ribulose 5-phosphate,Cobalt-precorrin 5A,Heme O,L-Aspartate,Octanoyl-[acp] >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Biosynthesis of cofactors.\" This pathway was implicated due to the alterations in several genes and compounds associated with cofactor synthesis. The genes GCH1, GCLC, ALDH2, ALAS1, MOCS2, NFS1, and CPOX are involved in the production of cofactors such as tetrahydrobiopterin, reduced FMN, and heme O. Additionally, the compounds 7,8-Dihydroneopterin, D-Ribose 5-phosphate, D-Ribulose 5-phosphate, and Cobalt-precorrin 5A are intermediates in these biosynthetic pathways. The alterations in these genes and compounds suggest a disruption in the biosynthesis of cofactors, which could impact various metabolic processes in the cell."}], "target": "Biosynthesis of cofactors"}
{"messages": [{"role": "user", "content": "List of genes : <<< SELENOI,PCYT1A >>>\nList of compounds : <<< CMP-N-trimethyl-2-aminoethylphosphonate,N-Monomethyl-2-aminoethylphosphonate,CMP-2-aminoethylphosphonate,FR 900098 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in our experiment is the Phosphonate and phosphinate metabolism. This conclusion is based on the alterations observed in the genes SELENOI and PCYT1A, as well as in the compounds CMP-N-trimethyl-2-aminoethylphosphonate, N-Monomethyl-2-aminoethylphosphonate, CMP-2-aminoethylphosphonate, and FR 900098. These genes and compounds are directly involved in the synthesis and metabolism of phosphonate and phosphinate compounds, which are structurally similar to phosphate but resistant to enzymatic hydrolysis. The alterations in these genes and compounds suggest a disruption in the Phosphonate and phosphinate metabolism pathway, which could potentially be linked to the specific condition under investigation. Further research is needed to fully understand the implications of these findings."}], "target": "Phosphonate and phosphinate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DBT,GOT1L1,IDH1,GPT,DLAT,PDHB,ACO2,GPT2,IDH3A,IDH3B,DLD,DHTKD1,IDH2,PDHA2,DLST,ACO1,AADAT,GOT1,ACY1,BCAT1,OGDHL,ABHD14A-ACY1,OGDH,AGXT,AGXT2 >>>\nList of compounds : <<< cis-(Homo)3-aconitate,S-(4-Methylthiobutylthiohydroximoyl)-L-cysteine,Indolylmethylthiohydroximate,Glutaryl-CoA,Hexahomomethionine,(S)-2-Aceto-2-hydroxybutanoate,2-Oxo-10-methylthiodecanoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the 2-Oxocarboxylic acid metabolism. This pathway was chosen due to the significant alterations observed in several genes and compounds directly involved in this metabolic process. Genes such as DBT, DLAT, DLD, DLST, and OGDH, which are critical enzymes in the 2-Oxocarboxylic acid metabolism, were found to be altered. Similarly, the identified compounds, including cis-(Homo)3-aconitate, Glutaryl-CoA, and (S)-2-Aceto-2-hydroxybutanoate, are key intermediates in this pathway. Therefore, the changes in these genes and compounds strongly suggest that the 2-Oxocarboxylic acid metabolism pathway is implicated in the condition under investigation."}], "target": "2-Oxocarboxylic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP2A7,UGT2B15,CYP26A1,UGT1A8,UGT1A9,UGT1A5,RDH11,UGT1A3,DHRS4,CYP2W1,ADH1A,UGT2B7,AWAT2,DHRS9,CYP26C1,ADH6,PNPLA4,ADH5,CYP3A4,CYP3A7,ADH7,UGT1A10,UGT2A2 >>>\nList of compounds : <<< 4-Oxoretinol,11-cis-Retinyl palmitate,all-trans-4-Oxoretinoic acid,beta-Carotene,Rhodopsin,all-trans-13,14-Dihydroretinol,Retinyl palmitate,11-cis-Retinol,all-trans-4-Hydroxyretinoic acid,Metarhodopsin,Iodopsin >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Retinol metabolism pathway. This conclusion is supported by the alterations observed in multiple genes and compounds associated with this pathway. Genes such as CYP26A1, CYP26C1, and CYP3A4, which are involved in the oxidation of retinol to retinoic acid, were altered. Similarly, genes like UGT1A10 and UGT2B7, which are responsible for the glucuronidation of retinoids, were also affected. The list of compounds includes various forms of retinol and its derivatives, such as Retinyl palmitate, 4-Oxoretinol, and all-trans-4-Hydroxyretinoic acid, further strengthening the association with the Retinol metabolism pathway. Therefore, the observed changes in gene expression and compound levels suggest that the Retinol metabolism pathway is significantly impacted in the given conditions."}], "target": "Retinol metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADH4,PKM,GLO1,DLAT,ACAT2,ME1,LDHA >>>\nList of compounds : <<< (R)-2-Hydroxybutane-1,2,4-tricarboxylate,Acetyl phosphate,(R)-2-Ethylmalate,2-(alpha-Hydroxyethyl)thiamine diphosphate,(S)-Lactate,Succinate,2-Propylmalate,Acetoacetyl-CoA,(S)-Malate,Phosphoenolpyruvate,Enzyme N6-(lipoyl)lysine,Methylglyoxal,Acetylenedicarboxylate,Acetaldehyde,Malonyl-CoA,alpha-Isopropylmalate,Thiamin diphosphate >>>"}, {"role": "assistant", "content": "The analysis of the altered genes and compounds indicates that the Pyruvate metabolism pathway is significantly involved in the condition. The genes ADH4, PKM, LDHA, and DLAT are directly associated with this pathway. ADH4 and LDHA are involved in the conversion of alcohol and lactate to acetaldehyde and pyruvate, respectively. PKM is a key enzyme in the final step of glycolysis, which produces pyruvate. DLAT is a component of the pyruvate dehydrogenase complex, which converts pyruvate to acetyl-CoA. The altered compounds, such as acetyl phosphate, acetaldehyde, lactate, and succinate, are also intermediates or products of the Pyruvate metabolism pathway. Additionally, the presence of compounds like 2-(alpha-Hydroxyethyl)thiamine diphosphate (a derivative of Thiamin diphosphate, a cofactor for pyruvate decarboxylase) and N6-(lipoyl)lysine (a component of the pyruvate dehydrogenase complex) further supports the involvement of this pathway."}], "target": "Pyruvate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OXSM,ACSL5,MECR,ACSL3,ACSL6,ACACB >>>\nList of compounds : <<< (3R)-3-Hydroxypalmitoyl-[acyl-carrier protein],Malonyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is fatty acid biosynthesis. This is supported by the alterations in genes and compounds associated with this pathway. The genes OXSM, ACSL5, MECR, ACSL3, ACSL6, and ACACB are all involved in fatty acid synthesis or metabolism. OXSM and MECR are involved in the final steps of fatty acid elongation, ACSL5, ACSL3, and ACSL6 are long-chain fatty acid-CoA ligases that activate fatty acids for beta-oxidation or synthesis, and ACACB is the beta-subunit of acetyl-CoA carboxylase, a key enzyme in fatty acid biosynthesis. The compounds (3R)-3-Hydroxypalmitoyl-[acyl-carrier protein] and Malonyl-CoA are also directly involved in fatty acid biosynthesis, with the former being an intermediate in the elongation process and the latter being the initial substrate for the pathway. Therefore, the observed alterations in these genes and compounds suggest that fatty acid biosynthesis is affected in the studied condition."}], "target": "Fatty acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH3B1,HAL,CARNMT1,ALDH3A1,HDC,ALDH7A1,CNDP1,AMDHD1,ALDH9A1,FTCD,CNDP2,MAOA,ALDH2,CARNS1,ALDH1B1,AOC1 >>>\nList of compounds : <<< Imidazole-4-acetate,L-Histidinol phosphate,N-Carbamyl-L-glutamate,Imidazole lactate,Thiourocanic acid,1-(5-Phosphoribosyl)imidazole-4-acetate,4-Imidazolone-5-propanoate,Imidazole-4-acetaldehyde,4-(beta-Acetylaminoethyl)imidazole,N-Formimino-L-aspartate,N-Formyl-L-glutamate,4-Oxoglutaramate,N-Methylhistamine,L-Histidinol,L-Aspartate,Hydantoin-5-propionate,beta-Alanyl-N(pi)-methyl-L-histidine,N-(5'-Phospho-D-1'-ribulosylformimino)-5-amino-1-(5''-phospho-D-ribosyl)-4-imidazolecarboxamide,1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, the metabolic pathway identified as significantly altered is Histidine metabolism. This conclusion aligns with the observed alterations in several genes and compounds associated with this pathway. Genes such as HAL, HDC, and MAOA, which are involved in the degradation of histidine, and ALDH2, ALDH3A1, and ALDH3B1, which are involved in the oxidation of histidine-derived aldehydes, were found to be altered. Similarly, the altered compounds, including Imidazole-4-acetate, L-Histidinol phosphate, N-Formyl-L-glutamate, and N-Methylhistamine, are intermediates or products of the Histidine metabolism pathway. These findings suggest that the observed condition may be linked to disruptions in Histidine metabolism."}], "target": "Histidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< INPPL1,MINPP1,PLCD3,PIP5K1B,MTMR14,PIK3C3,IPPK,PIK3CA,PIP4K2A,ITPKC,INPP5D,OCRL,PLCG1,IPMK,PI4K2A,PIP4K2B,MTMR2,INPP5B,PLCB2 >>>\nList of compounds : <<< D-Glyceraldehyde 3-phosphate,D-Tagaturonate,Acetyl-CoA,D-Glucose 6-phosphate,1D-myo-Inositol 1,4,5,6-tetrakisphosphate,5-Dehydro-L-gluconate,L-Bornesitol,1D-myo-Inositol 1,4-bisphosphate,1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate,5-Deoxy-D-glucuronate,D-myo-Inositol 1,2,4,5,6-pentakisphosphate,scyllo-Inositol,1-Phosphatidyl-1D-myo-inositol 3-phosphate,1D-myo-Inositol 1,3,4,6-tetrakisphosphate,1D-myo-Inositol 1,3,4-trisphosphate,Phosphatidylinositol-3,4,5-trisphosphate,2,4,6/3,5-Pentahydroxycyclohexanone,Glycerone phosphate,1D-myo-Inositol 3,4,5,6-tetrakisphosphate,1-Phosphatidyl-1D-myo-inositol 5-phosphate,D-Bornesitol,1-Phosphatidyl-1D-myo-inositol 4-phosphate,1-Keto-D-chiro-inositol,Phytic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the given genes and compounds is the Inositol Phosphate Metabolism pathway. This pathway is significantly involved in intracellular signaling, particularly in the regulation of calcium release and lipid metabolism. The identification of this pathway is supported by the presence of numerous genes associated with inositol phosphate metabolism in the list provided, such as INPP1, MINPP1, MTMR14, PIK3C3, PIK3CA, and INPP5D, among others. These genes encode enzymes responsible for the synthesis, dephosphorylation, and phosphorylation of inositol phosphates. Furthermore, the altered compounds, including various forms of inositol phosphates and phosphatidylinositols, are key intermediates in this pathway. Therefore, the changes observed in these genes and compounds suggest that the Inositol Phosphate Metabolism pathway plays a critical role in the specific condition being investigated."}], "target": "Inositol phosphate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< VKORC1,COQ5,HPD,COQ2,COQ3,COQ6,COQ7 >>>\nList of compounds : <<< Dihydroshikonofuran,4-Coumarate,gamma-Tocopherol,Geranylhydroquinone,Phytyl diphosphate,2-Methoxy-6-all-trans-polyprenyl-1,4-benzoquinol,Phytyl diphosphate,1,4-Dihydroxy-2-naphthoyl-CoA,6-Amino-6-deoxyfutalosine,2-Polyprenyl-6-methoxyphenol,6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol,Demethylmenaquinol,3,4-Dihydroxy-5-polyprenylbenzoate,(R)-3-(4-Hydroxyphenyl)lactate,Demethylphylloquinol,Chorismate,Isochorismate,all-trans-Nonaprenyl diphosphate,Menaquinone,Vitamin K1 epoxide,alpha-Tocopherol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the given list of genes and compounds is the Ubiquinone and other terpenoid-quinone biosynthesis pathway. This pathway was primarily identified due to the significant alteration of multiple COQ genes (COQ2, COQ3, COQ5, COQ6, COQ7), which are directly involved in the biosynthesis of ubiquinone (coenzyme Q). The alteration of these genes led to changes in the levels of several intermediates and end products in this pathway, such as Geranylhydroquinone, Demethylmenaquinol, Demethylphylloquinol, and Menaquinone. Additionally, the presence of compounds like Phytyl diphosphate and all-trans-Nonaprenyl diphosphate, which are precursors in this pathway, further supports this identification. The alteration of VKORC1, involved in vitamin K epoxide reduction, also suggests a possible link to this pathway, as vitamin K is structurally similar to ubiquinone."}], "target": "Ubiquinone and other terpenoid-quinone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B28,MGST1,ADH1B,UGT1A1,EPHX1,CBR3,GSTK1,UGT1A8,CYP3A5,ADH1C,UGT1A9,UGT2A1,CYP2D6,AKR7L,GSTO1,UGT1A3,AKR7A2,MGST3,GSTP1,UGT1A4,SULT2A1,CYP2A13,UGT1A7,ALDH3B2 >>>\nList of compounds : <<< Aflatoxin-M1-8,9-epoxide,Aflatoxin B1 diol,Aflatoxin B1-endo-8,9-epoxide,Benzo[a]pyrene-9,10-oxide,1-Nitrosonaphthalene,6-[2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,2-dihydro-7-hydroxy-9-methoxy-cyclopenta[c][1]benzopyran-3,4-dione,Chloroacetic acid,(1R)-Hydroxy-(2R)-N-acetyl-L-cysteinyl-1,2-dihydronaphthalene,1,2-Dihydronaphthalene-1,2-diol,Dichloroacetyl chloride,Aflatoxin B1 dialdehyde,Bromobenzene-3,4-dihydrodiol,alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde,Benzo[a]pyrene,Dichloroacetate,1,4-Naphthoquinone >>>"}, {"role": "assistant", "content": "The experiment identified the metabolic pathway of \"Metabolism of xenobiotics by cytochrome P450\" as a key player in the condition. This pathway was inferred based on the altered genes and compounds. The genes UGT2B28, MGST1, ADH1B, UGT1A1, EPHX1, CBR3, GSTK1, UGT1A8, CYP3A5, ADH1C, UGT1A9, UGT2A1, CYP2D6, AKR7L, GSTO1, UGT1A3, AKR7A2, MGST3, GSTP1, UGT1A4, SULT2A1, CYP2A13, and UGT1A7 are all involved in the metabolism of xenobiotics, which supports this finding. The compounds, such as Aflatoxin B1 diol, Benzo[a]pyrene-9,10-oxide, and Dichloroacetate, are known substrates or products of cytochrome P450 enzymes, further suggesting the involvement of this pathway. Thus, the changes in these genes and compounds suggest that the \"Metabolism of xenobiotics by cytochrome P450\" pathway is significantly altered in the given condition."}], "target": "Metabolism of xenobiotics by cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< HOGA1,HAO2,HYI,AMT,MDH2,CS,ACSS1,PGP,HAO1,MMUT,GRHPR,SHMT2,AGXT,DLD,CAT,GLDC,GCSH >>>\nList of compounds : <<< Acetyl-CoA,(S)-Malate,Crotonoyl-CoA,Acetoacetyl-CoA,Formyl-CoA,L-erythro-3-Methylmalyl-CoA,Glycolate,(2S)-Methylsuccinyl-CoA,Oxygen,D-Ribulose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glyoxylate and dicarboxylate metabolism. This pathway was implicated due to the alterations observed in several genes and compounds associated with it. The genes HOGA1, HAO2, HAO1, MMUT, AGXT, DLD, and CAT are directly involved in this pathway, which involves the conversion of isocitrate to succinate, bypassing the citrate synthase (CS) and alpha-ketoglutarate dehydrogenase reactions of the citric acid cycle. The altered compounds, such as Acetyl-CoA, (S)-Malate, Formyl-CoA, and D-Ribulose 1-phosphate, are intermediates or substrates in this pathway, further supporting its involvement. The Glyoxylate and dicarboxylate metabolism is particularly active in conditions where carbohydrates are scarce and lipids are the primary source of carbon, which may be the case in the specific conditions compared in this experiment."}], "target": "Glyoxylate and dicarboxylate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PRXL2B,PLA2G4C,PLA2G4E,PLA2G4D,CYP2C19,CBR1 >>>\nList of compounds : <<< 5,6-DHET,12-Keto-leukotriene B4,Hepoxilin A3,12-OxoETE,20-HETE,Leukotriene B4,9(S)-HETE,Hepoxilin B3,12(S)-HPETE,12(R)-HETE,Lipoxin A4,Prostaglandin F2alpha,14,15-EET,14,15-DHET,15-Deoxy-Delta12,14-PGJ2,8,9-EET,19(S)-HETE,(5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate,8(S)-HPETE,Arachidonate,Prostaglandin H2,Prostaglandin A2,11,14,15-THETA,(5Z,13E)-6,9alpha-Epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate,Thromboxane A2 >>>"}, {"role": "assistant", "content": "The analysis of the provided data suggests that the altered genes and compounds are associated with the Arachidonic acid metabolism pathway. This pathway is involved in the conversion of arachidonic acid into various eicosanoids, which are signaling molecules involved in inflammation, immune response, and other physiological processes. The genes PRXL2B, PLA2G4C, PLA2G4E, PLA2G4D, and CYP2C19 are all involved in the metabolism of arachidonic acid, and their alterations would likely affect the production and balance of eicosanoids. The altered compounds, such as Leukotriene B4, Prostaglandin F2alpha, Thromboxane A2, and various hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs), are all products of arachidonic acid metabolism, further supporting the involvement of this pathway in the observed condition."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP7A1,CYP1A1,SRD5A2,HSD11B1L,COMT,UGT2B7,CYP17A1,HSD11B2 >>>\nList of compounds : <<< 5alpha-Dihydrodeoxycorticosterone,19-Oxotestosterone,Testosterone glucuronide,19-Hydroxyandrost-4-ene-3,17-dione,11alpha-Hydroxyprogesterone >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Steroid Hormone Biosynthesis pathway. This pathway was implicated due to the alterations in genes such as CYP7A1, CYP1A1, SRD5A2, HSD11B1L, COMT, UGT2B7, CYP17A1, and HSD11B2, which are all known to be involved in the synthesis and metabolism of steroid hormones. Furthermore, the altered compounds - 5alpha-Dihydrodeoxycorticosterone, 19-Oxotestosterone, Testosterone glucuronide, 19-Hydroxyandrost-4-ene-3,17-dione, and 11alpha-Hydroxyprogesterone - are intermediates or end products of this pathway. Therefore, the changes in these genes and compounds suggest that the Steroid Hormone Biosynthesis pathway is likely to be involved in the observed condition."}], "target": "Steroid hormone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< CPS1,GLS2,ARG1,ABHD14A-ACY1,GPT,NOS2,GLS,GLUL,CAD,NAGS,GOT1L1,ASL,ACY1,GLUD2,NOS3 >>>\nList of compounds : <<< L-Citrulline,N-Acetyl-L-glutamate 5-phosphate,Ammonia,LysW-L-glutamate,L-Glutamine,L-Ornithine,N-Acetyl-L-glutamate,L-Aspartate,L-Glutamate,LysW-L-glutamyl 5-phosphate,N-Acetyl-L-glutamate 5-semialdehyde,2-Oxoglutarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Arginine biosynthesis. This pathway involves the conversion of L-glutamine to L-arginine, and several genes and compounds in the list indicate alterations in this process. For instance, the genes CPS1, GLS2, ARG1, ASL, and GLUD2 are directly involved in arginine biosynthesis. The presence of altered levels of L-glutamine, L-glutamate, L-ornithine, and L-citrulline also supports this finding, as these compounds are key intermediates in this pathway. Additionally, the involvement of NOS2 and NOS3, which produce nitric oxide from L-arginine, further emphasizes the role of arginine metabolism in the observed condition."}], "target": "Arginine biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< AOC3,PSPH,GLDC,PHGDH,ALDH7A1,GAMT,MAOA,BPGM,PGAM1,SRR,AMT,SARDH,AGXT2,ALAS1,BHMT,CBS,GATM,GCAT,PSAT1,GCSH,GLYCTK >>>\nList of compounds : <<< L-Allothreonine,L-Aspartate,3-Phospho-D-glycerate,L-Aspartate 4-semialdehyde,L-Cysteine,1,3-Diaminopropane,L-Cystathionine,Choline,D-Serine,5-Aminolevulinate,Glycine,D-Glycerate,2-Phospho-D-glycerate,Pyruvate,2-Oxobutanoate,3-Phosphonooxypyruvate,Aminoacetone,O-Phospho-L-serine,L-Threonine,Sarcosine,L-Serine,L-Homoserine,Betaine,5,10-Methylenetetrahydrofolate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycine, Serine and Threonine metabolism. This is supported by the alterations in genes such as AOC3, PSPH, GLDC, PHGDH, and GAMT, which are directly involved in this pathway. AOC3 and PSPH are involved in the synthesis of serine from 3-phosphoglycerate, while GLDC and PHGDH are involved in the conversion of serine to glycine. GAMT is involved in the catabolism of glycine. The altered compounds, including L-Serine, L-Threonine, L-Aspartate 4-semialdehyde, 3-Phospho-D-glycerate, and 2-Phospho-D-glycerate, are intermediates in this pathway, further supporting this identification. Therefore, the data suggest that the Glycine, Serine and Threonine metabolism pathway is significantly altered in the experimental condition."}], "target": "Glycine, serine and threonine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP7B1,AKR1C4,SCP2,CYP39A1,ACOX2,SLC27A5,AKR1D1,CYP8B1,CH25H,CYP46A1,CYP7A1,BAAT,CYP27A1,AMACR,HSD3B7 >>>\nList of compounds : <<< 3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane,7alpha-Hydroxycholest-4-en-3-one,Chenodeoxycholoyl-CoA,(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Primary bile acid biosynthesis. This is supported by the alterations in genes and compounds associated with this pathway. The genes CYP7A1, CYP7B1, CYP8B1, CYP27A1, and CYP39A1 are involved in the synthesis of primary bile acids from cholesterol. The gene ACOX2 is involved in peroxisomal beta-oxidation, which provides the substrate for bile acid synthesis. The gene BAAT encodes bile acid-CoA:amino acid N-acyltransferase, an enzyme involved in the conjugation of bile acids with amino acids. The compounds 3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane, 7alpha-Hydroxycholest-4-en-3-one, and (25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA are intermediates in the primary bile acid biosynthesis pathway. Therefore, the alteration of these genes and compounds strongly suggests that the primary bile acid biosynthesis pathway is involved in the condition being studied."}], "target": "Primary bile acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< HS6ST3,EXTL2,XYLT2,NDST1,B3GAT3,HS3ST5,EXTL3,B3GALT6,HS3ST3B1,XYLT1,NDST3,GLCE,HS6ST1,EXTL1,NDST4,HS6ST2,HS3ST1,HS3ST3A1,HS3ST2,HS2ST1,NDST2,EXT2,EXT1,B4GALT7 >>>\nList of compounds : <<< Adenosine 3',5'-bisphosphate,3'-Phosphoadenylyl sulfate,[Protein]-L-serine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Glycosaminoglycan biosynthesis - heparan sulfate / heparin. This pathway was inferred based on the alterations observed in the genes and compounds associated with it. The genes listed, including HS6ST3, EXTL2, XYLT2, NDST1, B3GAT3, HS3ST5, and others, are all known to encode enzymes involved in the biosynthesis of heparan sulfate and heparin. These enzymes are responsible for various modifications of the heparan sulfate/heparin chain, such as sulfation, epimerization, and addition of sugar residues. The alterations in these genes would therefore affect the structure and function of heparan sulfate/heparin. The presence of compounds such as Adenosine 3',5'-bisphosphate, 3'-Phosphoadenylyl sulfate, and [Protein]-L-serine, which are intermediates in this pathway, further supports the involvement of this pathway in the observed condition."}], "target": "Glycosaminoglycan biosynthesis - heparan sulfate / heparin"}
{"messages": [{"role": "user", "content": "List of genes : <<< MTHFS,ALDH1L1 >>>\nList of compounds : <<< 5-Formiminotetrahydrofolate,5,10-Methylenetetrahydrofolate,Folate,Dihydrofolate,5-Methyltetrahydrofolate >>>"}, {"role": "assistant", "content": "The one carbon pool by folate pathway was identified as the metabolic pathway of interest in this experiment, based on the alterations observed in the genes and compounds. The genes MTHFS and ALDH1L1, which are involved in this pathway, were found to be affected. MTHFS encodes an enzyme that catalyzes the conversion of 5-formiminotetrahydrofolate to 5,10-methylenetetrahydrofolate, while ALDH1L1 encodes an enzyme that converts 10-formyltetrahydrofolate to tetrahydrofolate. The altered compounds, including 5-formiminotetrahydrofolate, 5,10-methylenetetrahydrofolate, folate, dihydrofolate, and 5-methyltetrahydrofolate, are all intermediates or cofactors in this pathway. Therefore, the changes in these genes and compounds suggest that the one carbon pool by folate pathway is disrupted in the condition being studied."}], "target": "One carbon pool by folate"}
{"messages": [{"role": "user", "content": "List of genes : <<< LDHC,SUCLG1 >>>\nList of compounds : <<< Enzyme N6-(dihydrolipoyl)lysine,Enzyme N6-(S-propyldihydrolipoyl)lysine,Acetyl-CoA,Succinate,Propanal,Propane-1-ol,Methylmalonate,Glycerone phosphate,(Z)-But-2-ene-1,2,3-tricarboxylate,Enzyme N6-(lipoyl)lysine,3-Oxopropionyl-CoA,Propanoyl-CoA,(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate,Propynoate,beta-Alanyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Propanoate metabolism. This pathway was inferred based on the altered genes and compounds observed. The genes LDHC and SUCLG1 are involved in this pathway. LDHC encodes for L-2-hydroxyglutarate dehydrogenase, an enzyme that participates in propanoate metabolism, while SUCLG1 is involved in succinate metabolism, which is closely linked to the propanoate pathway. The presence of compounds such as Acetyl-CoA, Succinate, Propanoate, and Propionyl-CoA, which are key intermediates in the propanoate metabolism, further supports this identification. The alteration of enzymes N6-(dihydrolipoyl)lysine, N6-(S-propyldihydrolipoyl)lysine, and N6-(lipoyl)lysine, which are associated with the propanoate metabolism, also strengthens this conclusion. Therefore, it is likely that the Propanoate metabolism pathway is significantly affected in the given condition."}], "target": "Propanoate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SRD5A1,SULT1E1,SULT2B1,LRTOMT >>>\nList of compounds : <<< 2-Hydroxyestradiol,Adrenosterone,11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al,Tetrahydrocortisone,11beta-Hydroxyandrost-4-ene-3,17-dione,Androstenedione,17alpha-Hydroxyprogesterone,Estradiol-17alpha,5alpha-Pregnan-20alpha-ol-3-one,Dehydroepiandrosterone sulfate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Steroid Hormone Biosynthesis. This pathway fits with the altered genes and compounds as follows: The genes SRD5A1, LRTOMT, and SULT1E1, SULT2B1 are involved in the synthesis and metabolism of steroid hormones. SRD5A1 encodes an enzyme that converts testosterone to dihydrotestosterone, LRTOMT is involved in the biosynthesis of cholesterol, a precursor to steroid hormones, and SULT1E1 and SULT2B1 are sulfotransferases that metabolize steroid hormones. The altered compounds include various intermediates and end-products of the steroid hormone biosynthesis pathway, such as 2-Hydroxyestradiol, Adrenosterone, Androstenedione, and Dehydroepiandrosterone sulfate. The changes in these genes and compounds strongly suggest that the Steroid Hormone Biosynthesis pathway is involved in the specific condition being studied."}], "target": "Steroid hormone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< HEXA,GBGT1,ST3GAL2,FUT9,NAGA,ST8SIA1,FUT1,HEXB,GLA >>>\nList of compounds : <<< V3(NeuAc)2-Gb5Cer,Forssman antigen, IV3GalNAca-Gb4Cer,Globo-B,Lactosylceramide,NOR2 antigen,Disialosylglobopentaosylceramide,Galactosylgloboside,Globoside,Globo-A,GalGb3Cer,IV4-alpha-Gal-Gb4Cer,iGb3-Cer,IV3GalNAcb-Gb4Cer,Monosialylgalactosylgloboside >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosphingolipid biosynthesis - globo and isoglobo series. This pathway was implicated due to the significant alterations in genes such as HEXA, GBGT1, ST3GAL2, FUT9, NAGA, ST8SIA1, FUT1, HEXB, and GLA, which are known to be involved in the synthesis of glycosphingolipids. The changes in these genes correspond to the observed alterations in various glycosphingolipid compounds, including V3(NeuAc)2-Gb5Cer, Forssman antigen, IV3GalNAca-Gb4Cer, Globo-B, Lactosylceramide, NOR2 antigen, Disialosylglobopentaosylceramide, Galactosylgloboside, Globoside, Globo-A, GalGb3Cer, IV4-alpha-Gal-Gb4Cer, iGb3-Cer, IV3GalNAcb-Gb4Cer, and Monosialylgalactosylgloboside. These findings suggest that the Glycosphingolipid biosynthesis - globo and isoglobo series pathway is significantly affected in the given condition."}], "target": "Glycosphingolipid biosynthesis - globo and isoglobo series"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT1L1,GOT1,PAH,TAT >>>\nList of compounds : <<< L-Tyrosine,3-Hydroxybenzoate,1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,Anthranilate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Phenylalanine, tyrosine and tryptophan biosynthesis\" pathway. This conclusion is supported by the alterations observed in the genes and compounds. The gene GOT1 encodes a cytosolic aspartate aminotransferase, which is involved in the biosynthesis of aromatic amino acids, including phenylalanine and tyrosine. The gene PAH encodes phenylalanine hydroxylase, an enzyme that converts phenylalanine to tyrosine. The gene TAT encodes tyrosine aminotransferase, which catalyzes the conversion of tyrosine to 4-hydroxyphenylpyruvate. The altered compounds, L-Tyrosine, 3-Hydroxybenzoate, 1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate, and Anthranilate, are all intermediates or products of this pathway, further supporting the identification of this metabolic pathway."}], "target": "Phenylalanine, tyrosine and tryptophan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< GFUS,GMPPB,GFPT1,GNPNAT1,MPI,GALE >>>\nList of compounds : <<< GDP-beta-L-colitose,D-Fructose 6-phosphate,alpha-D-Galactose 1-phosphate,N-Acetyl-D-glucosamine,UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose,N-Acetyl-alpha-D-galactosamine 1-phosphate,dTDP-L-oleandrose,UDP-4-dehydro-6-deoxy-D-glucose,dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose,dTDP-4-oxo-2,6-dideoxy-L-mannose,dTDP-4-oxo-6-deoxy-D-glucose,UDP-2-acetamido-2,6-dideoxy-beta-L-glucose,dTDP-3-dehydro-6-deoxy-alpha-D-galactopyranose >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of nucleotide sugars. This pathway involves the conversion of simple sugars into nucleotide-activated sugars, which are crucial for the biosynthesis of glycoconjugates such as glycoproteins and glycolipids. The altered genes GFUS, GMPPB, GFPT1, GNPNAT1, MPI, and GALE are all involved in this pathway. GFUS and GMPPB are involved in the synthesis of GDP-mannose, a key nucleotide sugar, while GFPT1, MPI, and GALE are involved in the synthesis of UDP-glucose and UDP-Galactose, precursors for other nucleotide sugars. The altered compounds, including D-Fructose 6-phosphate, N-Acetyl-D-glucosamine, and various nucleotide sugars, further support this pathway's involvement. The changes in these genes and compounds suggest that the Biosynthesis of nucleotide sugars pathway is critical for the condition under investigation."}], "target": "Biosynthesis of nucleotide sugars"}
{"messages": [{"role": "user", "content": "List of genes : <<< TST,,PHGDH,GOT1,MTAP,LDHC,CBS,LACC1,BHMT,MAT1A,ENOPH1,DNMT1,LDHAL6B,SDS,GOT1L1 >>>\nList of compounds : <<< 2-Oxobutanoate,(S)-2-Aminobutanoate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Cysteine and Methionine metabolism. This conclusion is supported by the alterations observed in several genes and compounds associated with this pathway. The gene PHGDH, which encodes an enzyme involved in serine biosynthesis, a precursor for cysteine synthesis, was found to be altered. Additionally, the genes CBS and BHMT, which are involved in the transsulfuration pathway and methionine cycle respectively, both crucial components of cysteine and methionine metabolism, were also altered. The altered compounds, 2-Oxobutanoate and (S)-2-Aminobutanoate, are intermediates in these pathways, further supporting the identification of the Cysteine and Methionine metabolism as the affected pathway."}], "target": "Cysteine and methionine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACSBG2,ACSL4,CPT2,CPT1B,ACAT2,ACADM,HADH,ALDH1B1,ADH4,ADH1A >>>\nList of compounds : <<< cis,cis-3,6-Dodecadienoyl-CoA,Glutarate,(S)-3-Hydroxytetradecanoyl-CoA,alpha-Hydroxy fatty acid,Alkane,trans-Oct-2-enoyl-CoA,Long-chain acyl-[acyl-carrier protein],Acyl-carrier protein,Butanoyl-CoA,trans-Hexadec-2-enoyl-CoA,Aldehyde,Hexadecanal,trans-Hex-2-enoyl-CoA,Octanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Fatty Acid Degradation. This conclusion is supported by the altered genes and compounds. The genes ACSL4, CPT2, CPT1B, ACADM, HADH, ALDH1B1, ADH4, and ADH1A are all directly involved in this pathway. ACSL4 activates long-chain fatty acids, while CPT2 and CPT1B are involved in the transport of fatty acids into the mitochondria for degradation. ACADM, HADH, ALDH1B1, ADH4, and ADH1A are all enzymes that catalyze steps in the beta-oxidation process, a key part of fatty acid degradation. The altered compounds, including various acyl-CoA intermediates, alkane, and hexadecanal, are also indicative of changes in this pathway. For instance, the presence of cis,cis-3,6-Dodecadienoyl-CoA and trans-Hexadec-2-enoyl-CoA suggests the degradation of unsaturated fatty acids. Therefore, the data strongly suggest that the Fatty Acid Degradation pathway is affected in the given condition."}], "target": "Fatty acid degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< CHST11,CHST13,CHPF,B4GALT7,CHPF2,CHST7,B3GAT3,UST,XYLT1,CHST14,DSE,DSEL,CSGALNACT2,CHST12,CHST15,B3GALT6,CSGALNACT1,CHSY1 >>>\nList of compounds : <<< 3'-Phosphoadenylyl sulfate,Adenosine 3',5'-bisphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate. This pathway was inferred based on the alterations in genes and compounds. The genes listed, such as CHST11, CHST13, CHPF, B4GALT7, CHPF2, CHST7, B3GALT3, UST, XYLT1, CHST14, DSE, DSEL, CSGALNACT2, CHST12, CHST15, B3GALT6, CSGALNACT1, and CHSY1, are all known to be involved in the biosynthesis of chondroitin sulfate and dermatan sulfate. The two compounds, 3'-Phosphoadenylyl sulfate and Adenosine 3',5'-bisphosphate, are key intermediates in this pathway. Therefore, the changes in these genes and compounds suggest that the Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate pathway is significantly affected in the specific condition under investigation."}], "target": "Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"}
{"messages": [{"role": "user", "content": "List of genes : <<< FASN,CBR4,OLAH,ACSL3,ACSL1,MECR,OXSM,ACACA,HSD17B8 >>>\nList of compounds : <<< Acetoacetyl-[acp],Malonyl-CoA,cis-Dec-3-enoyl-[acp],(3R)-3-Hydroxyhexanoyl-[acyl-carrier protein],Acetoacetyl-[acp],3-Oxoacyl-[acyl-carrier protein],Decanoic acid,Hexadecanoyl-[acp],Acetyl-CoA,Octanoyl-[acp],Malonate,Dodecanoyl-[acyl-carrier protein],Acetyl-[acyl-carrier protein],(3R)-3-Hydroxypalmitoyl-[acyl-carrier protein],Acetyl-CoA,(9Z)-Octadecenoic acid,Acetyl-CoA,Tetradecanoyl-[acp],Malonyl-CoA,Octanoic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is fatty acid biosynthesis. This conclusion is supported by the alterations observed in the genes and compounds associated with this pathway. The genes FASN, ACSL1, ACSL3, MECR, OXSM, and ACACA are all involved in fatty acid synthesis and elongation. The compounds identified, such as Acetoacetyl-[acp], Malonyl-CoA, and various acyl-carrier proteins, are key intermediates in this pathway. Furthermore, the presence of compounds like Decanoic acid, Octanoic acid, and (9Z)-Octadecenoic acid suggest the production of various fatty acids. Therefore, the data strongly indicates that the fatty acid biosynthesis pathway is significantly impacted in the condition under study."}], "target": "Fatty acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< KMT2E,SETD1B,EHMT2,EHHADH,ALDH1B1,SMYD3,PHYKPL,SMYD2,NSD3,SETD2,PRDM7,KMT2B,PLOD1,SETDB1,KMT2C,CAMKMT,SMYD1,KMT5C,GCDH,MECOM,ACAT2 >>>\nList of compounds : <<< (2R,5S)-2,5-Diaminohexanoate,5-Acetamidopentanoate,L-Hydroxylysine,L-2-Aminoadipate,Procollagen 5-hydroxy-L-lysine,Butanoyl-CoA,2-Oxoadipate,Crotonoyl-CoA,(3S,5S)-3,5-Diaminohexanoate,Delta1-Piperideine-2-carboxylate,D-Lysopine,Glutarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Lysine degradation pathway. This is supported by the alterations in several genes and compounds associated with this pathway. The genes EHHADH, ALDH1B1, and GCDH are involved in the degradation of lysine and its intermediates. The compound 2-Oxoadipate is a key intermediate in lysine degradation, while Butanoyl-CoA and Crotonoyl-CoA are involved in the subsequent steps of this pathway. The presence of (2R,5S)-2,5-Diaminohexanoate, 5-Acetamidopentanoate, L-Hydroxylysine, L-2-Aminoadipate, Procollagen 5-hydroxy-L-lysine, Delta1-Piperideine-2-carboxylate, D-Lysopine, and Glutarate further strengthens the evidence for the involvement of the lysine degradation pathway. These compounds are either direct intermediates or derivatives of lysine, indicating an altered flux through this pathway."}], "target": "Lysine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDHA1,GOT1L1,GOT1,IDH1,ABHD14A-ACY1,NAGS,ACO1,GOT2,BCAT2,DLST,OGDH,ACY1,ACO2,DLAT,AGXT >>>\nList of compounds : <<< cis-(Homo)2-aconitate,4-Methylthio-2-oxobutanoic acid,Glucobrassicin,N-Acetylornithine,(S)-2-Aceto-2-hydroxybutanoate,LysW-L-glutamyl 5-phosphate,cis-Aconitate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the 2-Oxocarboxylic acid metabolism. This pathway involves the breakdown and conversion of 2-oxocarboxylic acids, also known as alpha-keto acids. The altered genes, including PDHA1, GOT1, GOT2, IDH1, DLST, OGDH, and ACO2, are all involved in this pathway. PDHA1 encodes the E1 component of pyruvate dehydrogenase, which is the entry point for glucose into the pathway. GOT1 and GOT2 encode aspartate aminotransferases, enzymes that convert oxaloacetate and 2-oxoglutarate. IDH1 is involved in the citric acid cycle, while DLST and OGDH participate in the oxidative decarboxylation of 2-oxoglutarate. ACO2 encodes aconitase, which catalyzes the isomerization of citrate to isocitrate. The altered compounds, such as cis-(Homo)2-aconitate, cis-Aconitate, and 4-Methylthio-2-oxobutanoic acid, are intermediates in this pathway, further supporting the identification of the 2-Oxocarboxylic acid metabolism as the affected pathway."}], "target": "2-Oxocarboxylic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYP1A1,ALDH1A2,RDH11 >>>\nList of compounds : <<< Bathorhodopsin,Metarhodopsin,Iodopsin,4-Oxoretinol,11-cis-Retinyl palmitate,9-cis-Retinal,Retinol,11-cis-Retinal,9-cis-Retinoic acid,Retinyl palmitate,all-trans-4-Hydroxyretinoic acid,Retinal,9-cis-Retinol,Retinoate,all-trans-4-Oxoretinoic acid,Lumirhodopsin,Metarhodopsin,all-trans-3,4-Didehydroretinol,all-trans-5,6-Epoxyretinoic acid,all-trans-18-Hydroxyretinoic acid,all-trans-Retinoyl-beta-glucuronide,Retinyl ester,Rhodopsin,all-trans-13,14-Dihydroretinol,beta-Carotene >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Retinol metabolism pathway. This conclusion is supported by the alterations observed in several genes and compounds associated with this pathway. The genes CYP1A1, ALDH1A2, and RDH11 are all known to play crucial roles in retinol metabolism. CYP1A1 is involved in the oxidation of retinol, ALDH1A2 in the oxidation of retinal to retinoic acid, and RDH11 in the reduction of retinal to retinol. The compounds identified, such as Retinol, Retinal, Retinoic acid, and their derivatives, are key intermediates and products in the Retinol metabolism pathway. Additionally, the presence of Rhodopsin, a protein that uses 11-cis-Retinal as a chromophore, further supports this conclusion. Therefore, the data suggest that the Retinol metabolism pathway is significantly altered in the compared conditions."}], "target": "Retinol metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AK9,HSD17B6 >>>\nList of compounds : <<< N6-(1,2-Dicarboxyethyl)-AMP,Citrate,UTP,Cobalt-precorrin 8,4-Phospho-D-erythronate,Tetrahydrosarcinapterin,3,4-Dihydroxy-5-polyprenylbenzoate,Octanoyl-[acp],Adenosyl cobyrinate a,c diamide,Orotidine 5'-phosphate,5-Phospho-alpha-D-ribose 1-diphosphate,Cobalt-precorrin 6,(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate,beta-D-Glucuronoside,UDP,GDP-L-galactose >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the biosynthesis of cofactors. This conclusion is supported by the alteration of several genes and compounds directly associated with this pathway. The genes AK9 and HSD17B6 are involved in cofactor biosynthesis, specifically in the production of coenzyme A and NADP+ respectively. The compounds N6-(1,2-Dicarboxyethyl)-AMP, Cobalt-precorrin 8, Adenosyl cobyrinate a,c diamide, and Orotidine 5'-phosphate are intermediates in the biosynthesis of cofactors such as AMP, cobalamin, and UMP. Other altered compounds like Citrate, UTP, and UDP are closely related to this pathway, providing further evidence. Therefore, the data suggests that the biosynthesis of cofactors pathway is significantly affected in the compared conditions."}], "target": "Biosynthesis of cofactors"}
{"messages": [{"role": "user", "content": "List of genes : <<< TXNDC12,G6PD,LANCL1,ODC1,GPX6 >>>\nList of compounds : <<< Glycine,Bis(glutathionyl)spermine disulfide,L-Cysteine,gamma-L-Glutamyl-L-cysteine,L-Glutamate,Glutathionylspermidine,Trypanothione,Trypanothione disulfide,NADP+,S-Substituted L-cysteine,Homotrypanothione disulfide,Ascorbate,Glycine,L-Ornithine,(5-L-Glutamyl)-L-amino acid,R-S-Glutathione,L-Amino acid,NADP+,Glutathione disulfide,Spermidine,S-Substituted N-acetyl-L-cysteine,Cadaverine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is Glutathione metabolism. This pathway involves the synthesis, oxidation, and reduction of glutathione, a tripeptide that plays a crucial role in antioxidant defense. The altered genes, including G6PD involved in glucose metabolism and NADP+ production, GPX6 involved in glutathione peroxidase activity, and ODC1 involved in polyamine biosynthesis, support this finding. The changes in compounds such as Glutathione disulfide, Glutathionylspermidine, Trypanothione, and NADP+, which are key intermediates in glutathione metabolism, further corroborate this identification. The presence of L-Ornithine and Spermidine, precursors in glutathione biosynthesis, also aligns with the altered Glutathione metabolism pathway."}], "target": "Glutathione metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDHA1,SUCLA2,SUCLG2 >>>\nList of compounds : <<< Fumarate,(S)-Malate,Enzyme N6-(dihydrolipoyl)lysine,Enzyme N6-(lipoyl)lysine,cis-Aconitate,Thiamin diphosphate,Isocitrate,Succinyl-CoA,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine,Oxaloacetate,Thiamin diphosphate,Oxalosuccinate,Succinate,Phosphoenolpyruvate,Enzyme N6-(lipoyl)lysine,Enzyme N6-(dihydrolipoyl)lysine,2-Oxoglutarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Citrate cycle (TCA cycle). The altered genes, PDHA1, SUCLA2, and SUCLG2, are all involved in this pathway. PDHA1 encodes for the E1 alpha subunit of pyruvate dehydrogenase, an enzyme that links glycolysis to the TCA cycle by converting pyruvate to acetyl-CoA. SUCLA2 and SUCLG2 encode for subunits of succinate-CoA ligase, an enzyme that catalyzes the conversion of succinyl-CoA to succinate in the TCA cycle. The altered compounds, including fumarate, (S)-malate, cis-aconitate, isocitrate, succinyl-CoA, oxaloacetate, succinate, and 2-oxoglutarate, are all intermediates in the TCA cycle. Additionally, the presence of N6-(dihydrolipoyl)lysine and N6-(lipoyl)lysine, which are cofactors in TCA cycle enzymes, further supports the involvement of this pathway."}], "target": "Citrate cycle (TCA cycle)"}
{"messages": [{"role": "user", "content": "List of genes : <<< CTH,MARS1,KYAT3,TXNRD1,PAPSS1,TXNRD2,INMT >>>\nList of compounds : <<< Adenylylselenate,Trimethylselenonium,Selenophosphoric acid,L-Selenocysteinyl-tRNA(Sec),L-Seryl-tRNA(Sec),Glutathioselenol,Methylselenocysteine Se-oxide,1-Methylseleno-N-acetyl-D-galactosamine,L-Seryl-tRNA(Sec) >>>"}, {"role": "assistant", "content": "The experiment identified the selenocompound metabolism pathway as being altered in the two conditions. This pathway was implicated due to the significant changes observed in multiple genes and compounds directly related to selenium metabolism. The genes CTH, MARS1, KYAT3, TXNRD1, PAPSS1, TXNRD2, and INMT are all involved in selenium metabolism, with roles in selenocysteine synthesis, selenoprotein biosynthesis, and redox reactions. The altered compounds, including Adenylylselenate, Trimethylselenonium, Selenophosphoric acid, L-Selenocysteinyl-tRNA(Sec), L-Seryl-tRNA(Sec), Glutathioselenol, Methylselenocysteine Se-oxide, 1-Methylseleno-N-acetyl-D-galactosamine, and L-Seryl-tRNA(Sec), are intermediates or products of selenocompound metabolism. Therefore, the changes in these genes and compounds suggest that the selenocompound metabolism pathway is significantly affected in the conditions studied."}], "target": "Selenocompound metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< TKTL2,RGN,G6PD,IDNK,PRPS2,PGLS,TKTL1,RBKS,GPI,FBP1,RPE,PGD,TALDO1 >>>\nList of compounds : <<< alpha-D-Ribose 1-phosphate,D-Glyceraldehyde,beta-D-Glucose,D-Glucono-1,5-lactone 6-phosphate,D-Xylulose 5-phosphate,2-Deoxy-D-ribose 1-phosphate,beta-D-Glucose 6-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Pentose Phosphate Pathway (PPP). This pathway was implicated due to the alterations in multiple genes and compounds directly associated with it. The genes TKTL2, TKTL1, G6PD, PGD, RPE, and TALDO1 are all involved in the PPP, with roles in transketolase activity, glucose-6-phosphate dehydrogenase, phosphogluconate dehydrogenase, ribulose-phosphate 3-epimerase, and transaldolase 1, respectively. The altered compounds, including beta-D-Glucose 6-phosphate, D-Xylulose 5-phosphate, and D-Glyceraldehyde, are intermediates in the PPP. Therefore, the changes observed in these genes and compounds suggest a significant role of the Pentose Phosphate Pathway in the condition under study."}], "target": "Pentose phosphate pathway"}
{"messages": [{"role": "user", "content": "List of genes : <<< DLST,OGDH,GPT,IDH1,BCAT2,ACO1,BCKDHB,DLD,IDH3B,GPT2,AGXT2,ACO2,GOT2,DLAT,PDHA1,GOT1,GOT1L1,IDH3A,CS,IDH2 >>>\nList of compounds : <<< (R)-2,3-Dihydroxy-3-methylpentanoate,N-Acetyl-L-glutamate,Trihomomethionine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the 2-Oxocarboxylic acid metabolism. This pathway, also known as the tricarboxylic acid (TCA) cycle or Krebs cycle, is a fundamental metabolic process that generates energy through the oxidation of acetyl-CoA derived from carbohydrates, fats, and proteins. The identified genes, including DLST, OGDH, ACO1, ACO2, DLAT, CS, and IDH1-3, are directly involved in the TCA cycle. The altered compounds, (R)-2,3-Dihydroxy-3-methylpentanoate and N-Acetyl-L-glutamate, are intermediates in this pathway. Trihomomethionine, an abnormal metabolite of methionine, can indirectly affect the TCA cycle via its impact on the methionine metabolism. Therefore, the changes in these genes and compounds strongly suggest that the 2-Oxocarboxylic acid metabolism pathway is involved in the condition under investigation."}], "target": "2-Oxocarboxylic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DAO,GLS,DDO,SRR,DGLUCY >>>\nList of compounds : <<< Pyruvate,Cadaverine,Pyruvate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is D-Amino acid metabolism. This pathway was implicated due to the alterations observed in the genes DAO, GLS, DDO, SRR, and DGLUCY. DAO (D-amino acid oxidase) and DDO (D-aspartate oxidase) are directly involved in the catabolism of D-amino acids. GLS (Glutaminase) and DGLUCY (D-glucose-6-phosphate isomerase) are involved in other pathways but their alterations could indicate a shift in metabolic flux towards D-amino acid metabolism to compensate for changes in the primary pathways. The alteration in the compound Cadaverine, a diamine produced in the decarboxylation of lysine, further supports this finding as it can be metabolized by DAO. The presence of altered Pyruvate levels could suggest a link between D-amino acid metabolism and central carbon metabolism."}], "target": "D-Amino acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSTT4,UGT2A2,ALDH3B1,UGT1A5,UGT2B17,MAOA,CYP2D6,UGT2B28,GSTP1,ALDH3A1,GSTA3,CYP2E1,FMO5,CYP3A5 >>>\nList of compounds : <<< 2-Phenyl-1,3-propanediol monocarbamate,Methadone,L-alpha-Acetyl-N,N-dinormethadol,2-Propylglutaric acid,4-Glutathionyl cyclophosphamide,Codeine-6-glucuronide,Oxcarbazepine (JAN/USP/INN),Aldophosphamide,Codeine (USP) >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Drug Metabolism - Cytochrome P450. This pathway is involved in the metabolism of numerous drugs and toxins in the body. The altered genes, including CYP2D6, CYP2E1, CYP3A5, and others, are all members of the cytochrome P450 superfamily, which are primarily involved in oxidative metabolism of drugs and other xenobiotics. The presence of compounds such as Methadone, Codeine, and Oxcarbazepine, which are known substrates for these enzymes, further supports the involvement of this pathway. The alterations in genes like UGTs (UGT2A2, UGT1A5, UGT2B17, UGT2B28) and GSTs (GSTT4, GSTP1, GSTA3), which are involved in phase II metabolism, could also indicate conjugation reactions following the initial oxidation by cytochrome P450 enzymes."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G4B,PLPP2,PLA2G2C,JMJD7-PLA2G4B,SELENOI,GAL3ST1,PLA2G2E,PAFAH1B1,PAFAH2,PAFAH1B3,PLPP1,PLA2G10,PLA2G5,PLD4,CEPT1,ENPP2,PEDS1,AGPS,GDPD3,PLA2G4C,PAFAH1B2,PLA2G7 >>>\nList of compounds : <<< 1-Alkyl-2-acetyl-sn-glycerol,Acylglycerone phosphate,1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine,1-Alkyl-sn-glycerol,2-Acyl-1-alkyl-sn-glycero-3-phosphate,1-Alkyl-sn-glycero-3-phosphate,Plasmenylcholine,1-Radyl-2-acyl-sn-glycero-3-phosphocholine,2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Ether Lipid Metabolism. This pathway is closely related to the altered genes and compounds. Several of the genes listed, including PLA2G4B, PLA2G2C, PLA2G2E, PLA2G4C, PLA2G7, PLD4, and AGPS, are involved in the synthesis, degradation, and remodeling of ether lipids. The compounds, such as 1-Alkyl-2-acetyl-sn-glycerol, 1-Alkyl-sn-glycero-3-phosphate, and Plasmenylcholine, are key intermediates and end products in the Ether Lipid Metabolism pathway. The alterations in these genes and compounds suggest that this pathway is significantly impacted in the condition being studied, emphasizing its potential role in the disease mechanism."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ENPP4,AK4,AK2,NME7 >>>\nList of compounds : <<< 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide,dATP,ADP-ribose,2',3'-Cyclic GMP,Deoxyadenosine,dAMP,1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide,Imidazolone,5-Phosphoribosylamine,dZMP,Ammonia,Aminoimidazole ribotide,P1,P4-Bis(5'-adenosyl)tetraphosphate,(R)(-)-Allantoin,Hypoxanthine,Oxalate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Purine metabolism. This is supported by the alterations in genes and compounds associated with this pathway. The genes ENPP4, AK4, AK2, and NME7 are all involved in purine metabolism. ENPP4 encodes an enzyme that hydrolyzes ATP to AMP, AK4 and AK2 are involved in ATP to AMP conversion, and NME7 is involved in the salvage pathway of purine nucleotides. The altered compounds, such as 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide, dATP, ADP-ribose, dAMP, and Hypoxanthine, are intermediates or products of the purine metabolism pathway. Therefore, the data suggests that the purine metabolism pathway is significantly affected in the experimental conditions."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NDUFB10,ATP5PO,SDHA,NDUFB5,ATP5ME,SDHC,NDUFB1,,ATP6V1G2,ATP6V0D2,ATP6V1E2,NDUFA4L2,CYC1,MT-ND2,,UQCR10,MT-ATP6,COX7B,ATP5MC2,NDUFB9,NDUFA3,NDUFB2,UQCR11,UQCRC2,COX5A >>>\nList of compounds : <<< NAD+,Oxygen,Diphosphate,H2O,H+,ADP,Triphosphate,Succinate,H+,Orthophosphate,H+ >>>"}, {"role": "assistant", "content": "The experiment identified the oxidative phosphorylation pathway as the primary metabolic pathway affected in the given conditions. This conclusion is supported by the alterations observed in genes associated with this pathway, such as NDUFB10, ATP5PO, SDHA, NDUFB5, ATP5ME, SDHC, NDUFB1, CYC1, UQCR10, MT-ATP6, COX7B, ATP5MC2, NDUFB9, NDUFA3, NDUFB2, UQCR11, UQCRC2, and COX5A. These genes encode proteins involved in the electron transport chain and ATP synthase, key components of oxidative phosphorylation. Moreover, the altered compounds, including NAD+, Oxygen, Diphosphate, H2O, ADP, Triphosphate, Succinate, and Orthophosphate, are all directly involved in the oxidative phosphorylation process, further corroborating this finding. Therefore, it is likely that the observed condition is related to disruptions in oxidative phosphorylation."}], "target": "Oxidative phosphorylation"}
{"messages": [{"role": "user", "content": "List of genes : <<< IDH3A,CS,IDH1,ACO2,AGXT,OGDH,GOT1L1,NAGS,DLST >>>\nList of compounds : <<< (R)-2-Hydroxybutane-1,2,4-tricarboxylate,(2R,3S)-3-Isopropylmalate,6-Methylthiohexanaldoxime,4-Methylthiobutanaldoxime,3-Benzylmalic acid,L-Methionine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the 2-Oxocarboxylic acid metabolism. This pathway was found to be affected due to the alterations in several genes and compounds. The genes IDH3A, CS, IDH1, ACO2, OGDH, GOT1L1 are all involved in the 2-Oxocarboxylic acid metabolism. IDH3A and IDH1 are involved in the citric acid cycle, CS and ACO2 are key enzymes in the citric acid cycle, OGDH is involved in the oxidative decarboxylation of 2-oxoglutarate, and GOT1L1 is involved in the transfer of amino groups between glutamate and 2-oxoglutarate. The altered compounds, such as (R)-2-Hydroxybutane-1,2,4-tricarboxylate, (2R,3S)-3-Isopropylmalate, 6-Methylthiohexanaldoxime, 4-Methylthiobutanaldoxime, 3-Benzylmalic acid, L-Methionine, are all intermediates or by-products of this pathway. Therefore, the alterations in these genes and compounds suggest that the 2-Oxocarboxylic acid metabolism is likely involved in the condition being studied."}], "target": "2-Oxocarboxylic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PMM1,HK2,GALK2,GNPNAT1,GPI,UGP2,CMAS,GALE,TGDS,GFPT1,GNE,HKDC1,HK3,PGM2,MIOX,GMDS,GALK1,GMPPA,NANS,GFUS,NANP,GCK,UAP1L1 >>>\nList of compounds : <<< dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose,dTDP-4-oxo-2,6-dideoxy-D-allose,UDP-3-ketoglucose,CDP-3,6-dideoxy-D-glucose,GDP-4-keto-6-deoxy-D-lyxo-heptose,N-Acetyl-alpha-D-glucosamine 1-phosphate,UDP-kanosamine,N-Acetyl-D-glucosamine,UDP-6-sulfoquinovose,UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine,UDP-2-acetamido-2,6-dideoxy-beta-L-mannose,N-Acetylneuraminate 9-phosphate,UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate,dTDP-3-methyl-4-oxo-2,6-dideoxy-D-glucose,dTDP-3-amino-3,4,6-trideoxy-D-glucose,2,4-Bis(acetamido)-2,4,6-trideoxy-beta-L-altropyranose,UDP-2-acetamido-2,6-dideoxy-beta-L-glucose,GDP-glucose,UDP-4-dehydro-6-deoxy-D-glucose,GDP-4-acetamido-4,6-dideoxy-alpha-D-mannose,D-Glucose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of nucleotide sugars. This pathway was indicated by the alterations in multiple genes and compounds involved in this process. Genes such as GNPNAT1, GPI, UGP2, CMAS, GALE, GFPT1, GNE, UAP1L1 are directly involved in the synthesis of nucleotide sugars. The altered compounds, including UDP-glucose, UDP-N-acetyl-glucosamine, and various nucleotide sugar intermediates, further support this finding. These compounds are key substrates and products in the biosynthesis of nucleotide sugars pathway, which is essential for the synthesis of glycoproteins, glycolipids, and proteoglycans. Therefore, the observed changes in these genes and compounds suggest a significant role for the Biosynthesis of nucleotide sugars pathway in the studied condition."}], "target": "Biosynthesis of nucleotide sugars"}
{"messages": [{"role": "user", "content": "List of genes : <<< NAGLU,SPAM1,IDUA,GALNS,ARSB,HPSE2,HYAL4,SGSH,HPSE,HEXB,HGSNAT,GUSB,HYAL2,HEXA,HYAL3,GLB1,GNS >>>\nList of compounds : <<< Dermatan sulfate,Chondroitin 4-sulfate,Heparan sulfate,Keratan sulfate,Hyaluronic acid,DWA-2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Glycosaminoglycan degradation. This pathway was implicated due to the alterations in genes and compounds associated with the degradation of various glycosaminoglycans (GAGs). The list of genes includes NAGLU, SPAM1, IDUA, GALNS, ARSB, HPSE2, HYAL4, SGSH, HPSE, HEXB, HGSNAT, GUSB, HYAL2, HEXA, HYAL3, GLB1, and GNS, all of which are involved in the degradation of different GAGs such as heparan sulfate, dermatan sulfate, chondroitin 4-sulfate, keratan sulfate, and hyaluronic acid. The presence of elevated levels of GAGs such as dermatan sulfate, chondroitin 4-sulfate, heparan sulfate, keratan sulfate, and hyaluronic acid in the experiment further supports the involvement of the Glycosaminoglycan degradation pathway. Additionally, the presence of the compound DWA-2, which is a known inhibitor of heparanase (encoded by HPSE), further implicates this pathway."}], "target": "Glycosaminoglycan degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< AADAT,SMYD3,KMT5C,NSD2,EHHADH,HADH,SETD2,KMT2E,DLD,KMT2D,SETMAR,SMYD1,SETDB2,KMT5A >>>\nList of compounds : <<< Acetyl-CoA,4-Trimethylammoniobutanal,6-Acetamido-2-oxohexanoate,Acetoacetyl-CoA,Succinate,L-Pipecolate,Glycine,Butanoyl-CoA,Carnitine,L-2-Aminoadipate 6-semialdehyde,5-Phosphooxy-L-lysine,L-2-Aminoadipate,Acetoacetate,6-Amino-2-oxohexanoate,5-Oxopentanoate,(S)-2-Hydroxyglutarate,N6-Acetyl-L-lysine,(3S)-3,6-Diaminohexanoate,Cadaverine,Enzyme N6-(dihydrolipoyl)lysine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Lysine degradation pathway. This pathway was indicated by the alterations in several genes and compounds associated with lysine metabolism. Genes such as EHHADH, HADH, and DLD are involved in the degradation of lysine, while SMYD1, SETDB2, and KMT5A are involved in the methylation of lysine residues in histones and other proteins. The altered compounds, including Acetyl-CoA, L-2-Aminoadipate, and N6-Acetyl-L-lysine, are intermediates or products of the lysine degradation pathway. The presence of Carnitine and Butanoyl-CoA suggests that the degradation of lysine may also be linked to fatty acid metabolism. Therefore, the data strongly support that the Lysine degradation pathway is involved in the specific condition under investigation."}], "target": "Lysine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< DBT,BCAT2 >>>\nList of compounds : <<< Thiamin diphosphate,Acetoacetate,Enzyme N6-(dihydrolipoyl)lysine,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine,3-Hydroxyisovalerate,L-Valine,(S)-Methylmalonate semialdehyde,(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA,Succinyl-CoA,Acetyl-CoA,Thiamin diphosphate,(R)-3-Amino-2-methylpropanoate,(S)-3-Hydroxy-3-methylglutaryl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Valine, Leucine and Isoleucine Degradation. This is supported by the alterations in the genes DBT (Dihydrolipoamide branched-chain transacylase) and BCAT2 (Branched-chain amino acid transaminase 2). DBT is a key enzyme in the degradation of branched-chain amino acids (BCAAs), including valine. BCAT2 is responsible for the initial step in BCAA catabolism, converting valine to alpha-ketoisocaproate. The altered compounds, such as L-Valine, (S)-Methylmalonate semialdehyde, and (2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA, are also intermediates in this pathway. The presence of Thiamin diphosphate, a coenzyme required by enzymes involved in BCAA degradation, further supports this conclusion. Therefore, the data suggest that the Valine, Leucine and Isoleucine Degradation pathway is significantly affected in the given condition."}], "target": "Valine, leucine and isoleucine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< PTGS2,PLA2G2E,PTGES3,ALOX12B,ALOX12,PTGES,PRXL2B,CYP4F2,HPGDS,PLA2G10,GPX4,PTGIS,CYP2C8,HPGD,TBXAS1,LTC4S,PLB1,PTGR1,GGT1,EPHX2,PLA2G12A,CYP2C19,CYP2C9 >>>\nList of compounds : <<< 12(S)-HPETE,Leukotriene F4,Prostaglandin E2,9(S)-HETE,20-OH-Leukotriene B4,Hepoxilin B3,(5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate,11-Dehydro-thromboxane B2,Hepoxilin A3,Trioxilin A3,Prostaglandin F2alpha,16(R)-HETE,15H-11,12-EETA,Arachidonate,Lipoxin B4,Prostaglandin J2,Thromboxane A2,Leukotriene E4,20-COOH-Leukotriene B4,Prostaglandin B2,15-Deoxy-Delta12,14-PGJ2,8(R)-HPETE,5,6-Epoxytetraene,5,6-DHET >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Arachidonic Acid Metabolism pathway. This is supported by the alteration of genes such as PTGS2, PLA2G2E, ALOX12B, and CYP2C8, which are known to be involved in this pathway. These genes encode enzymes that catalyze the conversion of arachidonic acid into various eicosanoids, including prostaglandins, leukotrienes, and thromboxanes. The altered compounds, such as Prostaglandin E2, Leukotriene F4, and Thromboxane A2, are also products of this pathway, further supporting the identification of the Arachidonic Acid Metabolism pathway. The dysregulation of this pathway has been associated with various conditions, including inflammation, cardiovascular disease, and cancer."}], "target": "Arachidonic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< COQ2,TAT,VKORC1,GGCX,COQ6,COQ3 >>>\nList of compounds : <<< trans-Cinnamate,4-(beta-D-Glucosyloxy)benzoate,Futalosine,Phylloquinol,4-Hydroxybenzoyl-CoA,Ubiquinol,p-Coumaroyl-CoA,Chorismate,6-Amino-6-deoxyfutalosine,1,4-Dihydroxy-2-naphthoate,Dihydroshikonofuran,Vitamin K1 epoxide,Phytyl diphosphate,Geranylhydroquinone,6-Geranylgeranyl-2-methylbenzene-1,4-diol,beta-Tocopherol,Demethylmenaquinol,2,3-Dimethyl-5-phytylquinol,Plastoquinol-9,1,4-Dihydroxy-6-naphthoate,1,4-Dihydroxy-2-naphthoyl-CoA,L-Tyrosine,Dihydroechinofuran >>>"}, {"role": "assistant", "content": "The analysis of the genetic and metabolic data indicates that the metabolic pathway involved is the \"Ubiquinone and other terpenoid-quinone biosynthesis\". This pathway was identified due to the altered genes COQ2, COQ3, COQ6, and the presence of metabolites such as Geranylhydroquinone, Phytyl diphosphate, Ubiquinol, and Demethylmenaquinol, which are key intermediates in this pathway. The genes COQ2, COQ3, and COQ6 are directly involved in the biosynthesis of ubiquinone (also known as coenzyme Q10), a vital component of the mitochondrial electron transport chain. The presence of Ubiquinol, the reduced form of ubiquinone, further supports this finding. Additionally, the presence of compounds like Geranylhydroquinone and Phytyl diphosphate suggests involvement in the terpenoid-quinone biosynthesis subpathway. These findings suggest that alterations in this pathway may be contributing to the observed condition."}], "target": "Ubiquinone and other terpenoid-quinone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PRPS1L1,PYCR1,PRPS2, >>>\nList of compounds : <<< 3-Phosphonooxypyruvate,N-Acetyl-L-glutamate 5-semialdehyde,LysW-gamma-L-alpha-aminoadipyl 6-phosphate,LysW-L-glutamyl 5-phosphate,N-Acetylornithine,N-Acetyl-L-2-amino-6-oxopimelate,S-Adenosyl-L-homocysteine,Chorismate,CO2,5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide,L-Isoleucine,(2S,4S)-4-Hydroxy-2,3,4,5-tetrahydrodipicolinate,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate,D-Fructose 1,6-bisphosphate,L-2-Aminoadipate,D-Xylulose 5-phosphate,L-Leucine,D-Ribulose 5-phosphate,D-Glyceraldehyde 3-phosphate,LL-2,6-Diaminoheptanedioate,O-Acetyl-L-serine,L-Glutamyl 5-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the biosynthesis of amino acids. This conclusion is supported by the alterations observed in genes and compounds related to this pathway. The genes PRPS1L1, PYCR1, and PRPS2 are involved in the biosynthesis of amino acids, specifically in the synthesis of serine, proline, and arginine. The altered compounds, such as N-Acetylornithine, L-Glutamyl 5-phosphate, and LL-2,6-Diaminoheptanedioate, are intermediates in the biosynthesis of arginine and lysine. The presence of compounds like D-Fructose 1,6-bisphosphate and D-Glyceraldehyde 3-phosphate indicate that glycolysis, a pathway that provides precursors for amino acid biosynthesis, is also affected. Therefore, the data suggest that the condition under study is linked to disturbances in the biosynthesis of amino acids."}], "target": "Biosynthesis of amino acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2A2,UGT2B17,CYP1A2,CYP3A7,UGT1A4,HSD11B2,HSD17B6,AKR1C4,SULT1E1,UGT1A7 >>>\nList of compounds : <<< 11beta-Hydroxyandrost-4-ene-3,17-dione,Pregnanediol,5alpha-Pregnan-17alpha-ol-3,20-dione,7alpha-Hydroxypregnenolone,Androsterone,Androstenedione,5beta-Androstane-3,17-dione >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, alterations were observed in multiple genes and compounds involved in the steroid hormone biosynthesis pathway. The genes UGT2A2, UGT2B17, CYP1A2, CYP3A7, UGT1A4, HSD11B2, HSD17B6, AKR1C4, and SULT1E1 were found to be affected. These genes code for enzymes that play crucial roles in the metabolism of steroid hormones, such as glucuronidation, hydroxylation, and oxidation. The altered compounds, including 11beta-Hydroxyandrost-4-ene-3,17-dione, Pregnanediol, 5alpha-Pregnan-17alpha-ol-3,20-dione, 7alpha-Hydroxypregnenolone, Androsterone, Androstenedione, and 5beta-Androstane-3,17-dione, are intermediates or products of this pathway. These findings suggest that the steroid hormone biosynthesis pathway is significantly impacted in the condition under study, which aligns with the observed changes in gene expression and metabolite levels."}], "target": "Steroid hormone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< HMGCS1,ACAT1,GAD2,ACAT2,ECHS1,ACADS,BDH1,ACSM2B,ABAT,HMGCLL1,ACSM6,AACS,ALDH5A1,HMGCL,HADHA,OXCT1,OXCT2,ACSM3,ACSM4,ACSM2A,ACSM1,ACSM5 >>>\nList of compounds : <<< Propane,Poly-beta-hydroxybutyrate,Acetoacetyl-CoA,Butane,Glutaconyl-1-CoA,Diacetyl,2-Hydroxyglutarate,(R)-3-Hydroxybutanoate,Fumarate,(S)-3-Hydroxy-3-methylglutaryl-CoA,(R)-Acetoin,Acetoacetate,meso-2,3-Butanediol,Propan-2-ol,1-Butanol,Butanoic acid,(R)-3-Hydroxybutanoyl-CoA >>>"}, {"role": "assistant", "content": "Based on the alterations in the genes and compounds provided, the metabolic pathway identified is Butanoate metabolism. This pathway involves the metabolism of butanoate and its derivatives. The genes HMGCS1, ACAT1, ACAT2, HMGCLL1, HMGCL, and ACSM2B are involved in ketogenesis, which is closely linked to butanoate metabolism. The presence of compounds such as Acetoacetyl-CoA, (S)-3-Hydroxy-3-methylglutaryl-CoA, Acetoacetate, and (R)-3-Hydroxybutanoyl-CoA further supports this identification, as these are intermediates in the butanoate metabolism pathway. Additionally, the genes AACS, ALDH5A1, and HADHA, as well as the compounds Butanoic acid and 1-Butanol, suggest involvement in fatty acid metabolism, which is also closely related to butanoate metabolism. Therefore, the data indicates that the Butanoate metabolism pathway is significantly altered in the given conditions."}], "target": "Butanoate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GNS,HEXA,HYAL3,IDUA,HYAL1,ARSB,HEXB,SGSH,SPAM1,HPSE,HPSE2,IDS,GALNS,HGSNAT,HYAL2,GUSB >>>\nList of compounds : <<< Chondroitin 4-sulfate,Dermatan sulfate,Heparan sulfate,Keratan sulfate,DWA-2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Glycosaminoglycan degradation pathway. This is supported by the alterations in the genes and compounds involved in the experiment. The genes GNS, HEXA, HYAL3, IDUA, HYAL1, ARSB, HEXB, SGSH, SPAM1, HPSE, HPSE2, IDS, GALNS, HGSNAT, HYAL2, and GUSB are all associated with the degradation of glycosaminoglycans (GAGs), a class of long, unbranched polysaccharides. The compounds Chondroitin 4-sulfate, Dermatan sulfate, Heparan sulfate, Keratan sulfate, and DWA-2 are all types of GAGs, further supporting the involvement of the Glycosaminoglycan degradation pathway. The alterations in these genes and compounds suggest disruptions in the breakdown and recycling of GAGs, which is a key function of this pathway."}], "target": "Glycosaminoglycan degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH1B1,GPAT4,DGKZ,DGKK,DGKH,PLPP3,GLYCTK,DGKE,LPIN3,DGKA,MOGAT1,PLPP1,DGAT2,MOGAT2,GPAT3,ALDH2 >>>\nList of compounds : <<< alpha-Kojibiosyldiacylglycerol,Lipoteichoic acid,3-Phospho-D-glycerate,1,2-Diacyl-3-beta-D-galactosyl-sn-glycerol,1,2-Diacyl-3-alpha-D-glucosyl-sn-glycerol,Acyl-[acyl-carrier protein],Digalactosyl-diacylglycerol,1,2-Diacyl-3-O-[beta-D-galactosyl-(1-&gt;6)-beta-D-galactosyl]-sn-glycerol,Glycerone phosphate,D-Glycerate,Glycerophosphoglycoglycerolipid,Propane-1,3-diol,Acyl1-monogalactosyl-diacylglycerol,1-Acylglycerol,UDP-6-sulfoquinovose,1,2-Diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol,1-Acyl-sn-glycerol 3-phosphate,Fatty acid,Acyl-CoA,2-Acyl-3-O-(beta-D-galactosyl)-sn-glycerol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Glycerolipid metabolism. This conclusion is supported by the alterations observed in genes and compounds associated with this pathway. The genes ALDH1B1, GPAT4, DGKZ, DGKK, DGKH, PLPP3, LPIN3, DGKA, MOGAT1, MOGAT2, GPAT3, and DGAT2 are all involved in various steps of glycerolipid metabolism, such as synthesis and degradation of triacylglycerols and phospholipids. Similarly, the altered compounds, including various diacylglycerols, acyl-CoA, fatty acids, and glycerophosphoglycerolipids, are key intermediates and products in glycerolipid metabolism. Therefore, the changes in these genes and compounds suggest that the Glycerolipid metabolism pathway is significantly affected in the compared conditions."}], "target": "Glycerolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH9A1,AOC2,ALDH3A1,CSAD,ALDH3B2,MLYCD,CARNS1,ALDH6A1,ALDH1B1,GADL1,ALDH7A1,ACADS,UPB1,SMOX,EHHADH >>>\nList of compounds : <<< Spermidine,1,3-Diaminopropane,beta-Alanyl-L-arginine,3-Oxopropanoate,beta-Alanyl-N(pi)-methyl-L-histidine,3-Aminopropiononitrile,N-Acetyl-beta-alanine,3-Ureidopropionate >>>"}, {"role": "assistant", "content": "The experiment identified the beta-Alanine metabolism pathway as being significantly altered. This is consistent with the observed changes in several genes and compounds related to this pathway. Genes such as ALDH9A1, AOC2, ALDH3A1, MLYCD, GADL1, and EHHADH are known to play crucial roles in the metabolism of beta-alanine. Similarly, the altered compounds, including beta-Alanine, 3-Oxopropanoate, beta-Alanyl-L-arginine, beta-Alanyl-N(pi)-methyl-L-histidine, N-Acetyl-beta-alanine, and 3-Ureidopropionate, are direct intermediates or by-products of this pathway. The changes in these genes and compounds suggest that the beta-Alanine metabolism pathway is dysregulated in the specific condition under investigation."}], "target": "beta-Alanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SUCLA2,MDH2,SDHD,FH,SUCLG1,DLAT,ACLY,PDHA1,PDHB,IDH2,PCK1,SDHC,IDH3G,ACO1,ACO2,IDH3A,MDH1,SDHB,SDHA,OGDH,IDH1,CS,DLD,DLST,SUCLG2 >>>\nList of compounds : <<< 2-(alpha-Hydroxyethyl)thiamine diphosphate,Pyruvate,Acetyl-CoA,Enzyme N6-(dihydrolipoyl)lysine,2-Oxoglutarate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Citrate cycle (TCA cycle). This is supported by the altered genes and compounds. The genes SUCLA2, SUCLG1, SUCLG2, MDH2, MDH1, IDH2, IDH3G, IDH3A, IDH1, CS, DLD, DLST, and SDHA, SDHB, SDHC, SDHD are involved in the TCA cycle. SUCLA2 and SUCLG1 are associated with succinate-CoA ligase, MDH2 and MDH1 with malate dehydrogenase, IDH2 and IDH3A with isocitrate dehydrogenase, CS with citrate synthase, DLD and DLST with dihydrolipoyl dehydrogenase and succinyl-CoA synthetase, and SDHA, SDHB, SDHC, SDHD with succinate dehydrogenase. The compounds 2-(alpha-Hydroxyethyl)thiamine diphosphate, Pyruvate, Acetyl-CoA, Enzyme N6-(dihydrolipoyl)lysine, and 2-Oxoglutarate are intermediates in the TCA cycle. Therefore, the alterations in these genes and compounds suggest a significant role of the TCA cycle in the specific condition."}], "target": "Citrate cycle (TCA cycle)"}
{"messages": [{"role": "user", "content": "List of genes : <<< IL4I1,PAH >>>\nList of compounds : <<< cis-3-(3-Carboxyethenyl)-3,5-cyclohexadiene-1,2-diol,3-Oxo-5,6-dehydrosuberyl-CoA semialdehyde,Phenylacetic acid,2-Hydroxyphenylacetate,L-Phenylalanine,2-Hydroxy-2,4-pentadienoate,Phenylacetylglycine,trans-2,3-Dihydroxycinnamate,Acetaldehyde,Phenylacetaldehyde,Phenyllactate,2-Hydroxy-6-ketononatrienedioate,Phenylpyruvate,2-Hydroxy-3-phenylpropenoate,3-Oxo-5,6-dehydrosuberyl-CoA,Fumarate,trans-Cinnamate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Phenylalanine metabolism. This conclusion is based on the altered genes and compounds observed. The genes PAH (Phenylalanine Hydroxylase) and IL4I1 (Interleukin 4 Induced 1) are both involved in the metabolism of phenylalanine. PAH is a key enzyme in the first step of phenylalanine catabolism, converting phenylalanine to tyrosine. IL4I1, on the other hand, is involved in the alternative pathway of phenylalanine metabolism, particularly during immune responses. The altered compounds, which include phenylalanine and its various metabolites such as phenylacetic acid, phenyllactate, and phenylpyruvate, further support the involvement of the phenylalanine metabolism pathway. The presence of other compounds like fumarate and trans-cinnamate suggests potential interactions with other metabolic pathways, but the primary pathway affected appears to be phenylalanine metabolism."}], "target": "Phenylalanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SIRT4,NMNAT1,NT5C,BST1,NMRK2,NT5E >>>\nList of compounds : <<< (R)-Nicotine,Nicotinurate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Nicotinate and nicotinamide metabolism. This pathway involves the metabolism of nicotinate (niacin) and nicotinamide (a form of vitamin B3) into NAD+ and NADP+, coenzymes essential for cellular energy metabolism and other cellular functions. The alteration of genes SIRT4, NMNAT1, NT5C, BST1, NMRK2, and NT5E supports this finding. SIRT4, NMNAT1, and NT5C are involved in NAD+ metabolism, while BST1, NMRK2, and NT5E are associated with nicotinamide metabolism. The presence of (R)-Nicotine and Nicotinurate, compounds related to nicotinate and nicotinamide metabolism, further validates the involvement of this pathway in the observed condition."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< A4GALT,GCNT2,FUT3,B3GALT5,B4GALT1,FUT4,B3GNT2,B4GALNT2,ST3GAL3,FUT6,FUT2,B3GNT5,ABO,B3GNT4,ST3GAL4,B3GALT2,FUT9,B3GALT1 >>>\nList of compounds : <<< IV3NeuAc,III3Fuc-nLc4Cer,Fuc-Lc4Cer,Type IIIA glycolipid,III3Fuc-nLc4Cer,nLc8Cer,VI6NeuAc-nLc6Cer,VI2Fuc-nLc6,Type IIIAb,IV2Fuc-Lc4Cer,Sialyl-6-paragloboside,III3,IV2Fuc-nLc4Cer,III3,IV2Fuca,IV3GalNAca-nLc4-Cer,Fuc-3'-isoLM1,IV2Fuc,III4Fuc-Lc4Cer,IV4GalNAcb-SPG ganglioside,Type IA glycolipid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycosphingolipid biosynthesis - lacto and neolacto series. This pathway was implicated due to the alterations in multiple genes and compounds associated with glycosphingolipid metabolism. The genes listed, such as A4GALT, GCNT2, FUT3, and B4GALT1, are known to be involved in the synthesis of lacto- and neolacto-series glycosphingolipids. The altered compounds, including IV3NeuAc, III3Fuc-nLc4Cer, Fuc-Lc4Cer, and Type IIIA glycolipid, are also products or intermediates in this pathway. Therefore, the changes in these genes and compounds suggest an alteration in the Glycosphingolipid biosynthesis - lacto and neolacto series pathway, which could be a contributing factor to the observed condition."}], "target": "Glycosphingolipid biosynthesis - lacto and neolacto series"}
{"messages": [{"role": "user", "content": "List of genes : <<< FMO3,CDO1,ADO >>>\nList of compounds : <<< Taurine,Cysteamine,Hypotaurine,N-Phosphotaurocyamine,Sulfite,Sulfoacetaldehyde,Acetaldehyde,3-Sulfino-L-alanine,2-Hydroxyethanesulfonate,5-L-Glutamyl-taurine,L-Glutamate,Acetyl-CoA,L-Alanine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Taurine and hypotaurine metabolism. This pathway was implicated due to the alterations in several genes and compounds directly involved in this pathway. The genes FMO3, CDO1, and ADO are known to play crucial roles in this pathway. FMO3 is involved in the oxidation of taurine, CDO1 is responsible for the conversion of cysteine to cysteine sulfinic acid, and ADO is involved in polyamine metabolism, which can indirectly affect taurine metabolism. The compounds Taurine, Hypotaurine, N-Phosphotaurocyamine, 5-L-Glutamyl-taurine, L-Glutamate, and Acetyl-CoA are direct intermediates or products of this pathway. The presence of Sulfite, Sulfoacetaldehyde, 3-Sulfino-L-alanine, and 2-Hydroxyethanesulfonate suggests potential crosstalk with sulfur metabolism, which is closely linked to taurine metabolism. Therefore, the alterations in these genes and compounds strongly suggest that the Taurine and hypotaurine metabolism pathway is significantly affected in the condition under study."}], "target": "Taurine and hypotaurine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GYS1,AMY1A,MGAM2,PYGM,G6PC3,GYG1,GCK,ENPP1 >>>\nList of compounds : <<< ADP-glucose,D-Glucose,Levan,alpha,alpha'-Trehalose 6-phosphate,GDP-glucose >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, the metabolic pathway identified as being altered is the Starch and Sucrose Metabolism pathway. This is supported by the alterations in several genes associated with this pathway. GYS1 and GYG1 are involved in glycogen synthesis, while AMY1A, MGAM2, and PYGM are involved in starch and glycogen breakdown. G6PC3 and GCK are involved in glucose metabolism, which is a key intermediate in this pathway. The altered compounds, including ADP-glucose, D-Glucose, Levan, and alpha,alpha'-Trehalose 6-phosphate, are all intermediates or products of this pathway, further supporting its involvement in the observed condition."}], "target": "Starch and sucrose metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< FXN,UGT2B10,UGT2B11,UGT1A1,UROS,FTH1,UGT1A6,UGT1A3,FECH,UGT2A2,UGT2B4,CP,ALAS2,BLVRB,ALAS1,UGT1A10,UGT1A4,PPOX,HMBS,HMOX1,UGT2A1,CPOX,HEPHL1,EPRS1,UGT2B7 >>>\nList of compounds : <<< Fe2+,Oxyhemoglobin,5-Oxo-delta-bilirubin,Adenosyl cobyrinate a,c diamide,12-Ethyl-8-propylbacteriochlorophyllide d,Glycine,(R)-1-Aminopropan-2-ol,Cobalt-dihydro-precorrin 6,15,17(3)-Seco-F430-17(3)-acid,Bacteriochlorophyllide b,Nickel-sirohydrochlorin,Cob(II)alamin,Bacteriochlorophyllide a >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Porphyrin metabolism pathway. This conclusion is supported by the alterations in various genes and compounds associated with this pathway. The genes FXN, FECH, PPOX, CPOX, HMBS, ALAS1, and ALAS2 are directly involved in porphyrin metabolism, which is responsible for the biosynthesis of heme, a critical component of hemoglobin. The compounds Fe2+, Oxyhemoglobin, 5-Oxo-delta-bilirubin, Adenosyl cobyrinate a,c diamide, and Cob(II)alamin are intermediates or products of this pathway. Additionally, the UGT genes, which encode UDP-glucuronosyltransferases involved in the detoxification of bilirubin, a byproduct of heme degradation, further support the involvement of the Porphyrin metabolism pathway in the observed condition."}], "target": "Porphyrin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A5,UGT1A6,UGT2B28,RPE,DHDH,SORD,RPEL1,UGT1A7,UGT1A8,UGP2,UGT2A3,AKR1B10 >>>\nList of compounds : <<< 5-Dehydro-4-deoxy-D-glucuronate,L-Ribulose 5-phosphate,D-Arabitol,D-Ribulose 5-phosphate,D-Glucose 1-phosphate,(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate,beta-D-Glucuronoside,D-Ribulose 1-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is \"Pentose and glucuronate interconversions\". This pathway involves the interconversion of pentose sugars and glucuronate, and it is closely linked with the metabolism of carbohydrates. The altered genes, including UGT1A5, UGT1A6, UGT2B28, UGT1A7, UGT1A8, UGT2A3, and AKR1B10, are all UDP-glucuronosyltransferases (UGTs) and aldo-keto reductases (AKRs) that play crucial roles in this pathway. These enzymes catalyze the conjugation of glucuronic acid to various substrates, including sugars and lipids. The altered compounds, such as 5-Dehydro-4-deoxy-D-glucuronate, L-Ribulose 5-phosphate, D-Arabitol, and D-Glucose 1-phosphate, are intermediates or products of this pathway. Therefore, the changes in these genes and compounds strongly suggest that the Pentose and glucuronate interconversions pathway is involved in the specific condition under investigation."}], "target": "Pentose and glucuronate interconversions"}
{"messages": [{"role": "user", "content": "List of genes : <<< GSTM3,GSTM1,UGT1A4,FMO3,GSTA5,UGT1A9,GSTT4,UGT2B7,GSTA4,GSTT2B,FMO2,UGT1A6,UGT1A8,CYP2C9,ALDH3B2,CYP2A7,UGT2B28,UGT1A10,,FMO4,FMO1,UGT2A2 >>>\nList of compounds : <<< 3-Carbamoyl-2-phenylpropionic acid,Citalopram propionic acid,Valproic acid (USP),Isophosphoramide mustard,Felbamate (USPINN),3-Carbamoyl-2-phenylpropionaldehyde,Lidocaine (JP18/USP/INN),4-Ketoifosfamide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Drug metabolism - cytochrome P450\". This pathway was implicated due to the alterations observed in several genes and compounds associated with it. The list of genes includes various cytochrome P450 enzymes (CYP2C9, CYP2A7), UDP-glucuronosyltransferases (UGT1A4, UGT1A6, UGT1A8, UGT1A9, UGT1A10, UGT2A2, UGT2B28, UGT2B7), flavin-containing monooxygenases (FMO1, FMO2, FMO3, FMO4), and glutathione S-transferases (GSTM1, GSTM3, GSTA4, GSTA5, GSTT2B, GSTT4), all of which are key players in drug metabolism via the cytochrome P450 pathway. Similarly, the list of compounds includes drugs like Citalopram propionic acid, Felbamate, and Lidocaine, which are known substrates for cytochrome P450 enzymes, further supporting the involvement of this pathway."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< PPT1,HACD1,ACOT2,ELOVL6,ACOT1,THEM4,ACAA2,ELOVL4,ELOVL1 >>>\nList of compounds : <<< trans-Hexadec-2-enoyl-CoA,3-Oxotetradecanoyl-CoA,3-Oxoacyl-CoA,trans-2,3-Dehydroacyl-CoA,(S)-3-Hydroxytetradecanoyl-CoA,trans-Dec-2-enoyl-CoA,3-Oxodecanoyl-CoA,3-Oxododecanoyl-CoA,trans-Tetradec-2-enoyl-CoA,Hexanoyl-CoA,(S)-3-Hydroxydodecanoyl-CoA,Tetradecanoyl-CoA,(3S)-3-Hydroxyacyl-CoA,trans-Oct-2-enoyl-CoA,Acyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Fatty Acid Elongation pathway. This conclusion is supported by the alterations in multiple genes and compounds associated with this pathway. The genes PPT1, HACD1, ACOT2, ELOVL6, ACOT1, THEM4, ACAA2, ELOVL4, and ELOVL1 are all involved in various aspects of fatty acid elongation, including palmitoyl-protein thioesterase activity, fatty-acyl-CoA biosynthesis, and elongation of very long chain fatty acids. The altered compounds, such as trans-Hexadec-2-enoyl-CoA, 3-Oxotetradecanoyl-CoA, and (S)-3-Hydroxydodecanoyl-CoA, are intermediates in the fatty acid elongation process. Therefore, the changes observed in these genes and compounds suggest that the Fatty Acid Elongation pathway is significantly involved in the condition under study."}], "target": "Fatty acid elongation"}
{"messages": [{"role": "user", "content": "List of genes : <<< NME4,PDE8B,ADCY5,ADSS1,GUCY1A1,HDDC3,AK7,GMPS >>>\nList of compounds : <<< P1,P4-Bis(5'-guanosyl) tetraphosphate,Acetyl adenylate,alpha-D-Ribose 1-phosphate,XTP,2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine,HCO3-,5-Phosphoribosylamine,Ammonia,RNA,(S)-Ureidoglycine,DNA,(R)(-)-Allantoin,Ammonia,Xanthine,Inosine 5'-tetraphosphate,Oxamate,P1,P3-Bis(5'-adenosyl) triphosphate,5'-Butyrylphosphoinosine,ADP-ribose,Deoxyadenosine,1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole,N6-Succino-2-amino-2'-deoxyadenylate,ADP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Purine metabolism. This conclusion is supported by the alterations observed in multiple genes and compounds associated with this pathway. Genes such as ADCY5, GUCY1A1, and AK7 are involved in purine synthesis and degradation, while NME4 and HDDC3 are associated with purine nucleotide metabolism. The compounds detected, including P1,P4-Bis(5'-guanosyl) tetraphosphate, Acetyl adenylate, Alpha-D-Ribose 1-phosphate, Xanthine, Inosine 5'-tetraphosphate, ADP-ribose, and Deoxyadenosine, are intermediates or products in the Purine metabolism pathway. Furthermore, the presence of compounds like (S)-Ureidoglycine, (R)(-)-Allantoin, and N6-Succino-2-amino-2'-deoxyadenylate suggest involvement in purine catabolism. Therefore, the data strongly suggests that the Purine metabolism pathway is affected in the given conditions."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SEPSECS,PSTK,PAPSS2,KYAT3,SEPHS2,TXNRD3,SEPHS1,MARS2,CTH,TXNRD1,SCLY,MARS1,PAPSS1,MTR,KYAT1,TXNRD2,INMT >>>\nList of compounds : <<< Methylselenocysteine Se-oxide,Se-Methylselenomethionine,L-Selenomethionine,L-Selenocysteinyl-tRNA(Sec),Glutathioselenol,Selenate,L-Selenocysteine,Selenite,Protein,L-Seryl-tRNA(Sec),L-Selenocystathionine,Selenodiglutathione,Selenohomocysteine,Methylselenopyruvate,Methylselenic acid,1-Methylseleno-N-acetyl-D-galactosamine,Selenophosphoric acid,Methaneselenol,Adenylylselenate,Selenomethionyl-tRNA(Met) >>>"}, {"role": "assistant", "content": "The experiment identified the metabolic pathway of selenocompound metabolism. This pathway was inferred based on the alteration of multiple genes and compounds associated with selenium metabolism. Genes such as SEPSECS, SEPHS1, SEPHS2, and MARS1/2 are involved in selenocysteine biosynthesis and incorporation into proteins, while PSTK, PAPSS1/2, and TXNRD1/2/3 are involved in selenium activation and reduction. The altered compounds, including L-Selenomethionine, L-Selenocysteine, and various selenium-containing metabolites, further support this pathway identification. The involvement of selenocompound metabolism fits with the observed gene and compound alterations, suggesting that selenium metabolism plays a significant role in the condition under study."}], "target": "Selenocompound metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DDC,ADH5,AOX1,ADH1A,ADH7,COMT,TPO,ADH1B,DBH,ADH4,LRTOMT,GOT1,TYRP1,ALDH3B2,TAT,DCT,HGD,FAHD1,IL4I1,MIF,AOC3,FAH,ALDH3B1,ADH6,ADH1C >>>\nList of compounds : <<< 4-Coumarate,4-Maleylacetoacetate,3-Methoxy-4-hydroxyphenylacetaldehyde >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Tyrosine metabolism. This conclusion is supported by the alterations in several genes and compounds associated with this pathway. Genes such as DDC, COMT, TYRP1, and DBH are directly involved in the metabolism of tyrosine, an amino acid. The presence of 3-Methoxy-4-hydroxyphenylacetaldehyde, a compound derived from tyrosine metabolism, further strengthens this conclusion. Additionally, genes like ADH5, ADH1A, ADH7, ADH1B, ADH4, ALDH3B2, and ALDH3B1, which are part of the alcohol dehydrogenase and aldehyde dehydrogenase families, can be involved in the oxidation steps of tyrosine metabolism. The presence of 4-Maleylacetoacetate, a compound from the tyrosine degradation pathway, also supports this finding. The identification of these genes and compounds suggests that the Tyrosine metabolism pathway is significantly affected in the experimental conditions."}], "target": "Tyrosine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HEXB,SLC33A1,GLB1,ST3GAL5,B4GALNT1,ST6GALNAC6,ST3GAL2,ST6GALNAC5,B3GALT4,ST6GALNAC4,ST3GAL1,HEXA >>>\nList of compounds : <<< GD1a,GT1b,Fucosyl-GM1,GD1b,9-O-Acetylated GT3,N-Acetylgalactosaminyl GD1a,GQ1c,GM1b,GT3 >>>"}, {"role": "assistant", "content": "The experiment identified the metabolic pathway involved as the Glycosphingolipid biosynthesis - ganglio series. This pathway was implicated due to the alterations in genes and compounds that are directly associated with it.\n\nThe genes HEXB, GLB1, HEXA are known to be involved in lysosomal storage disorders, specifically related to the degradation of gangliosides, which are complex glycosphingolipids found in the ganglio series pathway. The other genes, such as SLC33A1, ST3GAL5, B4GALNT1, ST6GALNAC6, ST3GAL2, ST6GALNAC5, B3GALT4, ST6GALNAC4, ST3GAL1, encode for enzymes that catalyze steps in the biosynthesis of gangliosides, further supporting the involvement of this pathway.\n\nThe altered compounds, including GD1a, GT1b, Fucosyl-GM1, GD1b, 9-O-Acetylated GT3, N-Acetylgalactosaminyl GD1a, GQ1c, GM1b, GT3, are all complex gangliosides found in the ganglio series pathway. The changes in these compounds suggest disruptions in the biosynthesis or degradation of gangliosides, aligning with the altered genes and supporting the identification of the Glycosphingolipid biosynthesis - ganglio series pathway."}], "target": "Glycosphingolipid biosynthesis - ganglio series"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADH6,G6PC1,HK3,ALDH3B2,ALDOC,FBP2,ENO2,GALM,ADPGK,HK2,GPI,LDHC,ADH5,PFKP,ADH7,ENO3 >>>\nList of compounds : <<< 2-Phospho-D-glycerate,2,3-Bisphospho-D-glycerate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycolysis / Gluconeogenesis. This conclusion is supported by the alterations observed in multiple genes and compounds associated with this pathway. The genes ADH6, ADH5, and ADH7 encode for alcohol dehydrogenases, which are involved in the interconversion of alcohols and aldehydes. G6PC1 and GPI are involved in glucose metabolism. HK3, HK2, PFKP, FBP2, and ADPGK are key enzymes in glycolysis, while ENO2 and ENO3 are involved in the penultimate step of glycolysis. ALDH3B2 and ALDOC are involved in the conversion of fructose 1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate, respectively. GALM is involved in galactose metabolism, which can feed into glycolysis. The compounds 2-Phospho-D-glycerate and 2,3-Bisphospho-D-glycerate are intermediates in the glycolysis pathway, further supporting the identification of this pathway. Therefore, the observed alterations in these genes and compounds suggest that the Glycolysis / Gluconeogenesis pathway is significantly affected in the given conditions."}], "target": "Glycolysis / Gluconeogenesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< GPAT3,ALDH9A1,AGPAT4 >>>\nList of compounds : <<< 1-Acylglycerol,Glycerophosphoglycoglycerolipid,Acyl-CoA,Acyl-[acyl-carrier protein],UDP-glucose,Acyl1-monogalactosyl-diacylglycerol,3-beta-D-Galactosyl-sn-glycerol,1,2-Diacyl-sn-glycerol,1,2-Diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol,Sulfoquinovosyldiacylglycerol,2-Acyl-3-O-(beta-D-galactosyl)-sn-glycerol,Lipoteichoic acid,Triacylglycerol,Acyl-CoA,Glycerophosphoglycoglycerolipid,UDP-6-sulfoquinovose,1,2-Diacyl-3-beta-D-galactosyl-sn-glycerol,Phosphatidate,alpha-Kojibiosyldiacylglycerol,Diglucosyldiacylglycerol >>>"}, {"role": "assistant", "content": "The experiment identified the Glycerolipid metabolism pathway as being significantly altered. This pathway was implicated due to the changes observed in several genes and compounds associated with glycerolipid synthesis and degradation. The genes GPAT3 and AGPAT4, which encode enzymes involved in the initial steps of glycerolipid biosynthesis, were altered. Similarly, ALDH9A1, which is involved in the metabolism of certain glycerolipids, was also affected. The compounds affected include various intermediates and end products of glycerolipid metabolism such as 1-Acylglycerol, Triacylglycerol, Phosphatidate, and Sulfoquinovosyldiacylglycerol. These findings suggest that the Glycerolipid metabolism pathway is dysregulated in the specific condition under study."}], "target": "Glycerolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< FUT1,ST8SIA1,HEXA,ABO,GLA,GBGT1 >>>\nList of compounds : <<< NORint,Globo-H,GalGb3Cer,Globotriaosylceramide,V3(NeuAc)2-Gb5Cer,NOR2 antigen,Forssman antigen, IV3GalNAca-Gb4Cer,Globoside,IV4-alpha-Gal-Gb4Cer,iGb4-Cer,iGb3-Cer,Lactosylceramide,Disialosylglobopentaosylceramide,Globo-A,IV3GalNAcb-Gb4Cer,Monosialylgalactosylgloboside >>>"}, {"role": "assistant", "content": "The experiment identified the metabolic pathway of Glycosphingolipid biosynthesis - globo and isoglobo series. This pathway was implicated due to the alterations observed in genes such as FUT1, ST8SIA1, HEXA, ABO, GLA, and GBGT1, all of which are known to be involved in the biosynthesis of glycosphingolipids. Furthermore, the altered compounds, including NORint, Globo-H, GalGb3Cer, Globotriaosylceramide, and others, are direct products or intermediates in this pathway, providing further evidence for its involvement. The alterations in these genes and compounds suggest disruptions in the biosynthesis and/or degradation of globo and isoglobo series glycosphingolipids, which could potentially contribute to the observed condition."}], "target": "Glycosphingolipid biosynthesis - globo and isoglobo series"}
{"messages": [{"role": "user", "content": "List of genes : <<< IL4I1,,MAT1A,BCAT2,MDH1,GNMT,PSAT1,TST,DNMT3A,KYAT1,GCLC >>>\nList of compounds : <<< 2-Oxobutanoate,L-Aspartate,Thiocysteine,S-Sulfo-L-cysteine,Pyruvate,3-Sulfopyruvate,4-Phospho-L-aspartate,S-Glutathionyl-L-cysteine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Cysteine and methionine metabolism\". This conclusion is supported by the alterations in several genes and compounds associated with this pathway. The genes include IL4I1, MAT1A, BCAT2, MDH1, GNMT, PSAT1, TST, DNMT3A, KYAT1, and GCLC, all of which play crucial roles in cysteine and methionine metabolism. For instance, MAT1A is involved in methionine biosynthesis, while GCLC and KYAT1 are key enzymes in cysteine synthesis. Similarly, the altered compounds such as Thiocysteine, S-Sulfo-L-cysteine, S-Glutathionyl-L-cysteine, and 3-Sulfopyruvate are intermediates or byproducts of this pathway. Therefore, the changes observed in these genes and compounds strongly suggest that the Cysteine and methionine metabolism pathway is significantly involved in the condition studied."}], "target": "Cysteine and methionine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A6,GSTM4,MAOB,UGT1A10,UGT2B11,GSTM5,UGT2B4,CYP2B6,,UGT2B10,UGT1A9,UGT1A1,UGT2B7,GSTT4,CYP2C9,UGT1A7,FMO1,ALDH3A1,GSTA4,UGT2A3,CYP2D7,GSTO2,CYP2C19 >>>\nList of compounds : <<< 10-Hydroxycarbazepine,Methadone,4-Hydroxy-2,6-dimethylaniline,Nornitrogen mustard,3-Carbamoyl-2-phenylpropionaldehyde,2-Phenyl-1,3-propanediol monocarbamate,2-n-Propyl-4-pentenoic acid,N,N-Didesmethyltamoxifen,N-Desmethyltamoxifen,3-Carbamoyl-2-phenylpropionic acid,Carbamazepine (JP18/USP/INN) >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Drug metabolism - cytochrome P450. This pathway was implicated due to the alterations in various genes and compounds associated with this pathway. The genes list includes several cytochrome P450 (CYP) enzymes (CYP2B6, CYP2C9, CYP2C19, CYP2D7), UDP-glucuronosyltransferases (UGTs), flavin-containing monooxygenases (FMO1), and glutathione S-transferases (GSTs). These enzymes are crucial components of the cytochrome P450 pathway, responsible for metabolizing a wide range of drugs and other xenobiotics. The compound list also supports this, as several are known substrates or metabolites of these enzymes, such as Carbamazepine, Methadone, and Tamoxifen metabolites. Therefore, the alterations in these genes and compounds suggest that the Drug metabolism - cytochrome P450 pathway is significantly involved in the condition being studied."}], "target": "Drug metabolism - cytochrome P450"}
{"messages": [{"role": "user", "content": "List of genes : <<< TXNRD1,SCLY,PSTK >>>\nList of compounds : <<< Selenate,L-Selenocysteinyl-tRNA(Sec),Methylselenopyruvate,L-Selenocysteine,Trimethylselenonium,Methaneselenol,Adenylylselenate,Selenophosphoric acid,Hydrogen selenide >>>"}, {"role": "assistant", "content": "The metabolic pathway that was identified in this experiment is the Selenocompound metabolism. This pathway was implicated due to the alterations observed in several genes and compounds specifically associated with selenium metabolism. The genes TXNRD1, SCLY, and PSTK, which were affected, are all known to play crucial roles in selenium metabolism. TXNRD1 and SCLY are involved in selenocysteine biosynthesis and incorporation into proteins, while PSTK is involved in phosphoselenate reduction during selenate assimilation. The compounds that were altered, including Selenate, L-Selenocysteinyl-tRNA(Sec), Methylselenopyruvate, L-Selenocysteine, and others, are all intermediates or products in the Selenocompound metabolism pathway. Therefore, the changes in these genes and compounds strongly suggest that the Selenocompound metabolism pathway is involved in the condition under investigation."}], "target": "Selenocompound metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GPT2,PFKP,CS,SHMT2,ABHD14A-ACY1,ALDOA,IDH3A,ALDOC,PGAM4,CBS,TKTL1,GOT1,ASL,GAPDH,ACO1,PYCR3,ENO4,MTR >>>\nList of compounds : <<< LysW-L-ornithine,5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide,Carbamoyl phosphate,L-Methionine,Shikimate,N-(5-Phospho-D-ribosyl)anthranilate,(S)-2-Acetolactate,D-Ribulose 5-phosphate,L-Glutamate,LysW-gamma-L-alpha-aminoadipyl 6-phosphate,D-arabino-Hex-3-ulose 6-phosphate,L-Glutamyl 5-phosphate,N6-(L-1,3-Dicarboxypropyl)-L-lysine,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate,Isocitrate,N-Succinyl-2-L-amino-6-oxoheptanedioate,Ammonia,(S)-3-Methyl-2-oxopentanoic acid,(R)-2-Hydroxybutane-1,2,4-tricarboxylate,L-Cysteine,L-2-Amino-6-oxoheptanedioate,2,3,4,5-Tetrahydrodipicolinate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Biosynthesis of Amino Acids. This pathway was inferred from the alterations in genes and compounds related to amino acid metabolism. For instance, GPT2, GOT1, and ASL are involved in the synthesis of alanine, aspartate, and arginine, respectively. The compounds L-Glutamate, L-Methionine, and L-Cysteine are essential amino acids, while other compounds like Carbamoyl phosphate, Shikimate, and (S)-2-Acetolactate are intermediates in amino acid biosynthesis. The alterations in these genes and compounds suggest a disruption or enhancement in amino acid production, fitting with the identified pathway."}], "target": "Biosynthesis of amino acids"}
{"messages": [{"role": "user", "content": "List of genes : <<< DLD,TKT,IDH3B,HK1,SDHA,ALDOA,IDH1,PHGDH,RPEL1,SUCLA2,GPT,FH,GLDC,ACSS2,MDH1,GLUD2,GAPDH >>>\nList of compounds : <<< Hydroxypyruvate,Coenzyme M,4-Hydroxybutyryl-CoA,D-Fructose 1,6-bisphosphate,Formylmethanofuran >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Carbon metabolism. This pathway was implicated due to the alterations observed in multiple genes and compounds associated with it. The genes DLD, SDHA, IDH1, IDH3B, MDH1, FH, and GLUD2 are all involved in the citric acid cycle, a central component of carbon metabolism. The genes HK1, ALDOA, GAPDH, and PHGDH are involved in glycolysis and gluconeogenesis, which are also part of carbon metabolism. The genes GLDC, ACSS2, and GPT are involved in amino acid metabolism, which intersects with carbon metabolism. The altered compounds, including D-Fructose 1,6-bisphosphate, Hydroxypyruvate, and Formylmethanofuran, are intermediates in glycolysis and the citric acid cycle, further supporting the involvement of carbon metabolism in the observed condition."}], "target": "Carbon metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MOCOS,GCH1,AKR1B10,GGH,AKR1B15,ALPG,QDPR >>>\nList of compounds : <<< Molybdopterin,Tetrahydrobiopterin,2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,7,8-Dihydromonapterin 3'-triphosphate,THF-L-glutamate,6-Carboxy-5,6,7,8-tetrahydropterin,Pyrimidodiazepine,5,6,7,8-Tetrahydromethanopterin,Folate,Guanylyl molybdenum cofactor,4-(beta-D-Ribofuranosyl)aniline 5'-phosphate,Cytidylyl molybdenum cofactor,2,5-Diaminopyrimidine nucleoside triphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Folate biosynthesis. This conclusion is supported by the altered genes and compounds. Several genes involved in this pathway were identified, including MOCOS and QDPR, which are essential for molybdopterin and tetrahydrobiopterin cofactor biosynthesis, respectively. These cofactors are critical for the proper functioning of enzymes involved in folate metabolism. Additionally, the altered compounds include various forms of folate and its precursors, such as 7,8-Dihydromonapterin 3'-triphosphate and 6-Carboxy-5,6,7,8-tetrahydropterin, further supporting the involvement of the folate biosynthesis pathway. The altered AKR1B10 and AKR1B15 genes, which are involved in the metabolism of carbohydrates and steroids, may also indirectly affect folate metabolism by altering the availability of precursors or cofactors."}], "target": "Folate biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ENO3,SDSL,AMT,ADH5 >>>\nList of compounds : <<< D-Ribulose 5-phosphate,2-(Methylthio)ethanesulfonate,5-Formyl-5,6,7,8-tetrahydromethanopterin >>>"}, {"role": "assistant", "content": "The experiment identified the Carbon metabolism pathway as being significantly altered. The genes ENO3, involved in glycolysis, and ADH5, involved in ethanol metabolism, provide a direct link to carbon metabolism. The alteration in these genes could affect the conversion of glucose to pyruvate and the conversion of acetaldehyde to ethanol, respectively. The compound D-Ribulose 5-phosphate, a key intermediate in the Calvin cycle and pentose phosphate pathway, further supports this. The presence of 5-Formyl-5,6,7,8-tetrahydromethanopterin, a cofactor in the methanogenesis pathway, suggests a possible link to carbon metabolism through the methane cycle. The altered gene SDSL, involved in sulfur metabolism, could be linked to carbon metabolism through the assimilation of sulfur into organic compounds."}], "target": "Carbon metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< B3GALT5,ABO,ST3GAL2,HEXB,FUT2,HEXA,ST8SIA1,FUT1,A4GALT,FUT9,A3GALT2,GLA,GBGT1 >>>\nList of compounds : <<< Globo-B,iGb4-Cer,Globo-A,Globotriaosylceramide,Disialosylglobopentaosylceramide,IV4-alpha-Gal-Gb4Cer,Galactosylgloboside,iGb3-Cer >>>"}, {"role": "assistant", "content": "Based on the experiment, the metabolic pathway identified is the Glycosphingolipid biosynthesis - globo and isoglobo series. This pathway was inferred from the alterations in genes and compounds associated with this process. The genes such as B3GALT5, ABO, ST3GAL2, HEXB, FUT2, HEXA, ST8SIA1, FUT1, A4GALT, FUT9, A3GALT2, GLA, and GBGT1 are all involved in the synthesis and modification of glycosphingolipids, specifically those in the globo and isoglobo series. The altered compounds, including Globo-B, iGb4-Cer, Globo-A, Globotriaosylceramide, Disialosylglobopentaosylceramide, IV4-alpha-Gal-Gb4Cer, and Galactosylgloboside, iGb3-Cer, are direct products or intermediates of this pathway. Therefore, the changes observed in this experiment suggest that the Glycosphingolipid biosynthesis - globo and isoglobo series pathway is significantly affected in the comparison of the two conditions."}], "target": "Glycosphingolipid biosynthesis - globo and isoglobo series"}
{"messages": [{"role": "user", "content": "List of genes : <<< AK2,ALPI,AK8,ACP1 >>>\nList of compounds : <<< Sulfur-carrier protein,ADP-5-ethyl-4-methylthiazole-2-carboxylate,Thiamin monophosphate,5-(2-Hydroxyethyl)-4-methylthiazole,Aminoimidazole ribotide,2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate,NAD+,Thiamine,Pyruvate,Iminoglycine,L-Tyrosine,[Enzyme]-S-sulfanylcysteine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Thiamine metabolism. This pathway was inferred due to the alterations in genes and compounds directly associated with thiamine synthesis and metabolism. The genes AK2, AK8, and ACP1 are involved in energy metabolism, which is closely linked to thiamine as it is a coenzyme in various energy-producing reactions. ALPI, although not directly involved in thiamine metabolism, can indirectly affect it through its role in lipid metabolism. The compounds Thiamin monophosphate, Thiamine, and its precursors 5-(2-Hydroxyethyl)-4-methylthiazole and 2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, as well as the Sulfur-carrier protein, are key intermediates in the thiamine biosynthesis pathway. The presence of NAD+, Pyruvate, and L-Tyrosine suggests potential downstream effects of thiamine metabolism on other pathways. Therefore, the alterations in these genes and compounds are consistent with the identification of the Thiamine metabolism pathway."}], "target": "Thiamine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HPSE2,HGSNAT,HYAL2 >>>\nList of compounds : <<< Keratan sulfate,Dermatan sulfate,Chondroitin 4-sulfate,DWA-2,Heparan sulfate,Hyaluronic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Glycosaminoglycan degradation. This pathway was implicated due to the alterations observed in genes and compounds associated with this process. The genes HPSE2, HGSNAT, and HYAL2 are all involved in the degradation of Glycosaminoglycans. HPSE2 encodes for Heparanase, an enzyme that degrades heparan sulfate. HGSNAT is involved in N-acetylglucosamine metabolism, a key component of Glycosaminoglycans. HYAL2 encodes for Hyaluronidase-2, which degrades hyaluronic acid. The altered compounds, including Keratan sulfate, Dermatan sulfate, Chondroitin 4-sulfate, Heparan sulfate, and Hyaluronic acid, are all types of Glycosaminoglycans. Therefore, the changes in these genes and compounds suggest a dysregulation in the Glycosaminoglycan degradation pathway."}], "target": "Glycosaminoglycan degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< LIPA,CYP2R1,SOAT2,DHCR7,HSD17B7,CYP27B1,LSS,DHCR24,LBR,SOAT1,EBP,MSMO1,SC5D,CYP24A1,CYP51A1,SQLE,CEL,FDFT1 >>>\nList of compounds : <<< Episterol,Presqualene diphosphate,3beta-Hydroxy-4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-4alpha-carboxylate,3beta-Hydroxyergosta-7,24(24(1))-dien-4alpha-carboxylate,Lanosterol,4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol,5-Dehydroepisterol,Cycloartenol,4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol,Desmosterol,Stigmasterol,24-Ethylidenelophenol,Obtusifoliol,(S)-2,3-Epoxysqualene,Lathosterol,5-Dehydroepisterol,Campesterol,24-Methylenecholesterol,Fecosterol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is steroid biosynthesis. This conclusion is supported by the alterations observed in multiple genes and compounds involved in this pathway. The list of genes includes LIPA, CYP2R1, SOAT2, DHCR7, HSD17B7, CYP27B1, LSS, DHCR24, LBR, SOAT1, EBP, MSMO1, SC5D, CYP24A1, CYP51A1, SQLE, CEL, and FDFT1, all of which are known to play crucial roles in steroid synthesis. Similarly, the list of compounds includes various steroid intermediates such as Episterol, Lanosterol, Desmosterol, Stigmasterol, and Campesterol, further strengthening the conclusion that steroid biosynthesis is the affected pathway. These findings suggest that the condition being studied may be associated with disruptions in steroid synthesis and metabolism."}], "target": "Steroid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< B3GNT3,B4GALNT2,B4GALT2,ST3GAL4,ST8SIA1,B3GNT4,FUT6,B3GALT2,FUT7,ST3GAL3,B3GNT5,FUT2,FUT1,FUT9,ABO,B4GALT3,ST3GAL6 >>>\nList of compounds : <<< Fuc-3'-isoLM1,Fuc-Lc4Cer,iso-nLc8Cer,Type II B antigen,III3,IV2Fuca,IV3GalNAca-nLc4-Cer,Sialyl-3-paragloboside,VI3NeuAc-nLc6Cer,Paragloboside,IV2Fuc-Lc4Cer,BLeb glycolipid,nLc7Cer,Type IIIAb,Gal-TypeIIA glycolipid,VI6NeuAc-nLc6Cer,nLc8Cer,Lc4Cer,III3Fuc-nLc4Cer,IV4GalNAcb-SPG ganglioside,ALeb glycolipid,VI2Fuc-nLc6 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Glycosphingolipid biosynthesis - lacto and neolacto series\". This pathway is involved in the synthesis of complex glycosphingolipids, which are important components of cell membranes. The altered genes in this experiment, such as B3GNT3, B4GALT2, FUT6, and others, are known to be involved in the enzymatic steps of this pathway, specifically in the addition of various sugar residues to the lipid backbone. The altered compounds, including Fuc-3'-isoLM1, Paragloboside, and VI6NeuAc-nLc6Cer, are intermediates or end products of this pathway. The changes in these genes and compounds suggest alterations in the synthesis and structure of glycosphingolipids, which could potentially contribute to the specific condition under investigation."}], "target": "Glycosphingolipid biosynthesis - lacto and neolacto series"}
{"messages": [{"role": "user", "content": "List of genes : <<< BLVRA,CP,FXN,HMOX1,HMBS >>>\nList of compounds : <<< Precorrin 8X,Coproporphyrin III,5-Methoxy-6-methylbenzimidazole,L-Urobilin,Pheophorbide a,Heme d1,3-Vinylbacteriochlorophyllide a,12-Ethyl-8-propyl-3-vinylbacteriochlorophyllide d >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Porphyrin metabolism. This conclusion is supported by the alterations observed in genes such as BLVRA, CP, FXN, HMOX1, and HMBS, all of which are known to be involved in this pathway. The BLVRA gene encodes an enzyme that catalyzes a step in heme biosynthesis, while HMBS is involved in the synthesis of porphyrinogens. The CP gene encodes an enzyme that catalyzes the conversion of protoporphyrinogen IX to protoporphyrin IX, a crucial step in heme biosynthesis. The FXN gene is involved in iron-sulfur cluster assembly, which is necessary for heme synthesis. The HMOX1 gene encodes an enzyme that degrades heme to biliverdin, which is then converted to bilirubin. The alterations in these genes suggest dysregulation in the Porphyrin metabolism pathway. Furthermore, the altered compounds, including Precorrin 8X, Coproporphyrin III, and Heme d1, are all intermediates in the Porphyrin metabolism pathway, providing additional evidence for the involvement of this pathway in the observed condition."}], "target": "Porphyrin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A7,MPO >>>\nList of compounds : <<< 6-Mercaptopurine ribonucleoside 5'-diphosphate,Isonicotinoyl-NAD adduct,Tegafur (JP18/USAN/INN),6-Mercaptopurine ribonucleoside triphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Drug metabolism - other enzymes.\" This pathway was implicated due to the alterations observed in genes UGT1A7 and MPO, and compounds 6-Mercaptopurine ribonucleoside 5'-diphosphate, Isonicotinoyl-NAD adduct, Tegafur, and 6-Mercaptopurine ribonucleoside triphosphate. UGT1A7 is a UDP-glucuronosyltransferase involved in the metabolism of various drugs and xenobiotics. Myeloperoxidase (MPO) is an enzyme that catalyzes the production of reactive oxidants, which can affect drug metabolism. The altered compounds are metabolites or substrates of these enzymes, further supporting the involvement of this pathway. Thus, the changes in these genes and compounds suggest an altered drug metabolism in the studied condition."}], "target": "Drug metabolism - other enzymes"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADA2,AK1,NT5C3A,AMPD1,CMPK1,UPP2,NT5E,NME3,CDA >>>\nList of compounds : <<< L-Glutamine,N6-(1,2-Dicarboxyethyl)-AMP,2'-Deoxyinosine 5'-phosphate,5-Phospho-alpha-D-ribose 1-diphosphate,Adenosine,AMP,dATP,dUMP,dIDP,5-Phospho-alpha-D-ribose 1-diphosphate,Adenine,CTP,Cytosine,Deoxycytidine,Hypoxanthine,dCDP,IMP,dUTP,XDP,GTP,dAMP,dCTP,ADP,GMP,dTMP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Nucleotide Metabolism. This conclusion is supported by the alterations observed in multiple genes associated with this pathway, including ADA2, AK1, NT5C3A, AMPD1, CMPK1, UPP2, NT5E, NME3, and CDA. These genes are involved in various processes such as nucleotide salvage, deamination, and phosphorylation. The changes in compounds such as L-Glutamine, N6-(1,2-Dicarboxyethyl)-AMP, 2'-Deoxyinosine 5'-phosphate, Adenosine, AMP, dATP, dUMP, and others, which are intermediates or products of nucleotide metabolism, further corroborate this finding. Therefore, it is reasonable to conclude that the Nucleotide Metabolism pathway is significantly affected in the studied conditions."}], "target": "Nucleotide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT1,ASPA,NIT2,GLS,GFPT2,GPT,GLS2,ASNS,ADSS1,ADSS2,RIMKLB,GAD2,ASS1,GOT1L1,GFPT1,NAT8L,CPS1,AGXT2,AGXT >>>\nList of compounds : <<< (S)-1-Pyrroline-5-carboxylate,N6-(1,2-Dicarboxyethyl)-AMP,N-Acetylaspartylglutamylglutamate,2-Oxosuccinamate,2-Oxoglutarate,L-Asparagine,L-Glutamine,N-Acetyl-L-aspartate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Alanine, aspartate and glutamate metabolism. This pathway was implicated due to the alterations observed in various genes and compounds involved in this process. The genes GOT1, GOT1L1, GLS, GLS2, and GAD2 are associated with the conversion of glutamate to alpha-ketoglutarate, which is a key step in this pathway. The genes ASPA, ASNS, and ASS1 are involved in aspartate and asparagine metabolism, which are closely linked to glutamate metabolism. The compounds (S)-1-Pyrroline-5-carboxylate, 2-Oxosuccinamate, 2-Oxoglutarate, L-Asparagine, L-Glutamine, and N-Acetyl-L-aspartate are intermediates or products of this pathway, further supporting its involvement. Therefore, the alterations in these genes and compounds suggest that the Alanine, aspartate and glutamate metabolism pathway is significantly affected in the condition under study."}], "target": "Alanine, aspartate and glutamate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACP5,RFK,ACP2,ACP1,FLAD1 >>>\nList of compounds : <<< L-3,4-Dihydroxybutan-2-one 4-phosphate,Prenol,FMN,7-Hydroxy-6-methyl-8-ribityllumazine,Ribitol,Riboflavin,2,5-Diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one,Reduced riboflavin,5-Amino-6-(1-D-ribitylamino)uracil,FADH2,Dimethylallyl phosphate,Reduced FMN,Dimethylallyl diphosphate,Lumichrome,2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Riboflavin metabolism. This conclusion is supported by the alteration of several genes and compounds directly involved in this pathway. The genes RFK (riboflavin kinase), FLAD1 (flavin adenine dinucleotide synthase subunit alpha), and the compounds Riboflavin, FMN (flavin mononucleotide), FADH2 (flavin adenine dinucleotide), Reduced riboflavin, and Reduced FMN are all key components of this pathway. The other genes and compounds listed, such as ACP5, ACP2, ACP1, and prenol, are involved in other metabolic pathways but their alteration could potentially affect the Riboflavin metabolism pathway due to the interconnected nature of cellular metabolism."}], "target": "Riboflavin metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACSL3,ACOX3,ADH5,ADH7,EHHADH,ALDH9A1,ACSL5,ACSL4,ECI1,CPT2,ECHS1,ACSBG2,ECI2,ALDH3A2,CPT1C,ALDH7A1,ADH1A,ACADM,ACAT2,ACADVL,HADHA,ADH6 >>>\nList of compounds : <<< Palmitoyl-CoA,3-Oxododecanoyl-CoA,cis,cis-3,6-Dodecadienoyl-CoA,Fatty acid,Primary alcohol,Hexadecanal,trans-Dec-2-enoyl-CoA,Decanoyl-CoA,Crotonoyl-CoA,Hexadecanoic acid,2-trans-Dodecenoyl-CoA,(S)-3-Hydroxyhexadecanoyl-CoA,Reduced rubredoxin,(S)-Hydroxyhexanoyl-CoA,Butanoyl-CoA,Aldehyde,Hexanoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is fatty acid degradation. This is supported by the alterations in genes and compounds associated with this pathway. The genes include ACSL3, ACSL5, ACSL4, CPT1C, CPT2, ACADM, and ACADVL, which are involved in the activation, transport, and breakdown of fatty acids in beta-oxidation. The compounds such as Palmitoyl-CoA, 3-Oxododecanoyl-CoA, cis,cis-3,6-Dodecadienoyl-CoA, and Hexadecanoic acid are intermediate metabolites in this pathway. The alteration in these genes and compounds suggests a dysregulation in fatty acid degradation, fitting with the identified pathway."}], "target": "Fatty acid degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< SLC27A5,SCP2,AKR1D1,ACOX2,CYP7B1 >>>\nList of compounds : <<< Choloyl-CoA,3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA,Taurine,(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA,Glycine,Chenodeoxycholate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Primary bile acid biosynthesis. This conclusion aligns with the altered genes and compounds observed. The genes SLC27A5, ACOX2, and CYP7B1 are known to be involved in bile acid synthesis. SLC27A5 transports long-chain fatty acids, which are precursors to bile acids. ACOX2 is a peroxisomal enzyme involved in the initial step of bile acid synthesis, and CYP7B1 is involved in the conversion of cholesterol to bile acids. The altered compounds, such as Choloyl-CoA, 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA, and Chenodeoxycholate, are intermediates in the primary bile acid biosynthesis pathway. The presence of Taurine and Glycine, which are conjugated to bile acids for secretion, further supports the involvement of this pathway. Therefore, the data suggest that Primary bile acid biosynthesis is significantly impacted under the investigated conditions."}], "target": "Primary bile acid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A1,STS,AKR1C2,HSD17B12,UGT2A1,HSD3B2,CYP2E1,UGT2B4,AKR1D1,HSD17B7,SRD5A2,CYP7B1,CYP3A7-CYP3A51P >>>\nList of compounds : <<< Estrone 3-sulfate,Cholesterol sulfate,11beta-Hydroxyandrost-4-ene-3,17-dione,Cholesterol,Androsterone glucuronide,2-Methoxyestradiol-17beta 3-sulfate,3beta-Hydroxypregn-5-en-20-one sulfate,22(R)-Hydroxycholesterol,Estradiol-17beta,17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione,2-Hydroxyestradiol,Dehydroepiandrosterone,16-Glucuronide-estriol,Dehydroepiandrosterone sulfate,Tetrahydrocorticosterone,5alpha-Pregnan-20alpha-ol-3-one,2-Methoxy-estradiol-17beta 3-glucuronide,Estradiol-17beta 3-glucuronide,Etiocholanolone,Estrone >>>"}, {"role": "assistant", "content": "Based on the analysis of the altered genes and compounds, the metabolic pathway identified is Steroid hormone biosynthesis. This pathway involves the conversion of cholesterol into various steroid hormones such as androgens, estrogens, progestogens, and corticosteroids. The genes listed, including UGT1A1, STS, AKR1C2, HSD17B12, UGT2A1, HSD3B2, CYP2E1, UGT2B4, AKR1D1, HSD17B7, SRD5A2, CYP7B1, and CYP3A7-CYP3A51P, all play roles in the synthesis, metabolism, and regulation of these steroid hormones. The altered compounds, which include various forms of cholesterol, androgens, and estrogens, further support the involvement of this pathway. The observed changes suggest disturbances in the synthesis, conjugation, and degradation of steroid hormones, which are all key processes in the Steroid hormone biosynthesis pathway."}], "target": "Steroid hormone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G12B,PLA2G2E,PLA2G4F,PLPP3,SELENOI,PLA2G1B,PAFAH1B3,PAFAH1B1,PLAAT3 >>>\nList of compounds : <<< 1-(1-Alkenyl)-sn-glycerol,1-Alkyl-2-acylglycerol,1-Organyl-2-lyso-sn-glycero-3-phosphocholine,1-(1-Alkenyl)-sn-glycero-3-phosphocholine,2-Acyl-1-alkyl-sn-glycero-3-phosphate,Galactosyl-1-alkyl-2-acylglycerol,2-Acetyl-1-alkyl-sn-glycero-3-phosphate,Acylglycerone phosphate,sn-Glycero-3-phosphocholine,1-Alkyl-2-acetyl-sn-glycerol,1-(1-Alkenyl)-sn-glycero-3-phosphate,O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine,1-Radyl-2-acyl-sn-glycero-3-phosphocholine,1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine,1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol,2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine,1-Alkyl-2-acylglycerophosphoethanolamine,O-Alkylglycerone phosphate,Plasmenylcholine,1-Alkyl-sn-glycerol,1-Alkyl-sn-glycero-3-phosphate,sn-Glycero-3-phosphoethanolamine,1-Alkenyl-2-acylglycerol,Seminolipid,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the Ether Lipid Metabolism pathway. This conclusion is supported by the alterations in genes and compounds involved in this pathway.\n\nThe genes PLA2G12B, PLA2G2E, PLA2G4F, PLA2G1B, PLAAT3, and SELENOI are all associated with the metabolism of phospholipids, specifically those containing ether bonds. The PAFAH1B3 and PAFAH1B1 genes are involved in the degradation of ether lipids, further supporting this pathway.\n\nThe compounds listed, such as 1-(1-Alkenyl)-sn-glycerol, 1-Alkyl-2-acylglycerol, and Plasmenylcholine, are key intermediates and end products in the Ether Lipid Metabolism pathway. Additionally, the presence of compounds like 1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol and Seminolipid, which are specific to this pathway, further strengthens the conclusion. Therefore, based on the altered genes and compounds, the Ether Lipid Metabolism pathway is implicated in the condition under investigation."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G4F,CYP2J2,PLA2G4B,CYP2E1,PLA2G2D,PLA2G2F,PLA2G12A,CYP2C9,PLA2G4C,PLA2G2C,PLA2G12B,PLA2G5,PLB1,CYP1A2,PLA2G3,PLA2G1B,PLA2G4E,PLAAT2 >>>\nList of compounds : <<< 12,13-Epoxy-9-hydroxy-10-octadecenoate,Phosphatidylcholine,9,10-12,13-Diepoxyoctadecanoate,8(R)-HPODE,9,10-Dihydroxy-12,13-epoxyoctadecanoate,9,10-Epoxy-13-hydroxy-11-octadecenoate,12,13-DHOME,Crepenynate,(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate,12,13-Epoxy-9-hydroxy-10-octadecenoate,9(10)-EpOME,9-OxoODE,13-OxoODE,9,12,13-TriHOME,5S,8R-DiHODE,12(13)-EpOME,Dihomo-gamma-linolenate,(7S,8S)-DiHODE,13(S)-HODE >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Linoleic Acid Metabolism. This pathway is strongly supported by the altered genes and compounds. The majority of the genes listed, such as PLA2Gs and CYPs, are involved in the metabolism of linoleic acid. These genes encode phospholipases and cytochrome P450 enzymes, which are responsible for the release and oxidation of linoleic acid, respectively. The compounds listed are metabolites of linoleic acid, including various hydroxy-, epoxy-, and oxo-derivatives. This suggests that the linoleic acid metabolism pathway is significantly altered in the two conditions being compared."}], "target": "Linoleic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALDH3A2,IVD,OXCT2,ALDH1B1,ALDH7A1,ALDH9A1,MCEE,EHHADH >>>\nList of compounds : <<< [Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine,3-Methyl-2-oxobutanoic acid,(S)-2-Methylbutanoyl-CoA,(S)-3-Hydroxyisobutyrate,2-Methylbut-2-enoyl-CoA,(S)-Methylmalonyl-CoA,Acetoacetyl-CoA,Enzyme N6-(dihydrolipoyl)lysine,(S)-3-Hydroxy-3-methylglutaryl-CoA,3-Methyl-1-hydroxybutyl-ThPP,Acetoacetate,3-Methylbutanoyl-CoA,L-Leucine,Acetyl-CoA,(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA,(S)-3-Methyl-2-oxopentanoic acid,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine,Thiamin diphosphate,2-Methylprop-2-enoyl-CoA,Succinyl-CoA,Methylmalonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Valine, Leucine, and Isoleucine Degradation. This pathway was identified due to the alterations in genes such as ALDH3A2, ALDH1B1, ALDH7A1, and ALDH9A1, which are involved in the degradation of branched-chain amino acids. The presence of compounds like L-Leucine, (S)-3-Methyl-2-oxobutanoic acid, and (S)-3-Methyl-2-oxopentanoic acid, which are intermediates in this pathway, further supports this identification. Additionally, the alteration in compounds like Acetoacetyl-CoA and Acetoacetate, which are end products of this pathway, provides further evidence. Therefore, the data suggests that this pathway is significantly affected in the given condition."}], "target": "Valine, leucine and isoleucine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< ST20-MTHFS,MTHFD2L,MTHFD2,MTFMT,GART,TYMS,MTHFD1,MTHFD1L,MTHFS,DHFR >>>\nList of compounds : <<< Folate,Tetrahydrofolate,5-Methyltetrahydrofolate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"One Carbon Pool by Folate\". This pathway was implicated due to the alterations in genes and compounds associated with folate metabolism. The genes ST20-MTHFS, MTHFD2L, MTHFD2, MTMFT, GART, TYMS, MTHFD1, MTHFD1L, MTHFS, and DHFR are all involved in different steps of this pathway, from folate conversion to tetrahydrofolate, to methylation reactions, and nucleotide synthesis. The altered compounds, Folate, Tetrahydrofolate, and 5-Methyltetrahydrofolate, are key intermediates in this pathway. Therefore, the changes observed in these genes and compounds suggest a significant role of the One Carbon Pool by Folate pathway in the condition under study."}], "target": "One carbon pool by folate"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G2D,PLA2G4A,PLA2G2F,PLA2G4B,PLB1,ACOX3,PLA2G2E,PLA2G1B,PLA2G4E >>>\nList of compounds : <<< Etherolenic acid,3-Oxo-OPC6-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the alpha-Linolenic acid metabolism. This pathway was implicated due to the alterations observed in several genes and compounds associated with it. The genes PLA2G2D, PLA2G4A, PLA2G2F, PLA2G4B, PLA2G2E, PLA2G1B, and PLA2G4E are all members of the phospholipase A2 family, which are involved in the initial step of alpha-Linolenic acid metabolism by releasing it from membrane phospholipids. The gene ACOX3 encodes an enzyme responsible for the first step in peroxisomal beta-oxidation of fatty acids, including alpha-Linolenic acid. The compound 3-Oxo-OPC6-CoA is an intermediate in this pathway. The presence of Etherolenic acid, a derivative of alpha-Linolenic acid, further supports the involvement of this pathway. Therefore, the observed alterations in these genes and compounds suggest a significant role for the alpha-Linolenic acid metabolism in the studied condition."}], "target": "alpha-Linolenic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DHFR,MTHFS,SHMT1,MTHFR,MTHFD1L,FTCD,SHMT2,GART,MTFMT,AMT,MTHFD2L,ALDH1L2,DHFR2,ATIC,MTR,ALDH1L1,MTHFD2,ST20-MTHFS,MTHFD1 >>>\nList of compounds : <<< 5,10-Methylenetetrahydrofolate,10-Formyltetrahydrofolate,5-Methyltetrahydrofolate,Folinic acid,5,10-Methenyltetrahydrofolate,Folate,Dihydrofolate,5-Formiminotetrahydrofolate >>>"}, {"role": "assistant", "content": "The experiment identified the One Carbon Pool by Folate metabolic pathway as being altered. This pathway is involved in the transfer of one-carbon units in various biosynthetic reactions, such as nucleotide synthesis, methylation reactions, and amino acid metabolism. The alteration of genes including DHFR, MTHFS, SHMT1, MTHFR, MTHFD1L, FTCD, SHMT2, GART, MTMFT, AMT, MTHFD2L, ALDH1L2, DHFR2, ATIC, MTR, MTHFD2, ST20-MTHFS, and MTHFD1 supports this finding. These genes encode enzymes that participate in folate metabolism and the interconversion of one-carbon units. Additionally, the alteration of compounds such as 5,10-Methylenetetrahydrofolate, 10-Formyltetrahydrofolate, 5-Methyltetrahydrofolate, Folinic acid, 5,10-Methenyltetrahydrofolate, Folate, Dihydrofolate, and 5-Formiminotetrahydrofolate, which are key intermediates in this pathway, further supports the involvement of the One Carbon Pool by Folate pathway in the observed condition."}], "target": "One carbon pool by folate"}
{"messages": [{"role": "user", "content": "List of genes : <<< DHFR,MTHFD2,MTFMT,SHMT2,AMT,ALDH1L1,MTHFD1,ST20-MTHFS,GART,FTCD,SHMT1 >>>\nList of compounds : <<< 5-Methyltetrahydrofolate,Tetrahydrofolate,Folate,5-Formiminotetrahydrofolate,Folinic acid,Dihydrofolate,10-Formyltetrahydrofolate >>>"}, {"role": "assistant", "content": "The experiment identified the One Carbon Pool by Folate metabolic pathway as being significantly altered in the two conditions. This pathway involves the transfer of one-carbon units, which is essential for various biosynthetic processes such as nucleotide synthesis, methylation reactions, and amino acid metabolism. The alterations in genes including DHFR, MTHFD2, MTFMT, SHMT2, AMT, ALDH1L1, MTHFD1, ST20-MTHFS, GART, FTCD, and SHMT1, which are key enzymes in this pathway, support this finding. Furthermore, the changes in compounds such as 5-Methyltetrahydrofolate, Tetrahydrofolate, Folate, 5-Formiminotetrahydrofolate, Folinic acid, Dihydrofolate, and 10-Formyltetrahydrofolate, which are intermediates and cofactors in this pathway, provide additional evidence for its involvement in the observed condition."}], "target": "One carbon pool by folate"}
{"messages": [{"role": "user", "content": "List of genes : <<< NADK,SIRT7 >>>\nList of compounds : <<< Succinate semialdehyde,(R)-6-Hydroxynicotine,1-Methylnicotinamide,Nicotinate D-ribonucleoside,L-Aspartate,Propanoate,2,3-Dimethylmaleate,6-Hydroxy-3-succinoylpyridine,Deamino-NAD+,Methylitaconate,6-Hydroxypseudooxynicotine,(S)-2-(Hydroxymethyl)glutarate,1-Methylpyrrolinium,5-(N-Methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol,6-Hydroxynicotinate,2,6-Dihydroxynicotinate,(2R,3S)-2,3-Dimethylmalate,2,5-Dihydroxypyridine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Nicotinate and Nicotinamide Metabolism. This pathway was implicated due to the alterations observed in the genes NADK and SIRT7, and the compounds associated with this pathway. NADK encodes Nicotinamide mononucleotide kinase, an enzyme involved in the synthesis of NAD+, while SIRT7 is a NAD+-dependent protein deacetylase. The altered compounds, such as Nicotinate D-ribonucleoside, 1-Methylnicotinamide, and Deamino-NAD+, are direct intermediates or products of this pathway. Additionally, the presence of compounds like 6-Hydroxynicotinate and 2,6-Dihydroxynicotinate, which are metabolites of nicotinate, further supports the involvement of this pathway. Therefore, the observed changes in gene expression and metabolite levels suggest perturbations in the Nicotinate and Nicotinamide Metabolism pathway."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AUH,ECHS1,MCCC2,OXCT2,ALDH3A2,DLD,BCKDHA,ALDH6A1,IL4I1,ACADS,HADHB,ACAA1,ALDH2,ACAD8,ABAT,AGXT2,BCKDHB,ACAA2,ALDH7A1,HIBADH,HMGCS1,HMGCS2,HMGCL >>>\nList of compounds : <<< [Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine,(S)-Methylmalonate semialdehyde,(S)-Methylmalonyl-CoA,3-Hydroxyisovalerate,(S)-3-Hydroxyisobutyrate,L-3-Aminoisobutanoate,L-Isoleucine,3-Methylbutanoyl-CoA,Acetoacetate,Methylmalonate,3-Methylglutaconyl-CoA,(S)-3-Methyl-2-oxopentanoic acid,(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA,Enzyme N6-(lipoyl)lysine,3-Methyl-1-hydroxybutyl-ThPP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Valine, Leucine, and Isoleucine Degradation pathway. This is supported by the altered genes and compounds. Several genes involved in this pathway were affected, including ECHS1, MCCC2, OXCT2, ACADS, HADHB, ACAA1, ACAA2, and HIBADH, which are associated with the degradation of branched-chain amino acids (BCAAs) like valine, leucine, and isoleucine. The altered compounds, such as (S)-Methylmalonate semialdehyde, (S)-Methylmalonyl-CoA, 3-Hydroxyisovalerate, L-Isoleucine, and 3-Methylbutanoyl-CoA, are intermediates in this pathway. The presence of these compounds further supports the identification of this pathway. Therefore, the changes in these genes and compounds suggest that the Valine, Leucine, and Isoleucine Degradation pathway is significantly affected in the given condition."}], "target": "Valine, leucine and isoleucine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< GALNT12,GALNT15,ST6GALNAC4,GALNT3,GALNT14 >>>\nList of compounds : <<< [Protein]-L-serine,UDP-N-acetyl-D-galactosamine,Tn antigen,T antigen,Sialyl-Tn antigen >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Mucin type O-glycan biosynthesis. This pathway was implicated due to the alterations observed in several genes and compounds directly involved in this process. The genes GALNT12, GALNT15, ST6GALNAC4, GALNT3, and GALNT14 are all responsible for the initiation and elongation of O-glycan chains in mucin proteins. The altered compounds, including [Protein]-L-serine, UDP-N-acetyl-D-galactosamine, Tn antigen, T antigen, and Sialyl-Tn antigen, are key substrates and products in this pathway. The Tn and T antigens are truncated O-glycans, and the Sialyl-Tn antigen is a sialylated form of the Tn antigen, all indicating disruptions in the O-glycan biosynthesis pathway. Therefore, the changes in these genes and compounds strongly suggest that the Mucin type O-glycan biosynthesis pathway is involved in the observed condition."}], "target": "Mucin type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< AUH,BCKDHA,ALDH2,MCCC1,MCCC2,ACAD8,AACS,ALDH7A1,ALDH6A1,PCCA,ACAT2,IVD,BCAT2,ACAA1,HMGCL,ABAT,MMUT,EHHADH,ALDH3A2 >>>\nList of compounds : <<< Enzyme N6-(dihydrolipoyl)lysine,Thiamin diphosphate,L-Valine,3-Methylglutaconyl-CoA,2-Methylprop-2-enoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the \"Valine, leucine and isoleucine degradation\" pathway. This conclusion is supported by the alterations in several genes and compounds associated with this pathway. The genes AUH, BCKDHA, BCAT2, and IVD are involved in the initial steps of the degradation of valine, leucine, and isoleucine. The gene ALDH2 and the compound Enzyme N6-(dihydrolipoyl)lysine are involved in the subsequent steps of this pathway. The presence of L-Valine and 3-Methylglutaconyl-CoA, intermediate compounds in this pathway, further strengthens this conclusion. The alterations in other genes such as MCCC1, MCCC2, and HMGCL may indicate crosstalk with other pathways, particularly the propanoate metabolism and ketone body metabolism, which are linked to the degradation of branched-chain amino acids."}], "target": "Valine, leucine and isoleucine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< MIF,PAH,ALDH3B1,GOT1,AOC3,AOC2,GOT2,ALDH3A1,GOT1L1,MAOB,DDC,MAOA,TAT,IL4I1 >>>\nList of compounds : <<< Succinate,trans-3-Hydroxycinnamate,3-Oxoadipyl-CoA,Phenylethyl alcohol,Fumarate,2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoA,Phenylacetylglutamine,L-Tyrosine,2-Phenylacetamide,2,6-Dihydroxyphenylacetate,Phenylpyruvate,Phenylacetic acid,4-Hydroxy-2-oxopentanoate,L-Phenylalanine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Phenylalanine metabolism. This is supported by the alterations observed in several genes and compounds involved in this pathway. For instance, genes such as PAH (Phenylalanine hydroxylase), DDC (Dopa decarboxylase), and MAOA and MAOB (Monoamine oxidases A and B) are directly involved in Phenylalanine metabolism. Similarly, the altered compounds including L-Phenylalanine, L-Tyrosine, Phenylpyruvate, Phenylacetic acid, and Phenylacetylglutamine are key intermediates in this pathway. Therefore, the changes in these genes and compounds suggest that the Phenylalanine metabolism pathway is significantly impacted in the given condition."}], "target": "Phenylalanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< LIPA,DHCR7,SOAT1 >>>\nList of compounds : <<< Vitamin D3,Lanosterol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Steroid Biosynthesis. This conclusion is supported by the alterations observed in the genes and compounds involved in this pathway. Specifically, LIPA (Lysosomal Acid Lipase) is involved in lipid metabolism and can indirectly affect steroid synthesis. DHCR7 (7-Dehydrocholesterol Reductase) is a key enzyme in the final step of cholesterol synthesis, which is a precursor to all steroids. SOAT1 (Sterol O-Acyltransferase 1) regulates cholesterol esterification and storage. The presence of Vitamin D3 and Lanosterol further supports this finding. Vitamin D3 is a steroid hormone, and Lanosterol is a key intermediate in the steroid biosynthesis pathway. Therefore, the alterations in these genes and compounds suggest that the Steroid Biosynthesis pathway is significantly affected in the experimental conditions."}], "target": "Steroid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G4D,PLPP3,LPCAT2,PLA2G12A,PLA2G2D,PLPP2,LPCAT4,AGPS,PLD2,GAL3ST1,SELENOI,PAFAH1B3,PLA2G2C,PLA2G1B,PAFAH1B1,PLAAT2,PLA2G6 >>>\nList of compounds : <<< 1-Organyl-2-lyso-sn-glycero-3-phosphocholine,2-Acyl-1-alkyl-sn-glycero-3-phosphate,1-Radyl-2-acyl-sn-glycero-3-phosphocholine,1-Alkyl-2-acetyl-sn-glycerol,1-Alkyl-2-acylglycerophosphoethanolamine,O-Alkylglycerone phosphate,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate,O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine,Plasmenylcholine,1-(1-Alkenyl)-sn-glycerol,Acylglycerone phosphate,Seminolipid,1-Alkyl-2-acylglycerol,1-Alkenyl-2-acylglycerol,1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Ether lipid metabolism. This pathway was indicated by the alterations in genes and compounds associated with ether lipids, specifically plasmalogens. Genes such as PLA2G4D, PLA2G12A, PLA2G2D, PLA2G2C, PLA2G1B, PLAAT2, and PLA2G6 are phospholipases involved in the remodeling of plasmalogens, while AGPS, SELENOI, and PAFAH1B1/1B3 are involved in their biosynthesis. The altered compounds, including Plasmenylcholine, 1-Alkyl-2-acylglycerophosphoethanolamine, and 1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol, are intermediates or end products in the Ether lipid metabolism pathway. Therefore, the changes in these genes and compounds suggest that the Ether lipid metabolism pathway is involved in the observed condition."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DGLUCY,GLS2,DDO >>>\nList of compounds : <<< 4-Methylthio-2-oxobutanoic acid,L-Phenylalanine,Cadaverine,D-Lombricine,L-Methionine,D-Cysteine,1-Pyrroline-2-carboxylate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is D-Amino acid metabolism. This pathway was implicated due to the alterations observed in several key genes and compounds. The gene DGLUCY is associated with the metabolism of D-amino acids, while GLS2 and DDO are involved in the metabolism of other amino acids, which can indirectly affect D-amino acid levels. The altered compounds, including D-Lombricine and D-Cysteine, are D-amino acids themselves, further supporting the involvement of this pathway. Additionally, the presence of 1-Pyrroline-2-carboxylate, an intermediate in amino acid metabolism, and the changes in L-Methionine and L-Phenylalanine, which can be converted to D-amino acids, provide additional evidence. Therefore, the data suggest that alterations in D-Amino acid metabolism may be a key factor in the observed conditions."}], "target": "D-Amino acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< AMPD2,NPR2,PAPSS1,ADCY8,PAICS,ADCY2,PRPS2,PDE4A,ADCY3,NT5C2,PDE10A,GMPR,PRPS1,RRM2B,NT5E,ADCY10 >>>\nList of compounds : <<< 2,8-Dihydroxyadenine,L-Glutamine,Adenosine 3',5'-bisphosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Purine metabolism. This is supported by the alterations in several genes and compounds directly involved in this pathway. The genes AMPD2, ADCY8, PAICS, PRPS1, PRPS2, NT5C2, NT5E, and GMPR are all associated with purine metabolism. AMPD2 and NT5E are involved in the degradation of purines, while PAICS, PRPS1, and PRPS2 are involved in purine biosynthesis. The presence of 2,8-Dihydroxyadenine, a metabolite in purine degradation, and Adenosine 3',5'-bisphosphate, a key intermediate in purine biosynthesis, further supports this finding. The alteration of L-Glutamine, which can be used as a nitrogen source for purine synthesis, also fits with the involvement of the Purine metabolism pathway in the observed condition."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CPT1B,SCD,SCD5,PPT1,ELOVL3,ACSL5 >>>\nList of compounds : <<< Malonate,Malonyl-[acyl-carrier protein],Linoleoyl-[acyl-carrier protein],(8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosahexaenoyl-CoA,Octanoyl-[acp],(9Z,12Z,15Z)-Octadecatrienoyl-CoA,trans-Hexadec-2-enoyl-CoA,Palmitoyl-CoA,Decanoyl-CoA,(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA,Linoleoyl-CoA,But-2-enoyl-[acyl-carrier protein],Palmitoyl-CoA,trans-Dec-2-enoyl-[acp],Butyryl-[acp],trans-Hex-2-enoyl-[acp],(3R)-3-Hydroxyoctanoyl-[acyl-carrier protein],(11Z,14Z,17Z)-Icosatrienoyl-CoA,(3R,6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexaenoyl-CoA,Acetoacetyl-CoA,(8Z,11Z,14Z,17Z,20Z)-Hexacosapentaenoyl-CoA,(6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA,(11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is fatty acid metabolism. This conclusion is supported by the alterations observed in genes and compounds directly involved in this pathway. The genes CPT1B, SCD, SCD5, ELOVL3, and ACSL5 are all associated with fatty acid synthesis, elongation, desaturation, and transport. The compounds identified, such as Malonyl-[acyl-carrier protein], Linoleoyl-[acyl-carrier protein], and various acyl-CoA compounds, are intermediates in fatty acid metabolism. The presence of these compounds and the alteration of genes involved in their metabolism suggest that fatty acid metabolism is significantly affected in the conditions being compared."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GDPD3,TMEM86B,GDPD1,PLA2G10,PLA2G12B,PLAAT2,PLA2G4D,PLA2G4B,PEDS1-UBE2V1,PLA2G1B,PLA2G4C >>>\nList of compounds : <<< 1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol,O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine,O-Alkylglycerone phosphate,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate,2-Acyl-1-alkyl-sn-glycero-3-phosphate,Galactosyl-1-alkyl-2-acylglycerol,sn-Glycero-3-phosphoethanolamine,1-Organyl-2-lyso-sn-glycero-3-phosphocholine,1-(1-Alkenyl)-sn-glycero-3-phosphate,1-Alkenyl-2-acylglycerol,1-Radyl-2-acyl-sn-glycero-3-phosphocholine,1-Alkyl-sn-glycerol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Ether Lipid Metabolism. This pathway was implicated due to the alterations observed in several genes and compounds associated with this pathway. The genes GDPD3, GDPD1, PLA2G10, PLA2G12B, PLAAT2, PLA2G4D, PLA2G4B, PLA2G1B, and PLA2G4C are involved in the synthesis and degradation of ether lipids. The altered compounds, such as 1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol, O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine, and 1-Alkyl-2-acylglycerol, are direct intermediates and products of the Ether Lipid Metabolism pathway. These findings suggest that the observed condition may be influenced by changes in ether lipid synthesis and metabolism."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MCCC2,MCEE,ACADSB,ACAT2,ACAD8 >>>\nList of compounds : <<< Thiamin diphosphate,L-Valine,Thiamin diphosphate,(S)-3-Methyl-2-oxopentanoic acid,Acetoacetate,L-3-Aminoisobutanoate,2-Methyl-1-hydroxypropyl-ThPP,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine,3-Methylglutaconyl-CoA,4-Methyl-2-oxopentanoate,3-Methyl-2-oxobutanoic acid,(S)-3-Hydroxy-3-methylglutaryl-CoA,L-Isoleucine,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine,Acetyl-CoA,3-Methyl-1-hydroxybutyl-ThPP,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine,2-Methylprop-2-enoyl-CoA,Propanoyl-CoA,Enzyme N6-(dihydrolipoyl)lysine,3-Hydroxyisovalerate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Valine, Leucine, and Isoleucine Degradation. This is supported by the alteration of several genes and compounds associated with this pathway. The genes MCCC2, MCEE, ACADSB, ACAT2, and ACAD8 are all involved in this pathway. MCCC2 and MCEE are involved in the degradation of isoleucine, while ACADSB and ACAT2 are involved in the degradation of valine. ACAD8 is involved in the degradation of both valine and isoleucine. The altered compounds, such as L-Valine, L-Isoleucine, (S)-3-Methyl-2-oxopentanoic acid, 3-Methylglutaconyl-CoA, and 3-Hydroxyisovalerate, are all intermediates in this pathway. Therefore, the data suggest that this pathway is significantly affected in the experimental conditions."}], "target": "Valine, leucine and isoleucine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLAAT3,PLA2G4C,PLA2G10,PLA2G2F,PLB1,PLA2G4D,PLA2G4B,ACOX1,PLA2G4A,PLAAT2,PLA2G12A >>>\nList of compounds : <<< (+)-7-Isojasmonic acid,Traumatin,13(S)-HOT >>>"}, {"role": "assistant", "content": "The experiment identified the alpha-linolenic acid metabolism pathway as being involved in the specific condition. This pathway was implicated due to the alterations observed in several genes and compounds associated with it. The genes PLAAT3, PLA2G4C, PLA2G10, PLA2G2F, PLB1, PLA2G4D, PLA2G4B, ACOX1, PLA2G4A, PLAAT2, and PLA2G12A are all involved in the metabolism of alpha-linolenic acid, either through the hydrolysis of phospholipids or the beta-oxidation of fatty acids. Additionally, the compounds (+)-7-Isojasmonic acid, Traumatin, and 13(S)-HOT are all metabolites of alpha-linolenic acid. The alterations in these genes and compounds suggest that the alpha-linolenic acid metabolism pathway is disrupted in the specific condition."}], "target": "alpha-Linolenic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT2B28,AKR1B15,UGT1A5,UGT1A3,GUSB,XYLB,UGT2B15,UGT2A2,CRPPA,UGT2B7,CRYL1 >>>\nList of compounds : <<< Pectin,D-Ribulose,UDP-glucose,D-Ribulose 1-phosphate,D-Xylono-1,4-lactone,CDP-ribitol,Glycerone phosphate,Glycerone phosphate,UDP-glucuronate,L-Arabitol,L-Arabinose,2-Dehydro-3-deoxy-L-galactonate,D-Galacturonate,5-Dehydro-4-deoxy-D-glucuronate,L-Ribulose 5-phosphate,D-Arabinose,3-Dehydro-L-gulonate,D-Altronate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Pentose and glucuronate interconversions\". This pathway involves the interconversion of pentose sugars and uronic acids, such as glucuronate, which are important in the metabolism of carbohydrates and the detoxification of xenobiotics. The altered genes in the experiment, including UGT2B28, UGT1A5, UGT1A3, UGT2B15, UGT2A2, and UGT2B7, are all UDP-glucuronosyltransferases, enzymes that catalyze the conjugation of glucuronic acid to various substrates. The altered compounds, including D-Ribulose, UDP-glucose, UDP-glucuronate, and various pentose and uronic acid derivatives, are all intermediates or products of this pathway. Therefore, the changes in these genes and compounds are consistent with the involvement of the pentose and glucuronate interconversions pathway in the observed condition."}], "target": "Pentose and glucuronate interconversions"}
{"messages": [{"role": "user", "content": "List of genes : <<< ALOX15,PLA2G5,PLA2G1B,CYP3A4,JMJD7-PLA2G4B,CYP1A2,CYP2C9,PLA2G4B,CYP2E1,PLA2G4F,PLA2G10,PLA2G3,CYP2C19,CYP2C8,PLA2G2A,PLA2G2C,PLA2G12B,PLAAT3,PLA2G4E,PLAAT2,PLA2G2D,PLA2G4C,CYP2J2 >>>\nList of compounds : <<< 13(S)-HODE,(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate,12,13-Epoxy-9-hydroxy-10-octadecenoate,9,10-DHOME,12(13)-EpOME >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Linoleic Acid Metabolism pathway. This is supported by the altered genes and compounds observed. The genes ALOX15, PLA2G5, PLA2G1B, and others from the phospholipase A2 group are involved in the metabolism of linoleic acid, specifically in the production of eicosanoids, which are signaling molecules derived from fatty acids. The compounds 13(S)-HODE, (8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate, and others are intermediates or products in the linoleic acid metabolism pathway. Furthermore, the presence of cytochrome P450 genes (CYP3A4, CYP1A2, etc.) suggests the involvement of oxidative metabolism of these compounds. Therefore, the alterations in these genes and compounds indicate that the Linoleic Acid Metabolism pathway is significantly affected in the specific condition investigated."}], "target": "Linoleic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ETHE1,PAPSS1,SELENBP1 >>>\nList of compounds : <<< Hydrogen sulfide,Adenylyl sulfate,2-(Methylthio)ethanesulfonate,Methanethiol,Polysulfide,S,S-Dimethyl-beta-propiothetin,Taurine,Acetaldehyde,Hydrogen sulfide,L-Cysteine,Adenosine 3',5'-bisphosphate,Thiosulfate,Dimethyl sulfide,Sulfate,Sulfite,Succinate,Sulfate,L-Homocysteine,Sulfur,Sulfate,Trithionate,3'-Phosphoadenylyl sulfate,Alkanesulfonate,Alkanesulfonate,Methanesulfonic acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is sulfur metabolism. This is supported by the alterations in genes and compounds related to this pathway. The genes ETHE1, PAPSS1, and SELENBP1 are involved in sulfur metabolism. ETHE1 encodes an enzyme involved in the catabolism of hydrogen sulfide, while PAPSS1 is responsible for the activation of sulfate to adenylyl sulfate, a key step in sulfate metabolism. SELENBP1 is involved in the regulation of selenium, which is closely related to sulfur metabolism. The altered compounds, such as hydrogen sulfide, adenylyl sulfate, methanethiol, sulfate, and sulfite, are all intermediates or products of sulfur metabolism. Therefore, the changes in these genes and compounds indicate that sulfur metabolism is significantly affected in the given condition."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DCXR,CRYL1,UGP2 >>>\nList of compounds : <<< D-Ribulose,L-Xylulose 1-phosphate,Pectate,L-Xylulose,D-Xylose,(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate,D-Arabinose,D-Fructuronate,Glycerone phosphate,4-Deoxy-L-erythro-hex-4-enopyranuronate,(4S)-4,6-Dihydroxy-2,5-dioxohexanoate,D-Tagaturonate,Glycerone phosphate,Xylitol,D-Glucuronate 1-phosphate,L-Xylulose 5-phosphate,2-Dehydro-3-deoxy-D-xylonate,D-Glucose 1-phosphate,3-Dehydro-L-gulonate,Ribitol,2-Oxoglutarate,D-Lyxose,L-Arabinose,2-Dehydro-3-deoxy-D-gluconate,D-Ribulose 5-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the \"Pentose and glucuronate interconversions\" pathway. This pathway involves the interconversion of pentose sugars (five-carbon sugars) and glucuronate, a derivative of glucose. The identification of this pathway is supported by the altered genes and compounds. The genes DCXR (D-arabinono-1,4-lactone oxidase), UGP2 (UDP-glucose pyrophosphorylase 2), and CRYL1 (crystallin lambda 1), all have roles in pentose and glucuronate metabolism. The presence of various pentose sugars (D-Ribulose, L-Xylulose, D-Xylose, D-Arabinose, L-Xylulose 5-phosphate, D-Ribulose 5-phosphate) and their derivatives in the list of compounds further substantiates this finding. The alterations in these genes and compounds suggest changes in the pentose phosphate pathway, a sub-pathway of the larger pentose and glucuronate interconversions pathway, which could be impacting the condition under study."}], "target": "Pentose and glucuronate interconversions"}
{"messages": [{"role": "user", "content": "List of genes : <<< TST,SQOR,PAPSS2,SUOX,SELENBP1,BPNT2 >>>\nList of compounds : <<< Hydrogen sulfide,Adenosine 3',5'-bisphosphate,Sulfite,S-Sulfanylglutathione,Thiosulfate,Sulfate,Dimethyl sulfide,Trithionate,Sulfate,Dimethyl sulfoxide,Thiosulfate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Sulfur Metabolism. This pathway was implicated due to the alterations in various genes and compounds associated with sulfur metabolism. The genes TST, SQOR, PAPSS2, SUOX, SELENBP1, and BPNT2 are all involved in different steps of this pathway. TST and SUOX are involved in the oxidation of sulfite to sulfate, while SQOR participates in the oxidation of sulfide to sulfite. PAPSS2 is responsible for the activation of sulfate to adenosine 3',5'-bisphosphate, a key intermediate in sulfate metabolism. SELENBP1 and BPNT2 are also involved in sulfur metabolism, specifically in the regulation of sulfur-containing compounds. The altered compounds, including hydrogen sulfide, sulfite, S-Sulfanylglutathione, thiosulfate, sulfate, dimethyl sulfide, trithionate, and dimethyl sulfoxide, are all intermediates or end products in the sulfur metabolism pathway. Therefore, the changes in these genes and compounds strongly suggest that the Sulfur Metabolism pathway is involved in the condition under investigation."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACADM,BCKDHA >>>\nList of compounds : <<< Acetoacetate,Enzyme N6-(lipoyl)lysine,3-Hydroxyisovalerate,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine,3-Methyl-2-oxobutanoic acid,(S)-Methylmalonyl-CoA,2-Methylacetoacetyl-CoA,(R)-Methylmalonyl-CoA,4-Methyl-2-oxopentanoate,3-Methylcrotonyl-CoA,(S)-3-Hydroxyisobutyrate,2-Methyl-1-hydroxybutyl-ThPP,(R)-3-Amino-2-methylpropanoate,Enzyme N6-(lipoyl)lysine,Enzyme N6-(dihydrolipoyl)lysine,Enzyme N6-(dihydrolipoyl)lysine,(S)-Methylmalonate semialdehyde,Propanoyl-CoA,3-Methyl-1-hydroxybutyl-ThPP,Branched chain fatty acid,Acetyl-CoA,L-Valine,(S)-3-Methyl-2-oxopentanoic acid,L-Leucine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is the \"Valine, leucine and isoleucine degradation\" pathway. This pathway involves the breakdown of the branched-chain amino acids valine, leucine, and isoleucine. The alterations in the genes ACADM and BCKDHA support this identification. ACADM is involved in the beta-oxidation of medium-chain fatty acids and branched-chain fatty acids, which are intermediates in this pathway. BCKDHA encodes a subunit of the branched-chain alpha-keto acid dehydrogenase complex, a key enzyme in the initial step of this pathway. The altered compounds, such as Acetoacetate, 3-Methyl-2-oxobutanoic acid, L-Valine, and L-Leucine, are also intermediates or products of this pathway, further supporting the identification."}], "target": "Valine, leucine and isoleucine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< GOT1L1,GOT2,TAT,GOT1,DDC,AOC3,IL4I1,MAOB,ALDH3B2,HPD,ALDH3B1 >>>\nList of compounds : <<< Phenylpyruvate,Pyruvate,(3S)-3-Hydroxyadipyl-CoA,2-Oxepin-2(3H)-ylideneacetyl-CoA,Phenylacetaldehyde,Phenethylamine,2-Phenylacetamide,Phenylacetylglycine,3-(2,3-Dihydroxyphenyl)propanoate,cis-3-(Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol,alpha-Oxo-benzeneacetic acid,L-Tyrosine,D-Phenylalanine,Phenylpropanoate,3-Hydroxyphenylacetate,Acetaldehyde,3-Oxoadipyl-CoA,Fumarate,2-Hydroxy-6-ketononatrienedioate,2-Hydroxy-2,4-pentadienoate >>>"}, {"role": "assistant", "content": "The analysis of the provided gene and compound data suggests that the metabolic pathway of \"Phenylalanine metabolism\" is involved in the specific condition. This conclusion is supported by the presence of several genes directly involved in this pathway, such as GOT1, GOT2, DDC, MAOB, and HPD. These genes encode enzymes that catalyze reactions in the phenylalanine metabolism pathway. The altered compounds also reinforce this finding, as many of them are intermediates or products of this pathway. These include Phenylalanine, Phenylpyruvate, Phenylacetaldehyde, Phenethylamine, and 3-Hydroxyphenylacetate. The identification of Phenylalanine metabolism as the affected pathway is consistent with the observed changes in both genes and compounds."}], "target": "Phenylalanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDE11A,NUDT16,ENTPD6,PDE7A,AMPD1 >>>\nList of compounds : <<< 3',5'-Cyclic AMP,2',3'-Cyclic AMP,RNA,dITP,5-Phospho-alpha-D-ribose 1-diphosphate,P1,P3-Bis(5'-adenosyl) triphosphate,dZDP,5-Hydroxyisourate,GTP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Purine metabolism. This conclusion is supported by the alterations in several genes and compounds associated with this pathway. The genes PDE11A, PDE7A, and AMPD1 are involved in the degradation of cyclic AMP (cAMP), a crucial regulator in purine metabolism. The altered compounds, including different forms of cAMP, RNA, dITP, 5-Phospho-alpha-D-ribose 1-diphosphate, P1,P3-Bis(5'-adenosyl) triphosphate, dZDP, 5-Hydroxyisourate, and GTP, are all intermediates or products of purine metabolism. Therefore, the changes observed in these genes and compounds suggest a significant impact on the Purine metabolism pathway."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACOX3,HADH,ELOVL4,FADS1,ACSF3 >>>\nList of compounds : <<< (3R)-3-Hydroxybutanoyl-[acyl-carrier protein],Acetyl-[acyl-carrier protein],(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA,(3R)-3-Hydroxyoctanoyl-[acyl-carrier protein],Icosenoyl-CoA,trans-Oct-2-enoyl-[acp],(9Z,12Z,15Z)-Octadecatrienoyl-CoA,(2E)-Octadecenoyl-[acp],trans-Dec-2-enoyl-CoA,Malonate,(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA,(8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosahexaenoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is fatty acid metabolism. This conclusion is supported by the alterations observed in several genes and compounds associated with this pathway. The genes ACOX3, HADH, ELOVL4, FADS1, and ACSF3 are all involved in fatty acid metabolism. ACOX3 and HADH are associated with peroxisomal beta-oxidation, ELOVL4 is involved in the elongation of very long chain fatty acids, FADS1 in the desaturation of fatty acids, and ACSF3 in the activation of fatty acids. The altered compounds, such as acyl-carrier proteins, CoA esters, and various unsaturated fatty acids, are intermediates and products of fatty acid metabolism. The presence of these compounds further supports the involvement of this pathway."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CYB5R4,HK2,FCSK,CYB5R3,GALK2,AMDHD2,CYB5R1,GNPDA2,NANP,UGP2,UGDH,HK1,PGM2,NAGK,UAP1L1,PMM1,NPL,PMM2,CHIA,RENBP,CHIT1 >>>\nList of compounds : <<< N-Acetylmuramate,D-Glucuronate,UDP-N-acetyl-D-galactosamine,CDP-4-dehydro-3,6-dideoxy-D-glucose epimer,D-Mannose,CDP-3,6-dideoxy-D-glucose,GDP-4-amino-4,6-dideoxy-alpha-D-mannose,alpha-D-Glucose 6-phosphate,N-Acetyl-D-mannosamine 6-phosphate,D-Glucuronate 1-phosphate,UDP-D-galacturonate,3-Deoxy-D-glycero-D-galacto-non-2-ulopyranosonate,UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate,UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose,UDP-L-Ara4N,N-Glycoloyl-neuraminate,UDP-2-acetamido-4-dehydro-2,6-dideoxyglucose,Ferrocytochrome b5,UDP-L-rhamnose,ADP-glucose >>>"}, {"role": "assistant", "content": "The amino sugar and nucleotide sugar metabolism pathway was identified as being involved in the condition. This is consistent with the alterations in genes and compounds observed. Several genes in this pathway were affected, including GALK2, UGDH, and UAP1L1, which are involved in the synthesis of nucleotide sugars. Additionally, genes such as NAGK and NPL, which are involved in amino sugar metabolism, were also altered. The presence of altered compounds such as UDP-N-acetyl-D-galactosamine, GDP-4-amino-4,6-dideoxy-alpha-D-mannose, and N-Acetyl-D-mannosamine 6-phosphate further supports the involvement of this pathway, as these compounds are intermediates in the metabolism of amino sugars and nucleotide sugars."}], "target": "Amino sugar and nucleotide sugar metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GPI,FPGT,HEXB,GFUS,HK3,PMM1,CYB5RL,GCK >>>\nList of compounds : <<< GDP-D-arabinopyranose,1,4-beta-D-Xylan,alpha-D-Galactosamine 1-phosphate,UDP-N-acetyl-D-galactosamine,UDP-L-rhamnose,CDP-ascarylose,N-Acetylneuraminate 9-phosphate,alpha-D-Galactose 1-phosphate,D-Galactosamine 6-phosphate,N-Acetylmuramate,Chitin,UDP-N-acetyl-D-mannosaminouronate,UDP-glucuronate,GDP-4-amino-4,6-dideoxy-alpha-D-mannose,1,6-Anhydro-N-acetyl-beta-muramate,UDP-N-acetyl-alpha-D-glucosamine,D-Mannose 6-phosphate,N-Acetyl-D-mannosamine 6-phosphate,UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate,3-Deoxy-D-glycero-D-galacto-non-2-ulopyranosonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the \"Amino sugar and nucleotide sugar metabolism\" pathway. This conclusion is supported by the alterations observed in several genes and compounds involved in this pathway. The genes GPI, FPGT, HEXB, GFUS, GCK, and PMM1 are all associated with the metabolism of amino sugars and nucleotide sugars. Similarly, the altered compounds, such as UDP-N-acetyl-D-galactosamine, UDP-N-acetyl-D-mannosaminouronate, N-Acetylneuraminate 9-phosphate, and D-Mannose 6-phosphate, are key intermediates in this pathway. These findings suggest that the observed condition is closely linked to the metabolism of amino sugars and nucleotide sugars."}], "target": "Amino sugar and nucleotide sugar metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CHKA,GPAT4,PLA2G2A,ETNK1 >>>\nList of compounds : <<< 2-Acyl-sn-glycero-3-phosphoserine,Phosphodimethylethanolamine,Phosphatidylglycerol,Aminoacyl-phosphatidylglycerol,Diacetylheptaprenylglycerol,CDP-diacylglycerol,Phosphatidate,Phosphatidyl-N-dimethylethanolamine,Acyl-CoA,CDP-glycerol,Diethanolamine,1-Phosphatidyl-D-myo-inositol,L-Serine-phosphoethanolamine,N-Methylethanolamine phosphate,2,3-Bis-(O-phytanyl)-sn-glycerol 1-phosphate,1,2-Diacyl-sn-glycerol,Diacylglycerylhomoserine,Acyl-CoA,CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol,Phosphatidylethanolamine,2,3-Bis-(O-geranylgeranyl)-sn-glycerol 1-phosphate,Glycerone phosphate,Diacylglyceryl-N,N,N-trimethylhomoserine,sn-Glycero-3-phosphocholine,1-Acyl-sn-glycero-3-phosphoserine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Glycerophospholipid metabolism. This pathway is involved in the synthesis, degradation, and remodeling of glycerophospholipids, which are major components of biological membranes. The altered genes - CHKA, GPAT4, PLA2G2A, and ETNK1 - are all directly involved in this pathway. CHKA and GPAT4 are involved in the biosynthesis of glycerophospholipids, while PLA2G2A is involved in their degradation. ETNK1 is responsible for the conversion of phosphatidylethanolamine to phosphatidylcholine, a key step in this pathway. The altered compounds, such as phosphatidate, phosphatidylethanolamine, and various forms of acyl-CoA, are intermediates in this pathway, further supporting the involvement of Glycerophospholipid metabolism in the observed condition."}], "target": "Glycerophospholipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CA3,CA7,GLUD2,GLUL,CA12,CA8,CA13,GLUD1,CPS1,CA5A,CA2,CA6 >>>\nList of compounds : <<< Ammonia,Nitrite,Hydrazine,Nitroalkane,Nitrogen >>>"}, {"role": "assistant", "content": "The experiment comparing two conditions revealed that the nitrogen metabolism pathway was significantly altered. This conclusion is supported by the observed changes in multiple genes and compounds related to this pathway. The genes identified, including CA3, CA7, GLUD2, GLUL, CA12, CA8, CA13, GLUD1, CPS1, CA5A, CA2, and CA6, are all involved in nitrogen metabolism, specifically in the urea cycle and ammonia detoxification. The altered compounds, such as ammonia, nitrite, hydrazine, nitroalkane, and nitrogen, are also key intermediates in this pathway. Therefore, the data suggest that the nitrogen metabolism pathway is disrupted in the condition under study."}], "target": "Nitrogen metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLD2,PLA2G2D,SELENOI,PEDS1-UBE2V1,TMEM86B,PLD4,PAFAH1B3,JMJD7-PLA2G4B,LPCAT1,LPCAT4,ENPP6,PLA2G2E,PLA2G7,PLA2G12B,LPCAT2,CEPT1 >>>\nList of compounds : <<< O-Alkylglycerone phosphate,sn-Glycero-3-phosphocholine,1-Alkyl-2-acetyl-sn-glycerol,Galactosyl-1-alkyl-2-acylglycerol,sn-Glycero-3-phosphoethanolamine,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate,Plasmenylcholine,1-Alkyl-2-acylglycerophosphoethanolamine,1-Alkyl-sn-glycerol,1-(1-Alkenyl)-sn-glycero-3-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Ether lipid metabolism. This is supported by the altered genes and compounds. The genes PLD2, PLA2G2D, PLA2G2E, PLA2G7, PLA2G12B, and PLA2G4B are phospholipases, enzymes known to be involved in ether lipid metabolism. SELENOI, a selenoprotein, is also implicated in this pathway. Additionally, LPCAT1, LPCAT2, and LPCAT4 are lysophosphatidylcholine acyltransferases, enzymes responsible for the final step in ether lipid biosynthesis. The altered compounds, including O-Alkylglycerone phosphate, sn-Glycero-3-phosphocholine, and Plasmenylcholine, are intermediates and products of the ether lipid metabolism pathway. Therefore, the alterations in these genes and compounds strongly suggest the involvement of the Ether lipid metabolism pathway in the condition being studied."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ARSA,ACER1,GM2A,B4GALT5,SGPP2,CERS6,CERS1,CERS4,CERS3,B4GALNT1,SGMS1,HEXB,SMPD1,GBA1,ASAH2,PLPP3 >>>\nList of compounds : <<< Ceramide phosphoethanolamine,Gangliotriaosylceramide-II3 sulfate,Psychosine,D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide,Sphingomyelin,Ceramide 2-aminoethylphosphonate,GM3,Digalactosylceramide,N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide,Dihydroceramide,3-Dehydrosphinganine,GM4,Galactosylceramide,Phytoceramide,Globoside,Digalactosylceramide sulfate,GA2,Glucosylceramide,Phytosphingosine,L-Serine,Ceramide 1-phosphate,N-Acylsphingosine,Sphingosine,D-Glucosylsphingosine >>>"}, {"role": "assistant", "content": "The experiment identified the sphingolipid metabolism pathway as being significantly altered. This pathway was implicated due to the changes observed in multiple genes and compounds associated with sphingolipid synthesis and degradation. The genes ARSA, ACER1, GM2A, B4GALT5, SGPP2, CERS6, CERS1, CERS4, CERS3, B4GALNT1, SGMS1, HEXB, SMPD1, GBA1, ASAH2, and PLPP3 are all involved in sphingolipid metabolism. Similarly, the altered compounds such as Ceramide phosphoethanolamine, Gangliotriaosylceramide-II3 sulfate, Psychosine, and Glucosylceramide, among others, are intermediates or end products of this pathway. The findings suggest that disruptions in this pathway may contribute to the specific condition being studied."}], "target": "Sphingolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HPD,MAOB,GOT1,TAT,DDC >>>\nList of compounds : <<< trans-2-Hydroxycinnamate,2-Hydroxyphenylacetate,3-(2-Hydroxyphenyl)propanoate,D-Phenylalanine,L-Phenylalanine,Phenylethyl alcohol,L-Tyrosine,Phenylacetic acid >>>"}, {"role": "assistant", "content": "In the experiment, the metabolic pathway identified to be significantly altered is the Phenylalanine metabolism. This is supported by the observation of altered genes and compounds associated with this pathway. The genes HPD, MAOB, GOT1, TAT, and DDC are all involved in Phenylalanine metabolism. HPD encodes the enzyme responsible for the first step in phenylalanine degradation, MAOB is involved in the breakdown of phenylalanine-derived compounds, GOT1 catalyzes the conversion of phenylalanine to tyrosine, TAT is a tyrosine aminotransferase, and DDC is involved in the conversion of DOPA to dopamine. The compounds trans-2-Hydroxycinnamate, 2-Hydroxyphenylacetate, 3-(2-Hydroxyphenyl)propanoate, D-Phenylalanine, L-Phenylalanine, Phenylethyl alcohol, L-Tyrosine, and Phenylacetic acid are all intermediates or products of the Phenylalanine metabolism pathway. Therefore, the alteration of these genes and compounds strongly suggests that the Phenylalanine metabolism pathway is involved in the condition being studied."}], "target": "Phenylalanine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< QPRT,NT5M,SIRT5,NMNAT1,SIRT7,NMNAT2,SIRT4,NUDT12,NMRK1,SIRT2,NADK2 >>>\nList of compounds : <<< 1-Methylnicotinamide,Pseudooxynicotine,2,5-Dihydroxypyridine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Nicotinate and nicotinamide metabolism. This pathway was implicated due to the alterations in genes and compounds directly associated with it. The genes QPRT, NT5M, NUDT12, NMRK1, and NADK2 are all involved in the metabolism of nicotinate and nicotinamide. Additionally, the compounds 1-Methylnicotinamide, Pseudooxynicotine, and 2,5-Dihydroxypyridine are intermediates or products of this pathway. The SIRT family genes (SIRT5, SIRT7, SIRT4, SIRT2) and NMNAT genes (NMNAT1, NMNAT2) are also involved in NAD+ metabolism, which is closely linked to the Nicotinate and nicotinamide metabolism pathway. Therefore, the alterations in these genes and compounds suggest a significant role of the Nicotinate and nicotinamide metabolism pathway in the observed condition."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGT1A8,UGT2B7,UGT2A2,UGT2B4,AKR1B15,RPEL1,DHDH,GUSB,UGT2B10,SORD,UGT1A3,FGGY,UGT1A9,AKR1B1,KL >>>\nList of compounds : <<< L-Glyceraldehyde,2,5-Dioxopentanoate,2-Dehydro-3-deoxy-D-gluconate,Ribitol,D-Xylose,D-Ribulose >>>"}, {"role": "assistant", "content": "In the experiment comparing two conditions, the metabolic pathway identified as significantly altered is the \"Pentose and glucuronate interconversions\" pathway. This conclusion is supported by the observed changes in several genes and compounds associated with this pathway. The genes UGT1A8, UGT2B7, UGT2A2, UGT2B4, UGT2B10, UGT1A3, and UGT1A9 are all UDP-glucuronosyltransferases, enzymes that play key roles in the glucuronidation process within this pathway. Moreover, the altered compounds such as L-Glyceraldehyde, 2,5-Dioxopentanoate, 2-Dehydro-3-deoxy-D-gluconate, Ribitol, D-Xylose, and D-Ribulose are intermediates or products of reactions within this pathway. The changes in these genes and compounds suggest perturbations in the Pentose and glucuronate interconversions pathway, which could contribute to the differences observed between the two conditions."}], "target": "Pentose and glucuronate interconversions"}
{"messages": [{"role": "user", "content": "List of genes : <<< CERS2,NEU2,GLB1,GBA1,KDSR,SPTLC1,GALC,PSAP,SPTLC2,PLPP1 >>>\nList of compounds : <<< Sphingosyl-phosphocholine,GA2,Sphinganine 1-phosphate,GA1,Digalactosylceramide sulfate,Sphingosine 1-phosphate,Dihydroceramide,Phytoceramide >>>"}, {"role": "assistant", "content": "The experiment identified the Sphingolipid metabolism pathway as being involved in the specific condition. This is supported by the alterations observed in several genes and compounds associated with this pathway. The genes CERS2, NEU2, GLB1, GBA1, KDSR, SPTLC1, GALC, PSAP, SPTLC2, and PLPP1 are all involved in the synthesis, degradation, and regulation of sphingolipids. The altered compounds, including Sphingosyl-phosphocholine, Sphinganine 1-phosphate, Sphingosine 1-phosphate, Dihydroceramide, and Phytoceramide, are intermediates or end products of this pathway. Furthermore, the presence of Digalactosylceramide sulfate and GA1, which are complex sphingolipids, further supports the involvement of the Sphingolipid metabolism pathway. These findings suggest that dysregulation of this pathway may contribute to the specific condition."}], "target": "Sphingolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G10,PLA2G2F,PLA2G6,CYP2J2,PLA2G5,CYP2C9,CYP3A4,PLA2G3,PLA2G2A,CYP1A2,PLAAT2,PLA2G4F,PLA2G4C >>>\nList of compounds : <<< 9(S)-HODE,Arachidonate,9,10,13-TriHOME,(6Z,9Z,12Z)-Octadecatrienoic acid,9-OxoODE,Dihomo-gamma-linolenate,12(13)-EpOME,Phosphatidylcholine >>>"}, {"role": "assistant", "content": "The experiment identified the Linoleic acid metabolism pathway as being significantly altered. This conclusion is supported by the changes observed in multiple genes and compounds directly involved in this pathway. The Phospholipase A2 (PLA2) family genes, including PLA2G10, PLA2G2F, PLA2G6, PLA2G5, PLA2G3, PLA2G2A, PLA2G4F, and PLA2G4C, are known to catalyze the release of linoleic acid from phospholipids. Additionally, the Cytochrome P450 (CYP) family genes, such as CYP2J2, CYP2C9, CYP3A4, and CYP1A2, are involved in the oxidation of linoleic acid and its derivatives. The observed changes in compounds such as 9(S)-HODE, Arachidonate, 9,10,13-TriHOME, (6Z,9Z,12Z)-Octadecatrienoic acid, 9-OxoODE, Dihomo-gamma-linolenate, and 12(13)-EpOME, which are intermediates and products of the Linoleic acid metabolism, further support this finding. Therefore, the alterations in these genes and compounds suggest a significant role of the Linoleic acid metabolism pathway in the condition under study."}], "target": "Linoleic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G2A,PLA2G10,CYP2C19,JMJD7-PLA2G4B,PLB1,PLA2G4E,CYP2E1,PLA2G2D,PLA2G4C,PLA2G6,PLA2G4B,PLA2G2C,CYP2C8 >>>\nList of compounds : <<< (9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid,Dihomo-gamma-linolenate,(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid,9,10,13-TriHOME,9(S)-HPODE,9,10-12,13-Diepoxyoctadecanoate,Arachidonate,Phosphatidylcholine,13(S)-HODE,12,13-Epoxy-9-hydroxy-10-octadecenoate >>>"}, {"role": "assistant", "content": "The analysis of the provided data suggests that the Linoleic acid metabolism pathway is significantly altered in the given condition. This conclusion is based on the observation of multiple genes and compounds associated with this pathway. Several genes identified, such as PLA2G2A, PLA2G10, PLA2G4B, and PLA2G6, are phospholipases that play crucial roles in the release of linoleic acid from phospholipids. The presence of compounds like Arachidonate, which is a product of linoleic acid metabolism, and various hydroperoxy and epoxy derivatives of linoleic acid, further support this conclusion. The alterations in genes such as CYP2C19 and CYP2C8, which encode for cytochrome P450 enzymes involved in the metabolism of fatty acids, also fit with this pathway. Therefore, it is likely that the Linoleic acid metabolism pathway is significantly involved in the given condition."}], "target": "Linoleic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DLD,DLST,AMT,BCKDHB,PDHA2,PDHB,LIAS,BCKDHA,DLAT,LIPT1,DBT,GCSH,ACSM1,GLDC,,DHTKD1,LIPT2 >>>\nList of compounds : <<< (S)-3-Methyl-2-oxopentanoic acid,Enzyme N6-(dihydrolipoyl)lysine,[Dihydrolipoyllysine-residue succinyltransferase] S-glutaryldihydrolipoyllysine,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine,Octanoic acid,Lipoyl-AMP,Thiamin diphosphate,Dihydrolipoylprotein,Thiamin diphosphate,Thiamin diphosphate,(S)-2-Methylbutanoyl-CoA,(R)-Lipoate,4-Methyl-2-oxopentanoate,Glycine,Dihydrolipoate,Lipoylprotein,[Lipoyl-carrier protein E2]-N6-octanoyl-L-lysine,5,10-Methylenetetrahydrofolate,Enzyme N6-(dihydrolipoyl)lysine,Enzyme N6-(lipoyl)lysine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Lipoic Acid Metabolism. This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes DLD, DLST, DLAT, and DBT are all involved in lipoic acid metabolism, specifically in the citric acid cycle and the oxidative decarboxylation of pyruvate. The altered compounds, such as Dihydrolipoylprotein, Lipoyl-AMP, and Enzyme N6-(dihydrolipoyl)lysine, are intermediates in this pathway. The presence of Thiamin diphosphate, a coenzyme required for the proper function of several enzymes in this pathway, further supports this conclusion. The alteration in these genes and compounds suggests a disruption in Lipoic Acid Metabolism, which could potentially impact energy production and oxidative stress response in the cell."}], "target": "Lipoic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SQOR,PAPSS1,TST >>>\nList of compounds : <<< L-Serine,Sulfur >>>"}, {"role": "assistant", "content": "The experiment identified the Sulfur metabolism pathway as the primary metabolic pathway involved in the condition. This conclusion is supported by the alterations observed in the genes SQOR, PAPSS1, and TST, and the compounds L-Serine and Sulfur. SQOR encodes for sulfide:quinone oxidoreductase, an enzyme involved in sulfur metabolism. PAPSS1 is associated with the activation of sulfate in the body, while TST is involved in the conversion of homocysteine to cystathionine in the transsulfuration pathway, a subpathway of sulfur metabolism. The alteration in L-Serine, which is a precursor in the transsulfuration pathway, further supports this finding. Therefore, the changes in these genes and compounds suggest that disturbances in sulfur metabolism may be contributing to the condition."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< NNT,SIRT3,NMRK2,NT5C1B,AOX1,NAPRT,NMNAT2,NT5E,NMRK1,NUDT12,SIRT4,NT5C,CD38,NMNAT1,ENPP1,PNP,NADK2 >>>\nList of compounds : <<< 2,6-Dihydroxy-N-methylmyosmine,Nicotinate D-ribonucleoside,6-Hydroxypseudooxynicotine,Propanoate,1-Methylnicotinamide,Maleic acid,(R)-6-Hydroxynicotine,Nicotinamide >>>"}, {"role": "assistant", "content": "The experiment suggests that the Nicotinate and Nicotinamide Metabolism pathway is involved in the condition of interest. This conclusion is supported by the alteration of multiple genes associated with this pathway, including NNT, SIRT3, NMRK2, NT5C1B, AOX1, NAPRT, NMNAT2, NT5E, NMRK1, NUDT12, SIRT4, NT5C, CD38, NMNAT1, ENPP1, and PNP. These genes play roles in nicotinamide adenine dinucleotide (NAD+) biosynthesis and degradation, which are central to this metabolic pathway. Furthermore, the altered compounds, such as Nicotinate D-ribonucleoside, 1-Methylnicotinamide, and Nicotinamide, are direct components or intermediates of this pathway. Therefore, it is likely that the observed condition is associated with disturbances in Nicotinate and Nicotinamide Metabolism."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLPP2,PLA2G2F,PLD3,PLPP3 >>>\nList of compounds : <<< 1-Alkyl-2-acylglycerophosphoethanolamine,1-Alkenyl-2-acylglycerol,O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine,1-(1-Alkenyl)-sn-glycero-3-phosphocholine,Seminolipid,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate,1-Alkyl-sn-glycerol,Acylglycerone phosphate >>>"}, {"role": "assistant", "content": "The experiment identified the Ether lipid metabolism pathway as being significantly altered in the two conditions. This pathway was implicated due to the changes observed in several genes and compounds associated with it. The genes PLPP2, PLA2G2F, PLD3, and PLPP3, all of which are known to play key roles in the biosynthesis and metabolism of ether lipids, were found to be altered. Similarly, the compounds identified, including 1-Alkyl-2-acylglycerophosphoethanolamine, 1-Alkenyl-2-acylglycerol, and others, are intermediates and end products of the Ether lipid metabolism pathway. These findings suggest that the observed condition may be linked to disruptions in the synthesis, degradation, or regulation of ether lipids, underscoring the importance of this pathway in the biological processes under investigation."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BCAT2,GADL1,CSAD,DPYD,ENPP1,VNN1,PANK2,BCAT1,ALDH3A2,ENPP3,VNN2,COASY,DPYS,AASDHPPT,PPCDC,PANK1,ALDH2,PPCS,ALDH1B1,UPB1,PANK3 >>>\nList of compounds : <<< N-((R)-Pantothenoyl)-L-cysteine,2-Dehydropantoate,Pantothenate,beta-Alanine,3-Ureidopropionate,(S)-2-Acetolactate,(R)-4'-Phosphopantothenoyl-L-cysteine,Pantetheine 4'-phosphate,3-Aminopropanal,(R)-2,3-Dihydroxy-3-methylbutanoate,L-Cysteine,CoA,Pantothenol,Pantetheine,5,6-Dihydrouracil,L-Aspartate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Pantothenate and CoA biosynthesis pathway. This conclusion is supported by the alterations observed in multiple genes and compounds associated with this pathway. Several genes involved in this pathway, such as BCAT2, PANK1, PANK2, PANK3, COASY, and ALDH2, were altered, indicating potential disruptions in the synthesis of pantothenate and CoA. Additionally, the levels of several key compounds in this pathway, including N-((R)-Pantothenoyl)-L-cysteine, 2-Dehydropantoate, Pantothenate, Pantetheine 4'-phosphate, CoA, Pantothenol, and Pantetheine, were also altered, further supporting the involvement of this pathway. The alterations in these genes and compounds suggest that the Pantothenate and CoA biosynthesis pathway may be dysregulated in the condition being studied."}], "target": "Pantothenate and CoA biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACSL5,CPT1B,ACOX1,ACOX3 >>>\nList of compounds : <<< trans-Hexadec-2-enoyl-[acp],Acetyl-CoA,(8Z,11Z,14Z,17Z,20Z)-Hexacosapentaenoyl-CoA,3-Oxodecanoyl-CoA,Acetyl-CoA,Acetyl-CoA,Stearoyl-CoA,(7Z,10Z,13Z)-Docosatrienoyl-CoA,3-Oxotetradecanoyl-[acp],Arachidonyl-CoA,(6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA >>>"}, {"role": "assistant", "content": "The experiment identified the fatty acid metabolism pathway as being significantly altered. This is supported by the changes observed in the genes and compounds associated with this pathway. The genes ACSL5, CPT1B, ACOX1, and ACOX3 are all involved in fatty acid metabolism. ACSL5 activates long-chain fatty acids for -oxidation, CPT1B transports fatty acids into the mitochondria for -oxidation, and ACOX1 and ACOX3 are involved in peroxisomal -oxidation. The altered compounds, such as trans-Hexadec-2-enoyl-[acp], Acetyl-CoA, and various acyl-CoA esters, are intermediates in fatty acid synthesis and degradation. The presence of these compounds, along with the changes in gene expression, suggests that the fatty acid metabolism pathway is indeed affected in this condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDHA2,ACSM1 >>>\nList of compounds : <<< (R)-Lipoate,Enzyme N6-(dihydrolipoyl)lysine,4-Carboxy-1-hydroxybutyryl-ThPP,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine,Enzyme N6-(dihydrolipoyl)lysine,(S)-3-Methyl-2-oxopentanoic acid,Enzyme N6-(dihydrolipoyl)lysine,Dihydrolipoylprotein,Succinyl-CoA,Enzyme N6-(dihydrolipoyl)lysine,Dihydrolipoate,Glycine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is Lipoic Acid Metabolism. This conclusion is supported by the alterations in the genes PDHA2 and ACSM1, and the presence of various compounds such as (R)-Lipoate, Enzyme N6-(dihydrolipoyl)lysine, and Dihydrolipoylprotein. The gene PDHA2 encodes the E1 alpha subunit of pyruvate dehydrogenase, an enzyme complex that requires lipoic acid for its function in the conversion of pyruvate to acetyl-CoA. ACSM1, on the other hand, is involved in fatty acid metabolism, another process that requires lipoic acid. The altered compounds are intermediates and cofactors in the Lipoic Acid Metabolism pathway, further supporting the identification of this pathway."}], "target": "Lipoic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MVD,PMVK,HMGCR,DHDDS,ICMT,FNTB,NUS1,PDSS1,CHURC1-FNTB,GGPS1,IDI2 >>>\nList of compounds : <<< all-trans-Decaprenyl diphosphate,trans-Anhydromevalonate phosphate,Protein C-terminal S-farnesyl-L-cysteine methyl ester,(R)-Mevalonate 3,5-bisphosphate,2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Terpenoid backbone biosynthesis. This pathway was implicated due to the alterations in genes such as MVD, PMVK, HMGCR, DHDDS, GGPS1, and IDI2, which are all known to be involved in this pathway. The MVD and PMVK genes are involved in the mevalonate pathway, a subpathway of terpenoid backbone biosynthesis. HMGCR, a rate-limiting enzyme in this pathway, was also altered. The alteration in DHDDS suggests changes in the synthesis of isopentenyl diphosphate and dimethylallyl diphosphate, which are key intermediates in terpenoid backbone biosynthesis. Furthermore, the alteration in GGPS1 and IDI2, which are involved in geranylgeranyl diphosphate and isopentenyl diphosphate synthesis respectively, further supports this conclusion. The altered compounds, including all-trans-Decaprenyl diphosphate, trans-Anhydromevalonate phosphate, and (R)-Mevalonate 3,5-bisphosphate, are also intermediates in this pathway, providing additional evidence."}], "target": "Terpenoid backbone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< LBR,CYP24A1,EBP,FDFT1,TM7SF2,DHCR24,LIPA,CYP2R1,HSD17B7,CEL,SOAT1,MSMO1,NSDHL,LSS,CYP51A1,CYP27B1,SC5D,SOAT2,SQLE >>>\nList of compounds : <<< 24-epi-Campesterol,Zymosterone,Lathosterol,(S)-2,3-Epoxysqualene,5-Dehydroepisterol,Cycloartenol,4alpha-Carboxy-stigmasta-7,24(24(1))-dien-3beta-ol,3beta-Hydroxy-4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-4alpha-carboxylate,Vitamin D3,Secalciferol,Ergosta-5,7,22,24(28)-tetraen-3beta-ol,7-Dehydrodesmosterol,Brassicasterol,4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol,Fecosterol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Steroid Biosynthesis. This pathway was implicated due to the alterations observed in genes and compounds directly involved in steroid synthesis. Genes such as LBR, CYP24A1, DHCR24, CYP2R1, HSD17B7, NSDHL, LSS, CYP51A1, CYP27B1, and SC5D are known to participate in this pathway. Similarly, the altered compounds, including 24-epi-Campesterol, Zymosterone, Lathosterol, (S)-2,3-Epoxysqualene, 5-Dehydroepisterol, Cycloartenol, and others, are intermediates in the Steroid Biosynthesis pathway. Therefore, the changes in these genes and compounds suggest that the Steroid Biosynthesis pathway is significantly involved in the condition under study."}], "target": "Steroid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< EHHADH,ELOVL5,CPT1A >>>\nList of compounds : <<< Hexadecanoyl-[acp],(S)-3-Hydroxyhexadecanoyl-CoA,(5Z,8Z,11Z)-Icosatrienoyl-CoA,Butyryl-[acp],(8Z,11Z)-Icosadienoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is Fatty Acid Metabolism. This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes EHHADH, ELOVL5, and CPT1A are key players in fatty acid metabolism. EHHADH encodes an enzyme involved in the last step of peroxisomal beta-oxidation of fatty acids, while ELOVL5 is responsible for elongating very long-chain fatty acids. CPT1A encodes the rate-limiting enzyme for fatty acid oxidation in the mitochondria. The altered compounds, such as Hexadecanoyl-[acp], (S)-3-Hydroxyhexadecanoyl-CoA, (5Z,8Z,11Z)-Icosatrienoyl-CoA, Butyryl-[acp], and (8Z,11Z)-Icosadienoyl-CoA, are intermediates in fatty acid synthesis and degradation, further supporting the involvement of the fatty acid metabolism pathway in the observed condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ECHS1,SUCLG2,ACSS1,EHHADH,DBT,LDHB,ACOX3,LDHAL6B,ACACA,ECHDC1,LDHAL6A,ABAT,MCEE,DLD,BCKDHB,ACACB >>>\nList of compounds : <<< 3-Oxopropanoate,Lactoyl-CoA,(R)-Methylmalonyl-CoA,Propanoate,(S)-Lactaldehyde >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Propanoate metabolism. This pathway was implicated due to the alterations observed in several genes and compounds directly associated with it. The genes ECHS1, SUCLG2, EHHADH, LDHB, ACOX3, LDHAL6B, ACACA, ECHDC1, LDHAL6A, ABAT, MCEE, and BCKDHB are all involved in various steps of the Propanoate metabolism pathway. The altered compounds, including 3-Oxopropanoate, Lactoyl-CoA, (R)-Methylmalonyl-CoA, Propanoate, and (S)-Lactaldehyde, are intermediates or products of this pathway. These findings suggest that the Propanoate metabolism pathway plays a significant role in the condition under investigation."}], "target": "Propanoate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SRR,DGLUCY,DAO,GLS2 >>>\nList of compounds : <<< UDP-N-acetylmuramoyl-L-alanyl-D-glutamate,2-Oxoglutarate,D-Histidine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is D-Amino acid metabolism. This conclusion is supported by the alterations in the genes and compounds observed. The gene SRR encodes the enzyme serine racemase, which is involved in the interconversion of L-serine and D-serine, a key step in D-amino acid metabolism. The gene DGLUCY encodes D-glucose-6-phosphate 1-dehydrogenase, which can indirectly affect D-amino acid metabolism through the pentose phosphate pathway. The gene DAO encodes D-amino acid oxidase, an enzyme that catalyzes the oxidative deamination of D-amino acids, further supporting the involvement of D-amino acid metabolism. The gene GLS2 encodes glutaminase 2, which is involved in glutamine metabolism, a pathway that can be linked to D-amino acid metabolism through the production of glutamate. The altered compounds, UDP-N-acetylmuramoyl-L-alanyl-D-glutamate and 2-Oxoglutarate, are also related to D-amino acid and glutamate metabolism, respectively. The presence of D-Histidine further supports the involvement of D-amino acid metabolism."}], "target": "D-Amino acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BCKDHA,DLAT,PDHB,,GCSH >>>\nList of compounds : <<< Glycine,Thiamin diphosphate,Dihydrolipoyl-AMP,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine,[Protein]-S8-aminomethyldihydrolipoyllysine,4-Methyl-2-oxopentanoate,Lipoylprotein,Enzyme N6-(dihydrolipoyl)lysine,Dihydrolipoylprotein,Thiamin diphosphate,Pyruvate,2-(alpha-Hydroxyethyl)thiamine diphosphate,3-Carboxy-1-hydroxypropyl-ThPP,[Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine,Enzyme N6-(dihydrolipoyl)lysine,Octanoyl-[acp],Enzyme N6-(dihydrolipoyl)lysine,3-Methyl-2-oxobutanoic acid,Succinyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified based on the given genes and compounds is the Lipoic acid metabolism. This pathway is closely linked to other metabolic processes such as the citric acid cycle and pyruvate metabolism, which are also implicated due to the presence of genes like BCKDHA, DLAT, and PDHB, and compounds such as Pyruvate and Succinyl-CoA. The altered genes BCKDHA, DLAT, and PDHB are involved in the conversion of branched-chain amino acids and pyruvate into the citric acid cycle, which requires lipoic acid as a cofactor. The altered compounds, including various dihydrolipoyl intermediates and Thiamin diphosphate, are direct participants or products of the Lipoic acid metabolism pathway. The presence of 3-Methyl-2-oxobutanoic acid further supports the involvement of branched-chain amino acid metabolism, which is connected to Lipoic acid metabolism. Thus, the findings suggest that Lipoic acid metabolism plays a crucial role in the observed condition."}], "target": "Lipoic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PRUNE1,AMPD2,GUCY2D,NT5M,NT5C,ALLC,PAPSS2,GUCY1B1,DCK,NUDT5,AMPD3,ADCY6,PRPS1L1,PAICS,NT5C1A,NPR1,ENTPD1 >>>\nList of compounds : <<< alpha-D-Ribose 1-phosphate,3',5'-Cyclic AMP,dGDP,IMP,N-Formiminoglycine,ATP,ADP,Hypoxanthine,dIDP,Deoxyguanosine,DNA,dATP,GDP,N6-Succino-2-amino-2'-deoxyadenylate,5'-Benzoylphosphoadenosine,Guanosine,5-Aminoimidazole,Guanosine 3'-phosphate,5'-Phosphoribosyl-N-formylglycinamide,3'-Phosphoadenylyl sulfate,dGTP,XTP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Purine metabolism. This pathway was implicated due to the alterations observed in multiple genes and compounds associated with purine synthesis, degradation, and salvage. The genes PRUNE1, AMPD2, AMPD3, DCK, NUDT5, ADCY6, PAICS, NT5C1A, and ENTPD1 are directly involved in purine metabolism. The compounds alpha-D-Ribose 1-phosphate, 3',5'-Cyclic AMP, IMP, Hypoxanthine, Deoxyguanosine, DNA, dATP, Guanosine, 5-Aminoimidazole, Guanosine 3'-phosphate, 5'-Phosphoribosyl-N-formylglycinamide, 3'-Phosphoadenylyl sulfate, and dGTP are key intermediates in this pathway. The alterations in these genes and compounds suggest that Purine metabolism is dysregulated in the specific condition under study."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACSBG2,ELOVL4,ACADVL,FADS1,ACOX3,HACD3,ACSL3,HSD17B8,ACSL6,ACADL,FASN,HACD4,CBR4,ELOVL2,HTD2,PPT2,ACAA1 >>>\nList of compounds : <<< But-2-enoyl-[acyl-carrier protein],3-Oxododecanoyl-CoA,Arachidonyl-CoA,(13Z,16Z,19Z,22Z)-Octacosatetraenoyl-CoA,(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA,(3R)-3-Hydroxyoctadecanoyl-[acyl-carrier protein],Tetracosenoyl-CoA,Crotonoyl-CoA,Hexanoyl-[acp],(3R)-3-Hydroxytetradecanoyl-[acyl-carrier protein],2-trans-Dodecenoyl-CoA,Acetyl-CoA,(S)-Hydroxydecanoyl-CoA,Acetoacetyl-CoA,(13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA,(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA,Palmitoyl-CoA >>>"}, {"role": "assistant", "content": "The analysis of the given genes and compounds suggests that the metabolic pathway involved is fatty acid metabolism. This pathway includes the synthesis, elongation, desaturation, and oxidation of fatty acids. The genes ACSBG2, ELOVL4, ACADVL, FADS1, ACOX3, HACD3, ACSL3, HSD17B8, ACSL6, ACADL, FASN, HACD4, CBR4, ELOVL2, HTD2, PPT2, and ACAA1 are all associated with fatty acid metabolism, supporting this conclusion. The compounds identified, such as But-2-enoyl-[acyl-carrier protein], 3-Oxododecanoyl-CoA, and Arachidonyl-CoA, are intermediates in fatty acid synthesis, elongation, and desaturation. Additionally, the presence of compounds like Acetyl-CoA and Acetoacetyl-CoA indicate beta-oxidation, a process for breaking down fatty acids to generate energy. Therefore, based on the altered genes and compounds, the fatty acid metabolism pathway is the primary metabolic pathway involved in the condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SCD,ELOVL1,HSD17B12,ACAA1,ACOX3,SCD5,CPT2,FASN,HACD4,CPT1C,ACSL6,ELOVL6,ELOVL3,ELOVL5,HADHB >>>\nList of compounds : <<< (13Z,16Z,19Z,22Z)-Octacosatetraenoyl-CoA,trans-Dec-2-enoyl-[acp],Oleoyl-[acyl-carrier protein],3-Oxodecanoyl-[acp],(5Z,8Z,11Z)-Icosatrienoyl-CoA,Octadecanoyl-[acyl-carrier protein],3-Oxopalmitoyl-CoA,Acetyl-[acyl-carrier protein],trans-Tetradec-2-enoyl-CoA,(6Z,9Z)-Octadecadienoyl-CoA,(7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA,(3R,6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexaenoyl-CoA,trans-Dec-2-enoyl-CoA,(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA,Tetradecanoyl-CoA,(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA,Arachidonyl-CoA,Dodecanoyl-[acyl-carrier protein],trans-Hexadec-2-enoyl-CoA,Hexadecanoic acid,Eicosanoyl-CoA,Tetracosanoyl-CoA,(3R)-3-Hydroxytetradecanoyl-[acyl-carrier protein],3-Oxohexanoyl-[acp] >>>"}, {"role": "assistant", "content": "The analysis of the altered genes and compounds suggests that the Fatty acid metabolism pathway is involved in the specific condition. The genes identified, such as SCD, ELOVL1, FASN, and ACSL6, are known to play key roles in fatty acid synthesis and elongation. Similarly, the compounds listed, including various acyl-CoA and acyl-carrier protein intermediates, are directly involved in fatty acid metabolism. The presence of compounds like (13Z,16Z,19Z,22Z)-Octacosatetraenoyl-CoA and (3R,6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexaenoyl-CoA, which are long-chain polyunsaturated fatty acids, further supports this conclusion. Therefore, based on the gene and compound data, it can be inferred that the Fatty acid metabolism pathway is significantly affected in the given condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ENTPD6,TK1,UPB1,DPYS,DTYMK,TYMP,ASMTL,DCK,NT5C3B,NT5C1B,UMPS >>>\nList of compounds : <<< 3',5'-Cyclic CMP,CTP,CDP,Pseudouridine,2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate,P1,P4-Bis(5'-uridyl) tetraphosphate,dCDP,Barbiturate,(R)-3-Amino-2-methylpropanoate,Cytosine,Urea,dUDP,Thymidine,Urea,3-Hydroxypropanoate,Cytidine,Carbamoyl phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Pyrimidine metabolism. This conclusion is supported by the alterations in genes and compounds associated with this pathway. The genes ENTPD6, TK1, UPB1, DPYS, DTYMK, TYMP, ASMTL, DCK, NT5C3B, NT5C1B, and UMPS are all involved in pyrimidine metabolism, which includes the synthesis, salvage, and degradation of pyrimidines. The altered compounds, such as 3',5'-Cyclic CMP, CTP, CDP, Pseudouridine, dCDP, Cytosine, Urea, dUDP, Thymidine, Cytidine, and Carbamoyl phosphate, are intermediates or products of this pathway. The identification of these genes and compounds strongly suggests that the Pyrimidine metabolism pathway is involved in the condition being studied."}], "target": "Pyrimidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DDO,DGLUCY,GLS,SRR,GLS2,DAO >>>\nList of compounds : <<< cis-4-Hydroxy-D-proline,L-Alanine,D-Cysteine,5-Guanidino-2-oxopentanoate,L-Arginine,Hydroxyproline,2-Oxoglutarate,D-Histidine,1-Pyrroline-2-carboxylate >>>"}, {"role": "assistant", "content": "The metabolic pathway that was identified in this experiment is D-Amino acid metabolism. This conclusion is supported by the alterations in the genes and compounds involved in this pathway.\n\nThe genes DDO, DAO, and DGLUCY are involved in the degradation of D-amino acids. DDO encodes D-aspartate oxidase, DAO encodes D-amino acid oxidase, and DGLUCY encodes D-glucosamine 3-kinase/D-glucosamine-6-phosphate deaminase, which is involved in the degradation of D-glucosamine.\n\nThe altered compounds also support this finding. The presence of D-Cysteine and Hydroxyproline, both D-amino acids, suggests that the metabolism of these compounds is altered. Additionally, the presence of 5-Guanidino-2-oxopentanoate and L-Arginine, intermediates in the D-amino acid metabolism pathway, further supports this conclusion.\n\nTherefore, based on the alterations in these genes and compounds, it is likely that the D-Amino acid metabolism pathway is involved in the observed condition."}], "target": "D-Amino acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLAAT3,PLA2G4A,ACOX3,PLA2G2F,PLA2G2D,PLA2G4D,PLA2G3,PLA2G4C >>>\nList of compounds : <<< 3,6-Nonadienal,Colnelenic acid,13(S)-HOT,trans-2-Enoyl-OPC6-CoA,Methyl jasmonate,9-Hydroxy-12-oxo-10(E),15(Z)-octadecadienoic acid >>>"}, {"role": "assistant", "content": "The experiment revealed that the alpha-linolenic acid metabolism pathway was significantly affected in the two conditions. This conclusion is supported by the altered genes and compounds. The genes identified, such as PLAAT3, PLA2G4A, ACOX3, and others from the PLA2 family, are involved in the metabolism of alpha-linolenic acid, particularly in its hydrolysis and oxidation. The altered compounds, including 3,6-Nonadienal, Colnelenic acid, 13(S)-HOT, and others, are known intermediates or products of alpha-linolenic acid metabolism. Therefore, the changes in these genes and compounds suggest a perturbation in the alpha-linolenic acid metabolism pathway."}], "target": "alpha-Linolenic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OGDHL,OGDH,AMT,BCKDHB,GCSH,BCKDHA,LIPT2,DLAT,LIPT1,LIAS, >>>\nList of compounds : <<< 4-Carboxy-1-hydroxybutyryl-ThPP,Glycine,Enzyme N6-(dihydrolipoyl)lysine,3-Methyl-1-hydroxybutyl-ThPP,5,10-Methylenetetrahydrofolate >>>"}, {"role": "assistant", "content": "The experiment identified the Lipoic acid metabolism pathway as the affected pathway based on the alterations observed in the genes and compounds. The genes OGDHL, OGDH, DLAT, and GCSH are involved in the citric acid cycle, which is closely linked to lipoic acid metabolism. The BCKDHB and BCKDHA genes are involved in the branched-chain amino acid metabolism, which also requires lipoic acid. The LIPT1, LIPT2, and LIAS genes are directly involved in lipoic acid metabolism, further supporting this conclusion. The altered compounds, including 4-Carboxy-1-hydroxybutyryl-ThPP, 3-Methyl-1-hydroxybutyl-ThPP, and Enzyme N6-(dihydrolipoyl)lysine, are intermediates or cofactors in lipoic acid metabolism, providing additional evidence for the involvement of this pathway in the observed condition."}], "target": "Lipoic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< OGDHL,,DHTKD1 >>>\nList of compounds : <<< Thiamin diphosphate,[Lipoyl-carrier protein E2]-N6-octanoyl-L-lysine,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine,[Glycine cleavage system H]-N6-octanoyl-L-lysine,Enzyme N6-(dihydrolipoyl)lysine,5,10-Methylenetetrahydrofolate,(S)-3-Methyl-2-oxopentanoic acid,Glycine,Lipoylprotein,3-Methyl-2-oxobutanoic acid,Lipoyl-AMP,Glutaryl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Lipoic Acid Metabolism. This pathway was implicated by the alterations in several genes and compounds associated with it. Specifically, the genes OGDHL and DHTKD1 were affected. OGDHL encodes for 2-Oxoglutarate Dehydrogenase, and DHTKD1 encodes for Dihydrolipoamide S-Succinyltransferase, both of which are key enzymes in this pathway. The altered compounds, including Lipoyl-carrier protein E2, Dihydrolipoyllysine-residue, and Lipoylprotein, are intermediates or cofactors involved in Lipoic Acid Metabolism. The presence of compounds like Glutaryl-CoA and (S)-3-Methyl-2-oxopentanoic acid, which are connected to this pathway, further supports this conclusion. Therefore, the data suggest that the Lipoic Acid Metabolism pathway is significantly impacted under the compared conditions."}], "target": "Lipoic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GDA,NME3,ADCY9,PDE11A,DGUOK,ADPRM,RRM2B,ENTPD5,PFAS,PDE7B,PDE6A,DCK,NUDT16,PAPSS2,ENTPD4,FHIT,PDE6D,IMPDH1,AMPD3,AMPD1,PDE10A,PDE3A >>>\nList of compounds : <<< Ammonia,N6-Succino-2-amino-2'-deoxyadenylate,1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide,N6-(1,2-Dicarboxyethyl)-AMP,D-Ribose 5-phosphate,P1,P4-Bis(5'-xanthosyl) tetraphosphate,Deoxyinosine,Urate-3-ribonucleoside,dITP,IMP,5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole,Inosine,CO2 >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Purine metabolism. This conclusion is supported by the alterations observed in multiple genes and compounds associated with this pathway. Genes such as GDA, ADCY9, PDE11A, PDE7B, PDE6A, PDE6D, IMPDH1, AMPD1, PDE10A, and PDE3A are involved in purine nucleotide synthesis, degradation, and signaling. The compounds identified, including Ammonia, N6-Succino-2-amino-2'-deoxyadenylate, 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide, N6-(1,2-Dicarboxyethyl)-AMP, D-Ribose 5-phosphate, Inosine, and IMP, are key intermediates in purine metabolism. Therefore, the changes in these genes and compounds suggest that Purine metabolism is the affected metabolic pathway in the specified condition."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SUCLG1,ABAT,ACADS,HADHA,HIBCH,DLD,ACACB,ACSS2,LDHA,BCKDHB,ECHDC1,ACSS3,MLYCD,LDHB,LDHAL6B,MCEE,BCKDHA,ACACA,LDHAL6A,DBT >>>\nList of compounds : <<< (Z)-But-2-ene-1,2,3-tricarboxylate,(S)-Lactaldehyde,Methylmalonate,Propenoyl-CoA,Propane-1-ol,3-Hydroxypropanoate,Methylglyoxal,2-Hydroxybutanoic acid,Propanoate,(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate,Malonyl-CoA,Thiamin diphosphate,Propionyladenylate,Propanoyl-CoA,Propynoate,Hydroxyacetone,3-Hydroxypropionyl-CoA,2-Oxobutanoate,(S)-Lactate,Enzyme N6-(S-propyldihydrolipoyl)lysine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Propanoate metabolism. This pathway is supported by the alterations in multiple genes and compounds associated with it. Genes such as BCKDHA, BCKDHB, and ACACA, which are involved in the initial steps of propanoate metabolism, were altered. The presence of compounds like Propanoate, Propionyladenylate, and Propanoic acid further supports this. The alteration in SUCLG1, ACADS, and HADHA, genes involved in fatty acid metabolism, also fits as this pathway interlinks with propanoate metabolism. Additionally, the presence of compounds like (S)-Lactate and (S)-Lactaldehyde, which are end products of propanoate metabolism, further strengthens this conclusion."}], "target": "Propanoate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDE10A,RRM2B,IMPDH2,NUDT2,ADCY5,AK4,ENTPD4,GMPR,LACC1,PDE6H,PDE8B,AK5,PDE6B,RRM2,NT5C1B-RDH14,GUCY2D,ATIC,PDE4C,NME4,ADCY3,PDE3A,PAPSS1,PGM1 >>>\nList of compounds : <<< N-Formiminoglycine,Guanine >>>"}, {"role": "assistant", "content": "The experiment identified the Purine metabolism pathway as the primary pathway affected in the given conditions. This conclusion is supported by the alterations in several genes and compounds involved in this pathway. Genes such as IMPDH2, GMPR, NUDT2, and ATIC are directly involved in the synthesis and breakdown of purine nucleotides, which are the building blocks of DNA and RNA. The alteration in PDE10A, PDE6H, PDE8B, and PDE4C, which are phosphodiesterases that break down cyclic nucleotides derived from purines, further supports this. The presence of Guanine, a purine base, among the altered compounds, further strengthens this conclusion. The involvement of N-Formiminoglycine, a compound involved in one-carbon metabolism, may suggest a link between these two pathways in this specific condition."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G6,PLPP2,CHPT1,PLA2G12A,PAFAH1B3,PLB1,PLD1,PLD4,PLA2G2C,PLA2G4D,LPCAT2,PAFAH1B1,CEPT1,PLA2G10,SELENOI,PLA2G7,PLA2G5,GDPD3,PLA2G4C,PLAAT3,AGPS,PLA2G2E >>>\nList of compounds : <<< Plasmenylcholine,1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine,Galactosyl-1-alkyl-2-acylglycerol,1-Alkyl-sn-glycerol,1-Alkyl-2-acylglycerophosphoethanolamine,1-(1-Alkenyl)-sn-glycerol,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Ether lipid metabolism. This conclusion is supported by the altered genes and compounds observed. The genes list includes several phospholipases (PLA2G6, PLA2G12A, PLA2G2C, PLA2G4D, PLA2G2E, PLA2G5, PLA2G7), which are involved in the breakdown of phospholipids, a key step in ether lipid metabolism. Additionally, several genes related to ether lipid synthesis and remodeling are present, such as LPCAT2, AGPS, and GDPD3. The compound list further supports this finding, as all the listed compounds are intermediates or products of the ether lipid metabolism pathway. These include Plasmenylcholine, 1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine, and 2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate, which are all ether lipids. Therefore, the data suggest that alterations in the Ether lipid metabolism pathway are likely associated with the observed condition."}], "target": "Ether lipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDHB,GCSH,LIAS,,LIPT2,DLAT,BCKDHA,ACSM1,PDHA1,BCKDHB,OGDHL,AMT,DHTKD1,DLD,DBT,DLST,GLDC >>>\nList of compounds : <<< Enzyme N6-(lipoyl)lysine,2-(alpha-Hydroxyethyl)thiamine diphosphate,Thiamin diphosphate,[Dihydrolipoyllysine-residue succinyltransferase] S-glutaryldihydrolipoyllysine,2-Methyl-1-hydroxybutyl-ThPP,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine,Glutaryl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Lipoic Acid Metabolism. This pathway was indicated by the alterations in several genes including PDHB, GCSH, LIAS, LIPT2, DLAT, BCKDHA, BCKDHB, DLD, DBT, and DLST. These genes encode enzymes involved in the synthesis, recycling, and utilization of lipoic acid, a cofactor essential for the function of several multienzyme complexes in this pathway.\n\nThe list of compounds further supports this finding. These include Enzyme N6-(lipoyl)lysine, 2-(alpha-Hydroxyethyl)thiamine diphosphate, Thiamin diphosphate, and various intermediate compounds of the lipoic acid metabolism such as Glutaryl-CoA. The presence of these compounds suggests active metabolic processes in the Lipoic Acid Metabolism pathway. Therefore, the observed alterations in the genes and compounds are consistent with the involvement of the Lipoic Acid Metabolism pathway in the specific condition under study."}], "target": "Lipoic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< UGP2,UGT1A10,UGT1A8,UGT1A7,UGT2B15,UGT2B4 >>>\nList of compounds : <<< L-Galactonate,Glycerol,(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate,UDP-glucose,D-Xylulose,L-Xylulose,L-Gulonate,D-Ribulose 1-phosphate,4-Deoxy-L-erythro-hex-4-enopyranuronate,L-Xylulose 5-phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is \"Pentose and glucuronate interconversions.\" This pathway was implicated due to the alterations observed in several genes and compounds associated with it. The genes UGP2, UGT1A10, UGT1A8, UGT1A7, UGT2B15, and UGT2B4 are all involved in glucuronidation, a process in which UDP-glucose is converted to UDP-glucuronate, a key step in this pathway. The altered compounds, including UDP-glucose, L-Galactonate, L-Gulonate, D-Ribulose 1-phosphate, and L-Xylulose 5-phosphate, are direct intermediates or byproducts of this pathway. These findings suggest that the \"Pentose and glucuronate interconversions\" pathway is significantly affected in the compared conditions."}], "target": "Pentose and glucuronate interconversions"}
{"messages": [{"role": "user", "content": "List of genes : <<< FGGY,UGT1A3,UGT2B15,XYLB,UGT1A1,UGT1A8,UGT2B17,DCXR,AKR1B1 >>>\nList of compounds : <<< L-Gulonate,Glycerone phosphate,L-Xylulose,4-Deoxy-L-erythro-hex-4-enopyranuronate,D-Mannonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Pentose and glucuronate interconversions. This pathway was inferred based on the altered genes and compounds. Genes such as XYLB, which encodes for xylose isomerase involved in the pentose phosphate pathway, and FGGY, which encodes for fructose-1,6-bisphosphatase, were found to be altered. Additionally, DCXR, encoding for D-arabino-1,4-lactone oxidase, and AKR1B1, encoding for aldo-keto reductase family 1 member B1, both involved in glucuronate metabolism, were altered. The compounds L-Xylulose, a pentose sugar, L-Gulonate, a precursor to ascorbic acid in the pentose pathway, D-Mannonate, a product of glucuronate metabolism, and Glycerone phosphate, a intermediate in both glycolysis and pentose phosphate pathway, were also found to be altered. These findings suggest a significant role for the Pentose and glucuronate interconversions pathway in the observed condition."}], "target": "Pentose and glucuronate interconversions"}
{"messages": [{"role": "user", "content": "List of genes : <<< NT5C,NADK2,NT5DC4,ENPP1,SIRT7,NT5C2,NADSYN1,NT5C1B,SIRT6,QPRT,NMNAT2,NAPRT,NMRK2,NT5C1B-RDH14,SIRT2,SIRT3,NT5E,NT5M,PNP,NAMPT >>>\nList of compounds : <<< L-Aspartate,Methylitaconate,NAD+,6-Oxo-1,4,5,6-tetrahydronicotinate,Pseudooxynicotine,2,6-Dihydroxy-N-methylmyosmine,2,3,6-Trihydroxypyridine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Nicotinate and Nicotinamide metabolism. This pathway was implicated due to the alterations observed in multiple genes directly involved in this pathway, including NADSYN1, NAPRT, NMNAT2, NAMPT, and NT5C/NT5M family genes. These genes are crucial for the synthesis, salvage, and degradation of nicotinamide adenine dinucleotide (NAD+) and its phosphorylated forms. The altered compounds, such as NAD+, 6-Oxo-1,4,5,6-tetrahydronicotinate, and 2,3,6-Trihydroxypyridine, are intermediates or products of this pathway, further supporting this identification. The Nicotinate and Nicotinamide metabolism pathway plays a vital role in energy metabolism and cellular signaling, and its dysregulation can contribute to various conditions."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DPYS,BCAT1,ALDH1B1,ENPP3,PPCS,UPB1,VNN1,AASDHPPT,ALDH3A2,PANK1,COASY,PPCDC >>>\nList of compounds : <<< (R)-Pantoate,Acyl-carrier protein,5,6-Dihydrouracil >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Pantothenate and CoA biosynthesis pathway. This pathway was implicated due to the alterations in several genes directly involved in its regulation. These genes include PANK1, which encodes pantothenate kinase 1 responsible for the first step in CoA biosynthesis, COASY, which encodes CoA synthase involved in the last step of CoA biosynthesis, and PPCDC, which encodes phosphopantothenoylcysteine decarboxylase, another key enzyme in this pathway. The alteration in the levels of (R)-Pantoate, a precursor in CoA biosynthesis, and Acyl-carrier protein, a protein that carries the growing fatty acid chain during fatty acid biosynthesis which requires CoA, further supports the involvement of this pathway. The altered genes and compounds suggest a potential disruption in the Pantothenate and CoA biosynthesis pathway, which could impact various cellular processes dependent on CoA, such as fatty acid synthesis and energy production."}], "target": "Pantothenate and CoA biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< DAO,DGLUCY,SRR,GLS2,GLS,DDO >>>\nList of compounds : <<< O-D-Alanyl-poly(ribitol phosphate),D-Lysine,Glycine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the D-Amino acid metabolism. This pathway was implicated due to the alterations observed in several genes and compounds associated with D-amino acid metabolism. The genes DAO (D-amino acid oxidase), DGLUCY (D-glucosamine 3-kinase), and DDO (D-aspartate oxidase) are directly involved in the metabolism of D-amino acids. The presence of O-D-Alanyl-poly(ribitol phosphate), a compound containing a D-amino acid, further supports this finding. The alterations in GLS2, GLS, and the compound D-Lysine, although primarily associated with L-amino acid metabolism, may indicate a crosstalk or regulatory role between D- and L-amino acid metabolism in the observed condition. The presence of Glycine, a common intermediate in various metabolic pathways, could suggest potential effects on other pathways as well."}], "target": "D-Amino acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ICMT,FDPS,FNTB,CHURC1-FNTB,HMGCS2,ZMPSTE24,PDSS2,PCYOX1,DHDDS,MVK,HMGCS1,HMGCR,MVD >>>\nList of compounds : <<< all-trans-Decaprenyl diphosphate,2-trans,6-trans-Farnesal,(R)-Mevalonate 3-phosphate,Acetoacetyl-CoA,(R)-Mevalonate 3,5-bisphosphate,(2E,6E)-Farnesol >>>"}, {"role": "assistant", "content": "The experiment identified the Terpenoid backbone biosynthesis pathway as the primary metabolic pathway affected by the observed changes. This pathway is involved in the synthesis of isoprenoids, a large and diverse class of compounds that includes sterols, carotenoids, and terpenes. The alterations in genes such as ICMT, FDPS, HMGCS1, HMGCR, and MVD, which are known to play key roles in this pathway, support this finding. The changes in compounds such as (R)-Mevalonate 3-phosphate, (R)-Mevalonate 3,5-bisphosphate, and (2E,6E)-Farnesol, which are intermediates in this pathway, further reinforce this conclusion. The alteration in Acetoacetyl-CoA, a precursor to the mevalonate pathway, also suggests a disturbance in this pathway. Therefore, the data suggest that the Terpenoid backbone biosynthesis pathway is significantly affected in the condition under study."}], "target": "Terpenoid backbone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ENPP1,NT5C1B-RDH14,NT5C1A,NNT,PNP,SIRT1,NT5M,SIRT2,SIRT7,NUDT13,NAPRT,NT5E,NADK,SIRT3,NADSYN1,NMRK1,NT5C1B,NMNAT3,AOX1,NMNAT2,NT5C,BST1,QPRT,NUDT12 >>>\nList of compounds : <<< 2,6-Dihydroxy-N-methylmyosmine,2,3-Dimethylmaleate,Propanoate,6-Hydroxynicotinate,Pyruvate,2,6-Dihydroxypseudooxynicotine,(2R,3S)-2,3-Dimethylmalate,Methylitaconate,Pseudooxynicotine,N-Formylmaleamic acid,Maleic acid,Maleamate,Nicotinate,Succinate semialdehyde,1-Methylnicotinamide,2,5-Dihydroxypyridine,6-Hydroxy-3-succinoylpyridine,2-Formylglutarate,1-Methylpyrrolinium,Nicotinurate,(S)-2-(Hydroxymethyl)glutarate,3-Succinoylpyridine,Iminoaspartate,N1-Methyl-4-pyridone-5-carboxamide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Nicotinate and Nicotinamide Metabolism. This pathway is involved in the synthesis, breakdown, and salvage of nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular metabolism. The altered genes, including NT5C1B, NT5C1A, PNP, NUDT13, NAPRT, NT5E, NADK, NADSYN1, and NMNAT2, are all directly involved in this pathway, contributing to the synthesis, degradation, and recycling of NAD+. The altered compounds, such as Nicotinate, Nicotinurate, 6-Hydroxynicotinate, and 1-Methylnicotinamide, are intermediates or products of this pathway. Therefore, the changes in these genes and compounds suggest that the Nicotinate and Nicotinamide Metabolism pathway is significantly affected in the given condition."}], "target": "Nicotinate and nicotinamide metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACADVL,ELOVL7,EHHADH,ECHS1,PPT1,ACADS,SCD5 >>>\nList of compounds : <<< Arachidonyl-CoA,(S)-Hydroxydecanoyl-CoA,(3R)-3-Hydroxyoctanoyl-[acyl-carrier protein],trans-Oct-2-enoyl-[acp],Hexadecanoic acid,Tetradecanoyl-CoA,(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA,8,11,14-Eicosatrienoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is fatty acid metabolism, which is supported by the alterations in the genes and compounds. The genes ACADVL, ELOVL7, EHHADH, ECHS1, ACADS, and SCD5 are all involved in various aspects of fatty acid metabolism. ACADVL and ACADS are involved in the beta-oxidation of fatty acids, ELOVL7 is involved in the elongation of very long chain fatty acids, EHHADH is involved in the oxidation of medium and short chain fatty acids, ECHS1 is involved in the last step of the beta-oxidation of fatty acids, and SCD5 is involved in the biosynthesis of monounsaturated fatty acids. The altered compounds, such as Arachidonyl-CoA, (S)-Hydroxydecanoyl-CoA, and (2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA, are all intermediates or products of fatty acid metabolism. Therefore, the alterations in these genes and compounds suggest that the fatty acid metabolism pathway is involved in the specific condition being studied."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< GALNT13,GALNT14,GALNT10,GALNT12 >>>\nList of compounds : <<< Sialyl-Tn antigen,Tn antigen,UDP-N-acetyl-D-galactosamine,T antigen >>>"}, {"role": "assistant", "content": "The experiment identified the Mucin type O-glycan biosynthesis pathway as being significantly altered in the two conditions compared. This conclusion is supported by the changes observed in both the genes and compounds associated with this pathway. The genes GALNT13, GALNT14, GALNT10, and GALNT12 are all involved in the initiation of O-glycan biosynthesis by adding N-acetylgalactosamine (GalNAc) to serine or threonine residues on proteins. The alterations in these genes could disrupt this initial step. Furthermore, the changes in the levels of Sialyl-Tn antigen, Tn antigen, UDP-N-acetyl-D-galactosamine, and T antigen, which are intermediate products or end products of this pathway, further validate the involvement of the Mucin type O-glycan biosynthesis pathway in the observed condition."}], "target": "Mucin type O-glycan biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< HACD1,FASN,ECHS1,ELOVL4,ELOVL2,HADHA,ACSF3,ACSL3,ACACA,TECR,ACADL,EHHADH,ACAT2,CPT1B,ACAA1,HSD17B8,SCP2,ACSL6,ACADSB,FADS2 >>>\nList of compounds : <<< Oleoyl-[acyl-carrier protein],Acetyl-CoA,(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA,(5Z,8Z,11Z)-Icosatrienoyl-CoA,Hexadecanoyl-[acp],Montanoyl-CoA,Hexadecanoic acid,Lauroyl-CoA,Tetracosanoyl-CoA,Docosanoyl-CoA,(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA,3-Oxooctanoyl-CoA,(3R)-3-Hydroxybutanoyl-[acyl-carrier protein],3-Oxohexanoyl-[acp],(11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway that was identified in this experiment is the Fatty Acid Metabolism pathway. This is evidenced by the alterations in multiple genes involved in various stages of fatty acid synthesis, elongation, and oxidation. These include genes such as HACD1, FASN (fatty acid synthase), ELOVL4, ELOVL2 (elongation of very long chain fatty acids), HADHA (hydroxyacyl-CoA dehydrogenase), ACACA (acetyl-CoA carboxylase), ACADL (acyl-CoA dehydrogenase), and ACAT2 (acetyl-CoA acetyltransferase). The changes in compounds such as Acetyl-CoA, Oleoyl-[acyl-carrier protein], and various long-chain acyl-CoAs further support this finding. Overall, the data suggest that the Fatty Acid Metabolism pathway is significantly affected in the given condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACACB,ACSS1,ACSS2,HIBCH,BCKDHA,MCEE,ECHS1,ACOX3,SUCLA2 >>>\nList of compounds : <<< Methylglyoxal,Succinate,Enzyme N6-(lipoyl)lysine,(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate,Lactoyl-CoA,(S)-Lactaldehyde,Succinyl-CoA,Glycerone phosphate,Propynoate,2-Methyl-trans-aconitate,Propanoyl-CoA,Acetyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Propanoate metabolism. This pathway was implicated due to the alterations in several key genes and compounds. The genes ACACB, ACSS1, and ACSS2 are involved in the production of Acetyl-CoA, a crucial compound in Propanoate metabolism. The presence of Propionyl-CoA and 2-Methyl-trans-aconitate further supports this, as they are intermediate compounds in this pathway. The alteration in BCKDHA, a gene involved in branched-chain amino acid degradation, which can lead to Propanoate production, also supports this finding. The identification of Methylglyoxal, Succinate, and Succinyl-CoA, which are connected to the Propanoate metabolism via other pathways, further strengthens the conclusion. Therefore, based on these gene and compound alterations, it can be inferred that the Propanoate metabolism pathway is involved in the observed condition."}], "target": "Propanoate metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< SCP2,CPT1A,ECHS1,OXSM,ELOVL6,FADS1,HTD2,ACSL5,HADHA,CPT1B,MECR,ACSBG1,ACSL6,ELOVL2,HACD2,ACAA1,ELOVL7,ACOX3,HADH,CPT2 >>>\nList of compounds : <<< 3-Oxohexanoyl-CoA,(3R)-3-Hydroxybutanoyl-[acyl-carrier protein],(7Z,10Z,13Z)-Docosatrienoyl-CoA,(13Z,16Z)-Docosadienoyl-CoA,(S)-Hydroxyhexanoyl-CoA,Lauroyl-CoA,Acetyl-[acyl-carrier protein] >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Fatty Acid Metabolism. This pathway involves the synthesis and breakdown of fatty acids, a process crucial for energy production and cellular membrane structure. The altered genes, including SCP2, CPT1A, ELOVL6, FADS1, ACSL5, HADHA, CPT1B, MECR, ACSBG1, ACSL6, HACD2, ACAA1, ACOX3, and HADH, are all directly involved in fatty acid metabolism. For instance, CPT1A and CPT1B are key enzymes in fatty acid oxidation, while ELOVL6 and FADS1 are involved in fatty acid elongation and desaturation. The altered compounds, such as 3-Oxohexanoyl-CoA, (3R)-3-Hydroxybutanoyl-[acyl-carrier protein], and Lauroyl-CoA, are intermediates in fatty acid metabolism, providing further evidence for the involvement of this pathway. Therefore, the data suggest that alterations in Fatty Acid Metabolism may be a significant factor in the observed conditions."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CA1,GLUD1,CA9,CA6,CA14,CA5A,CPS1,CA8,CA12,CA4,CA7,CA2,GLUL,GLUD2,CA13 >>>\nList of compounds : <<< Nitrous oxide,Nitrogen,Nitric oxide,Hydroxylamine,Nitrite,Formate,Carbamoyl phosphate,Oxygen,Hydrazine,Nitrate,HCO3-,Nitrite,Nitrogen,Nitroalkane,Formamide,Nitrous oxide,Nitrite,Ammonia >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is Nitrogen Metabolism. This conclusion is supported by the alterations in genes and compounds related to this pathway. Several genes involved in this pathway were found to be altered, including CA1, GLUD1, CPS1, GLUL, and GLUD2. Carbonic anhydrases (CA), such as CA1, CA9, CA6, CA14, CA5A, CA8, CA12, CA4, CA7, and CA13, play a role in pH regulation and CO2/bicarbonate interconversion, which are closely linked with nitrogen metabolism. Moreover, CPS1 is a key enzyme in the urea cycle, a part of nitrogen metabolism. The altered compounds, such as Nitrous oxide, Nitric oxide, Nitrite, Ammonia, Carbamoyl phosphate, and HCO3-, are also directly involved in nitrogen metabolism. Therefore, the evidence suggests that the Nitrogen Metabolism pathway is significantly impacted in the observed conditions."}], "target": "Nitrogen metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ELOVL3,ACOT1,ELOVL1,HACD1 >>>\nList of compounds : <<< Decanoyl-CoA,Long-chain acyl-CoA,Very-long-chain 3-oxoacyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the Fatty acid elongation pathway. This pathway involves the elongation of fatty acid chains, typically from C16 to C24 or longer, via the sequential addition of two-carbon units. The identification of this pathway is supported by the alterations observed in the genes and compounds. The genes ELOVL3, ELOVL1, and HACD1 are directly involved in the fatty acid elongation process. ELOVL3 and ELOVL1 are elongases that catalyze the addition of two carbons to very long-chain fatty acids, while HACD1 is involved in the elongation of very long-chain fatty acids. The presence of Decanoyl-CoA, Long-chain acyl-CoA, and Very-long-chain 3-oxoacyl-CoA further supports this, as these are intermediates in the fatty acid elongation process. Therefore, the observed alterations in these genes and compounds suggest a significant role of the fatty acid elongation pathway in the condition under study."}], "target": "Fatty acid elongation"}
{"messages": [{"role": "user", "content": "List of genes : <<< DCK,NT5C1B,UCKL1,NME2,AK9,DHODH,DCTD,UCK1,TYMS,ENTPD8,ENPP1 >>>\nList of compounds : <<< 3-Oxopropanoate,5,6-Dihydrouracil,2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate,Deoxycytidine,dTMP,Pseudouridine,Thymidine,Ureidoacrylate,UDP,CTP,N-Carbamoyl-L-aspartate,Malonate,UTP,CMP,DNA,Methylmalonate,(S)-Dihydroorotate,dCDP,3-Ureidopropionate,dCTP,beta-Alanine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is Pyrimidine metabolism. This conclusion is supported by the altered genes and compounds involved in the pathway. Genes such as DCK, NT5C1B, UCKL1, NME2, DHODH, DCTD, UCK1, TYMS, ENTPD8, and ENPP1 are all implicated in pyrimidine metabolism. DCK, NT5C1B, UCKL1, and UCK1 are involved in pyrimidine nucleotide metabolism, DHODH and DCTD in pyrimidine deoxyribonucleotide biosynthesis, TYMS in thymidylate synthesis, and ENTPD8 and ENPP1 in pyrimidine nucleoside phosphorylation. The altered compounds, including 3-Oxopropanoate, 5,6-Dihydrouracil, 2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate, Deoxycytidine, dTMP, Pseudouridine, Thymidine, Ureidoacrylate, UDP, CTP, N-Carbamoyl-L-aspartate, Malonate, UTP, CMP, DNA, Methylmalonate, (S)-Dihydroorotate, dCDP, 3-Ureidopropionate, dCTP, and beta-Alanine, are intermediates or products of the pyrimidine metabolism pathway. Therefore, the changes in these genes and compounds suggest that the Pyrimidine metabolism pathway is significantly affected in the specific condition under investigation."}], "target": "Pyrimidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< DHFR2,FTCD,AMT,MTHFD2,ATIC,MTR,MTFMT >>>\nList of compounds : <<< Folate,5,10-Methenyltetrahydrofolate,Dihydrofolate,10-Formyltetrahydrofolate,5-Formiminotetrahydrofolate,Tetrahydrofolate,5,10-Methylenetetrahydrofolate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the One Carbon Pool by Folate pathway. This pathway was inferred from the alterations in genes and compounds associated with folate metabolism. The genes DHFR2, FTCD, AMT, MTHFD2, ATIC, MTR, and MTFMT are all involved in this pathway. DHFR2 and MTHFD2 are involved in folate biosynthesis and interconversion, while FTCD, AMT, ATIC, MTR, and MTFMT participate in the transfer of one-carbon units. The altered compounds, including Folate, 5,10-Methenyltetrahydrofolate, Dihydrofolate, 10-Formyltetrahydrofolate, 5-Formiminotetrahydrofolate, Tetrahydrofolate, and 5,10-Methylenetetrahydrofolate, are all intermediates in this pathway. These findings suggest that the One Carbon Pool by Folate pathway is significantly impacted in the given condition."}], "target": "One carbon pool by folate"}
{"messages": [{"role": "user", "content": "List of genes : <<< PAPSS1,BPNT1,SUOX,MPST,SELENBP1 >>>\nList of compounds : <<< Sulfate,Polysulfide,Methanesulfonic acid,Dimethyl sulfoxide,Sulfate,Thiosulfate,Sulfate,Tetrathionate,L-Homoserine,Sulfate,L-Serine,3-(Methylthio)propanoate,Sulfite,Sulfate,Succinate,Polysulfide,Adenosine 3',5'-bisphosphate,Taurine >>>"}, {"role": "assistant", "content": "The experiment comparing two conditions identified the Sulfur metabolism pathway as the main pathway involved. This is supported by the alterations observed in several genes and compounds associated with this pathway. The genes PAPSS1, BPNT1, SUOX, MPST, and SELENBP1 are all involved in sulfur metabolism. PAPSS1 and BPNT1 are involved in sulfate activation, SUOX in sulfite oxidation, MPST in methionine salvage, and SELENBP1 in selenium metabolism, which is closely related to sulfur. The compounds Sulfate, Polysulfide, Methanesulfonic acid, Dimethyl sulfoxide, Thiosulfate, Tetrathionate, L-Homoserine, L-Serine, 3-(Methylthio)propanoate, Sulfite, Taurine, and Adenosine 3',5'-bisphosphate are all intermediates or products of sulfur metabolism. Therefore, the alterations in these genes and compounds strongly suggest that the Sulfur metabolism pathway is significantly affected in the condition under study."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACAA1,PLAAT3,PLA2G1B,ACOX1,PLA2G4D,PLA2G12A,PLA2G3,PLA2G2D,PLA2G4C,PLB1,PLA2G5,PLA2G4A,PLA2G10,PLA2G4E,ACOX3,JMJD7-PLA2G4B,PLA2G4F,PLA2G6 >>>\nList of compounds : <<< 3-Hexenol,3-Oxo-OPC4-CoA,(3Z)-Hex-3-en-1-yl acetate,Phosphatidylcholine,OPC4-CoA,12-Oxo-9(Z)-dodecenoic acid,Colnelenic acid,3-Oxo-OPC8-CoA,(+)-7-Isomethyljasmonate,13(S)-HOT,OPC8-CoA,2(R)-HPOT,Heptadecatrienal,9-Hydroxy-12-oxo-10(E),15(Z)-octadecadienoic acid >>>"}, {"role": "assistant", "content": "The alpha-linolenic acid metabolism pathway was identified as the primary pathway involved in the specific condition. This is supported by the alteration of multiple genes associated with this pathway, including ACOX1, ACOX3, and JMJD7-PLA2G4B, which are involved in the oxidation of fatty acids, a key step in alpha-linolenic acid metabolism. Additionally, several phospholipase A2 (PLA2) genes were altered, which are known to catalyze the hydrolysis of phosphatidylcholine, a compound found to be altered in the experiment. The presence of various intermediates and products of alpha-linolenic acid metabolism, such as OPC4-CoA, OPC8-CoA, and 12-Oxo-9(Z)-dodecenoic acid, further supports the involvement of this pathway."}], "target": "alpha-Linolenic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< EHHADH,ELOVL6,FADS2,HSD17B8,ELOVL4,HADHB,ACADL,ACOX1,HACD1,ACSL5,ACAT1,HSD17B4,HTD2,ACSBG1,PPT1,ACSL3,ACSL1,ACADM,ACOX3,MECR,HACD2,ECHS1,ACADS,ACSL6 >>>\nList of compounds : <<< Docosanoyl-CoA,(11Z,14Z)-Icosadienoyl-CoA,Acetyl-[acyl-carrier protein],(3R)-3-Hydroxydecanoyl-[acyl-carrier protein],(3R)-3-Hydroxyoctadecanoyl-[acyl-carrier protein],Crotonoyl-CoA,(2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA,(13Z,16Z)-Docosadienoyl-CoA,Docosenoyl-CoA,L-Palmitoylcarnitine,(3R,6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexaenoyl-CoA,Ximenoyl-CoA,(S)-Hydroxydecanoyl-CoA,Butanoyl-CoA,Palmitoyl-CoA,Lauroyl-CoA,Tetradecanoyl-[acp],alpha-Linolenoyl-ACP,(8Z,11Z,14Z,17Z)-Icosatetraenoyl-CoA,Icosenoyl-CoA,(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA,3-Oxotetradecanoyl-CoA,trans-Dec-2-enoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the given data is fatty acid metabolism. This pathway was implicated due to the alterations in several genes and compounds associated with this process. The genes EHHADH, ELOVL6, FADS2, HSD17B8, ELOVL4, HADHB, ACADL, ACOX1, HACD1, ACSL5, ACAT1, HSD17B4, HTD2, ACSBG1, ACSL3, ACSL1, ACADM, ACOX3, MECR, HACD2, ECHS1, ACADS, and ACSL6 are all involved in various aspects of fatty acid synthesis, elongation, desaturation, oxidation, and transport. Similarly, the compounds listed, such as Docosanoyl-CoA, (11Z,14Z)-Icosadienoyl-CoA, and Palmitoyl-CoA, are intermediates or products of fatty acid metabolism. Therefore, the changes observed in these genes and compounds suggest a significant role for the fatty acid metabolism pathway in the given condition."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< HADHB,ALDH9A1,ALDH3A2,ACAD8,BCAT1,BCKDHA,HMGCS2,ALDH7A1,HIBCH,AUH,ACAA1,DLD,ABAT >>>\nList of compounds : <<< [Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine,(S)-3-Hydroxy-3-methylglutaryl-CoA,3-Methyl-1-hydroxybutyl-ThPP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Valine, Leucine and Isoleucine Degradation pathway. This pathway was implicated due to the alterations in the genes and compounds involved. The genes HADHB, ALDH9A1, ALDH3A2, ACAD8, BCKDHA, HIBCH, and ACAA1 are all known to play roles in the degradation of branched-chain amino acids, including valine, leucine, and isoleucine. The altered compounds, such as S-(2-methylbutanoyl)dihydrolipoyllysine and (S)-3-Hydroxy-3-methylglutaryl-CoA, are intermediates in this pathway. The presence of 3-Methyl-1-hydroxybutyl-ThPP, a product of valine degradation, further supports this identification. Therefore, the data suggests that the Valine, Leucine and Isoleucine Degradation pathway is significantly affected in the given condition."}], "target": "Valine, leucine and isoleucine degradation"}
{"messages": [{"role": "user", "content": "List of genes : <<< PLA2G2E,PLA2G12B,PLA2G3,PLA2G2D,PLA2G4C,PLAAT2,PLAAT3,PLA2G12A,FADS2,ACOX1,PLA2G1B,PLA2G2A,PLA2G6,PLA2G4E,ACOX3,ACAA1 >>>\nList of compounds : <<< 17-Hydroxylinolenic acid,9(S)-HOT,3-Oxo-OPC4-CoA,Volicitin,10-OPDA,9-Hydroxy-12-oxo-15(Z)-octadecenoic acid,OPC6-CoA,3-Hexenal,9-Hydroxy-12-oxo-10(E),15(Z)-octadecadienoic acid >>>"}, {"role": "assistant", "content": "The alpha-linolenic acid metabolism pathway was identified in the experiment. This pathway was implicated due to the alterations in numerous genes involved in the metabolism of alpha-linolenic acid. These include phospholipases (PLA2G2E, PLA2G12B, PLA2G3, PLA2G2D, PLA2G4C, PLA2G12A, PLA2G1B, PLA2G2A, PLA2G6, PLA2G4E), fatty acid desaturase (FADS2), and peroxisomal acyl-coenzyme A oxidases (ACOX1, ACOX3). The changes in these genes suggest an altered breakdown of alpha-linolenic acid. Furthermore, the altered compounds, such as 17-Hydroxylinolenic acid, 9(S)-HOT, 10-OPDA, and OPC6-CoA, are intermediates in the alpha-linolenic acid metabolism pathway, providing additional evidence for its involvement. These findings suggest that the specific condition being studied may be related to disruptions in the metabolism of alpha-linolenic acid."}], "target": "alpha-Linolenic acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CEL,SOAT2,LSS,CYP27B1,SC5D,LIPA,HSD17B7,TM7SF2,FDFT1,LBR,SQLE,NSDHL,SOAT1,DHCR24,CYP2R1,DHCR7,EBP,MSMO1 >>>\nList of compounds : <<< Ergosta-5,7,22,24(28)-tetraen-3beta-ol,Desmosterol,Obtusifoliol >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Steroid biosynthesis. This pathway was indicated by the alterations in the genes and compounds involved. The genes CEL, SOAT2, LSS, CYP27B1, SC5D, LIPA, HSD17B7, TM7SF2, FDFT1, LBR, SQLE, NSDHL, SOAT1, DHCR24, CYP2R1, DHCR7, and EBP are all associated with steroid biosynthesis. These genes encode enzymes that catalyze various steps in the conversion of lanosterol to cholesterol and other steroid hormones. The altered compounds Ergosta-5,7,22,24(28)-tetraen-3beta-ol, Desmosterol, and Obtusifoliol are intermediates in the steroid biosynthesis pathway, further supporting this identification. Therefore, the data suggests that the Steroid biosynthesis pathway is implicated in the observed condition."}], "target": "Steroid biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< ENPP3,NT5C,ENTPD1,NUDT2,RRM2B,ENTPD6,CDA,NT5E,NT5C2,UPB1 >>>\nList of compounds : <<< CDP,Uridine,UDP,5,6-Dihydrouracil,dTMP >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is Pyrimidine metabolism. This pathway was found to be involved based on the alterations in the genes ENPP3, NT5C, ENTPD1, NUDT2, RRM2B, ENTPD6, CDA, NT5E, NT5C2, and UPB1, all of which are associated with pyrimidine metabolism. Additionally, changes were observed in several pyrimidine-related compounds such as CDP, Uridine, UDP, 5,6-Dihydrouracil, and dTMP. These gene and compound alterations suggest modifications in the synthesis, degradation, and salvage of pyrimidine nucleotides, which are crucial for DNA and RNA synthesis. Therefore, the Pyrimidine metabolism pathway appears to be implicated in the observed condition."}], "target": "Pyrimidine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< RENBP,GALK2,CYB5RL,PMM1,HK3,UGP2,GNE,PGM3,,NPL,UAP1L1,NANP,GALK1,GALE,CMAS,HEXB,HK1 >>>\nList of compounds : <<< CDP-4-dehydro-3,6-dideoxy-D-glucose,UDP-L-Ara4FN,Chitosan,alpha-D-Galactosamine 1-phosphate,1,6-Anhydro-N-acetyl-beta-muramate,D-Glucosamine,UDP-alpha-D-galactose,GDP-4-acetamido-4,6-dideoxy-alpha-D-mannose,UDP-N-acetyl-D-galactosamine,UDP-D-xylose,D-Mannose 6-phosphate,UDP-L-rhamnose,UDP-L-arabinofuranose,alpha-D-Glucosamine 1-phosphate,D-Mannose 6-phosphate,UDP-alpha-D-galactofuranose,UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate,UDP-N,N'-diacetylbacillosamine,CDP-3,6-dideoxy-D-mannose,alpha-D-Galactose 1-phosphate,D-Glucosamine,GDP-4-dehydro-6-deoxy-D-mannose,GDP-glucose,CMP-3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the \"Amino sugar and nucleotide sugar metabolism\" pathway. This conclusion is supported by the alterations observed in the genes and compounds associated with this pathway. The list of genes includes several enzymes involved in the synthesis and metabolism of amino sugars and nucleotide sugars, such as GALK1, GALK2, GALE, HEXB, UAP1L1, and PGM3. Similarly, the list of compounds includes various intermediates and products of this pathway, such as UDP-N-acetyl-D-galactosamine, UDP-L-arabinofuranose, and D-Glucosamine. Therefore, the alterations in these genes and compounds suggest that the amino sugar and nucleotide sugar metabolism pathway plays a significant role in the condition being studied."}], "target": "Amino sugar and nucleotide sugar metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< MTHFD1L,SHMT1,MTHFR,MTHFS,ALDH1L2,SHMT2,ALDH1L1,MTR >>>\nList of compounds : <<< Dihydrofolate,5,10-Methylenetetrahydrofolate,Folate >>>"}, {"role": "assistant", "content": "The experiment identified the One Carbon Pool by Folate metabolic pathway as the one significantly altered in the two conditions. This pathway is involved in the transfer of one-carbon units for various biosynthetic processes. The alterations in genes such as MTHFD1L, SHMT1, MTHFR, MTHFS, ALDH1L2, SHMT2, ALDH1L1, and MTR are key indicators. These genes encode enzymes that play crucial roles in this pathway, including methylenetetrahydrofolate dehydrogenase, serine hydroxymethyltransferase, methylenetetrahydrofolate reductase, and methionine synthase. The changes in compounds like Dihydrofolate, 5,10-Methylenetetrahydrofolate, and Folate, which are essential cofactors in this pathway, further support this conclusion. Therefore, the observed alterations in genes and compounds are consistent with changes in the One Carbon Pool by Folate metabolic pathway."}], "target": "One carbon pool by folate"}
{"messages": [{"role": "user", "content": "List of genes : <<< PDSS2,CHURC1-FNTB,GGPS1 >>>\nList of compounds : <<< Isopentenyl diphosphate,all-trans-Heptaprenyl diphosphate,trans,trans-Farnesyl diphosphate,(R)-Mevalonate,2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol,S-Farnesyl protein,(R)-Mevalonate 3-phosphate,trans,octacis-Decaprenyl diphosphate,2-cis,6-cis-Farnesyl diphosphate,all-trans-Decaprenyl diphosphate,Isopentenyl phosphate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Terpenoid backbone biosynthesis pathway. This conclusion is supported by the altered genes and compounds observed. The genes PDSS2, CHURC1-FNTB, and GGPS1 are all involved in this pathway. PDSS2 encodes an enzyme in the mevalonate pathway that synthesizes isopentenyl diphosphate (IPP), a key precursor in terpenoid biosynthesis. CHURC1-FNTB is involved in the synthesis of geranylgeranyl diphosphate, which is derived from IPP and dimethylallyl diphosphate. GGPS1 encodes geranylgeranyl diphosphate synthase, further supporting the involvement of this pathway. The altered compounds, including various diphosphate intermediates, (R)-Mevalonate, and 2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol, are all directly associated with the Terpenoid backbone biosynthesis pathway. Therefore, the data suggests that this pathway is significantly impacted in the compared conditions."}], "target": "Terpenoid backbone biosynthesis"}
{"messages": [{"role": "user", "content": "List of genes : <<< DDO,SRR,GLS2,GLS >>>\nList of compounds : <<< Linatine,LL-2,6-Diaminoheptanedioate,L-Histidine,D-Threonine,2-Amino-5-oxohexanoate,L-Serine,Cadaverine,L-Phenylalanine,D-Cysteine,2-Oxoglutarate,cis-4-Hydroxy-D-proline,D-Lombricine,Phenylpyruvate,Bacitracin,5-D-Glutamyl-D-glutamyl-peptide,D-Arginine,Oxaloacetate,O-D-Alanyl-poly(ribitol phosphate),2-Oxoglutarate,N-Acetyl-D-glutamate,meso-2,6-Diaminoheptanedioate >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in the experiment is the D-Amino acid metabolism. This pathway was highlighted due to the significant alterations in various genes and compounds associated with it. The genes DDO, SRR, GLS2, and GLS were found to be altered, which are known to be involved in the metabolism of D-amino acids. Furthermore, the altered compounds, such as D-Threonine, D-Cysteine, D-Lombricine, D-Arginine, and N-Acetyl-D-glutamate, are all D-amino acids or their derivatives, providing strong evidence for the involvement of the D-Amino acid metabolism pathway in the observed condition."}], "target": "D-Amino acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< BPNT2,PAPSS1,TST >>>\nList of compounds : <<< Hydrogen sulfide,S-Sulfanylglutathione,Methanesulfonic acid,Thiosulfate,Alkanesulfonate,L-Cysteine,L-Homocysteine,Adenylyl sulfate,Methanethiol,Sulfate,Polysulfide,Sulfite,Polysulfide,Sulfate,Trithionate,Sulfate,L-Homoserine >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the sulfur metabolism pathway. This conclusion is based on the significant alterations observed in genes and compounds associated with this pathway. The genes BPNT2, PAPSS1, and TST are known to play crucial roles in sulfur metabolism. BPNT2 is involved in the synthesis of thiamine, which is crucial for sulfur metabolism. PAPSS1 is a key enzyme in the activation of sulfate for subsequent metabolic reactions. TST is involved in the catabolism of cysteine and methionine, both of which are sulfur-containing amino acids. The altered compounds, including hydrogen sulfide, S-sulfanylglutathione, methanesulfonic acid, thiosulfate, alkanesulfonate, L-cysteine, L-homocysteine, adenylyl sulfate, methanethiol, sulfate, polysulfide, sulfite, trithionate, and L-homoserine, are all intermediates or byproducts of sulfur metabolism. Therefore, the observed changes in these genes and compounds suggest that the sulfur metabolism pathway is significantly affected in the compared conditions."}], "target": "Sulfur metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< CPT2,ACSL5,ACSF3,FADS1,ELOVL7,ACAT1,FADS2,HSD17B4,SCD,PPT2,ELOVL2,SCP2,PPT1,HSD17B12,ACACA,ACOX3,ACSL1,CPT1C,ACAA2,ACADVL,CBR4,ACSL4,EHHADH,HACD2 >>>\nList of compounds : <<< trans-Hexadec-2-enoyl-CoA,Octadecanoyl-[acyl-carrier protein],trans-Oct-2-enoyl-CoA,Malonate,Oleoyl-[acyl-carrier protein],3-Oxooctanoyl-CoA,Palmitoyl-CoA,(8Z,11Z)-Icosadienoyl-CoA,trans-Oct-2-enoyl-[acp],(3R)-3-Hydroxybutanoyl-[acyl-carrier protein],3-Hydroxyoctadecanoyl-CoA,3-Oxooctanoyl-[acp],(7Z,10Z,13Z)-Docosatrienoyl-CoA,(3R)-3-Hydroxypalmitoyl-[acyl-carrier protein],(2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA,Hexanoyl-CoA,3-Oxododecanoyl-[acp],(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA,Acyl-carrier protein,(6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA,Lauroyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is fatty acid metabolism. This conclusion is supported by the alterations in genes and compounds directly involved in this pathway. The genes CPT2, ACSL5, ACSF3, FADS1, ELOVL7, ACAT1, FADS2, SCD, HSD17B4, ELOVL2, SCP2, HSD17B12, ACACA, ACOX3, ACSL1, CPT1C, ACAA2, ACADVL, and CBR4 are all associated with fatty acid synthesis, elongation, desaturation, and degradation. Similarly, the altered compounds, such as trans-Hexadec-2-enoyl-CoA, Octadecanoyl-[acyl-carrier protein], and Palmitoyl-CoA, are intermediates in fatty acid metabolism. The presence of these compounds and the alteration of genes involved in their metabolism suggest that the fatty acid metabolism pathway is significantly affected in the condition being studied."}], "target": "Fatty acid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ADPRM,ADA2,PGM2,AK6,ADCY1,PDE4C,PRUNE1,AMPD1,NME6,PFAS,NT5C1A,ADSL,GMPR2,GUCY1A1,NME2,ENTPD4,AK4,AK5,PGM1,PDE1A,PRPS1L1,PNP,ENTPD5 >>>\nList of compounds : <<< DNA,Urea,dAMP,N6-Succino-2-amino-2'-deoxyadenylate,HCO3-,Sulfate,2',3'-Cyclic AMP,dITP,Inosine 5'-tetraphosphate,5'-Benzoylphosphoadenosine,Adenylyl sulfate,Glyoxylate,dGDP,Aminoimidazole ribotide,5-Amino-4-imidazolecarboxyamide,1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate,Adenosine tetraphosphate >>>"}, {"role": "assistant", "content": "The experiment identified the Purine metabolism pathway as being significantly altered. This conclusion is supported by the observed changes in several key genes and compounds associated with this pathway. Genes such as ADPRM, ADA2, AMPD1, ADSL, NME2, and PRPS1L1 are directly involved in Purine metabolism. The altered compounds, including dAMP, dITP, dGDP, Adenylyl sulfate, Adenosine tetraphosphate, and Aminoimidazole ribotide, are intermediates or products of this pathway. The presence of compounds like N6-Succino-2-amino-2'-deoxyadenylate and 5-Amino-4-imidazolecarboxyamide, which are modified purine nucleotides, further strengthens the implication of Purine metabolism in the observed condition. Therefore, the results suggest that the condition is likely associated with dysregulation in Purine metabolism."}], "target": "Purine metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACOT1,HADHB,MECR,ACOT7,HACD1,HACD3,ELOVL3,ELOVL7,TECR,THEM4,ECHS1,ELOVL4,ELOVL2,HSD17B12,ACOT4,ACOT2,HACD2,HADH,THEM5,ELOVL5,PPT2,ACAA2,ELOVL6 >>>\nList of compounds : <<< (S)-3-Hydroxytetradecanoyl-CoA,Lauroyl-CoA,3-Oxodecanoyl-CoA,3-Oxohexanoyl-CoA,Long-chain fatty acid,(S)-Hydroxyhexanoyl-CoA,trans-Dec-2-enoyl-CoA,Tetradecanoyl-CoA,(3S)-3-Hydroxyacyl-CoA,3-Oxotetradecanoyl-CoA,(S)-3-Hydroxyhexadecanoyl-CoA,Octanoyl-CoA,Hexadecanoic acid,Acyl-CoA,Very-long-chain 3-oxoacyl-CoA,Hexanoyl-CoA,trans-2,3-Dehydroacyl-CoA,3-Oxooctanoyl-CoA,trans-Hexadec-2-enoyl-CoA >>>"}, {"role": "assistant", "content": "The metabolic pathway identified from the experiment is the Fatty Acid Elongation pathway. This conclusion is supported by the altered genes and compounds involved in the experiment. The genes such as ACOT1, HADHB, MECR, ELOVL3, ELOVL7, TECR, ECHS1, ELOVL4, ELOVL2, HSD17B12, ACOT4, ACOT2, HACD2, HADH, THEM5, ELOVL5, and ELOVL6 are all known to play crucial roles in fatty acid elongation. Similarly, the altered compounds including (S)-3-Hydroxytetradecanoyl-CoA, Lauroyl-CoA, 3-Oxodecanoyl-CoA, 3-Oxohexanoyl-CoA, Long-chain fatty acid, (S)-Hydroxyhexanoyl-CoA, trans-Dec-2-enoyl-CoA, Tetradecanoyl-CoA, (3S)-3-Hydroxyacyl-CoA, 3-Oxotetradecanoyl-CoA, (S)-3-Hydroxyhexadecanoyl-CoA, Octanoyl-CoA, Hexadecanoic acid, Acyl-CoA, Very-long-chain 3-oxoacyl-CoA, Hexanoyl-CoA, trans-2,3-Dehydroacyl-CoA, 3-Oxooctanoyl-CoA, and trans-Hexadec-2-enoyl-CoA are intermediates in the fatty acid elongation process. Therefore, the alterations in these genes and compounds suggest that the Fatty Acid Elongation pathway is involved in the specific condition under investigation."}], "target": "Fatty acid elongation"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACER2,ACER3,ASAH2,ASAH1,NEU1,CERS3,SPTLC2,DEGS2,UGCG,B4GALT6,GBA1,SGMS1,SPHK2 >>>\nList of compounds : <<< Ceramide phosphoethanolamine,GA1,Sphingosine 1-phosphate,Lactosylceramide,GA2,alpha-D-Galactosyl-(1-&gt;4)-beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(1&lt;-&gt;1)-ceramide,Sphingosyl-phosphocholine,Palmitoyl-CoA,Phytoceramide >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Sphingolipid metabolism. This conclusion is supported by the alterations observed in various genes and compounds associated with this pathway. The genes ACER2, ACER3, ASAH2, ASAH1, NEU1, CERS3, SPTLC2, DEGS2, UGCG, B4GALT6, GBA1, SGMS1, and SPHK2 are all involved in the synthesis, degradation, or regulation of sphingolipids. Similarly, the altered compounds such as Ceramide phosphoethanolamine, Glucosylceramide (GA1, GA2), Lactosylceramide, Sphingosine 1-phosphate, Sphingosyl-phosphocholine, Palmitoyl-CoA, and Phytoceramide are key intermediates or end products in the sphingolipid metabolism pathway. Therefore, the changes in these genes and compounds suggest a significant role of the sphingolipid metabolism pathway in the observed condition."}], "target": "Sphingolipid metabolism"}
{"messages": [{"role": "user", "content": "List of genes : <<< ACAA2,ELOVL6,HACD3,HADHB >>>\nList of compounds : <<< Hexanoyl-CoA,Very-long-chain trans-2,3-dehydroacyl-CoA,Palmitoyl-CoA,Fatty acid,(S)-Hydroxyhexanoyl-CoA,2-trans-Dodecenoyl-CoA,Very-long-chain (3R)-3-hydroxyacyl-CoA,Acyl-CoA,trans-2,3-Dehydroacyl-CoA,(S)-Hydroxydecanoyl-CoA,Octanoyl-CoA,trans-Tetradec-2-enoyl-CoA,trans-Dec-2-enoyl-CoA,3-Oxodecanoyl-CoA,Palmitoyl-CoA,Decanoyl-CoA,Hexadecanoic acid,Lauroyl-CoA,trans-Hex-2-enoyl-CoA,(S)-3-Hydroxytetradecanoyl-CoA,2,3-Dehydroacyl-CoA,trans-Hexadec-2-enoyl-CoA,Long-chain fatty acid >>>"}, {"role": "assistant", "content": "The metabolic pathway identified in this experiment is the Fatty Acid Elongation pathway. This conclusion is supported by the alterations observed in the genes and compounds involved in this pathway. The genes ACAA2, ELOVL6, HACD3, and HADHB are all known to play crucial roles in fatty acid elongation. ACAA2 encodes an enzyme involved in the final step of fatty acid beta-oxidation, which is closely linked to fatty acid elongation. ELOVL6 is a key enzyme in elongating very long chain fatty acids. HACD3 is involved in the elongation of very long chain fatty acids and the synthesis of sphingolipids, while HADHB encodes a subunit of the mitochondrial trifunctional protein, which is involved in both beta-oxidation and the elongation of odd-chain fatty acids. The altered compounds, including various acyl-CoAs and long-chain fatty acids, are direct intermediates or products of the fatty acid elongation process, further supporting this conclusion."}], "target": "Fatty acid elongation"}
